0000315700 fmr:C000205004Member 2025-07-31 2026-07-31 0000315700 fmr:C000205004_LG_ClassMember_9YRMember 2017-07-31 2026-07-31 0000315700 fmr:C000205004_ClassMember_AsOf_2018Member 2025-07-31 2026-07-31 0000315700 fmr:C000205004_ClassMember_AsOf_2019Member 2025-07-31 2026-07-31 0000315700 fmr:C000205004_ClassMember_AsOf_2020Member 2025-07-31 2026-07-31 0000315700 fmr:C000205004_ClassMember_AsOf_2021Member 2025-07-31 2026-07-31 0000315700 fmr:C000205004_ClassMember_AsOf_2022Member 2025-07-31 2026-07-31 0000315700 fmr:C000205004_ClassMember_AsOf_2023Member 2025-07-31 2026-07-31 0000315700 fmr:C000205004_ClassMember_AsOf_2024Member 2025-07-31 2026-07-31 0000315700 fmr:C000205004_ClassMember_AsOf_2025Member 2025-07-31 2026-07-31 0000315700 fmr:C000205004_ClassMember_AsOf_2026Member 2025-07-31 2026-07-31 0000315700 fmr:C000205004_LG_1_AdditionalIndexMember_9YRMember 2017-07-31 2026-07-31 0000315700 fmr:C000205004_1_AdditionalIndexMember_AsOf_2018Member 2025-07-31 2026-07-31 0000315700 fmr:C000205004_1_AdditionalIndexMember_AsOf_2019Member 2025-07-31 2026-07-31 0000315700 fmr:C000205004_1_AdditionalIndexMember_AsOf_2020Member 2025-07-31 2026-07-31 0000315700 fmr:C000205004_1_AdditionalIndexMember_AsOf_2021Member 2025-07-31 2026-07-31 0000315700 fmr:C000205004_1_AdditionalIndexMember_AsOf_2022Member 2025-07-31 2026-07-31 0000315700 fmr:C000205004_1_AdditionalIndexMember_AsOf_2023Member 2025-07-31 2026-07-31 0000315700 fmr:C000205004_1_AdditionalIndexMember_AsOf_2024Member 2025-07-31 2026-07-31 0000315700 fmr:C000205004_1_AdditionalIndexMember_AsOf_2025Member 2025-07-31 2026-07-31 0000315700 fmr:C000205004_1_AdditionalIndexMember_AsOf_2026Member 2025-07-31 2026-07-31 0000315700 fmr:C000205004_LG_2_AdditionalIndexMember_9YRMember 2017-07-31 2026-07-31 0000315700 fmr:C000205004_2_AdditionalIndexMember_AsOf_2018Member 2025-07-31 2026-07-31 0000315700 fmr:C000205004_2_AdditionalIndexMember_AsOf_2019Member 2025-07-31 2026-07-31 0000315700 fmr:C000205004_2_AdditionalIndexMember_AsOf_2020Member 2025-07-31 2026-07-31 0000315700 fmr:C000205004_2_AdditionalIndexMember_AsOf_2021Member 2025-07-31 2026-07-31 0000315700 fmr:C000205004_2_AdditionalIndexMember_AsOf_2022Member 2025-07-31 2026-07-31 0000315700 fmr:C000205004_2_AdditionalIndexMember_AsOf_2023Member 2025-07-31 2026-07-31 0000315700 fmr:C000205004_2_AdditionalIndexMember_AsOf_2024Member 2025-07-31 2026-07-31 0000315700 fmr:C000205004_2_AdditionalIndexMember_AsOf_2025Member 2025-07-31 2026-07-31 0000315700 fmr:C000205004_2_AdditionalIndexMember_AsOf_2026Member 2025-07-31 2026-07-31 0000315700 fmr:C000205004_NoLoadClassMember_1YRMember 2025-07-31 2026-07-31 0000315700 fmr:C000205004_NoLoadClassMember_5YRMember 2021-07-31 2026-07-31 0000315700 fmr:C000205004_NoLoadClassMember_2025-08-01_2026-07-31Member 2025-07-31 2026-07-31 0000315700 fmr:C000205004_0_AdditionalIndexMember_1YRMember 2025-07-31 2026-07-31 0000315700 fmr:C000205004_0_AdditionalIndexMember_5YRMember 2021-07-31 2026-07-31 0000315700 fmr:C000205004_0_AdditionalIndexMember_LOCMember 2025-07-31 2026-07-31 0000315700 fmr:C000205004_1_BBIndexMember_1YRMember 2025-07-31 2026-07-31 0000315700 fmr:C000205004_1_BBIndexMember_5YRMember 2021-07-31 2026-07-31 0000315700 fmr:C000205004_1_BBIndexMember_LOCMember 2025-07-31 2026-07-31 0000315700 fmr:C000205004Member 2018-10-02 2026-07-31 0000315700 fmr:C000205004Member 2026-07-31 0000315700 fmr:C000205004Member fmr:TI0Member 2026-07-31 0000315700 fmr:C000205004Member fmr:TI1Member 2026-07-31 0000315700 fmr:C000205004Member fmr:TI2Member 2026-07-31 0000315700 fmr:C000205004Member fmr:TI3Member 2026-07-31 0000315700 fmr:C000205004Member fmr:TI4Member 2026-07-31 0000315700 fmr:C000205004Member fmr:TI5Member 2026-07-31 0000315700 fmr:C000205004Member fmr:TI6Member 2026-07-31 0000315700 fmr:AACommonStocksMember fmr:C000205004Member 2026-07-31 0000315700 fmr:AAPreferredStocksMember fmr:C000205004Member 2026-07-31 0000315700 fmr:AAPreferredSecuritiesMember fmr:C000205004Member 2026-07-31 0000315700 fmr:AABondsMember fmr:C000205004Member 2026-07-31 0000315700 fmr:AAShortTermInvestmentsandNetOtherAssetsLiabilitiesMember fmr:C000205004Member 2026-07-31 0000315700 fmr:C000205004Member country:US 2026-07-31 0000315700 fmr:C000205004Member country:NL 2026-07-31 0000315700 fmr:C000205004Member country:JP 2026-07-31 0000315700 fmr:C000205004Member country:IL 2026-07-31 0000315700 fmr:C000205004Member country:TW 2026-07-31 0000315700 fmr:C000205004Member country:KR 2026-07-31 0000315700 fmr:C000205004Member country:CA 2026-07-31 0000315700 fmr:C000205004Member fmr:TH0Member 2026-07-31 0000315700 fmr:C000205004Member fmr:TH1Member 2026-07-31 0000315700 fmr:C000205004Member fmr:TH2Member 2026-07-31 0000315700 fmr:C000205004Member fmr:TH3Member 2026-07-31 0000315700 fmr:C000205004Member fmr:TH4Member 2026-07-31 0000315700 fmr:C000205004Member fmr:TH5Member 2026-07-31 0000315700 fmr:C000205004Member fmr:TH6Member 2026-07-31 0000315700 fmr:C000205004Member fmr:TH7Member 2026-07-31 0000315700 fmr:C000205004Member fmr:TH8Member 2026-07-31 0000315700 fmr:C000205004Member fmr:TH9Member 2026-07-31 0000315700 fmr:C000014552Member 2025-07-31 2026-07-31 0000315700 fmr:C000014552_LG_ClassMember_11YRMember 2015-07-31 2026-07-31 0000315700 fmr:C000014552_ClassMember_AsOf_2016Member 2025-07-31 2026-07-31 0000315700 fmr:C000014552_ClassMember_AsOf_2017Member 2025-07-31 2026-07-31 0000315700 fmr:C000014552_ClassMember_AsOf_2018Member 2025-07-31 2026-07-31 0000315700 fmr:C000014552_ClassMember_AsOf_2019Member 2025-07-31 2026-07-31 0000315700 fmr:C000014552_ClassMember_AsOf_2020Member 2025-07-31 2026-07-31 0000315700 fmr:C000014552_ClassMember_AsOf_2021Member 2025-07-31 2026-07-31 0000315700 fmr:C000014552_ClassMember_AsOf_2022Member 2025-07-31 2026-07-31 0000315700 fmr:C000014552_ClassMember_AsOf_2023Member 2025-07-31 2026-07-31 0000315700 fmr:C000014552_ClassMember_AsOf_2024Member 2025-07-31 2026-07-31 0000315700 fmr:C000014552_ClassMember_AsOf_2025Member 2025-07-31 2026-07-31 0000315700 fmr:C000014552_ClassMember_AsOf_2026Member 2025-07-31 2026-07-31 0000315700 fmr:C000014552_LG_1_AdditionalIndexMember_11YRMember 2015-07-31 2026-07-31 0000315700 fmr:C000014552_1_AdditionalIndexMember_AsOf_2016Member 2025-07-31 2026-07-31 0000315700 fmr:C000014552_1_AdditionalIndexMember_AsOf_2017Member 2025-07-31 2026-07-31 0000315700 fmr:C000014552_1_AdditionalIndexMember_AsOf_2018Member 2025-07-31 2026-07-31 0000315700 fmr:C000014552_1_AdditionalIndexMember_AsOf_2019Member 2025-07-31 2026-07-31 0000315700 fmr:C000014552_1_AdditionalIndexMember_AsOf_2020Member 2025-07-31 2026-07-31 0000315700 fmr:C000014552_1_AdditionalIndexMember_AsOf_2021Member 2025-07-31 2026-07-31 0000315700 fmr:C000014552_1_AdditionalIndexMember_AsOf_2022Member 2025-07-31 2026-07-31 0000315700 fmr:C000014552_1_AdditionalIndexMember_AsOf_2023Member 2025-07-31 2026-07-31 0000315700 fmr:C000014552_1_AdditionalIndexMember_AsOf_2024Member 2025-07-31 2026-07-31 0000315700 fmr:C000014552_1_AdditionalIndexMember_AsOf_2025Member 2025-07-31 2026-07-31 0000315700 fmr:C000014552_1_AdditionalIndexMember_AsOf_2026Member 2025-07-31 2026-07-31 0000315700 fmr:C000014552_LG_2_AdditionalIndexMember_11YRMember 2015-07-31 2026-07-31 0000315700 fmr:C000014552_2_AdditionalIndexMember_AsOf_2016Member 2025-07-31 2026-07-31 0000315700 fmr:C000014552_2_AdditionalIndexMember_AsOf_2017Member 2025-07-31 2026-07-31 0000315700 fmr:C000014552_2_AdditionalIndexMember_AsOf_2018Member 2025-07-31 2026-07-31 0000315700 fmr:C000014552_2_AdditionalIndexMember_AsOf_2019Member 2025-07-31 2026-07-31 0000315700 fmr:C000014552_2_AdditionalIndexMember_AsOf_2020Member 2025-07-31 2026-07-31 0000315700 fmr:C000014552_2_AdditionalIndexMember_AsOf_2021Member 2025-07-31 2026-07-31 0000315700 fmr:C000014552_2_AdditionalIndexMember_AsOf_2022Member 2025-07-31 2026-07-31 0000315700 fmr:C000014552_2_AdditionalIndexMember_AsOf_2023Member 2025-07-31 2026-07-31 0000315700 fmr:C000014552_2_AdditionalIndexMember_AsOf_2024Member 2025-07-31 2026-07-31 0000315700 fmr:C000014552_2_AdditionalIndexMember_AsOf_2025Member 2025-07-31 2026-07-31 0000315700 fmr:C000014552_2_AdditionalIndexMember_AsOf_2026Member 2025-07-31 2026-07-31 0000315700 fmr:C000014552_ClassMember_1YRMember 2025-07-31 2026-07-31 0000315700 fmr:C000014552_ClassMember_5YRMember 2021-07-31 2026-07-31 0000315700 fmr:C000014552_ClassMember_10YRMember 2016-07-31 2026-07-31 0000315700 fmr:C000014552_NoLoadClassMember_1YRMember 2025-07-31 2026-07-31 0000315700 fmr:C000014552_NoLoadClassMember_5YRMember 2021-07-31 2026-07-31 0000315700 fmr:C000014552_NoLoadClassMember_10YRMember 2016-07-31 2026-07-31 0000315700 fmr:C000014552_0_AdditionalIndexMember_1YRMember 2025-07-31 2026-07-31 0000315700 fmr:C000014552_0_AdditionalIndexMember_5YRMember 2021-07-31 2026-07-31 0000315700 fmr:C000014552_0_AdditionalIndexMember_10YRMember 2016-07-31 2026-07-31 0000315700 fmr:C000014552_1_BBIndexMember_1YRMember 2025-07-31 2026-07-31 0000315700 fmr:C000014552_1_BBIndexMember_5YRMember 2021-07-31 2026-07-31 0000315700 fmr:C000014552_1_BBIndexMember_10YRMember 2016-07-31 2026-07-31 0000315700 fmr:C000014552Member 2026-07-31 0000315700 fmr:C000014552Member fmr:TI0Member 2026-07-31 0000315700 fmr:C000014552Member fmr:TI1Member 2026-07-31 0000315700 fmr:C000014552Member fmr:TI2Member 2026-07-31 0000315700 fmr:C000014552Member fmr:TI3Member 2026-07-31 0000315700 fmr:C000014552Member fmr:TI4Member 2026-07-31 0000315700 fmr:C000014552Member fmr:TI5Member 2026-07-31 0000315700 fmr:C000014552Member fmr:TI6Member 2026-07-31 0000315700 fmr:AACommonStocksMember fmr:C000014552Member 2026-07-31 0000315700 fmr:AAPreferredStocksMember fmr:C000014552Member 2026-07-31 0000315700 fmr:AAPreferredSecuritiesMember fmr:C000014552Member 2026-07-31 0000315700 fmr:AABondsMember fmr:C000014552Member 2026-07-31 0000315700 fmr:AAShortTermInvestmentsandNetOtherAssetsLiabilitiesMember fmr:C000014552Member 2026-07-31 0000315700 fmr:C000014552Member country:US 2026-07-31 0000315700 fmr:C000014552Member country:NL 2026-07-31 0000315700 fmr:C000014552Member country:JP 2026-07-31 0000315700 fmr:C000014552Member country:IL 2026-07-31 0000315700 fmr:C000014552Member country:TW 2026-07-31 0000315700 fmr:C000014552Member country:KR 2026-07-31 0000315700 fmr:C000014552Member country:CA 2026-07-31 0000315700 fmr:C000014552Member fmr:TH0Member 2026-07-31 0000315700 fmr:C000014552Member fmr:TH1Member 2026-07-31 0000315700 fmr:C000014552Member fmr:TH2Member 2026-07-31 0000315700 fmr:C000014552Member fmr:TH3Member 2026-07-31 0000315700 fmr:C000014552Member fmr:TH4Member 2026-07-31 0000315700 fmr:C000014552Member fmr:TH5Member 2026-07-31 0000315700 fmr:C000014552Member fmr:TH6Member 2026-07-31 0000315700 fmr:C000014552Member fmr:TH7Member 2026-07-31 0000315700 fmr:C000014552Member fmr:TH8Member 2026-07-31 0000315700 fmr:C000014552Member fmr:TH9Member 2026-07-31 0000315700 fmr:C000014553Member 2025-07-31 2026-07-31 0000315700 fmr:C000014553_LG_ClassMember_11YRMember 2015-07-31 2026-07-31 0000315700 fmr:C000014553_ClassMember_AsOf_2016Member 2025-07-31 2026-07-31 0000315700 fmr:C000014553_ClassMember_AsOf_2017Member 2025-07-31 2026-07-31 0000315700 fmr:C000014553_ClassMember_AsOf_2018Member 2025-07-31 2026-07-31 0000315700 fmr:C000014553_ClassMember_AsOf_2019Member 2025-07-31 2026-07-31 0000315700 fmr:C000014553_ClassMember_AsOf_2020Member 2025-07-31 2026-07-31 0000315700 fmr:C000014553_ClassMember_AsOf_2021Member 2025-07-31 2026-07-31 0000315700 fmr:C000014553_ClassMember_AsOf_2022Member 2025-07-31 2026-07-31 0000315700 fmr:C000014553_ClassMember_AsOf_2023Member 2025-07-31 2026-07-31 0000315700 fmr:C000014553_ClassMember_AsOf_2024Member 2025-07-31 2026-07-31 0000315700 fmr:C000014553_ClassMember_AsOf_2025Member 2025-07-31 2026-07-31 0000315700 fmr:C000014553_ClassMember_AsOf_2026Member 2025-07-31 2026-07-31 0000315700 fmr:C000014553_LG_1_AdditionalIndexMember_11YRMember 2015-07-31 2026-07-31 0000315700 fmr:C000014553_1_AdditionalIndexMember_AsOf_2016Member 2025-07-31 2026-07-31 0000315700 fmr:C000014553_1_AdditionalIndexMember_AsOf_2017Member 2025-07-31 2026-07-31 0000315700 fmr:C000014553_1_AdditionalIndexMember_AsOf_2018Member 2025-07-31 2026-07-31 0000315700 fmr:C000014553_1_AdditionalIndexMember_AsOf_2019Member 2025-07-31 2026-07-31 0000315700 fmr:C000014553_1_AdditionalIndexMember_AsOf_2020Member 2025-07-31 2026-07-31 0000315700 fmr:C000014553_1_AdditionalIndexMember_AsOf_2021Member 2025-07-31 2026-07-31 0000315700 fmr:C000014553_1_AdditionalIndexMember_AsOf_2022Member 2025-07-31 2026-07-31 0000315700 fmr:C000014553_1_AdditionalIndexMember_AsOf_2023Member 2025-07-31 2026-07-31 0000315700 fmr:C000014553_1_AdditionalIndexMember_AsOf_2024Member 2025-07-31 2026-07-31 0000315700 fmr:C000014553_1_AdditionalIndexMember_AsOf_2025Member 2025-07-31 2026-07-31 0000315700 fmr:C000014553_1_AdditionalIndexMember_AsOf_2026Member 2025-07-31 2026-07-31 0000315700 fmr:C000014553_LG_2_AdditionalIndexMember_11YRMember 2015-07-31 2026-07-31 0000315700 fmr:C000014553_2_AdditionalIndexMember_AsOf_2016Member 2025-07-31 2026-07-31 0000315700 fmr:C000014553_2_AdditionalIndexMember_AsOf_2017Member 2025-07-31 2026-07-31 0000315700 fmr:C000014553_2_AdditionalIndexMember_AsOf_2018Member 2025-07-31 2026-07-31 0000315700 fmr:C000014553_2_AdditionalIndexMember_AsOf_2019Member 2025-07-31 2026-07-31 0000315700 fmr:C000014553_2_AdditionalIndexMember_AsOf_2020Member 2025-07-31 2026-07-31 0000315700 fmr:C000014553_2_AdditionalIndexMember_AsOf_2021Member 2025-07-31 2026-07-31 0000315700 fmr:C000014553_2_AdditionalIndexMember_AsOf_2022Member 2025-07-31 2026-07-31 0000315700 fmr:C000014553_2_AdditionalIndexMember_AsOf_2023Member 2025-07-31 2026-07-31 0000315700 fmr:C000014553_2_AdditionalIndexMember_AsOf_2024Member 2025-07-31 2026-07-31 0000315700 fmr:C000014553_2_AdditionalIndexMember_AsOf_2025Member 2025-07-31 2026-07-31 0000315700 fmr:C000014553_2_AdditionalIndexMember_AsOf_2026Member 2025-07-31 2026-07-31 0000315700 fmr:C000014553_NoLoadClassMember_1YRMember 2025-07-31 2026-07-31 0000315700 fmr:C000014553_NoLoadClassMember_5YRMember 2021-07-31 2026-07-31 0000315700 fmr:C000014553_NoLoadClassMember_10YRMember 2016-07-31 2026-07-31 0000315700 fmr:C000014553_0_AdditionalIndexMember_1YRMember 2025-07-31 2026-07-31 0000315700 fmr:C000014553_0_AdditionalIndexMember_5YRMember 2021-07-31 2026-07-31 0000315700 fmr:C000014553_0_AdditionalIndexMember_10YRMember 2016-07-31 2026-07-31 0000315700 fmr:C000014553_1_BBIndexMember_1YRMember 2025-07-31 2026-07-31 0000315700 fmr:C000014553_1_BBIndexMember_5YRMember 2021-07-31 2026-07-31 0000315700 fmr:C000014553_1_BBIndexMember_10YRMember 2016-07-31 2026-07-31 0000315700 fmr:C000014553Member 2026-07-31 0000315700 fmr:C000014553Member fmr:TI0Member 2026-07-31 0000315700 fmr:C000014553Member fmr:TI1Member 2026-07-31 0000315700 fmr:C000014553Member fmr:TI2Member 2026-07-31 0000315700 fmr:C000014553Member fmr:TI3Member 2026-07-31 0000315700 fmr:C000014553Member fmr:TI4Member 2026-07-31 0000315700 fmr:C000014553Member fmr:TI5Member 2026-07-31 0000315700 fmr:C000014553Member fmr:TI6Member 2026-07-31 0000315700 fmr:AACommonStocksMember fmr:C000014553Member 2026-07-31 0000315700 fmr:AAPreferredStocksMember fmr:C000014553Member 2026-07-31 0000315700 fmr:AAPreferredSecuritiesMember fmr:C000014553Member 2026-07-31 0000315700 fmr:AABondsMember fmr:C000014553Member 2026-07-31 0000315700 fmr:AAShortTermInvestmentsandNetOtherAssetsLiabilitiesMember fmr:C000014553Member 2026-07-31 0000315700 fmr:C000014553Member country:US 2026-07-31 0000315700 fmr:C000014553Member country:NL 2026-07-31 0000315700 fmr:C000014553Member country:JP 2026-07-31 0000315700 fmr:C000014553Member country:IL 2026-07-31 0000315700 fmr:C000014553Member country:TW 2026-07-31 0000315700 fmr:C000014553Member country:KR 2026-07-31 0000315700 fmr:C000014553Member country:CA 2026-07-31 0000315700 fmr:C000014553Member fmr:TH0Member 2026-07-31 0000315700 fmr:C000014553Member fmr:TH1Member 2026-07-31 0000315700 fmr:C000014553Member fmr:TH2Member 2026-07-31 0000315700 fmr:C000014553Member fmr:TH3Member 2026-07-31 0000315700 fmr:C000014553Member fmr:TH4Member 2026-07-31 0000315700 fmr:C000014553Member fmr:TH5Member 2026-07-31 0000315700 fmr:C000014553Member fmr:TH6Member 2026-07-31 0000315700 fmr:C000014553Member fmr:TH7Member 2026-07-31 0000315700 fmr:C000014553Member fmr:TH8Member 2026-07-31 0000315700 fmr:C000014553Member fmr:TH9Member 2026-07-31 0000315700 fmr:C000014551Member 2025-07-31 2026-07-31 0000315700 fmr:C000014551_LG_ClassMember_11YRMember 2015-07-31 2026-07-31 0000315700 fmr:C000014551_ClassMember_AsOf_2016Member 2025-07-31 2026-07-31 0000315700 fmr:C000014551_ClassMember_AsOf_2017Member 2025-07-31 2026-07-31 0000315700 fmr:C000014551_ClassMember_AsOf_2018Member 2025-07-31 2026-07-31 0000315700 fmr:C000014551_ClassMember_AsOf_2019Member 2025-07-31 2026-07-31 0000315700 fmr:C000014551_ClassMember_AsOf_2020Member 2025-07-31 2026-07-31 0000315700 fmr:C000014551_ClassMember_AsOf_2021Member 2025-07-31 2026-07-31 0000315700 fmr:C000014551_ClassMember_AsOf_2022Member 2025-07-31 2026-07-31 0000315700 fmr:C000014551_ClassMember_AsOf_2023Member 2025-07-31 2026-07-31 0000315700 fmr:C000014551_ClassMember_AsOf_2024Member 2025-07-31 2026-07-31 0000315700 fmr:C000014551_ClassMember_AsOf_2025Member 2025-07-31 2026-07-31 0000315700 fmr:C000014551_ClassMember_AsOf_2026Member 2025-07-31 2026-07-31 0000315700 fmr:C000014551_LG_1_AdditionalIndexMember_11YRMember 2015-07-31 2026-07-31 0000315700 fmr:C000014551_1_AdditionalIndexMember_AsOf_2016Member 2025-07-31 2026-07-31 0000315700 fmr:C000014551_1_AdditionalIndexMember_AsOf_2017Member 2025-07-31 2026-07-31 0000315700 fmr:C000014551_1_AdditionalIndexMember_AsOf_2018Member 2025-07-31 2026-07-31 0000315700 fmr:C000014551_1_AdditionalIndexMember_AsOf_2019Member 2025-07-31 2026-07-31 0000315700 fmr:C000014551_1_AdditionalIndexMember_AsOf_2020Member 2025-07-31 2026-07-31 0000315700 fmr:C000014551_1_AdditionalIndexMember_AsOf_2021Member 2025-07-31 2026-07-31 0000315700 fmr:C000014551_1_AdditionalIndexMember_AsOf_2022Member 2025-07-31 2026-07-31 0000315700 fmr:C000014551_1_AdditionalIndexMember_AsOf_2023Member 2025-07-31 2026-07-31 0000315700 fmr:C000014551_1_AdditionalIndexMember_AsOf_2024Member 2025-07-31 2026-07-31 0000315700 fmr:C000014551_1_AdditionalIndexMember_AsOf_2025Member 2025-07-31 2026-07-31 0000315700 fmr:C000014551_1_AdditionalIndexMember_AsOf_2026Member 2025-07-31 2026-07-31 0000315700 fmr:C000014551_LG_2_AdditionalIndexMember_11YRMember 2015-07-31 2026-07-31 0000315700 fmr:C000014551_2_AdditionalIndexMember_AsOf_2016Member 2025-07-31 2026-07-31 0000315700 fmr:C000014551_2_AdditionalIndexMember_AsOf_2017Member 2025-07-31 2026-07-31 0000315700 fmr:C000014551_2_AdditionalIndexMember_AsOf_2018Member 2025-07-31 2026-07-31 0000315700 fmr:C000014551_2_AdditionalIndexMember_AsOf_2019Member 2025-07-31 2026-07-31 0000315700 fmr:C000014551_2_AdditionalIndexMember_AsOf_2020Member 2025-07-31 2026-07-31 0000315700 fmr:C000014551_2_AdditionalIndexMember_AsOf_2021Member 2025-07-31 2026-07-31 0000315700 fmr:C000014551_2_AdditionalIndexMember_AsOf_2022Member 2025-07-31 2026-07-31 0000315700 fmr:C000014551_2_AdditionalIndexMember_AsOf_2023Member 2025-07-31 2026-07-31 0000315700 fmr:C000014551_2_AdditionalIndexMember_AsOf_2024Member 2025-07-31 2026-07-31 0000315700 fmr:C000014551_2_AdditionalIndexMember_AsOf_2025Member 2025-07-31 2026-07-31 0000315700 fmr:C000014551_2_AdditionalIndexMember_AsOf_2026Member 2025-07-31 2026-07-31 0000315700 fmr:C000014551_ClassMember_1YRMember 2025-07-31 2026-07-31 0000315700 fmr:C000014551_ClassMember_5YRMember 2021-07-31 2026-07-31 0000315700 fmr:C000014551_ClassMember_10YRMember 2016-07-31 2026-07-31 0000315700 fmr:C000014551_NoLoadClassMember_1YRMember 2025-07-31 2026-07-31 0000315700 fmr:C000014551_NoLoadClassMember_5YRMember 2021-07-31 2026-07-31 0000315700 fmr:C000014551_NoLoadClassMember_10YRMember 2016-07-31 2026-07-31 0000315700 fmr:C000014551_0_AdditionalIndexMember_1YRMember 2025-07-31 2026-07-31 0000315700 fmr:C000014551_0_AdditionalIndexMember_5YRMember 2021-07-31 2026-07-31 0000315700 fmr:C000014551_0_AdditionalIndexMember_10YRMember 2016-07-31 2026-07-31 0000315700 fmr:C000014551_1_BBIndexMember_1YRMember 2025-07-31 2026-07-31 0000315700 fmr:C000014551_1_BBIndexMember_5YRMember 2021-07-31 2026-07-31 0000315700 fmr:C000014551_1_BBIndexMember_10YRMember 2016-07-31 2026-07-31 0000315700 fmr:C000014551Member 2026-07-31 0000315700 fmr:C000014551Member fmr:TI0Member 2026-07-31 0000315700 fmr:C000014551Member fmr:TI1Member 2026-07-31 0000315700 fmr:C000014551Member fmr:TI2Member 2026-07-31 0000315700 fmr:C000014551Member fmr:TI3Member 2026-07-31 0000315700 fmr:C000014551Member fmr:TI4Member 2026-07-31 0000315700 fmr:C000014551Member fmr:TI5Member 2026-07-31 0000315700 fmr:C000014551Member fmr:TI6Member 2026-07-31 0000315700 fmr:AACommonStocksMember fmr:C000014551Member 2026-07-31 0000315700 fmr:AAPreferredStocksMember fmr:C000014551Member 2026-07-31 0000315700 fmr:AAPreferredSecuritiesMember fmr:C000014551Member 2026-07-31 0000315700 fmr:AABondsMember fmr:C000014551Member 2026-07-31 0000315700 fmr:AAShortTermInvestmentsandNetOtherAssetsLiabilitiesMember fmr:C000014551Member 2026-07-31 0000315700 fmr:C000014551Member country:US 2026-07-31 0000315700 fmr:C000014551Member country:NL 2026-07-31 0000315700 fmr:C000014551Member country:JP 2026-07-31 0000315700 fmr:C000014551Member country:IL 2026-07-31 0000315700 fmr:C000014551Member country:TW 2026-07-31 0000315700 fmr:C000014551Member country:KR 2026-07-31 0000315700 fmr:C000014551Member country:CA 2026-07-31 0000315700 fmr:C000014551Member fmr:TH0Member 2026-07-31 0000315700 fmr:C000014551Member fmr:TH1Member 2026-07-31 0000315700 fmr:C000014551Member fmr:TH2Member 2026-07-31 0000315700 fmr:C000014551Member fmr:TH3Member 2026-07-31 0000315700 fmr:C000014551Member fmr:TH4Member 2026-07-31 0000315700 fmr:C000014551Member fmr:TH5Member 2026-07-31 0000315700 fmr:C000014551Member fmr:TH6Member 2026-07-31 0000315700 fmr:C000014551Member fmr:TH7Member 2026-07-31 0000315700 fmr:C000014551Member fmr:TH8Member 2026-07-31 0000315700 fmr:C000014551Member fmr:TH9Member 2026-07-31 0000315700 fmr:C000014549Member 2025-07-31 2026-07-31 0000315700 fmr:C000014549_LG_ClassMember_11YRMember 2015-07-31 2026-07-31 0000315700 fmr:C000014549_ClassMember_AsOf_2016Member 2025-07-31 2026-07-31 0000315700 fmr:C000014549_ClassMember_AsOf_2017Member 2025-07-31 2026-07-31 0000315700 fmr:C000014549_ClassMember_AsOf_2018Member 2025-07-31 2026-07-31 0000315700 fmr:C000014549_ClassMember_AsOf_2019Member 2025-07-31 2026-07-31 0000315700 fmr:C000014549_ClassMember_AsOf_2020Member 2025-07-31 2026-07-31 0000315700 fmr:C000014549_ClassMember_AsOf_2021Member 2025-07-31 2026-07-31 0000315700 fmr:C000014549_ClassMember_AsOf_2022Member 2025-07-31 2026-07-31 0000315700 fmr:C000014549_ClassMember_AsOf_2023Member 2025-07-31 2026-07-31 0000315700 fmr:C000014549_ClassMember_AsOf_2024Member 2025-07-31 2026-07-31 0000315700 fmr:C000014549_ClassMember_AsOf_2025Member 2025-07-31 2026-07-31 0000315700 fmr:C000014549_ClassMember_AsOf_2026Member 2025-07-31 2026-07-31 0000315700 fmr:C000014549_LG_1_AdditionalIndexMember_11YRMember 2015-07-31 2026-07-31 0000315700 fmr:C000014549_1_AdditionalIndexMember_AsOf_2016Member 2025-07-31 2026-07-31 0000315700 fmr:C000014549_1_AdditionalIndexMember_AsOf_2017Member 2025-07-31 2026-07-31 0000315700 fmr:C000014549_1_AdditionalIndexMember_AsOf_2018Member 2025-07-31 2026-07-31 0000315700 fmr:C000014549_1_AdditionalIndexMember_AsOf_2019Member 2025-07-31 2026-07-31 0000315700 fmr:C000014549_1_AdditionalIndexMember_AsOf_2020Member 2025-07-31 2026-07-31 0000315700 fmr:C000014549_1_AdditionalIndexMember_AsOf_2021Member 2025-07-31 2026-07-31 0000315700 fmr:C000014549_1_AdditionalIndexMember_AsOf_2022Member 2025-07-31 2026-07-31 0000315700 fmr:C000014549_1_AdditionalIndexMember_AsOf_2023Member 2025-07-31 2026-07-31 0000315700 fmr:C000014549_1_AdditionalIndexMember_AsOf_2024Member 2025-07-31 2026-07-31 0000315700 fmr:C000014549_1_AdditionalIndexMember_AsOf_2025Member 2025-07-31 2026-07-31 0000315700 fmr:C000014549_1_AdditionalIndexMember_AsOf_2026Member 2025-07-31 2026-07-31 0000315700 fmr:C000014549_LG_2_AdditionalIndexMember_11YRMember 2015-07-31 2026-07-31 0000315700 fmr:C000014549_2_AdditionalIndexMember_AsOf_2016Member 2025-07-31 2026-07-31 0000315700 fmr:C000014549_2_AdditionalIndexMember_AsOf_2017Member 2025-07-31 2026-07-31 0000315700 fmr:C000014549_2_AdditionalIndexMember_AsOf_2018Member 2025-07-31 2026-07-31 0000315700 fmr:C000014549_2_AdditionalIndexMember_AsOf_2019Member 2025-07-31 2026-07-31 0000315700 fmr:C000014549_2_AdditionalIndexMember_AsOf_2020Member 2025-07-31 2026-07-31 0000315700 fmr:C000014549_2_AdditionalIndexMember_AsOf_2021Member 2025-07-31 2026-07-31 0000315700 fmr:C000014549_2_AdditionalIndexMember_AsOf_2022Member 2025-07-31 2026-07-31 0000315700 fmr:C000014549_2_AdditionalIndexMember_AsOf_2023Member 2025-07-31 2026-07-31 0000315700 fmr:C000014549_2_AdditionalIndexMember_AsOf_2024Member 2025-07-31 2026-07-31 0000315700 fmr:C000014549_2_AdditionalIndexMember_AsOf_2025Member 2025-07-31 2026-07-31 0000315700 fmr:C000014549_2_AdditionalIndexMember_AsOf_2026Member 2025-07-31 2026-07-31 0000315700 fmr:C000014549_ClassMember_1YRMember 2025-07-31 2026-07-31 0000315700 fmr:C000014549_ClassMember_5YRMember 2021-07-31 2026-07-31 0000315700 fmr:C000014549_ClassMember_10YRMember 2016-07-31 2026-07-31 0000315700 fmr:C000014549_NoLoadClassMember_1YRMember 2025-07-31 2026-07-31 0000315700 fmr:C000014549_NoLoadClassMember_5YRMember 2021-07-31 2026-07-31 0000315700 fmr:C000014549_NoLoadClassMember_10YRMember 2016-07-31 2026-07-31 0000315700 fmr:C000014549_0_AdditionalIndexMember_1YRMember 2025-07-31 2026-07-31 0000315700 fmr:C000014549_0_AdditionalIndexMember_5YRMember 2021-07-31 2026-07-31 0000315700 fmr:C000014549_0_AdditionalIndexMember_10YRMember 2016-07-31 2026-07-31 0000315700 fmr:C000014549_1_BBIndexMember_1YRMember 2025-07-31 2026-07-31 0000315700 fmr:C000014549_1_BBIndexMember_5YRMember 2021-07-31 2026-07-31 0000315700 fmr:C000014549_1_BBIndexMember_10YRMember 2016-07-31 2026-07-31 0000315700 fmr:C000014549Member 2026-07-31 0000315700 fmr:C000014549Member fmr:TI0Member 2026-07-31 0000315700 fmr:C000014549Member fmr:TI1Member 2026-07-31 0000315700 fmr:C000014549Member fmr:TI2Member 2026-07-31 0000315700 fmr:C000014549Member fmr:TI3Member 2026-07-31 0000315700 fmr:C000014549Member fmr:TI4Member 2026-07-31 0000315700 fmr:C000014549Member fmr:TI5Member 2026-07-31 0000315700 fmr:C000014549Member fmr:TI6Member 2026-07-31 0000315700 fmr:AACommonStocksMember fmr:C000014549Member 2026-07-31 0000315700 fmr:AAPreferredStocksMember fmr:C000014549Member 2026-07-31 0000315700 fmr:AAPreferredSecuritiesMember fmr:C000014549Member 2026-07-31 0000315700 fmr:AABondsMember fmr:C000014549Member 2026-07-31 0000315700 fmr:AAShortTermInvestmentsandNetOtherAssetsLiabilitiesMember fmr:C000014549Member 2026-07-31 0000315700 fmr:C000014549Member country:US 2026-07-31 0000315700 fmr:C000014549Member country:NL 2026-07-31 0000315700 fmr:C000014549Member country:JP 2026-07-31 0000315700 fmr:C000014549Member country:IL 2026-07-31 0000315700 fmr:C000014549Member country:TW 2026-07-31 0000315700 fmr:C000014549Member country:KR 2026-07-31 0000315700 fmr:C000014549Member country:CA 2026-07-31 0000315700 fmr:C000014549Member fmr:TH0Member 2026-07-31 0000315700 fmr:C000014549Member fmr:TH1Member 2026-07-31 0000315700 fmr:C000014549Member fmr:TH2Member 2026-07-31 0000315700 fmr:C000014549Member fmr:TH3Member 2026-07-31 0000315700 fmr:C000014549Member fmr:TH4Member 2026-07-31 0000315700 fmr:C000014549Member fmr:TH5Member 2026-07-31 0000315700 fmr:C000014549Member fmr:TH6Member 2026-07-31 0000315700 fmr:C000014549Member fmr:TH7Member 2026-07-31 0000315700 fmr:C000014549Member fmr:TH8Member 2026-07-31 0000315700 fmr:C000014549Member fmr:TH9Member 2026-07-31 0000315700 fmr:C000205003Member 2025-07-31 2026-07-31 0000315700 fmr:C000205003_LG_ClassMember_9YRMember 2017-07-31 2026-07-31 0000315700 fmr:C000205003_ClassMember_AsOf_2018Member 2025-07-31 2026-07-31 0000315700 fmr:C000205003_ClassMember_AsOf_2019Member 2025-07-31 2026-07-31 0000315700 fmr:C000205003_ClassMember_AsOf_2020Member 2025-07-31 2026-07-31 0000315700 fmr:C000205003_ClassMember_AsOf_2021Member 2025-07-31 2026-07-31 0000315700 fmr:C000205003_ClassMember_AsOf_2022Member 2025-07-31 2026-07-31 0000315700 fmr:C000205003_ClassMember_AsOf_2023Member 2025-07-31 2026-07-31 0000315700 fmr:C000205003_ClassMember_AsOf_2024Member 2025-07-31 2026-07-31 0000315700 fmr:C000205003_ClassMember_AsOf_2025Member 2025-07-31 2026-07-31 0000315700 fmr:C000205003_ClassMember_AsOf_2026Member 2025-07-31 2026-07-31 0000315700 fmr:C000205003_LG_1_AdditionalIndexMember_9YRMember 2017-07-31 2026-07-31 0000315700 fmr:C000205003_1_AdditionalIndexMember_AsOf_2018Member 2025-07-31 2026-07-31 0000315700 fmr:C000205003_1_AdditionalIndexMember_AsOf_2019Member 2025-07-31 2026-07-31 0000315700 fmr:C000205003_1_AdditionalIndexMember_AsOf_2020Member 2025-07-31 2026-07-31 0000315700 fmr:C000205003_1_AdditionalIndexMember_AsOf_2021Member 2025-07-31 2026-07-31 0000315700 fmr:C000205003_1_AdditionalIndexMember_AsOf_2022Member 2025-07-31 2026-07-31 0000315700 fmr:C000205003_1_AdditionalIndexMember_AsOf_2023Member 2025-07-31 2026-07-31 0000315700 fmr:C000205003_1_AdditionalIndexMember_AsOf_2024Member 2025-07-31 2026-07-31 0000315700 fmr:C000205003_1_AdditionalIndexMember_AsOf_2025Member 2025-07-31 2026-07-31 0000315700 fmr:C000205003_1_AdditionalIndexMember_AsOf_2026Member 2025-07-31 2026-07-31 0000315700 fmr:C000205003_LG_2_AdditionalIndexMember_9YRMember 2017-07-31 2026-07-31 0000315700 fmr:C000205003_2_AdditionalIndexMember_AsOf_2018Member 2025-07-31 2026-07-31 0000315700 fmr:C000205003_2_AdditionalIndexMember_AsOf_2019Member 2025-07-31 2026-07-31 0000315700 fmr:C000205003_2_AdditionalIndexMember_AsOf_2020Member 2025-07-31 2026-07-31 0000315700 fmr:C000205003_2_AdditionalIndexMember_AsOf_2021Member 2025-07-31 2026-07-31 0000315700 fmr:C000205003_2_AdditionalIndexMember_AsOf_2022Member 2025-07-31 2026-07-31 0000315700 fmr:C000205003_2_AdditionalIndexMember_AsOf_2023Member 2025-07-31 2026-07-31 0000315700 fmr:C000205003_2_AdditionalIndexMember_AsOf_2024Member 2025-07-31 2026-07-31 0000315700 fmr:C000205003_2_AdditionalIndexMember_AsOf_2025Member 2025-07-31 2026-07-31 0000315700 fmr:C000205003_2_AdditionalIndexMember_AsOf_2026Member 2025-07-31 2026-07-31 0000315700 fmr:C000205003_NoLoadClassMember_1YRMember 2025-07-31 2026-07-31 0000315700 fmr:C000205003_NoLoadClassMember_5YRMember 2021-07-31 2026-07-31 0000315700 fmr:C000205003_NoLoadClassMember_2025-08-01_2026-07-31Member 2025-07-31 2026-07-31 0000315700 fmr:C000205003_0_AdditionalIndexMember_1YRMember 2025-07-31 2026-07-31 0000315700 fmr:C000205003_0_AdditionalIndexMember_5YRMember 2021-07-31 2026-07-31 0000315700 fmr:C000205003_0_AdditionalIndexMember_LOCMember 2025-07-31 2026-07-31 0000315700 fmr:C000205003_1_BBIndexMember_1YRMember 2025-07-31 2026-07-31 0000315700 fmr:C000205003_1_BBIndexMember_5YRMember 2021-07-31 2026-07-31 0000315700 fmr:C000205003_1_BBIndexMember_LOCMember 2025-07-31 2026-07-31 0000315700 fmr:C000205003Member 2018-10-02 2026-07-31 0000315700 fmr:C000205003Member 2026-07-31 0000315700 fmr:C000205003Member fmr:TI0Member 2026-07-31 0000315700 fmr:C000205003Member fmr:TI1Member 2026-07-31 0000315700 fmr:C000205003Member fmr:TI2Member 2026-07-31 0000315700 fmr:C000205003Member fmr:TI3Member 2026-07-31 0000315700 fmr:C000205003Member fmr:TI4Member 2026-07-31 0000315700 fmr:C000205003Member fmr:TI5Member 2026-07-31 0000315700 fmr:C000205003Member fmr:TI6Member 2026-07-31 0000315700 fmr:C000205003Member fmr:TI7Member 2026-07-31 0000315700 fmr:C000205003Member fmr:TI8Member 2026-07-31 0000315700 fmr:C000205003Member fmr:TI9Member 2026-07-31 0000315700 fmr:AACommonStocksMember fmr:C000205003Member 2026-07-31 0000315700 fmr:AAShortTermInvestmentsandNetOtherAssetsLiabilitiesMember fmr:C000205003Member 2026-07-31 0000315700 fmr:C000205003Member country:US 2026-07-31 0000315700 fmr:C000205003Member fmr:TH0Member 2026-07-31 0000315700 fmr:C000205003Member fmr:TH1Member 2026-07-31 0000315700 fmr:C000205003Member fmr:TH2Member 2026-07-31 0000315700 fmr:C000205003Member fmr:TH3Member 2026-07-31 0000315700 fmr:C000205003Member fmr:TH4Member 2026-07-31 0000315700 fmr:C000205003Member fmr:TH5Member 2026-07-31 0000315700 fmr:C000205003Member fmr:TH6Member 2026-07-31 0000315700 fmr:C000205003Member fmr:TH7Member 2026-07-31 0000315700 fmr:C000205003Member fmr:TH8Member 2026-07-31 0000315700 fmr:C000205003Member fmr:TH9Member 2026-07-31 0000315700 fmr:C000014542Member 2025-07-31 2026-07-31 0000315700 fmr:C000014542_LG_ClassMember_11YRMember 2015-07-31 2026-07-31 0000315700 fmr:C000014542_ClassMember_AsOf_2016Member 2025-07-31 2026-07-31 0000315700 fmr:C000014542_ClassMember_AsOf_2017Member 2025-07-31 2026-07-31 0000315700 fmr:C000014542_ClassMember_AsOf_2018Member 2025-07-31 2026-07-31 0000315700 fmr:C000014542_ClassMember_AsOf_2019Member 2025-07-31 2026-07-31 0000315700 fmr:C000014542_ClassMember_AsOf_2020Member 2025-07-31 2026-07-31 0000315700 fmr:C000014542_ClassMember_AsOf_2021Member 2025-07-31 2026-07-31 0000315700 fmr:C000014542_ClassMember_AsOf_2022Member 2025-07-31 2026-07-31 0000315700 fmr:C000014542_ClassMember_AsOf_2023Member 2025-07-31 2026-07-31 0000315700 fmr:C000014542_ClassMember_AsOf_2024Member 2025-07-31 2026-07-31 0000315700 fmr:C000014542_ClassMember_AsOf_2025Member 2025-07-31 2026-07-31 0000315700 fmr:C000014542_ClassMember_AsOf_2026Member 2025-07-31 2026-07-31 0000315700 fmr:C000014542_LG_1_AdditionalIndexMember_11YRMember 2015-07-31 2026-07-31 0000315700 fmr:C000014542_1_AdditionalIndexMember_AsOf_2016Member 2025-07-31 2026-07-31 0000315700 fmr:C000014542_1_AdditionalIndexMember_AsOf_2017Member 2025-07-31 2026-07-31 0000315700 fmr:C000014542_1_AdditionalIndexMember_AsOf_2018Member 2025-07-31 2026-07-31 0000315700 fmr:C000014542_1_AdditionalIndexMember_AsOf_2019Member 2025-07-31 2026-07-31 0000315700 fmr:C000014542_1_AdditionalIndexMember_AsOf_2020Member 2025-07-31 2026-07-31 0000315700 fmr:C000014542_1_AdditionalIndexMember_AsOf_2021Member 2025-07-31 2026-07-31 0000315700 fmr:C000014542_1_AdditionalIndexMember_AsOf_2022Member 2025-07-31 2026-07-31 0000315700 fmr:C000014542_1_AdditionalIndexMember_AsOf_2023Member 2025-07-31 2026-07-31 0000315700 fmr:C000014542_1_AdditionalIndexMember_AsOf_2024Member 2025-07-31 2026-07-31 0000315700 fmr:C000014542_1_AdditionalIndexMember_AsOf_2025Member 2025-07-31 2026-07-31 0000315700 fmr:C000014542_1_AdditionalIndexMember_AsOf_2026Member 2025-07-31 2026-07-31 0000315700 fmr:C000014542_LG_2_AdditionalIndexMember_11YRMember 2015-07-31 2026-07-31 0000315700 fmr:C000014542_2_AdditionalIndexMember_AsOf_2016Member 2025-07-31 2026-07-31 0000315700 fmr:C000014542_2_AdditionalIndexMember_AsOf_2017Member 2025-07-31 2026-07-31 0000315700 fmr:C000014542_2_AdditionalIndexMember_AsOf_2018Member 2025-07-31 2026-07-31 0000315700 fmr:C000014542_2_AdditionalIndexMember_AsOf_2019Member 2025-07-31 2026-07-31 0000315700 fmr:C000014542_2_AdditionalIndexMember_AsOf_2020Member 2025-07-31 2026-07-31 0000315700 fmr:C000014542_2_AdditionalIndexMember_AsOf_2021Member 2025-07-31 2026-07-31 0000315700 fmr:C000014542_2_AdditionalIndexMember_AsOf_2022Member 2025-07-31 2026-07-31 0000315700 fmr:C000014542_2_AdditionalIndexMember_AsOf_2023Member 2025-07-31 2026-07-31 0000315700 fmr:C000014542_2_AdditionalIndexMember_AsOf_2024Member 2025-07-31 2026-07-31 0000315700 fmr:C000014542_2_AdditionalIndexMember_AsOf_2025Member 2025-07-31 2026-07-31 0000315700 fmr:C000014542_2_AdditionalIndexMember_AsOf_2026Member 2025-07-31 2026-07-31 0000315700 fmr:C000014542_ClassMember_1YRMember 2025-07-31 2026-07-31 0000315700 fmr:C000014542_ClassMember_5YRMember 2021-07-31 2026-07-31 0000315700 fmr:C000014542_ClassMember_10YRMember 2016-07-31 2026-07-31 0000315700 fmr:C000014542_NoLoadClassMember_1YRMember 2025-07-31 2026-07-31 0000315700 fmr:C000014542_NoLoadClassMember_5YRMember 2021-07-31 2026-07-31 0000315700 fmr:C000014542_NoLoadClassMember_10YRMember 2016-07-31 2026-07-31 0000315700 fmr:C000014542_0_AdditionalIndexMember_1YRMember 2025-07-31 2026-07-31 0000315700 fmr:C000014542_0_AdditionalIndexMember_5YRMember 2021-07-31 2026-07-31 0000315700 fmr:C000014542_0_AdditionalIndexMember_10YRMember 2016-07-31 2026-07-31 0000315700 fmr:C000014542_1_BBIndexMember_1YRMember 2025-07-31 2026-07-31 0000315700 fmr:C000014542_1_BBIndexMember_5YRMember 2021-07-31 2026-07-31 0000315700 fmr:C000014542_1_BBIndexMember_10YRMember 2016-07-31 2026-07-31 0000315700 fmr:C000014542Member 2026-07-31 0000315700 fmr:C000014542Member fmr:TI0Member 2026-07-31 0000315700 fmr:C000014542Member fmr:TI1Member 2026-07-31 0000315700 fmr:C000014542Member fmr:TI2Member 2026-07-31 0000315700 fmr:C000014542Member fmr:TI3Member 2026-07-31 0000315700 fmr:C000014542Member fmr:TI4Member 2026-07-31 0000315700 fmr:C000014542Member fmr:TI5Member 2026-07-31 0000315700 fmr:C000014542Member fmr:TI6Member 2026-07-31 0000315700 fmr:C000014542Member fmr:TI7Member 2026-07-31 0000315700 fmr:C000014542Member fmr:TI8Member 2026-07-31 0000315700 fmr:C000014542Member fmr:TI9Member 2026-07-31 0000315700 fmr:AACommonStocksMember fmr:C000014542Member 2026-07-31 0000315700 fmr:AAShortTermInvestmentsandNetOtherAssetsLiabilitiesMember fmr:C000014542Member 2026-07-31 0000315700 fmr:C000014542Member country:US 2026-07-31 0000315700 fmr:C000014542Member fmr:TH0Member 2026-07-31 0000315700 fmr:C000014542Member fmr:TH1Member 2026-07-31 0000315700 fmr:C000014542Member fmr:TH2Member 2026-07-31 0000315700 fmr:C000014542Member fmr:TH3Member 2026-07-31 0000315700 fmr:C000014542Member fmr:TH4Member 2026-07-31 0000315700 fmr:C000014542Member fmr:TH5Member 2026-07-31 0000315700 fmr:C000014542Member fmr:TH6Member 2026-07-31 0000315700 fmr:C000014542Member fmr:TH7Member 2026-07-31 0000315700 fmr:C000014542Member fmr:TH8Member 2026-07-31 0000315700 fmr:C000014542Member fmr:TH9Member 2026-07-31 0000315700 fmr:C000014543Member 2025-07-31 2026-07-31 0000315700 fmr:C000014543_LG_ClassMember_11YRMember 2015-07-31 2026-07-31 0000315700 fmr:C000014543_ClassMember_AsOf_2016Member 2025-07-31 2026-07-31 0000315700 fmr:C000014543_ClassMember_AsOf_2017Member 2025-07-31 2026-07-31 0000315700 fmr:C000014543_ClassMember_AsOf_2018Member 2025-07-31 2026-07-31 0000315700 fmr:C000014543_ClassMember_AsOf_2019Member 2025-07-31 2026-07-31 0000315700 fmr:C000014543_ClassMember_AsOf_2020Member 2025-07-31 2026-07-31 0000315700 fmr:C000014543_ClassMember_AsOf_2021Member 2025-07-31 2026-07-31 0000315700 fmr:C000014543_ClassMember_AsOf_2022Member 2025-07-31 2026-07-31 0000315700 fmr:C000014543_ClassMember_AsOf_2023Member 2025-07-31 2026-07-31 0000315700 fmr:C000014543_ClassMember_AsOf_2024Member 2025-07-31 2026-07-31 0000315700 fmr:C000014543_ClassMember_AsOf_2025Member 2025-07-31 2026-07-31 0000315700 fmr:C000014543_ClassMember_AsOf_2026Member 2025-07-31 2026-07-31 0000315700 fmr:C000014543_LG_1_AdditionalIndexMember_11YRMember 2015-07-31 2026-07-31 0000315700 fmr:C000014543_1_AdditionalIndexMember_AsOf_2016Member 2025-07-31 2026-07-31 0000315700 fmr:C000014543_1_AdditionalIndexMember_AsOf_2017Member 2025-07-31 2026-07-31 0000315700 fmr:C000014543_1_AdditionalIndexMember_AsOf_2018Member 2025-07-31 2026-07-31 0000315700 fmr:C000014543_1_AdditionalIndexMember_AsOf_2019Member 2025-07-31 2026-07-31 0000315700 fmr:C000014543_1_AdditionalIndexMember_AsOf_2020Member 2025-07-31 2026-07-31 0000315700 fmr:C000014543_1_AdditionalIndexMember_AsOf_2021Member 2025-07-31 2026-07-31 0000315700 fmr:C000014543_1_AdditionalIndexMember_AsOf_2022Member 2025-07-31 2026-07-31 0000315700 fmr:C000014543_1_AdditionalIndexMember_AsOf_2023Member 2025-07-31 2026-07-31 0000315700 fmr:C000014543_1_AdditionalIndexMember_AsOf_2024Member 2025-07-31 2026-07-31 0000315700 fmr:C000014543_1_AdditionalIndexMember_AsOf_2025Member 2025-07-31 2026-07-31 0000315700 fmr:C000014543_1_AdditionalIndexMember_AsOf_2026Member 2025-07-31 2026-07-31 0000315700 fmr:C000014543_LG_2_AdditionalIndexMember_11YRMember 2015-07-31 2026-07-31 0000315700 fmr:C000014543_2_AdditionalIndexMember_AsOf_2016Member 2025-07-31 2026-07-31 0000315700 fmr:C000014543_2_AdditionalIndexMember_AsOf_2017Member 2025-07-31 2026-07-31 0000315700 fmr:C000014543_2_AdditionalIndexMember_AsOf_2018Member 2025-07-31 2026-07-31 0000315700 fmr:C000014543_2_AdditionalIndexMember_AsOf_2019Member 2025-07-31 2026-07-31 0000315700 fmr:C000014543_2_AdditionalIndexMember_AsOf_2020Member 2025-07-31 2026-07-31 0000315700 fmr:C000014543_2_AdditionalIndexMember_AsOf_2021Member 2025-07-31 2026-07-31 0000315700 fmr:C000014543_2_AdditionalIndexMember_AsOf_2022Member 2025-07-31 2026-07-31 0000315700 fmr:C000014543_2_AdditionalIndexMember_AsOf_2023Member 2025-07-31 2026-07-31 0000315700 fmr:C000014543_2_AdditionalIndexMember_AsOf_2024Member 2025-07-31 2026-07-31 0000315700 fmr:C000014543_2_AdditionalIndexMember_AsOf_2025Member 2025-07-31 2026-07-31 0000315700 fmr:C000014543_2_AdditionalIndexMember_AsOf_2026Member 2025-07-31 2026-07-31 0000315700 fmr:C000014543_NoLoadClassMember_1YRMember 2025-07-31 2026-07-31 0000315700 fmr:C000014543_NoLoadClassMember_5YRMember 2021-07-31 2026-07-31 0000315700 fmr:C000014543_NoLoadClassMember_10YRMember 2016-07-31 2026-07-31 0000315700 fmr:C000014543_0_AdditionalIndexMember_1YRMember 2025-07-31 2026-07-31 0000315700 fmr:C000014543_0_AdditionalIndexMember_5YRMember 2021-07-31 2026-07-31 0000315700 fmr:C000014543_0_AdditionalIndexMember_10YRMember 2016-07-31 2026-07-31 0000315700 fmr:C000014543_1_BBIndexMember_1YRMember 2025-07-31 2026-07-31 0000315700 fmr:C000014543_1_BBIndexMember_5YRMember 2021-07-31 2026-07-31 0000315700 fmr:C000014543_1_BBIndexMember_10YRMember 2016-07-31 2026-07-31 0000315700 fmr:C000014543Member 2026-07-31 0000315700 fmr:C000014543Member fmr:TI0Member 2026-07-31 0000315700 fmr:C000014543Member fmr:TI1Member 2026-07-31 0000315700 fmr:C000014543Member fmr:TI2Member 2026-07-31 0000315700 fmr:C000014543Member fmr:TI3Member 2026-07-31 0000315700 fmr:C000014543Member fmr:TI4Member 2026-07-31 0000315700 fmr:C000014543Member fmr:TI5Member 2026-07-31 0000315700 fmr:C000014543Member fmr:TI6Member 2026-07-31 0000315700 fmr:C000014543Member fmr:TI7Member 2026-07-31 0000315700 fmr:C000014543Member fmr:TI8Member 2026-07-31 0000315700 fmr:C000014543Member fmr:TI9Member 2026-07-31 0000315700 fmr:AACommonStocksMember fmr:C000014543Member 2026-07-31 0000315700 fmr:AAShortTermInvestmentsandNetOtherAssetsLiabilitiesMember fmr:C000014543Member 2026-07-31 0000315700 fmr:C000014543Member country:US 2026-07-31 0000315700 fmr:C000014543Member fmr:TH0Member 2026-07-31 0000315700 fmr:C000014543Member fmr:TH1Member 2026-07-31 0000315700 fmr:C000014543Member fmr:TH2Member 2026-07-31 0000315700 fmr:C000014543Member fmr:TH3Member 2026-07-31 0000315700 fmr:C000014543Member fmr:TH4Member 2026-07-31 0000315700 fmr:C000014543Member fmr:TH5Member 2026-07-31 0000315700 fmr:C000014543Member fmr:TH6Member 2026-07-31 0000315700 fmr:C000014543Member fmr:TH7Member 2026-07-31 0000315700 fmr:C000014543Member fmr:TH8Member 2026-07-31 0000315700 fmr:C000014543Member fmr:TH9Member 2026-07-31 0000315700 fmr:C000014541Member 2025-07-31 2026-07-31 0000315700 fmr:C000014541_LG_ClassMember_11YRMember 2015-07-31 2026-07-31 0000315700 fmr:C000014541_ClassMember_AsOf_2016Member 2025-07-31 2026-07-31 0000315700 fmr:C000014541_ClassMember_AsOf_2017Member 2025-07-31 2026-07-31 0000315700 fmr:C000014541_ClassMember_AsOf_2018Member 2025-07-31 2026-07-31 0000315700 fmr:C000014541_ClassMember_AsOf_2019Member 2025-07-31 2026-07-31 0000315700 fmr:C000014541_ClassMember_AsOf_2020Member 2025-07-31 2026-07-31 0000315700 fmr:C000014541_ClassMember_AsOf_2021Member 2025-07-31 2026-07-31 0000315700 fmr:C000014541_ClassMember_AsOf_2022Member 2025-07-31 2026-07-31 0000315700 fmr:C000014541_ClassMember_AsOf_2023Member 2025-07-31 2026-07-31 0000315700 fmr:C000014541_ClassMember_AsOf_2024Member 2025-07-31 2026-07-31 0000315700 fmr:C000014541_ClassMember_AsOf_2025Member 2025-07-31 2026-07-31 0000315700 fmr:C000014541_ClassMember_AsOf_2026Member 2025-07-31 2026-07-31 0000315700 fmr:C000014541_LG_1_AdditionalIndexMember_11YRMember 2015-07-31 2026-07-31 0000315700 fmr:C000014541_1_AdditionalIndexMember_AsOf_2016Member 2025-07-31 2026-07-31 0000315700 fmr:C000014541_1_AdditionalIndexMember_AsOf_2017Member 2025-07-31 2026-07-31 0000315700 fmr:C000014541_1_AdditionalIndexMember_AsOf_2018Member 2025-07-31 2026-07-31 0000315700 fmr:C000014541_1_AdditionalIndexMember_AsOf_2019Member 2025-07-31 2026-07-31 0000315700 fmr:C000014541_1_AdditionalIndexMember_AsOf_2020Member 2025-07-31 2026-07-31 0000315700 fmr:C000014541_1_AdditionalIndexMember_AsOf_2021Member 2025-07-31 2026-07-31 0000315700 fmr:C000014541_1_AdditionalIndexMember_AsOf_2022Member 2025-07-31 2026-07-31 0000315700 fmr:C000014541_1_AdditionalIndexMember_AsOf_2023Member 2025-07-31 2026-07-31 0000315700 fmr:C000014541_1_AdditionalIndexMember_AsOf_2024Member 2025-07-31 2026-07-31 0000315700 fmr:C000014541_1_AdditionalIndexMember_AsOf_2025Member 2025-07-31 2026-07-31 0000315700 fmr:C000014541_1_AdditionalIndexMember_AsOf_2026Member 2025-07-31 2026-07-31 0000315700 fmr:C000014541_LG_2_AdditionalIndexMember_11YRMember 2015-07-31 2026-07-31 0000315700 fmr:C000014541_2_AdditionalIndexMember_AsOf_2016Member 2025-07-31 2026-07-31 0000315700 fmr:C000014541_2_AdditionalIndexMember_AsOf_2017Member 2025-07-31 2026-07-31 0000315700 fmr:C000014541_2_AdditionalIndexMember_AsOf_2018Member 2025-07-31 2026-07-31 0000315700 fmr:C000014541_2_AdditionalIndexMember_AsOf_2019Member 2025-07-31 2026-07-31 0000315700 fmr:C000014541_2_AdditionalIndexMember_AsOf_2020Member 2025-07-31 2026-07-31 0000315700 fmr:C000014541_2_AdditionalIndexMember_AsOf_2021Member 2025-07-31 2026-07-31 0000315700 fmr:C000014541_2_AdditionalIndexMember_AsOf_2022Member 2025-07-31 2026-07-31 0000315700 fmr:C000014541_2_AdditionalIndexMember_AsOf_2023Member 2025-07-31 2026-07-31 0000315700 fmr:C000014541_2_AdditionalIndexMember_AsOf_2024Member 2025-07-31 2026-07-31 0000315700 fmr:C000014541_2_AdditionalIndexMember_AsOf_2025Member 2025-07-31 2026-07-31 0000315700 fmr:C000014541_2_AdditionalIndexMember_AsOf_2026Member 2025-07-31 2026-07-31 0000315700 fmr:C000014541_ClassMember_1YRMember 2025-07-31 2026-07-31 0000315700 fmr:C000014541_ClassMember_5YRMember 2021-07-31 2026-07-31 0000315700 fmr:C000014541_ClassMember_10YRMember 2016-07-31 2026-07-31 0000315700 fmr:C000014541_NoLoadClassMember_1YRMember 2025-07-31 2026-07-31 0000315700 fmr:C000014541_NoLoadClassMember_5YRMember 2021-07-31 2026-07-31 0000315700 fmr:C000014541_NoLoadClassMember_10YRMember 2016-07-31 2026-07-31 0000315700 fmr:C000014541_0_AdditionalIndexMember_1YRMember 2025-07-31 2026-07-31 0000315700 fmr:C000014541_0_AdditionalIndexMember_5YRMember 2021-07-31 2026-07-31 0000315700 fmr:C000014541_0_AdditionalIndexMember_10YRMember 2016-07-31 2026-07-31 0000315700 fmr:C000014541_1_BBIndexMember_1YRMember 2025-07-31 2026-07-31 0000315700 fmr:C000014541_1_BBIndexMember_5YRMember 2021-07-31 2026-07-31 0000315700 fmr:C000014541_1_BBIndexMember_10YRMember 2016-07-31 2026-07-31 0000315700 fmr:C000014541Member 2026-07-31 0000315700 fmr:C000014541Member fmr:TI0Member 2026-07-31 0000315700 fmr:C000014541Member fmr:TI1Member 2026-07-31 0000315700 fmr:C000014541Member fmr:TI2Member 2026-07-31 0000315700 fmr:C000014541Member fmr:TI3Member 2026-07-31 0000315700 fmr:C000014541Member fmr:TI4Member 2026-07-31 0000315700 fmr:C000014541Member fmr:TI5Member 2026-07-31 0000315700 fmr:C000014541Member fmr:TI6Member 2026-07-31 0000315700 fmr:C000014541Member fmr:TI7Member 2026-07-31 0000315700 fmr:C000014541Member fmr:TI8Member 2026-07-31 0000315700 fmr:C000014541Member fmr:TI9Member 2026-07-31 0000315700 fmr:AACommonStocksMember fmr:C000014541Member 2026-07-31 0000315700 fmr:AAShortTermInvestmentsandNetOtherAssetsLiabilitiesMember fmr:C000014541Member 2026-07-31 0000315700 fmr:C000014541Member country:US 2026-07-31 0000315700 fmr:C000014541Member fmr:TH0Member 2026-07-31 0000315700 fmr:C000014541Member fmr:TH1Member 2026-07-31 0000315700 fmr:C000014541Member fmr:TH2Member 2026-07-31 0000315700 fmr:C000014541Member fmr:TH3Member 2026-07-31 0000315700 fmr:C000014541Member fmr:TH4Member 2026-07-31 0000315700 fmr:C000014541Member fmr:TH5Member 2026-07-31 0000315700 fmr:C000014541Member fmr:TH6Member 2026-07-31 0000315700 fmr:C000014541Member fmr:TH7Member 2026-07-31 0000315700 fmr:C000014541Member fmr:TH8Member 2026-07-31 0000315700 fmr:C000014541Member fmr:TH9Member 2026-07-31 0000315700 fmr:C000014539Member 2025-07-31 2026-07-31 0000315700 fmr:C000014539_LG_ClassMember_11YRMember 2015-07-31 2026-07-31 0000315700 fmr:C000014539_ClassMember_AsOf_2016Member 2025-07-31 2026-07-31 0000315700 fmr:C000014539_ClassMember_AsOf_2017Member 2025-07-31 2026-07-31 0000315700 fmr:C000014539_ClassMember_AsOf_2018Member 2025-07-31 2026-07-31 0000315700 fmr:C000014539_ClassMember_AsOf_2019Member 2025-07-31 2026-07-31 0000315700 fmr:C000014539_ClassMember_AsOf_2020Member 2025-07-31 2026-07-31 0000315700 fmr:C000014539_ClassMember_AsOf_2021Member 2025-07-31 2026-07-31 0000315700 fmr:C000014539_ClassMember_AsOf_2022Member 2025-07-31 2026-07-31 0000315700 fmr:C000014539_ClassMember_AsOf_2023Member 2025-07-31 2026-07-31 0000315700 fmr:C000014539_ClassMember_AsOf_2024Member 2025-07-31 2026-07-31 0000315700 fmr:C000014539_ClassMember_AsOf_2025Member 2025-07-31 2026-07-31 0000315700 fmr:C000014539_ClassMember_AsOf_2026Member 2025-07-31 2026-07-31 0000315700 fmr:C000014539_LG_1_AdditionalIndexMember_11YRMember 2015-07-31 2026-07-31 0000315700 fmr:C000014539_1_AdditionalIndexMember_AsOf_2016Member 2025-07-31 2026-07-31 0000315700 fmr:C000014539_1_AdditionalIndexMember_AsOf_2017Member 2025-07-31 2026-07-31 0000315700 fmr:C000014539_1_AdditionalIndexMember_AsOf_2018Member 2025-07-31 2026-07-31 0000315700 fmr:C000014539_1_AdditionalIndexMember_AsOf_2019Member 2025-07-31 2026-07-31 0000315700 fmr:C000014539_1_AdditionalIndexMember_AsOf_2020Member 2025-07-31 2026-07-31 0000315700 fmr:C000014539_1_AdditionalIndexMember_AsOf_2021Member 2025-07-31 2026-07-31 0000315700 fmr:C000014539_1_AdditionalIndexMember_AsOf_2022Member 2025-07-31 2026-07-31 0000315700 fmr:C000014539_1_AdditionalIndexMember_AsOf_2023Member 2025-07-31 2026-07-31 0000315700 fmr:C000014539_1_AdditionalIndexMember_AsOf_2024Member 2025-07-31 2026-07-31 0000315700 fmr:C000014539_1_AdditionalIndexMember_AsOf_2025Member 2025-07-31 2026-07-31 0000315700 fmr:C000014539_1_AdditionalIndexMember_AsOf_2026Member 2025-07-31 2026-07-31 0000315700 fmr:C000014539_LG_2_AdditionalIndexMember_11YRMember 2015-07-31 2026-07-31 0000315700 fmr:C000014539_2_AdditionalIndexMember_AsOf_2016Member 2025-07-31 2026-07-31 0000315700 fmr:C000014539_2_AdditionalIndexMember_AsOf_2017Member 2025-07-31 2026-07-31 0000315700 fmr:C000014539_2_AdditionalIndexMember_AsOf_2018Member 2025-07-31 2026-07-31 0000315700 fmr:C000014539_2_AdditionalIndexMember_AsOf_2019Member 2025-07-31 2026-07-31 0000315700 fmr:C000014539_2_AdditionalIndexMember_AsOf_2020Member 2025-07-31 2026-07-31 0000315700 fmr:C000014539_2_AdditionalIndexMember_AsOf_2021Member 2025-07-31 2026-07-31 0000315700 fmr:C000014539_2_AdditionalIndexMember_AsOf_2022Member 2025-07-31 2026-07-31 0000315700 fmr:C000014539_2_AdditionalIndexMember_AsOf_2023Member 2025-07-31 2026-07-31 0000315700 fmr:C000014539_2_AdditionalIndexMember_AsOf_2024Member 2025-07-31 2026-07-31 0000315700 fmr:C000014539_2_AdditionalIndexMember_AsOf_2025Member 2025-07-31 2026-07-31 0000315700 fmr:C000014539_2_AdditionalIndexMember_AsOf_2026Member 2025-07-31 2026-07-31 0000315700 fmr:C000014539_ClassMember_1YRMember 2025-07-31 2026-07-31 0000315700 fmr:C000014539_ClassMember_5YRMember 2021-07-31 2026-07-31 0000315700 fmr:C000014539_ClassMember_10YRMember 2016-07-31 2026-07-31 0000315700 fmr:C000014539_NoLoadClassMember_1YRMember 2025-07-31 2026-07-31 0000315700 fmr:C000014539_NoLoadClassMember_5YRMember 2021-07-31 2026-07-31 0000315700 fmr:C000014539_NoLoadClassMember_10YRMember 2016-07-31 2026-07-31 0000315700 fmr:C000014539_0_AdditionalIndexMember_1YRMember 2025-07-31 2026-07-31 0000315700 fmr:C000014539_0_AdditionalIndexMember_5YRMember 2021-07-31 2026-07-31 0000315700 fmr:C000014539_0_AdditionalIndexMember_10YRMember 2016-07-31 2026-07-31 0000315700 fmr:C000014539_1_BBIndexMember_1YRMember 2025-07-31 2026-07-31 0000315700 fmr:C000014539_1_BBIndexMember_5YRMember 2021-07-31 2026-07-31 0000315700 fmr:C000014539_1_BBIndexMember_10YRMember 2016-07-31 2026-07-31 0000315700 fmr:C000014539Member 2026-07-31 0000315700 fmr:C000014539Member fmr:TI0Member 2026-07-31 0000315700 fmr:C000014539Member fmr:TI1Member 2026-07-31 0000315700 fmr:C000014539Member fmr:TI2Member 2026-07-31 0000315700 fmr:C000014539Member fmr:TI3Member 2026-07-31 0000315700 fmr:C000014539Member fmr:TI4Member 2026-07-31 0000315700 fmr:C000014539Member fmr:TI5Member 2026-07-31 0000315700 fmr:C000014539Member fmr:TI6Member 2026-07-31 0000315700 fmr:C000014539Member fmr:TI7Member 2026-07-31 0000315700 fmr:C000014539Member fmr:TI8Member 2026-07-31 0000315700 fmr:C000014539Member fmr:TI9Member 2026-07-31 0000315700 fmr:AACommonStocksMember fmr:C000014539Member 2026-07-31 0000315700 fmr:AAShortTermInvestmentsandNetOtherAssetsLiabilitiesMember fmr:C000014539Member 2026-07-31 0000315700 fmr:C000014539Member country:US 2026-07-31 0000315700 fmr:C000014539Member fmr:TH0Member 2026-07-31 0000315700 fmr:C000014539Member fmr:TH1Member 2026-07-31 0000315700 fmr:C000014539Member fmr:TH2Member 2026-07-31 0000315700 fmr:C000014539Member fmr:TH3Member 2026-07-31 0000315700 fmr:C000014539Member fmr:TH4Member 2026-07-31 0000315700 fmr:C000014539Member fmr:TH5Member 2026-07-31 0000315700 fmr:C000014539Member fmr:TH6Member 2026-07-31 0000315700 fmr:C000014539Member fmr:TH7Member 2026-07-31 0000315700 fmr:C000014539Member fmr:TH8Member 2026-07-31 0000315700 fmr:C000014539Member fmr:TH9Member 2026-07-31 0000315700 fmr:C000205005Member 2025-07-31 2026-07-31 0000315700 fmr:C000205005_LG_ClassMember_9YRMember 2017-07-31 2026-07-31 0000315700 fmr:C000205005_ClassMember_AsOf_2018Member 2025-07-31 2026-07-31 0000315700 fmr:C000205005_ClassMember_AsOf_2019Member 2025-07-31 2026-07-31 0000315700 fmr:C000205005_ClassMember_AsOf_2020Member 2025-07-31 2026-07-31 0000315700 fmr:C000205005_ClassMember_AsOf_2021Member 2025-07-31 2026-07-31 0000315700 fmr:C000205005_ClassMember_AsOf_2022Member 2025-07-31 2026-07-31 0000315700 fmr:C000205005_ClassMember_AsOf_2023Member 2025-07-31 2026-07-31 0000315700 fmr:C000205005_ClassMember_AsOf_2024Member 2025-07-31 2026-07-31 0000315700 fmr:C000205005_ClassMember_AsOf_2025Member 2025-07-31 2026-07-31 0000315700 fmr:C000205005_ClassMember_AsOf_2026Member 2025-07-31 2026-07-31 0000315700 fmr:C000205005_LG_1_AdditionalIndexMember_9YRMember 2017-07-31 2026-07-31 0000315700 fmr:C000205005_1_AdditionalIndexMember_AsOf_2018Member 2025-07-31 2026-07-31 0000315700 fmr:C000205005_1_AdditionalIndexMember_AsOf_2019Member 2025-07-31 2026-07-31 0000315700 fmr:C000205005_1_AdditionalIndexMember_AsOf_2020Member 2025-07-31 2026-07-31 0000315700 fmr:C000205005_1_AdditionalIndexMember_AsOf_2021Member 2025-07-31 2026-07-31 0000315700 fmr:C000205005_1_AdditionalIndexMember_AsOf_2022Member 2025-07-31 2026-07-31 0000315700 fmr:C000205005_1_AdditionalIndexMember_AsOf_2023Member 2025-07-31 2026-07-31 0000315700 fmr:C000205005_1_AdditionalIndexMember_AsOf_2024Member 2025-07-31 2026-07-31 0000315700 fmr:C000205005_1_AdditionalIndexMember_AsOf_2025Member 2025-07-31 2026-07-31 0000315700 fmr:C000205005_1_AdditionalIndexMember_AsOf_2026Member 2025-07-31 2026-07-31 0000315700 fmr:C000205005_LG_2_AdditionalIndexMember_9YRMember 2017-07-31 2026-07-31 0000315700 fmr:C000205005_2_AdditionalIndexMember_AsOf_2018Member 2025-07-31 2026-07-31 0000315700 fmr:C000205005_2_AdditionalIndexMember_AsOf_2019Member 2025-07-31 2026-07-31 0000315700 fmr:C000205005_2_AdditionalIndexMember_AsOf_2020Member 2025-07-31 2026-07-31 0000315700 fmr:C000205005_2_AdditionalIndexMember_AsOf_2021Member 2025-07-31 2026-07-31 0000315700 fmr:C000205005_2_AdditionalIndexMember_AsOf_2022Member 2025-07-31 2026-07-31 0000315700 fmr:C000205005_2_AdditionalIndexMember_AsOf_2023Member 2025-07-31 2026-07-31 0000315700 fmr:C000205005_2_AdditionalIndexMember_AsOf_2024Member 2025-07-31 2026-07-31 0000315700 fmr:C000205005_2_AdditionalIndexMember_AsOf_2025Member 2025-07-31 2026-07-31 0000315700 fmr:C000205005_2_AdditionalIndexMember_AsOf_2026Member 2025-07-31 2026-07-31 0000315700 fmr:C000205005_NoLoadClassMember_1YRMember 2025-07-31 2026-07-31 0000315700 fmr:C000205005_NoLoadClassMember_5YRMember 2021-07-31 2026-07-31 0000315700 fmr:C000205005_NoLoadClassMember_2025-08-01_2026-07-31Member 2025-07-31 2026-07-31 0000315700 fmr:C000205005_0_AdditionalIndexMember_1YRMember 2025-07-31 2026-07-31 0000315700 fmr:C000205005_0_AdditionalIndexMember_5YRMember 2021-07-31 2026-07-31 0000315700 fmr:C000205005_0_AdditionalIndexMember_LOCMember 2025-07-31 2026-07-31 0000315700 fmr:C000205005_1_BBIndexMember_1YRMember 2025-07-31 2026-07-31 0000315700 fmr:C000205005_1_BBIndexMember_5YRMember 2021-07-31 2026-07-31 0000315700 fmr:C000205005_1_BBIndexMember_LOCMember 2025-07-31 2026-07-31 0000315700 fmr:C000205005Member 2018-10-02 2026-07-31 0000315700 fmr:C000205005Member 2026-07-31 0000315700 fmr:C000205005Member fmr:TI0Member 2026-07-31 0000315700 fmr:C000205005Member fmr:TI1Member 2026-07-31 0000315700 fmr:C000205005Member fmr:TI2Member 2026-07-31 0000315700 fmr:C000205005Member fmr:TI3Member 2026-07-31 0000315700 fmr:C000205005Member fmr:TI4Member 2026-07-31 0000315700 fmr:C000205005Member fmr:TI5Member 2026-07-31 0000315700 fmr:AACommonStocksMember fmr:C000205005Member 2026-07-31 0000315700 fmr:AAShortTermInvestmentsandNetOtherAssetsLiabilitiesMember fmr:C000205005Member 2026-07-31 0000315700 fmr:C000205005Member country:US 2026-07-31 0000315700 fmr:C000205005Member country:GB 2026-07-31 0000315700 fmr:C000205005Member country:PR 2026-07-31 0000315700 fmr:C000205005Member country:AU 2026-07-31 0000315700 fmr:C000205005Member fmr:GrandCaymanUKOverseasTerMember 2026-07-31 0000315700 fmr:C000205005Member country:MX 2026-07-31 0000315700 fmr:C000205005Member country:FR 2026-07-31 0000315700 fmr:C000205005Member fmr:TH0Member 2026-07-31 0000315700 fmr:C000205005Member fmr:TH1Member 2026-07-31 0000315700 fmr:C000205005Member fmr:TH2Member 2026-07-31 0000315700 fmr:C000205005Member fmr:TH3Member 2026-07-31 0000315700 fmr:C000205005Member fmr:TH4Member 2026-07-31 0000315700 fmr:C000205005Member fmr:TH5Member 2026-07-31 0000315700 fmr:C000205005Member fmr:TH6Member 2026-07-31 0000315700 fmr:C000205005Member fmr:TH7Member 2026-07-31 0000315700 fmr:C000205005Member fmr:TH8Member 2026-07-31 0000315700 fmr:C000205005Member fmr:TH9Member 2026-07-31 0000315700 fmr:C000014557Member 2025-07-31 2026-07-31 0000315700 fmr:C000014557_LG_ClassMember_11YRMember 2015-07-31 2026-07-31 0000315700 fmr:C000014557_ClassMember_AsOf_2016Member 2025-07-31 2026-07-31 0000315700 fmr:C000014557_ClassMember_AsOf_2017Member 2025-07-31 2026-07-31 0000315700 fmr:C000014557_ClassMember_AsOf_2018Member 2025-07-31 2026-07-31 0000315700 fmr:C000014557_ClassMember_AsOf_2019Member 2025-07-31 2026-07-31 0000315700 fmr:C000014557_ClassMember_AsOf_2020Member 2025-07-31 2026-07-31 0000315700 fmr:C000014557_ClassMember_AsOf_2021Member 2025-07-31 2026-07-31 0000315700 fmr:C000014557_ClassMember_AsOf_2022Member 2025-07-31 2026-07-31 0000315700 fmr:C000014557_ClassMember_AsOf_2023Member 2025-07-31 2026-07-31 0000315700 fmr:C000014557_ClassMember_AsOf_2024Member 2025-07-31 2026-07-31 0000315700 fmr:C000014557_ClassMember_AsOf_2025Member 2025-07-31 2026-07-31 0000315700 fmr:C000014557_ClassMember_AsOf_2026Member 2025-07-31 2026-07-31 0000315700 fmr:C000014557_LG_1_AdditionalIndexMember_11YRMember 2015-07-31 2026-07-31 0000315700 fmr:C000014557_1_AdditionalIndexMember_AsOf_2016Member 2025-07-31 2026-07-31 0000315700 fmr:C000014557_1_AdditionalIndexMember_AsOf_2017Member 2025-07-31 2026-07-31 0000315700 fmr:C000014557_1_AdditionalIndexMember_AsOf_2018Member 2025-07-31 2026-07-31 0000315700 fmr:C000014557_1_AdditionalIndexMember_AsOf_2019Member 2025-07-31 2026-07-31 0000315700 fmr:C000014557_1_AdditionalIndexMember_AsOf_2020Member 2025-07-31 2026-07-31 0000315700 fmr:C000014557_1_AdditionalIndexMember_AsOf_2021Member 2025-07-31 2026-07-31 0000315700 fmr:C000014557_1_AdditionalIndexMember_AsOf_2022Member 2025-07-31 2026-07-31 0000315700 fmr:C000014557_1_AdditionalIndexMember_AsOf_2023Member 2025-07-31 2026-07-31 0000315700 fmr:C000014557_1_AdditionalIndexMember_AsOf_2024Member 2025-07-31 2026-07-31 0000315700 fmr:C000014557_1_AdditionalIndexMember_AsOf_2025Member 2025-07-31 2026-07-31 0000315700 fmr:C000014557_1_AdditionalIndexMember_AsOf_2026Member 2025-07-31 2026-07-31 0000315700 fmr:C000014557_LG_2_AdditionalIndexMember_11YRMember 2015-07-31 2026-07-31 0000315700 fmr:C000014557_2_AdditionalIndexMember_AsOf_2016Member 2025-07-31 2026-07-31 0000315700 fmr:C000014557_2_AdditionalIndexMember_AsOf_2017Member 2025-07-31 2026-07-31 0000315700 fmr:C000014557_2_AdditionalIndexMember_AsOf_2018Member 2025-07-31 2026-07-31 0000315700 fmr:C000014557_2_AdditionalIndexMember_AsOf_2019Member 2025-07-31 2026-07-31 0000315700 fmr:C000014557_2_AdditionalIndexMember_AsOf_2020Member 2025-07-31 2026-07-31 0000315700 fmr:C000014557_2_AdditionalIndexMember_AsOf_2021Member 2025-07-31 2026-07-31 0000315700 fmr:C000014557_2_AdditionalIndexMember_AsOf_2022Member 2025-07-31 2026-07-31 0000315700 fmr:C000014557_2_AdditionalIndexMember_AsOf_2023Member 2025-07-31 2026-07-31 0000315700 fmr:C000014557_2_AdditionalIndexMember_AsOf_2024Member 2025-07-31 2026-07-31 0000315700 fmr:C000014557_2_AdditionalIndexMember_AsOf_2025Member 2025-07-31 2026-07-31 0000315700 fmr:C000014557_2_AdditionalIndexMember_AsOf_2026Member 2025-07-31 2026-07-31 0000315700 fmr:C000014557_ClassMember_1YRMember 2025-07-31 2026-07-31 0000315700 fmr:C000014557_ClassMember_5YRMember 2021-07-31 2026-07-31 0000315700 fmr:C000014557_ClassMember_10YRMember 2016-07-31 2026-07-31 0000315700 fmr:C000014557_NoLoadClassMember_1YRMember 2025-07-31 2026-07-31 0000315700 fmr:C000014557_NoLoadClassMember_5YRMember 2021-07-31 2026-07-31 0000315700 fmr:C000014557_NoLoadClassMember_10YRMember 2016-07-31 2026-07-31 0000315700 fmr:C000014557_0_AdditionalIndexMember_1YRMember 2025-07-31 2026-07-31 0000315700 fmr:C000014557_0_AdditionalIndexMember_5YRMember 2021-07-31 2026-07-31 0000315700 fmr:C000014557_0_AdditionalIndexMember_10YRMember 2016-07-31 2026-07-31 0000315700 fmr:C000014557_1_BBIndexMember_1YRMember 2025-07-31 2026-07-31 0000315700 fmr:C000014557_1_BBIndexMember_5YRMember 2021-07-31 2026-07-31 0000315700 fmr:C000014557_1_BBIndexMember_10YRMember 2016-07-31 2026-07-31 0000315700 fmr:C000014557Member 2026-07-31 0000315700 fmr:C000014557Member fmr:TI0Member 2026-07-31 0000315700 fmr:C000014557Member fmr:TI1Member 2026-07-31 0000315700 fmr:C000014557Member fmr:TI2Member 2026-07-31 0000315700 fmr:C000014557Member fmr:TI3Member 2026-07-31 0000315700 fmr:C000014557Member fmr:TI4Member 2026-07-31 0000315700 fmr:C000014557Member fmr:TI5Member 2026-07-31 0000315700 fmr:AACommonStocksMember fmr:C000014557Member 2026-07-31 0000315700 fmr:AAShortTermInvestmentsandNetOtherAssetsLiabilitiesMember fmr:C000014557Member 2026-07-31 0000315700 fmr:C000014557Member country:US 2026-07-31 0000315700 fmr:C000014557Member country:GB 2026-07-31 0000315700 fmr:C000014557Member country:PR 2026-07-31 0000315700 fmr:C000014557Member country:AU 2026-07-31 0000315700 fmr:C000014557Member fmr:GrandCaymanUKOverseasTerMember 2026-07-31 0000315700 fmr:C000014557Member country:MX 2026-07-31 0000315700 fmr:C000014557Member country:FR 2026-07-31 0000315700 fmr:C000014557Member fmr:TH0Member 2026-07-31 0000315700 fmr:C000014557Member fmr:TH1Member 2026-07-31 0000315700 fmr:C000014557Member fmr:TH2Member 2026-07-31 0000315700 fmr:C000014557Member fmr:TH3Member 2026-07-31 0000315700 fmr:C000014557Member fmr:TH4Member 2026-07-31 0000315700 fmr:C000014557Member fmr:TH5Member 2026-07-31 0000315700 fmr:C000014557Member fmr:TH6Member 2026-07-31 0000315700 fmr:C000014557Member fmr:TH7Member 2026-07-31 0000315700 fmr:C000014557Member fmr:TH8Member 2026-07-31 0000315700 fmr:C000014557Member fmr:TH9Member 2026-07-31 0000315700 fmr:C000014558Member 2025-07-31 2026-07-31 0000315700 fmr:C000014558_LG_ClassMember_11YRMember 2015-07-31 2026-07-31 0000315700 fmr:C000014558_ClassMember_AsOf_2016Member 2025-07-31 2026-07-31 0000315700 fmr:C000014558_ClassMember_AsOf_2017Member 2025-07-31 2026-07-31 0000315700 fmr:C000014558_ClassMember_AsOf_2018Member 2025-07-31 2026-07-31 0000315700 fmr:C000014558_ClassMember_AsOf_2019Member 2025-07-31 2026-07-31 0000315700 fmr:C000014558_ClassMember_AsOf_2020Member 2025-07-31 2026-07-31 0000315700 fmr:C000014558_ClassMember_AsOf_2021Member 2025-07-31 2026-07-31 0000315700 fmr:C000014558_ClassMember_AsOf_2022Member 2025-07-31 2026-07-31 0000315700 fmr:C000014558_ClassMember_AsOf_2023Member 2025-07-31 2026-07-31 0000315700 fmr:C000014558_ClassMember_AsOf_2024Member 2025-07-31 2026-07-31 0000315700 fmr:C000014558_ClassMember_AsOf_2025Member 2025-07-31 2026-07-31 0000315700 fmr:C000014558_ClassMember_AsOf_2026Member 2025-07-31 2026-07-31 0000315700 fmr:C000014558_LG_1_AdditionalIndexMember_11YRMember 2015-07-31 2026-07-31 0000315700 fmr:C000014558_1_AdditionalIndexMember_AsOf_2016Member 2025-07-31 2026-07-31 0000315700 fmr:C000014558_1_AdditionalIndexMember_AsOf_2017Member 2025-07-31 2026-07-31 0000315700 fmr:C000014558_1_AdditionalIndexMember_AsOf_2018Member 2025-07-31 2026-07-31 0000315700 fmr:C000014558_1_AdditionalIndexMember_AsOf_2019Member 2025-07-31 2026-07-31 0000315700 fmr:C000014558_1_AdditionalIndexMember_AsOf_2020Member 2025-07-31 2026-07-31 0000315700 fmr:C000014558_1_AdditionalIndexMember_AsOf_2021Member 2025-07-31 2026-07-31 0000315700 fmr:C000014558_1_AdditionalIndexMember_AsOf_2022Member 2025-07-31 2026-07-31 0000315700 fmr:C000014558_1_AdditionalIndexMember_AsOf_2023Member 2025-07-31 2026-07-31 0000315700 fmr:C000014558_1_AdditionalIndexMember_AsOf_2024Member 2025-07-31 2026-07-31 0000315700 fmr:C000014558_1_AdditionalIndexMember_AsOf_2025Member 2025-07-31 2026-07-31 0000315700 fmr:C000014558_1_AdditionalIndexMember_AsOf_2026Member 2025-07-31 2026-07-31 0000315700 fmr:C000014558_LG_2_AdditionalIndexMember_11YRMember 2015-07-31 2026-07-31 0000315700 fmr:C000014558_2_AdditionalIndexMember_AsOf_2016Member 2025-07-31 2026-07-31 0000315700 fmr:C000014558_2_AdditionalIndexMember_AsOf_2017Member 2025-07-31 2026-07-31 0000315700 fmr:C000014558_2_AdditionalIndexMember_AsOf_2018Member 2025-07-31 2026-07-31 0000315700 fmr:C000014558_2_AdditionalIndexMember_AsOf_2019Member 2025-07-31 2026-07-31 0000315700 fmr:C000014558_2_AdditionalIndexMember_AsOf_2020Member 2025-07-31 2026-07-31 0000315700 fmr:C000014558_2_AdditionalIndexMember_AsOf_2021Member 2025-07-31 2026-07-31 0000315700 fmr:C000014558_2_AdditionalIndexMember_AsOf_2022Member 2025-07-31 2026-07-31 0000315700 fmr:C000014558_2_AdditionalIndexMember_AsOf_2023Member 2025-07-31 2026-07-31 0000315700 fmr:C000014558_2_AdditionalIndexMember_AsOf_2024Member 2025-07-31 2026-07-31 0000315700 fmr:C000014558_2_AdditionalIndexMember_AsOf_2025Member 2025-07-31 2026-07-31 0000315700 fmr:C000014558_2_AdditionalIndexMember_AsOf_2026Member 2025-07-31 2026-07-31 0000315700 fmr:C000014558_NoLoadClassMember_1YRMember 2025-07-31 2026-07-31 0000315700 fmr:C000014558_NoLoadClassMember_5YRMember 2021-07-31 2026-07-31 0000315700 fmr:C000014558_NoLoadClassMember_10YRMember 2016-07-31 2026-07-31 0000315700 fmr:C000014558_0_AdditionalIndexMember_1YRMember 2025-07-31 2026-07-31 0000315700 fmr:C000014558_0_AdditionalIndexMember_5YRMember 2021-07-31 2026-07-31 0000315700 fmr:C000014558_0_AdditionalIndexMember_10YRMember 2016-07-31 2026-07-31 0000315700 fmr:C000014558_1_BBIndexMember_1YRMember 2025-07-31 2026-07-31 0000315700 fmr:C000014558_1_BBIndexMember_5YRMember 2021-07-31 2026-07-31 0000315700 fmr:C000014558_1_BBIndexMember_10YRMember 2016-07-31 2026-07-31 0000315700 fmr:C000014558Member 2026-07-31 0000315700 fmr:C000014558Member fmr:TI0Member 2026-07-31 0000315700 fmr:C000014558Member fmr:TI1Member 2026-07-31 0000315700 fmr:C000014558Member fmr:TI2Member 2026-07-31 0000315700 fmr:C000014558Member fmr:TI3Member 2026-07-31 0000315700 fmr:C000014558Member fmr:TI4Member 2026-07-31 0000315700 fmr:C000014558Member fmr:TI5Member 2026-07-31 0000315700 fmr:AACommonStocksMember fmr:C000014558Member 2026-07-31 0000315700 fmr:AAShortTermInvestmentsandNetOtherAssetsLiabilitiesMember fmr:C000014558Member 2026-07-31 0000315700 fmr:C000014558Member country:US 2026-07-31 0000315700 fmr:C000014558Member country:GB 2026-07-31 0000315700 fmr:C000014558Member country:PR 2026-07-31 0000315700 fmr:C000014558Member country:AU 2026-07-31 0000315700 fmr:C000014558Member fmr:GrandCaymanUKOverseasTerMember 2026-07-31 0000315700 fmr:C000014558Member country:MX 2026-07-31 0000315700 fmr:C000014558Member country:FR 2026-07-31 0000315700 fmr:C000014558Member fmr:TH0Member 2026-07-31 0000315700 fmr:C000014558Member fmr:TH1Member 2026-07-31 0000315700 fmr:C000014558Member fmr:TH2Member 2026-07-31 0000315700 fmr:C000014558Member fmr:TH3Member 2026-07-31 0000315700 fmr:C000014558Member fmr:TH4Member 2026-07-31 0000315700 fmr:C000014558Member fmr:TH5Member 2026-07-31 0000315700 fmr:C000014558Member fmr:TH6Member 2026-07-31 0000315700 fmr:C000014558Member fmr:TH7Member 2026-07-31 0000315700 fmr:C000014558Member fmr:TH8Member 2026-07-31 0000315700 fmr:C000014558Member fmr:TH9Member 2026-07-31 0000315700 fmr:C000014556Member 2025-07-31 2026-07-31 0000315700 fmr:C000014556_LG_ClassMember_11YRMember 2015-07-31 2026-07-31 0000315700 fmr:C000014556_ClassMember_AsOf_2016Member 2025-07-31 2026-07-31 0000315700 fmr:C000014556_ClassMember_AsOf_2017Member 2025-07-31 2026-07-31 0000315700 fmr:C000014556_ClassMember_AsOf_2018Member 2025-07-31 2026-07-31 0000315700 fmr:C000014556_ClassMember_AsOf_2019Member 2025-07-31 2026-07-31 0000315700 fmr:C000014556_ClassMember_AsOf_2020Member 2025-07-31 2026-07-31 0000315700 fmr:C000014556_ClassMember_AsOf_2021Member 2025-07-31 2026-07-31 0000315700 fmr:C000014556_ClassMember_AsOf_2022Member 2025-07-31 2026-07-31 0000315700 fmr:C000014556_ClassMember_AsOf_2023Member 2025-07-31 2026-07-31 0000315700 fmr:C000014556_ClassMember_AsOf_2024Member 2025-07-31 2026-07-31 0000315700 fmr:C000014556_ClassMember_AsOf_2025Member 2025-07-31 2026-07-31 0000315700 fmr:C000014556_ClassMember_AsOf_2026Member 2025-07-31 2026-07-31 0000315700 fmr:C000014556_LG_1_AdditionalIndexMember_11YRMember 2015-07-31 2026-07-31 0000315700 fmr:C000014556_1_AdditionalIndexMember_AsOf_2016Member 2025-07-31 2026-07-31 0000315700 fmr:C000014556_1_AdditionalIndexMember_AsOf_2017Member 2025-07-31 2026-07-31 0000315700 fmr:C000014556_1_AdditionalIndexMember_AsOf_2018Member 2025-07-31 2026-07-31 0000315700 fmr:C000014556_1_AdditionalIndexMember_AsOf_2019Member 2025-07-31 2026-07-31 0000315700 fmr:C000014556_1_AdditionalIndexMember_AsOf_2020Member 2025-07-31 2026-07-31 0000315700 fmr:C000014556_1_AdditionalIndexMember_AsOf_2021Member 2025-07-31 2026-07-31 0000315700 fmr:C000014556_1_AdditionalIndexMember_AsOf_2022Member 2025-07-31 2026-07-31 0000315700 fmr:C000014556_1_AdditionalIndexMember_AsOf_2023Member 2025-07-31 2026-07-31 0000315700 fmr:C000014556_1_AdditionalIndexMember_AsOf_2024Member 2025-07-31 2026-07-31 0000315700 fmr:C000014556_1_AdditionalIndexMember_AsOf_2025Member 2025-07-31 2026-07-31 0000315700 fmr:C000014556_1_AdditionalIndexMember_AsOf_2026Member 2025-07-31 2026-07-31 0000315700 fmr:C000014556_LG_2_AdditionalIndexMember_11YRMember 2015-07-31 2026-07-31 0000315700 fmr:C000014556_2_AdditionalIndexMember_AsOf_2016Member 2025-07-31 2026-07-31 0000315700 fmr:C000014556_2_AdditionalIndexMember_AsOf_2017Member 2025-07-31 2026-07-31 0000315700 fmr:C000014556_2_AdditionalIndexMember_AsOf_2018Member 2025-07-31 2026-07-31 0000315700 fmr:C000014556_2_AdditionalIndexMember_AsOf_2019Member 2025-07-31 2026-07-31 0000315700 fmr:C000014556_2_AdditionalIndexMember_AsOf_2020Member 2025-07-31 2026-07-31 0000315700 fmr:C000014556_2_AdditionalIndexMember_AsOf_2021Member 2025-07-31 2026-07-31 0000315700 fmr:C000014556_2_AdditionalIndexMember_AsOf_2022Member 2025-07-31 2026-07-31 0000315700 fmr:C000014556_2_AdditionalIndexMember_AsOf_2023Member 2025-07-31 2026-07-31 0000315700 fmr:C000014556_2_AdditionalIndexMember_AsOf_2024Member 2025-07-31 2026-07-31 0000315700 fmr:C000014556_2_AdditionalIndexMember_AsOf_2025Member 2025-07-31 2026-07-31 0000315700 fmr:C000014556_2_AdditionalIndexMember_AsOf_2026Member 2025-07-31 2026-07-31 0000315700 fmr:C000014556_ClassMember_1YRMember 2025-07-31 2026-07-31 0000315700 fmr:C000014556_ClassMember_5YRMember 2021-07-31 2026-07-31 0000315700 fmr:C000014556_ClassMember_10YRMember 2016-07-31 2026-07-31 0000315700 fmr:C000014556_NoLoadClassMember_1YRMember 2025-07-31 2026-07-31 0000315700 fmr:C000014556_NoLoadClassMember_5YRMember 2021-07-31 2026-07-31 0000315700 fmr:C000014556_NoLoadClassMember_10YRMember 2016-07-31 2026-07-31 0000315700 fmr:C000014556_0_AdditionalIndexMember_1YRMember 2025-07-31 2026-07-31 0000315700 fmr:C000014556_0_AdditionalIndexMember_5YRMember 2021-07-31 2026-07-31 0000315700 fmr:C000014556_0_AdditionalIndexMember_10YRMember 2016-07-31 2026-07-31 0000315700 fmr:C000014556_1_BBIndexMember_1YRMember 2025-07-31 2026-07-31 0000315700 fmr:C000014556_1_BBIndexMember_5YRMember 2021-07-31 2026-07-31 0000315700 fmr:C000014556_1_BBIndexMember_10YRMember 2016-07-31 2026-07-31 0000315700 fmr:C000014556Member 2026-07-31 0000315700 fmr:C000014556Member fmr:TI0Member 2026-07-31 0000315700 fmr:C000014556Member fmr:TI1Member 2026-07-31 0000315700 fmr:C000014556Member fmr:TI2Member 2026-07-31 0000315700 fmr:C000014556Member fmr:TI3Member 2026-07-31 0000315700 fmr:C000014556Member fmr:TI4Member 2026-07-31 0000315700 fmr:C000014556Member fmr:TI5Member 2026-07-31 0000315700 fmr:AACommonStocksMember fmr:C000014556Member 2026-07-31 0000315700 fmr:AAShortTermInvestmentsandNetOtherAssetsLiabilitiesMember fmr:C000014556Member 2026-07-31 0000315700 fmr:C000014556Member country:US 2026-07-31 0000315700 fmr:C000014556Member country:GB 2026-07-31 0000315700 fmr:C000014556Member country:PR 2026-07-31 0000315700 fmr:C000014556Member country:AU 2026-07-31 0000315700 fmr:C000014556Member fmr:GrandCaymanUKOverseasTerMember 2026-07-31 0000315700 fmr:C000014556Member country:MX 2026-07-31 0000315700 fmr:C000014556Member country:FR 2026-07-31 0000315700 fmr:C000014556Member fmr:TH0Member 2026-07-31 0000315700 fmr:C000014556Member fmr:TH1Member 2026-07-31 0000315700 fmr:C000014556Member fmr:TH2Member 2026-07-31 0000315700 fmr:C000014556Member fmr:TH3Member 2026-07-31 0000315700 fmr:C000014556Member fmr:TH4Member 2026-07-31 0000315700 fmr:C000014556Member fmr:TH5Member 2026-07-31 0000315700 fmr:C000014556Member fmr:TH6Member 2026-07-31 0000315700 fmr:C000014556Member fmr:TH7Member 2026-07-31 0000315700 fmr:C000014556Member fmr:TH8Member 2026-07-31 0000315700 fmr:C000014556Member fmr:TH9Member 2026-07-31 0000315700 fmr:C000014554Member 2025-07-31 2026-07-31 0000315700 fmr:C000014554_LG_ClassMember_11YRMember 2015-07-31 2026-07-31 0000315700 fmr:C000014554_ClassMember_AsOf_2016Member 2025-07-31 2026-07-31 0000315700 fmr:C000014554_ClassMember_AsOf_2017Member 2025-07-31 2026-07-31 0000315700 fmr:C000014554_ClassMember_AsOf_2018Member 2025-07-31 2026-07-31 0000315700 fmr:C000014554_ClassMember_AsOf_2019Member 2025-07-31 2026-07-31 0000315700 fmr:C000014554_ClassMember_AsOf_2020Member 2025-07-31 2026-07-31 0000315700 fmr:C000014554_ClassMember_AsOf_2021Member 2025-07-31 2026-07-31 0000315700 fmr:C000014554_ClassMember_AsOf_2022Member 2025-07-31 2026-07-31 0000315700 fmr:C000014554_ClassMember_AsOf_2023Member 2025-07-31 2026-07-31 0000315700 fmr:C000014554_ClassMember_AsOf_2024Member 2025-07-31 2026-07-31 0000315700 fmr:C000014554_ClassMember_AsOf_2025Member 2025-07-31 2026-07-31 0000315700 fmr:C000014554_ClassMember_AsOf_2026Member 2025-07-31 2026-07-31 0000315700 fmr:C000014554_LG_1_AdditionalIndexMember_11YRMember 2015-07-31 2026-07-31 0000315700 fmr:C000014554_1_AdditionalIndexMember_AsOf_2016Member 2025-07-31 2026-07-31 0000315700 fmr:C000014554_1_AdditionalIndexMember_AsOf_2017Member 2025-07-31 2026-07-31 0000315700 fmr:C000014554_1_AdditionalIndexMember_AsOf_2018Member 2025-07-31 2026-07-31 0000315700 fmr:C000014554_1_AdditionalIndexMember_AsOf_2019Member 2025-07-31 2026-07-31 0000315700 fmr:C000014554_1_AdditionalIndexMember_AsOf_2020Member 2025-07-31 2026-07-31 0000315700 fmr:C000014554_1_AdditionalIndexMember_AsOf_2021Member 2025-07-31 2026-07-31 0000315700 fmr:C000014554_1_AdditionalIndexMember_AsOf_2022Member 2025-07-31 2026-07-31 0000315700 fmr:C000014554_1_AdditionalIndexMember_AsOf_2023Member 2025-07-31 2026-07-31 0000315700 fmr:C000014554_1_AdditionalIndexMember_AsOf_2024Member 2025-07-31 2026-07-31 0000315700 fmr:C000014554_1_AdditionalIndexMember_AsOf_2025Member 2025-07-31 2026-07-31 0000315700 fmr:C000014554_1_AdditionalIndexMember_AsOf_2026Member 2025-07-31 2026-07-31 0000315700 fmr:C000014554_LG_2_AdditionalIndexMember_11YRMember 2015-07-31 2026-07-31 0000315700 fmr:C000014554_2_AdditionalIndexMember_AsOf_2016Member 2025-07-31 2026-07-31 0000315700 fmr:C000014554_2_AdditionalIndexMember_AsOf_2017Member 2025-07-31 2026-07-31 0000315700 fmr:C000014554_2_AdditionalIndexMember_AsOf_2018Member 2025-07-31 2026-07-31 0000315700 fmr:C000014554_2_AdditionalIndexMember_AsOf_2019Member 2025-07-31 2026-07-31 0000315700 fmr:C000014554_2_AdditionalIndexMember_AsOf_2020Member 2025-07-31 2026-07-31 0000315700 fmr:C000014554_2_AdditionalIndexMember_AsOf_2021Member 2025-07-31 2026-07-31 0000315700 fmr:C000014554_2_AdditionalIndexMember_AsOf_2022Member 2025-07-31 2026-07-31 0000315700 fmr:C000014554_2_AdditionalIndexMember_AsOf_2023Member 2025-07-31 2026-07-31 0000315700 fmr:C000014554_2_AdditionalIndexMember_AsOf_2024Member 2025-07-31 2026-07-31 0000315700 fmr:C000014554_2_AdditionalIndexMember_AsOf_2025Member 2025-07-31 2026-07-31 0000315700 fmr:C000014554_2_AdditionalIndexMember_AsOf_2026Member 2025-07-31 2026-07-31 0000315700 fmr:C000014554_ClassMember_1YRMember 2025-07-31 2026-07-31 0000315700 fmr:C000014554_ClassMember_5YRMember 2021-07-31 2026-07-31 0000315700 fmr:C000014554_ClassMember_10YRMember 2016-07-31 2026-07-31 0000315700 fmr:C000014554_NoLoadClassMember_1YRMember 2025-07-31 2026-07-31 0000315700 fmr:C000014554_NoLoadClassMember_5YRMember 2021-07-31 2026-07-31 0000315700 fmr:C000014554_NoLoadClassMember_10YRMember 2016-07-31 2026-07-31 0000315700 fmr:C000014554_0_AdditionalIndexMember_1YRMember 2025-07-31 2026-07-31 0000315700 fmr:C000014554_0_AdditionalIndexMember_5YRMember 2021-07-31 2026-07-31 0000315700 fmr:C000014554_0_AdditionalIndexMember_10YRMember 2016-07-31 2026-07-31 0000315700 fmr:C000014554_1_BBIndexMember_1YRMember 2025-07-31 2026-07-31 0000315700 fmr:C000014554_1_BBIndexMember_5YRMember 2021-07-31 2026-07-31 0000315700 fmr:C000014554_1_BBIndexMember_10YRMember 2016-07-31 2026-07-31 0000315700 fmr:C000014554Member 2026-07-31 0000315700 fmr:C000014554Member fmr:TI0Member 2026-07-31 0000315700 fmr:C000014554Member fmr:TI1Member 2026-07-31 0000315700 fmr:C000014554Member fmr:TI2Member 2026-07-31 0000315700 fmr:C000014554Member fmr:TI3Member 2026-07-31 0000315700 fmr:C000014554Member fmr:TI4Member 2026-07-31 0000315700 fmr:C000014554Member fmr:TI5Member 2026-07-31 0000315700 fmr:AACommonStocksMember fmr:C000014554Member 2026-07-31 0000315700 fmr:AAShortTermInvestmentsandNetOtherAssetsLiabilitiesMember fmr:C000014554Member 2026-07-31 0000315700 fmr:C000014554Member country:US 2026-07-31 0000315700 fmr:C000014554Member country:GB 2026-07-31 0000315700 fmr:C000014554Member country:PR 2026-07-31 0000315700 fmr:C000014554Member country:AU 2026-07-31 0000315700 fmr:C000014554Member fmr:GrandCaymanUKOverseasTerMember 2026-07-31 0000315700 fmr:C000014554Member country:MX 2026-07-31 0000315700 fmr:C000014554Member country:FR 2026-07-31 0000315700 fmr:C000014554Member fmr:TH0Member 2026-07-31 0000315700 fmr:C000014554Member fmr:TH1Member 2026-07-31 0000315700 fmr:C000014554Member fmr:TH2Member 2026-07-31 0000315700 fmr:C000014554Member fmr:TH3Member 2026-07-31 0000315700 fmr:C000014554Member fmr:TH4Member 2026-07-31 0000315700 fmr:C000014554Member fmr:TH5Member 2026-07-31 0000315700 fmr:C000014554Member fmr:TH6Member 2026-07-31 0000315700 fmr:C000014554Member fmr:TH7Member 2026-07-31 0000315700 fmr:C000014554Member fmr:TH8Member 2026-07-31 0000315700 fmr:C000014554Member fmr:TH9Member 2026-07-31 0000315700 fmr:C000204999Member 2025-07-31 2026-07-31 0000315700 fmr:C000204999_LG_ClassMember_9YRMember 2017-07-31 2026-07-31 0000315700 fmr:C000204999_ClassMember_AsOf_2018Member 2025-07-31 2026-07-31 0000315700 fmr:C000204999_ClassMember_AsOf_2019Member 2025-07-31 2026-07-31 0000315700 fmr:C000204999_ClassMember_AsOf_2020Member 2025-07-31 2026-07-31 0000315700 fmr:C000204999_ClassMember_AsOf_2021Member 2025-07-31 2026-07-31 0000315700 fmr:C000204999_ClassMember_AsOf_2022Member 2025-07-31 2026-07-31 0000315700 fmr:C000204999_ClassMember_AsOf_2023Member 2025-07-31 2026-07-31 0000315700 fmr:C000204999_ClassMember_AsOf_2024Member 2025-07-31 2026-07-31 0000315700 fmr:C000204999_ClassMember_AsOf_2025Member 2025-07-31 2026-07-31 0000315700 fmr:C000204999_ClassMember_AsOf_2026Member 2025-07-31 2026-07-31 0000315700 fmr:C000204999_LG_1_AdditionalIndexMember_9YRMember 2017-07-31 2026-07-31 0000315700 fmr:C000204999_1_AdditionalIndexMember_AsOf_2018Member 2025-07-31 2026-07-31 0000315700 fmr:C000204999_1_AdditionalIndexMember_AsOf_2019Member 2025-07-31 2026-07-31 0000315700 fmr:C000204999_1_AdditionalIndexMember_AsOf_2020Member 2025-07-31 2026-07-31 0000315700 fmr:C000204999_1_AdditionalIndexMember_AsOf_2021Member 2025-07-31 2026-07-31 0000315700 fmr:C000204999_1_AdditionalIndexMember_AsOf_2022Member 2025-07-31 2026-07-31 0000315700 fmr:C000204999_1_AdditionalIndexMember_AsOf_2023Member 2025-07-31 2026-07-31 0000315700 fmr:C000204999_1_AdditionalIndexMember_AsOf_2024Member 2025-07-31 2026-07-31 0000315700 fmr:C000204999_1_AdditionalIndexMember_AsOf_2025Member 2025-07-31 2026-07-31 0000315700 fmr:C000204999_1_AdditionalIndexMember_AsOf_2026Member 2025-07-31 2026-07-31 0000315700 fmr:C000204999_LG_2_AdditionalIndexMember_9YRMember 2017-07-31 2026-07-31 0000315700 fmr:C000204999_2_AdditionalIndexMember_AsOf_2018Member 2025-07-31 2026-07-31 0000315700 fmr:C000204999_2_AdditionalIndexMember_AsOf_2019Member 2025-07-31 2026-07-31 0000315700 fmr:C000204999_2_AdditionalIndexMember_AsOf_2020Member 2025-07-31 2026-07-31 0000315700 fmr:C000204999_2_AdditionalIndexMember_AsOf_2021Member 2025-07-31 2026-07-31 0000315700 fmr:C000204999_2_AdditionalIndexMember_AsOf_2022Member 2025-07-31 2026-07-31 0000315700 fmr:C000204999_2_AdditionalIndexMember_AsOf_2023Member 2025-07-31 2026-07-31 0000315700 fmr:C000204999_2_AdditionalIndexMember_AsOf_2024Member 2025-07-31 2026-07-31 0000315700 fmr:C000204999_2_AdditionalIndexMember_AsOf_2025Member 2025-07-31 2026-07-31 0000315700 fmr:C000204999_2_AdditionalIndexMember_AsOf_2026Member 2025-07-31 2026-07-31 0000315700 fmr:C000204999_NoLoadClassMember_1YRMember 2025-07-31 2026-07-31 0000315700 fmr:C000204999_NoLoadClassMember_5YRMember 2021-07-31 2026-07-31 0000315700 fmr:C000204999_NoLoadClassMember_2025-08-01_2026-07-31Member 2025-07-31 2026-07-31 0000315700 fmr:C000204999_0_AdditionalIndexMember_1YRMember 2025-07-31 2026-07-31 0000315700 fmr:C000204999_0_AdditionalIndexMember_5YRMember 2021-07-31 2026-07-31 0000315700 fmr:C000204999_0_AdditionalIndexMember_LOCMember 2025-07-31 2026-07-31 0000315700 fmr:C000204999_1_BBIndexMember_1YRMember 2025-07-31 2026-07-31 0000315700 fmr:C000204999_1_BBIndexMember_5YRMember 2021-07-31 2026-07-31 0000315700 fmr:C000204999_1_BBIndexMember_LOCMember 2025-07-31 2026-07-31 0000315700 fmr:C000204999Member 2018-10-02 2026-07-31 0000315700 fmr:C000204999Member 2026-07-31 0000315700 fmr:C000204999Member fmr:TI0Member 2026-07-31 0000315700 fmr:C000204999Member fmr:TI1Member 2026-07-31 0000315700 fmr:C000204999Member fmr:TI2Member 2026-07-31 0000315700 fmr:AACommonStocksMember fmr:C000204999Member 2026-07-31 0000315700 fmr:AAPreferredStocksMember fmr:C000204999Member 2026-07-31 0000315700 fmr:AABondsMember fmr:C000204999Member 2026-07-31 0000315700 fmr:AAPreferredSecuritiesMember fmr:C000204999Member 2026-07-31 0000315700 fmr:AAShortTermInvestmentsandNetOtherAssetsLiabilitiesMember fmr:C000204999Member 2026-07-31 0000315700 fmr:C000204999Member country:US 2026-07-31 0000315700 fmr:C000204999Member country:NL 2026-07-31 0000315700 fmr:C000204999Member country:DK 2026-07-31 0000315700 fmr:C000204999Member country:CA 2026-07-31 0000315700 fmr:C000204999Member country:FR 2026-07-31 0000315700 fmr:C000204999Member country:BE 2026-07-31 0000315700 fmr:C000204999Member country:GB 2026-07-31 0000315700 fmr:C000204999Member country:DE 2026-07-31 0000315700 fmr:C000204999Member country:AU 2026-07-31 0000315700 fmr:C000204999Member fmr:TH0Member 2026-07-31 0000315700 fmr:C000204999Member fmr:TH1Member 2026-07-31 0000315700 fmr:C000204999Member fmr:TH2Member 2026-07-31 0000315700 fmr:C000204999Member fmr:TH3Member 2026-07-31 0000315700 fmr:C000204999Member fmr:TH4Member 2026-07-31 0000315700 fmr:C000204999Member fmr:TH5Member 2026-07-31 0000315700 fmr:C000204999Member fmr:TH6Member 2026-07-31 0000315700 fmr:C000204999Member fmr:TH7Member 2026-07-31 0000315700 fmr:C000204999Member fmr:TH8Member 2026-07-31 0000315700 fmr:C000204999Member fmr:TH9Member 2026-07-31 0000315700 fmr:C000014522Member 2025-07-31 2026-07-31 0000315700 fmr:C000014522_LG_ClassMember_11YRMember 2015-07-31 2026-07-31 0000315700 fmr:C000014522_ClassMember_AsOf_2016Member 2025-07-31 2026-07-31 0000315700 fmr:C000014522_ClassMember_AsOf_2017Member 2025-07-31 2026-07-31 0000315700 fmr:C000014522_ClassMember_AsOf_2018Member 2025-07-31 2026-07-31 0000315700 fmr:C000014522_ClassMember_AsOf_2019Member 2025-07-31 2026-07-31 0000315700 fmr:C000014522_ClassMember_AsOf_2020Member 2025-07-31 2026-07-31 0000315700 fmr:C000014522_ClassMember_AsOf_2021Member 2025-07-31 2026-07-31 0000315700 fmr:C000014522_ClassMember_AsOf_2022Member 2025-07-31 2026-07-31 0000315700 fmr:C000014522_ClassMember_AsOf_2023Member 2025-07-31 2026-07-31 0000315700 fmr:C000014522_ClassMember_AsOf_2024Member 2025-07-31 2026-07-31 0000315700 fmr:C000014522_ClassMember_AsOf_2025Member 2025-07-31 2026-07-31 0000315700 fmr:C000014522_ClassMember_AsOf_2026Member 2025-07-31 2026-07-31 0000315700 fmr:C000014522_LG_1_AdditionalIndexMember_11YRMember 2015-07-31 2026-07-31 0000315700 fmr:C000014522_1_AdditionalIndexMember_AsOf_2016Member 2025-07-31 2026-07-31 0000315700 fmr:C000014522_1_AdditionalIndexMember_AsOf_2017Member 2025-07-31 2026-07-31 0000315700 fmr:C000014522_1_AdditionalIndexMember_AsOf_2018Member 2025-07-31 2026-07-31 0000315700 fmr:C000014522_1_AdditionalIndexMember_AsOf_2019Member 2025-07-31 2026-07-31 0000315700 fmr:C000014522_1_AdditionalIndexMember_AsOf_2020Member 2025-07-31 2026-07-31 0000315700 fmr:C000014522_1_AdditionalIndexMember_AsOf_2021Member 2025-07-31 2026-07-31 0000315700 fmr:C000014522_1_AdditionalIndexMember_AsOf_2022Member 2025-07-31 2026-07-31 0000315700 fmr:C000014522_1_AdditionalIndexMember_AsOf_2023Member 2025-07-31 2026-07-31 0000315700 fmr:C000014522_1_AdditionalIndexMember_AsOf_2024Member 2025-07-31 2026-07-31 0000315700 fmr:C000014522_1_AdditionalIndexMember_AsOf_2025Member 2025-07-31 2026-07-31 0000315700 fmr:C000014522_1_AdditionalIndexMember_AsOf_2026Member 2025-07-31 2026-07-31 0000315700 fmr:C000014522_LG_2_AdditionalIndexMember_11YRMember 2015-07-31 2026-07-31 0000315700 fmr:C000014522_2_AdditionalIndexMember_AsOf_2016Member 2025-07-31 2026-07-31 0000315700 fmr:C000014522_2_AdditionalIndexMember_AsOf_2017Member 2025-07-31 2026-07-31 0000315700 fmr:C000014522_2_AdditionalIndexMember_AsOf_2018Member 2025-07-31 2026-07-31 0000315700 fmr:C000014522_2_AdditionalIndexMember_AsOf_2019Member 2025-07-31 2026-07-31 0000315700 fmr:C000014522_2_AdditionalIndexMember_AsOf_2020Member 2025-07-31 2026-07-31 0000315700 fmr:C000014522_2_AdditionalIndexMember_AsOf_2021Member 2025-07-31 2026-07-31 0000315700 fmr:C000014522_2_AdditionalIndexMember_AsOf_2022Member 2025-07-31 2026-07-31 0000315700 fmr:C000014522_2_AdditionalIndexMember_AsOf_2023Member 2025-07-31 2026-07-31 0000315700 fmr:C000014522_2_AdditionalIndexMember_AsOf_2024Member 2025-07-31 2026-07-31 0000315700 fmr:C000014522_2_AdditionalIndexMember_AsOf_2025Member 2025-07-31 2026-07-31 0000315700 fmr:C000014522_2_AdditionalIndexMember_AsOf_2026Member 2025-07-31 2026-07-31 0000315700 fmr:C000014522_ClassMember_1YRMember 2025-07-31 2026-07-31 0000315700 fmr:C000014522_ClassMember_5YRMember 2021-07-31 2026-07-31 0000315700 fmr:C000014522_ClassMember_10YRMember 2016-07-31 2026-07-31 0000315700 fmr:C000014522_NoLoadClassMember_1YRMember 2025-07-31 2026-07-31 0000315700 fmr:C000014522_NoLoadClassMember_5YRMember 2021-07-31 2026-07-31 0000315700 fmr:C000014522_NoLoadClassMember_10YRMember 2016-07-31 2026-07-31 0000315700 fmr:C000014522_0_AdditionalIndexMember_1YRMember 2025-07-31 2026-07-31 0000315700 fmr:C000014522_0_AdditionalIndexMember_5YRMember 2021-07-31 2026-07-31 0000315700 fmr:C000014522_0_AdditionalIndexMember_10YRMember 2016-07-31 2026-07-31 0000315700 fmr:C000014522_1_BBIndexMember_1YRMember 2025-07-31 2026-07-31 0000315700 fmr:C000014522_1_BBIndexMember_5YRMember 2021-07-31 2026-07-31 0000315700 fmr:C000014522_1_BBIndexMember_10YRMember 2016-07-31 2026-07-31 0000315700 fmr:C000014522Member 2026-07-31 0000315700 fmr:C000014522Member fmr:TI0Member 2026-07-31 0000315700 fmr:C000014522Member fmr:TI1Member 2026-07-31 0000315700 fmr:C000014522Member fmr:TI2Member 2026-07-31 0000315700 fmr:AACommonStocksMember fmr:C000014522Member 2026-07-31 0000315700 fmr:AAPreferredStocksMember fmr:C000014522Member 2026-07-31 0000315700 fmr:AABondsMember fmr:C000014522Member 2026-07-31 0000315700 fmr:AAPreferredSecuritiesMember fmr:C000014522Member 2026-07-31 0000315700 fmr:AAShortTermInvestmentsandNetOtherAssetsLiabilitiesMember fmr:C000014522Member 2026-07-31 0000315700 fmr:C000014522Member country:US 2026-07-31 0000315700 fmr:C000014522Member country:NL 2026-07-31 0000315700 fmr:C000014522Member country:DK 2026-07-31 0000315700 fmr:C000014522Member country:CA 2026-07-31 0000315700 fmr:C000014522Member country:FR 2026-07-31 0000315700 fmr:C000014522Member country:BE 2026-07-31 0000315700 fmr:C000014522Member country:GB 2026-07-31 0000315700 fmr:C000014522Member country:DE 2026-07-31 0000315700 fmr:C000014522Member country:AU 2026-07-31 0000315700 fmr:C000014522Member fmr:TH0Member 2026-07-31 0000315700 fmr:C000014522Member fmr:TH1Member 2026-07-31 0000315700 fmr:C000014522Member fmr:TH2Member 2026-07-31 0000315700 fmr:C000014522Member fmr:TH3Member 2026-07-31 0000315700 fmr:C000014522Member fmr:TH4Member 2026-07-31 0000315700 fmr:C000014522Member fmr:TH5Member 2026-07-31 0000315700 fmr:C000014522Member fmr:TH6Member 2026-07-31 0000315700 fmr:C000014522Member fmr:TH7Member 2026-07-31 0000315700 fmr:C000014522Member fmr:TH8Member 2026-07-31 0000315700 fmr:C000014522Member fmr:TH9Member 2026-07-31 0000315700 fmr:C000014523Member 2025-07-31 2026-07-31 0000315700 fmr:C000014523_LG_ClassMember_11YRMember 2015-07-31 2026-07-31 0000315700 fmr:C000014523_ClassMember_AsOf_2016Member 2025-07-31 2026-07-31 0000315700 fmr:C000014523_ClassMember_AsOf_2017Member 2025-07-31 2026-07-31 0000315700 fmr:C000014523_ClassMember_AsOf_2018Member 2025-07-31 2026-07-31 0000315700 fmr:C000014523_ClassMember_AsOf_2019Member 2025-07-31 2026-07-31 0000315700 fmr:C000014523_ClassMember_AsOf_2020Member 2025-07-31 2026-07-31 0000315700 fmr:C000014523_ClassMember_AsOf_2021Member 2025-07-31 2026-07-31 0000315700 fmr:C000014523_ClassMember_AsOf_2022Member 2025-07-31 2026-07-31 0000315700 fmr:C000014523_ClassMember_AsOf_2023Member 2025-07-31 2026-07-31 0000315700 fmr:C000014523_ClassMember_AsOf_2024Member 2025-07-31 2026-07-31 0000315700 fmr:C000014523_ClassMember_AsOf_2025Member 2025-07-31 2026-07-31 0000315700 fmr:C000014523_ClassMember_AsOf_2026Member 2025-07-31 2026-07-31 0000315700 fmr:C000014523_LG_1_AdditionalIndexMember_11YRMember 2015-07-31 2026-07-31 0000315700 fmr:C000014523_1_AdditionalIndexMember_AsOf_2016Member 2025-07-31 2026-07-31 0000315700 fmr:C000014523_1_AdditionalIndexMember_AsOf_2017Member 2025-07-31 2026-07-31 0000315700 fmr:C000014523_1_AdditionalIndexMember_AsOf_2018Member 2025-07-31 2026-07-31 0000315700 fmr:C000014523_1_AdditionalIndexMember_AsOf_2019Member 2025-07-31 2026-07-31 0000315700 fmr:C000014523_1_AdditionalIndexMember_AsOf_2020Member 2025-07-31 2026-07-31 0000315700 fmr:C000014523_1_AdditionalIndexMember_AsOf_2021Member 2025-07-31 2026-07-31 0000315700 fmr:C000014523_1_AdditionalIndexMember_AsOf_2022Member 2025-07-31 2026-07-31 0000315700 fmr:C000014523_1_AdditionalIndexMember_AsOf_2023Member 2025-07-31 2026-07-31 0000315700 fmr:C000014523_1_AdditionalIndexMember_AsOf_2024Member 2025-07-31 2026-07-31 0000315700 fmr:C000014523_1_AdditionalIndexMember_AsOf_2025Member 2025-07-31 2026-07-31 0000315700 fmr:C000014523_1_AdditionalIndexMember_AsOf_2026Member 2025-07-31 2026-07-31 0000315700 fmr:C000014523_LG_2_AdditionalIndexMember_11YRMember 2015-07-31 2026-07-31 0000315700 fmr:C000014523_2_AdditionalIndexMember_AsOf_2016Member 2025-07-31 2026-07-31 0000315700 fmr:C000014523_2_AdditionalIndexMember_AsOf_2017Member 2025-07-31 2026-07-31 0000315700 fmr:C000014523_2_AdditionalIndexMember_AsOf_2018Member 2025-07-31 2026-07-31 0000315700 fmr:C000014523_2_AdditionalIndexMember_AsOf_2019Member 2025-07-31 2026-07-31 0000315700 fmr:C000014523_2_AdditionalIndexMember_AsOf_2020Member 2025-07-31 2026-07-31 0000315700 fmr:C000014523_2_AdditionalIndexMember_AsOf_2021Member 2025-07-31 2026-07-31 0000315700 fmr:C000014523_2_AdditionalIndexMember_AsOf_2022Member 2025-07-31 2026-07-31 0000315700 fmr:C000014523_2_AdditionalIndexMember_AsOf_2023Member 2025-07-31 2026-07-31 0000315700 fmr:C000014523_2_AdditionalIndexMember_AsOf_2024Member 2025-07-31 2026-07-31 0000315700 fmr:C000014523_2_AdditionalIndexMember_AsOf_2025Member 2025-07-31 2026-07-31 0000315700 fmr:C000014523_2_AdditionalIndexMember_AsOf_2026Member 2025-07-31 2026-07-31 0000315700 fmr:C000014523_NoLoadClassMember_1YRMember 2025-07-31 2026-07-31 0000315700 fmr:C000014523_NoLoadClassMember_5YRMember 2021-07-31 2026-07-31 0000315700 fmr:C000014523_NoLoadClassMember_10YRMember 2016-07-31 2026-07-31 0000315700 fmr:C000014523_0_AdditionalIndexMember_1YRMember 2025-07-31 2026-07-31 0000315700 fmr:C000014523_0_AdditionalIndexMember_5YRMember 2021-07-31 2026-07-31 0000315700 fmr:C000014523_0_AdditionalIndexMember_10YRMember 2016-07-31 2026-07-31 0000315700 fmr:C000014523_1_BBIndexMember_1YRMember 2025-07-31 2026-07-31 0000315700 fmr:C000014523_1_BBIndexMember_5YRMember 2021-07-31 2026-07-31 0000315700 fmr:C000014523_1_BBIndexMember_10YRMember 2016-07-31 2026-07-31 0000315700 fmr:C000014523Member 2026-07-31 0000315700 fmr:C000014523Member fmr:TI0Member 2026-07-31 0000315700 fmr:C000014523Member fmr:TI1Member 2026-07-31 0000315700 fmr:C000014523Member fmr:TI2Member 2026-07-31 0000315700 fmr:AACommonStocksMember fmr:C000014523Member 2026-07-31 0000315700 fmr:AAPreferredStocksMember fmr:C000014523Member 2026-07-31 0000315700 fmr:AABondsMember fmr:C000014523Member 2026-07-31 0000315700 fmr:AAPreferredSecuritiesMember fmr:C000014523Member 2026-07-31 0000315700 fmr:AAShortTermInvestmentsandNetOtherAssetsLiabilitiesMember fmr:C000014523Member 2026-07-31 0000315700 fmr:C000014523Member country:US 2026-07-31 0000315700 fmr:C000014523Member country:NL 2026-07-31 0000315700 fmr:C000014523Member country:DK 2026-07-31 0000315700 fmr:C000014523Member country:CA 2026-07-31 0000315700 fmr:C000014523Member country:FR 2026-07-31 0000315700 fmr:C000014523Member country:BE 2026-07-31 0000315700 fmr:C000014523Member country:GB 2026-07-31 0000315700 fmr:C000014523Member country:DE 2026-07-31 0000315700 fmr:C000014523Member country:AU 2026-07-31 0000315700 fmr:C000014523Member fmr:TH0Member 2026-07-31 0000315700 fmr:C000014523Member fmr:TH1Member 2026-07-31 0000315700 fmr:C000014523Member fmr:TH2Member 2026-07-31 0000315700 fmr:C000014523Member fmr:TH3Member 2026-07-31 0000315700 fmr:C000014523Member fmr:TH4Member 2026-07-31 0000315700 fmr:C000014523Member fmr:TH5Member 2026-07-31 0000315700 fmr:C000014523Member fmr:TH6Member 2026-07-31 0000315700 fmr:C000014523Member fmr:TH7Member 2026-07-31 0000315700 fmr:C000014523Member fmr:TH8Member 2026-07-31 0000315700 fmr:C000014523Member fmr:TH9Member 2026-07-31 0000315700 fmr:C000014521Member 2025-07-31 2026-07-31 0000315700 fmr:C000014521_LG_ClassMember_11YRMember 2015-07-31 2026-07-31 0000315700 fmr:C000014521_ClassMember_AsOf_2016Member 2025-07-31 2026-07-31 0000315700 fmr:C000014521_ClassMember_AsOf_2017Member 2025-07-31 2026-07-31 0000315700 fmr:C000014521_ClassMember_AsOf_2018Member 2025-07-31 2026-07-31 0000315700 fmr:C000014521_ClassMember_AsOf_2019Member 2025-07-31 2026-07-31 0000315700 fmr:C000014521_ClassMember_AsOf_2020Member 2025-07-31 2026-07-31 0000315700 fmr:C000014521_ClassMember_AsOf_2021Member 2025-07-31 2026-07-31 0000315700 fmr:C000014521_ClassMember_AsOf_2022Member 2025-07-31 2026-07-31 0000315700 fmr:C000014521_ClassMember_AsOf_2023Member 2025-07-31 2026-07-31 0000315700 fmr:C000014521_ClassMember_AsOf_2024Member 2025-07-31 2026-07-31 0000315700 fmr:C000014521_ClassMember_AsOf_2025Member 2025-07-31 2026-07-31 0000315700 fmr:C000014521_ClassMember_AsOf_2026Member 2025-07-31 2026-07-31 0000315700 fmr:C000014521_LG_1_AdditionalIndexMember_11YRMember 2015-07-31 2026-07-31 0000315700 fmr:C000014521_1_AdditionalIndexMember_AsOf_2016Member 2025-07-31 2026-07-31 0000315700 fmr:C000014521_1_AdditionalIndexMember_AsOf_2017Member 2025-07-31 2026-07-31 0000315700 fmr:C000014521_1_AdditionalIndexMember_AsOf_2018Member 2025-07-31 2026-07-31 0000315700 fmr:C000014521_1_AdditionalIndexMember_AsOf_2019Member 2025-07-31 2026-07-31 0000315700 fmr:C000014521_1_AdditionalIndexMember_AsOf_2020Member 2025-07-31 2026-07-31 0000315700 fmr:C000014521_1_AdditionalIndexMember_AsOf_2021Member 2025-07-31 2026-07-31 0000315700 fmr:C000014521_1_AdditionalIndexMember_AsOf_2022Member 2025-07-31 2026-07-31 0000315700 fmr:C000014521_1_AdditionalIndexMember_AsOf_2023Member 2025-07-31 2026-07-31 0000315700 fmr:C000014521_1_AdditionalIndexMember_AsOf_2024Member 2025-07-31 2026-07-31 0000315700 fmr:C000014521_1_AdditionalIndexMember_AsOf_2025Member 2025-07-31 2026-07-31 0000315700 fmr:C000014521_1_AdditionalIndexMember_AsOf_2026Member 2025-07-31 2026-07-31 0000315700 fmr:C000014521_LG_2_AdditionalIndexMember_11YRMember 2015-07-31 2026-07-31 0000315700 fmr:C000014521_2_AdditionalIndexMember_AsOf_2016Member 2025-07-31 2026-07-31 0000315700 fmr:C000014521_2_AdditionalIndexMember_AsOf_2017Member 2025-07-31 2026-07-31 0000315700 fmr:C000014521_2_AdditionalIndexMember_AsOf_2018Member 2025-07-31 2026-07-31 0000315700 fmr:C000014521_2_AdditionalIndexMember_AsOf_2019Member 2025-07-31 2026-07-31 0000315700 fmr:C000014521_2_AdditionalIndexMember_AsOf_2020Member 2025-07-31 2026-07-31 0000315700 fmr:C000014521_2_AdditionalIndexMember_AsOf_2021Member 2025-07-31 2026-07-31 0000315700 fmr:C000014521_2_AdditionalIndexMember_AsOf_2022Member 2025-07-31 2026-07-31 0000315700 fmr:C000014521_2_AdditionalIndexMember_AsOf_2023Member 2025-07-31 2026-07-31 0000315700 fmr:C000014521_2_AdditionalIndexMember_AsOf_2024Member 2025-07-31 2026-07-31 0000315700 fmr:C000014521_2_AdditionalIndexMember_AsOf_2025Member 2025-07-31 2026-07-31 0000315700 fmr:C000014521_2_AdditionalIndexMember_AsOf_2026Member 2025-07-31 2026-07-31 0000315700 fmr:C000014521_ClassMember_1YRMember 2025-07-31 2026-07-31 0000315700 fmr:C000014521_ClassMember_5YRMember 2021-07-31 2026-07-31 0000315700 fmr:C000014521_ClassMember_10YRMember 2016-07-31 2026-07-31 0000315700 fmr:C000014521_NoLoadClassMember_1YRMember 2025-07-31 2026-07-31 0000315700 fmr:C000014521_NoLoadClassMember_5YRMember 2021-07-31 2026-07-31 0000315700 fmr:C000014521_NoLoadClassMember_10YRMember 2016-07-31 2026-07-31 0000315700 fmr:C000014521_0_AdditionalIndexMember_1YRMember 2025-07-31 2026-07-31 0000315700 fmr:C000014521_0_AdditionalIndexMember_5YRMember 2021-07-31 2026-07-31 0000315700 fmr:C000014521_0_AdditionalIndexMember_10YRMember 2016-07-31 2026-07-31 0000315700 fmr:C000014521_1_BBIndexMember_1YRMember 2025-07-31 2026-07-31 0000315700 fmr:C000014521_1_BBIndexMember_5YRMember 2021-07-31 2026-07-31 0000315700 fmr:C000014521_1_BBIndexMember_10YRMember 2016-07-31 2026-07-31 0000315700 fmr:C000014521Member 2026-07-31 0000315700 fmr:C000014521Member fmr:TI0Member 2026-07-31 0000315700 fmr:C000014521Member fmr:TI1Member 2026-07-31 0000315700 fmr:C000014521Member fmr:TI2Member 2026-07-31 0000315700 fmr:AACommonStocksMember fmr:C000014521Member 2026-07-31 0000315700 fmr:AAPreferredStocksMember fmr:C000014521Member 2026-07-31 0000315700 fmr:AABondsMember fmr:C000014521Member 2026-07-31 0000315700 fmr:AAPreferredSecuritiesMember fmr:C000014521Member 2026-07-31 0000315700 fmr:AAShortTermInvestmentsandNetOtherAssetsLiabilitiesMember fmr:C000014521Member 2026-07-31 0000315700 fmr:C000014521Member country:US 2026-07-31 0000315700 fmr:C000014521Member country:NL 2026-07-31 0000315700 fmr:C000014521Member country:DK 2026-07-31 0000315700 fmr:C000014521Member country:CA 2026-07-31 0000315700 fmr:C000014521Member country:FR 2026-07-31 0000315700 fmr:C000014521Member country:BE 2026-07-31 0000315700 fmr:C000014521Member country:GB 2026-07-31 0000315700 fmr:C000014521Member country:DE 2026-07-31 0000315700 fmr:C000014521Member country:AU 2026-07-31 0000315700 fmr:C000014521Member fmr:TH0Member 2026-07-31 0000315700 fmr:C000014521Member fmr:TH1Member 2026-07-31 0000315700 fmr:C000014521Member fmr:TH2Member 2026-07-31 0000315700 fmr:C000014521Member fmr:TH3Member 2026-07-31 0000315700 fmr:C000014521Member fmr:TH4Member 2026-07-31 0000315700 fmr:C000014521Member fmr:TH5Member 2026-07-31 0000315700 fmr:C000014521Member fmr:TH6Member 2026-07-31 0000315700 fmr:C000014521Member fmr:TH7Member 2026-07-31 0000315700 fmr:C000014521Member fmr:TH8Member 2026-07-31 0000315700 fmr:C000014521Member fmr:TH9Member 2026-07-31 0000315700 fmr:C000014519Member 2025-07-31 2026-07-31 0000315700 fmr:C000014519_LG_ClassMember_11YRMember 2015-07-31 2026-07-31 0000315700 fmr:C000014519_ClassMember_AsOf_2016Member 2025-07-31 2026-07-31 0000315700 fmr:C000014519_ClassMember_AsOf_2017Member 2025-07-31 2026-07-31 0000315700 fmr:C000014519_ClassMember_AsOf_2018Member 2025-07-31 2026-07-31 0000315700 fmr:C000014519_ClassMember_AsOf_2019Member 2025-07-31 2026-07-31 0000315700 fmr:C000014519_ClassMember_AsOf_2020Member 2025-07-31 2026-07-31 0000315700 fmr:C000014519_ClassMember_AsOf_2021Member 2025-07-31 2026-07-31 0000315700 fmr:C000014519_ClassMember_AsOf_2022Member 2025-07-31 2026-07-31 0000315700 fmr:C000014519_ClassMember_AsOf_2023Member 2025-07-31 2026-07-31 0000315700 fmr:C000014519_ClassMember_AsOf_2024Member 2025-07-31 2026-07-31 0000315700 fmr:C000014519_ClassMember_AsOf_2025Member 2025-07-31 2026-07-31 0000315700 fmr:C000014519_ClassMember_AsOf_2026Member 2025-07-31 2026-07-31 0000315700 fmr:C000014519_LG_1_AdditionalIndexMember_11YRMember 2015-07-31 2026-07-31 0000315700 fmr:C000014519_1_AdditionalIndexMember_AsOf_2016Member 2025-07-31 2026-07-31 0000315700 fmr:C000014519_1_AdditionalIndexMember_AsOf_2017Member 2025-07-31 2026-07-31 0000315700 fmr:C000014519_1_AdditionalIndexMember_AsOf_2018Member 2025-07-31 2026-07-31 0000315700 fmr:C000014519_1_AdditionalIndexMember_AsOf_2019Member 2025-07-31 2026-07-31 0000315700 fmr:C000014519_1_AdditionalIndexMember_AsOf_2020Member 2025-07-31 2026-07-31 0000315700 fmr:C000014519_1_AdditionalIndexMember_AsOf_2021Member 2025-07-31 2026-07-31 0000315700 fmr:C000014519_1_AdditionalIndexMember_AsOf_2022Member 2025-07-31 2026-07-31 0000315700 fmr:C000014519_1_AdditionalIndexMember_AsOf_2023Member 2025-07-31 2026-07-31 0000315700 fmr:C000014519_1_AdditionalIndexMember_AsOf_2024Member 2025-07-31 2026-07-31 0000315700 fmr:C000014519_1_AdditionalIndexMember_AsOf_2025Member 2025-07-31 2026-07-31 0000315700 fmr:C000014519_1_AdditionalIndexMember_AsOf_2026Member 2025-07-31 2026-07-31 0000315700 fmr:C000014519_LG_2_AdditionalIndexMember_11YRMember 2015-07-31 2026-07-31 0000315700 fmr:C000014519_2_AdditionalIndexMember_AsOf_2016Member 2025-07-31 2026-07-31 0000315700 fmr:C000014519_2_AdditionalIndexMember_AsOf_2017Member 2025-07-31 2026-07-31 0000315700 fmr:C000014519_2_AdditionalIndexMember_AsOf_2018Member 2025-07-31 2026-07-31 0000315700 fmr:C000014519_2_AdditionalIndexMember_AsOf_2019Member 2025-07-31 2026-07-31 0000315700 fmr:C000014519_2_AdditionalIndexMember_AsOf_2020Member 2025-07-31 2026-07-31 0000315700 fmr:C000014519_2_AdditionalIndexMember_AsOf_2021Member 2025-07-31 2026-07-31 0000315700 fmr:C000014519_2_AdditionalIndexMember_AsOf_2022Member 2025-07-31 2026-07-31 0000315700 fmr:C000014519_2_AdditionalIndexMember_AsOf_2023Member 2025-07-31 2026-07-31 0000315700 fmr:C000014519_2_AdditionalIndexMember_AsOf_2024Member 2025-07-31 2026-07-31 0000315700 fmr:C000014519_2_AdditionalIndexMember_AsOf_2025Member 2025-07-31 2026-07-31 0000315700 fmr:C000014519_2_AdditionalIndexMember_AsOf_2026Member 2025-07-31 2026-07-31 0000315700 fmr:C000014519_ClassMember_1YRMember 2025-07-31 2026-07-31 0000315700 fmr:C000014519_ClassMember_5YRMember 2021-07-31 2026-07-31 0000315700 fmr:C000014519_ClassMember_10YRMember 2016-07-31 2026-07-31 0000315700 fmr:C000014519_NoLoadClassMember_1YRMember 2025-07-31 2026-07-31 0000315700 fmr:C000014519_NoLoadClassMember_5YRMember 2021-07-31 2026-07-31 0000315700 fmr:C000014519_NoLoadClassMember_10YRMember 2016-07-31 2026-07-31 0000315700 fmr:C000014519_0_AdditionalIndexMember_1YRMember 2025-07-31 2026-07-31 0000315700 fmr:C000014519_0_AdditionalIndexMember_5YRMember 2021-07-31 2026-07-31 0000315700 fmr:C000014519_0_AdditionalIndexMember_10YRMember 2016-07-31 2026-07-31 0000315700 fmr:C000014519_1_BBIndexMember_1YRMember 2025-07-31 2026-07-31 0000315700 fmr:C000014519_1_BBIndexMember_5YRMember 2021-07-31 2026-07-31 0000315700 fmr:C000014519_1_BBIndexMember_10YRMember 2016-07-31 2026-07-31 0000315700 fmr:C000014519Member 2026-07-31 0000315700 fmr:C000014519Member fmr:TI0Member 2026-07-31 0000315700 fmr:C000014519Member fmr:TI1Member 2026-07-31 0000315700 fmr:C000014519Member fmr:TI2Member 2026-07-31 0000315700 fmr:AACommonStocksMember fmr:C000014519Member 2026-07-31 0000315700 fmr:AAPreferredStocksMember fmr:C000014519Member 2026-07-31 0000315700 fmr:AABondsMember fmr:C000014519Member 2026-07-31 0000315700 fmr:AAPreferredSecuritiesMember fmr:C000014519Member 2026-07-31 0000315700 fmr:AAShortTermInvestmentsandNetOtherAssetsLiabilitiesMember fmr:C000014519Member 2026-07-31 0000315700 fmr:C000014519Member country:US 2026-07-31 0000315700 fmr:C000014519Member country:NL 2026-07-31 0000315700 fmr:C000014519Member country:DK 2026-07-31 0000315700 fmr:C000014519Member country:CA 2026-07-31 0000315700 fmr:C000014519Member country:FR 2026-07-31 0000315700 fmr:C000014519Member country:BE 2026-07-31 0000315700 fmr:C000014519Member country:GB 2026-07-31 0000315700 fmr:C000014519Member country:DE 2026-07-31 0000315700 fmr:C000014519Member country:AU 2026-07-31 0000315700 fmr:C000014519Member fmr:TH0Member 2026-07-31 0000315700 fmr:C000014519Member fmr:TH1Member 2026-07-31 0000315700 fmr:C000014519Member fmr:TH2Member 2026-07-31 0000315700 fmr:C000014519Member fmr:TH3Member 2026-07-31 0000315700 fmr:C000014519Member fmr:TH4Member 2026-07-31 0000315700 fmr:C000014519Member fmr:TH5Member 2026-07-31 0000315700 fmr:C000014519Member fmr:TH6Member 2026-07-31 0000315700 fmr:C000014519Member fmr:TH7Member 2026-07-31 0000315700 fmr:C000014519Member fmr:TH8Member 2026-07-31 0000315700 fmr:C000014519Member fmr:TH9Member 2026-07-31 0000315700 fmr:C000264535Member 2025-07-31 2026-07-31 0000315700 fmr:C000264535_LG_ClassMember_2YRMember 2024-07-31 2026-07-31 0000315700 fmr:C000264535_ClassMember_AsOf_2025Member 2025-07-31 2026-07-31 0000315700 fmr:C000264535_ClassMember_AsOf_2026Member 2025-07-31 2026-07-31 0000315700 fmr:C000264535_LG_1_AdditionalIndexMember_2YRMember 2024-07-31 2026-07-31 0000315700 fmr:C000264535_1_AdditionalIndexMember_AsOf_2025Member 2025-07-31 2026-07-31 0000315700 fmr:C000264535_1_AdditionalIndexMember_AsOf_2026Member 2025-07-31 2026-07-31 0000315700 fmr:C000264535_LG_2_AdditionalIndexMember_2YRMember 2024-07-31 2026-07-31 0000315700 fmr:C000264535_2_AdditionalIndexMember_AsOf_2025Member 2025-07-31 2026-07-31 0000315700 fmr:C000264535_2_AdditionalIndexMember_AsOf_2026Member 2025-07-31 2026-07-31 0000315700 fmr:C000264535Member 2026-07-31 0000315700 fmr:C000264535Member fmr:TI0Member 2026-07-31 0000315700 fmr:C000264535Member fmr:TI1Member 2026-07-31 0000315700 fmr:C000264535Member fmr:TI2Member 2026-07-31 0000315700 fmr:C000264535Member fmr:TI3Member 2026-07-31 0000315700 fmr:C000264535Member fmr:TI4Member 2026-07-31 0000315700 fmr:C000264535Member fmr:TI5Member 2026-07-31 0000315700 fmr:C000264535Member fmr:TI6Member 2026-07-31 0000315700 fmr:C000264535Member fmr:TI7Member 2026-07-31 0000315700 fmr:C000264535Member fmr:TI8Member 2026-07-31 0000315700 fmr:C000264535Member fmr:TI9Member 2026-07-31 0000315700 fmr:AACommonStocksMember fmr:C000264535Member 2026-07-31 0000315700 fmr:AAShortTermInvestmentsandNetOtherAssetsLiabilitiesMember fmr:C000264535Member 2026-07-31 0000315700 fmr:C000264535Member country:US 2026-07-31 0000315700 fmr:C000264535Member fmr:TH0Member 2026-07-31 0000315700 fmr:C000264535Member fmr:TH1Member 2026-07-31 0000315700 fmr:C000264535Member fmr:TH2Member 2026-07-31 0000315700 fmr:C000264535Member fmr:TH3Member 2026-07-31 0000315700 fmr:C000264535Member fmr:TH4Member 2026-07-31 0000315700 fmr:C000264535Member fmr:TH5Member 2026-07-31 0000315700 fmr:C000264535Member fmr:TH6Member 2026-07-31 0000315700 fmr:C000264535Member fmr:TH7Member 2026-07-31 0000315700 fmr:C000264535Member fmr:TH8Member 2026-07-31 0000315700 fmr:C000264535Member fmr:TH9Member 2026-07-31 0000315700 fmr:C000205006Member 2025-07-31 2026-07-31 0000315700 fmr:C000205006_LG_ClassMember_9YRMember 2017-07-31 2026-07-31 0000315700 fmr:C000205006_ClassMember_AsOf_2018Member 2025-07-31 2026-07-31 0000315700 fmr:C000205006_ClassMember_AsOf_2019Member 2025-07-31 2026-07-31 0000315700 fmr:C000205006_ClassMember_AsOf_2020Member 2025-07-31 2026-07-31 0000315700 fmr:C000205006_ClassMember_AsOf_2021Member 2025-07-31 2026-07-31 0000315700 fmr:C000205006_ClassMember_AsOf_2022Member 2025-07-31 2026-07-31 0000315700 fmr:C000205006_ClassMember_AsOf_2023Member 2025-07-31 2026-07-31 0000315700 fmr:C000205006_ClassMember_AsOf_2024Member 2025-07-31 2026-07-31 0000315700 fmr:C000205006_ClassMember_AsOf_2025Member 2025-07-31 2026-07-31 0000315700 fmr:C000205006_ClassMember_AsOf_2026Member 2025-07-31 2026-07-31 0000315700 fmr:C000205006_LG_1_AdditionalIndexMember_9YRMember 2017-07-31 2026-07-31 0000315700 fmr:C000205006_1_AdditionalIndexMember_AsOf_2018Member 2025-07-31 2026-07-31 0000315700 fmr:C000205006_1_AdditionalIndexMember_AsOf_2019Member 2025-07-31 2026-07-31 0000315700 fmr:C000205006_1_AdditionalIndexMember_AsOf_2020Member 2025-07-31 2026-07-31 0000315700 fmr:C000205006_1_AdditionalIndexMember_AsOf_2021Member 2025-07-31 2026-07-31 0000315700 fmr:C000205006_1_AdditionalIndexMember_AsOf_2022Member 2025-07-31 2026-07-31 0000315700 fmr:C000205006_1_AdditionalIndexMember_AsOf_2023Member 2025-07-31 2026-07-31 0000315700 fmr:C000205006_1_AdditionalIndexMember_AsOf_2024Member 2025-07-31 2026-07-31 0000315700 fmr:C000205006_1_AdditionalIndexMember_AsOf_2025Member 2025-07-31 2026-07-31 0000315700 fmr:C000205006_1_AdditionalIndexMember_AsOf_2026Member 2025-07-31 2026-07-31 0000315700 fmr:C000205006_LG_2_AdditionalIndexMember_9YRMember 2017-07-31 2026-07-31 0000315700 fmr:C000205006_2_AdditionalIndexMember_AsOf_2018Member 2025-07-31 2026-07-31 0000315700 fmr:C000205006_2_AdditionalIndexMember_AsOf_2019Member 2025-07-31 2026-07-31 0000315700 fmr:C000205006_2_AdditionalIndexMember_AsOf_2020Member 2025-07-31 2026-07-31 0000315700 fmr:C000205006_2_AdditionalIndexMember_AsOf_2021Member 2025-07-31 2026-07-31 0000315700 fmr:C000205006_2_AdditionalIndexMember_AsOf_2022Member 2025-07-31 2026-07-31 0000315700 fmr:C000205006_2_AdditionalIndexMember_AsOf_2023Member 2025-07-31 2026-07-31 0000315700 fmr:C000205006_2_AdditionalIndexMember_AsOf_2024Member 2025-07-31 2026-07-31 0000315700 fmr:C000205006_2_AdditionalIndexMember_AsOf_2025Member 2025-07-31 2026-07-31 0000315700 fmr:C000205006_2_AdditionalIndexMember_AsOf_2026Member 2025-07-31 2026-07-31 0000315700 fmr:C000205006_NoLoadClassMember_1YRMember 2025-07-31 2026-07-31 0000315700 fmr:C000205006_NoLoadClassMember_5YRMember 2021-07-31 2026-07-31 0000315700 fmr:C000205006_NoLoadClassMember_2025-08-01_2026-07-31Member 2025-07-31 2026-07-31 0000315700 fmr:C000205006_0_AdditionalIndexMember_1YRMember 2025-07-31 2026-07-31 0000315700 fmr:C000205006_0_AdditionalIndexMember_5YRMember 2021-07-31 2026-07-31 0000315700 fmr:C000205006_0_AdditionalIndexMember_LOCMember 2025-07-31 2026-07-31 0000315700 fmr:C000205006_1_BBIndexMember_1YRMember 2025-07-31 2026-07-31 0000315700 fmr:C000205006_1_BBIndexMember_5YRMember 2021-07-31 2026-07-31 0000315700 fmr:C000205006_1_BBIndexMember_LOCMember 2025-07-31 2026-07-31 0000315700 fmr:C000205006Member 2018-10-02 2026-07-31 0000315700 fmr:C000205006Member 2026-07-31 0000315700 fmr:C000205006Member fmr:TI0Member 2026-07-31 0000315700 fmr:C000205006Member fmr:TI1Member 2026-07-31 0000315700 fmr:C000205006Member fmr:TI2Member 2026-07-31 0000315700 fmr:C000205006Member fmr:TI3Member 2026-07-31 0000315700 fmr:C000205006Member fmr:TI4Member 2026-07-31 0000315700 fmr:C000205006Member fmr:TI5Member 2026-07-31 0000315700 fmr:C000205006Member fmr:TI6Member 2026-07-31 0000315700 fmr:C000205006Member fmr:TI7Member 2026-07-31 0000315700 fmr:AACommonStocksMember fmr:C000205006Member 2026-07-31 0000315700 fmr:AAPreferredStocksMember fmr:C000205006Member 2026-07-31 0000315700 fmr:AABondsMember fmr:C000205006Member 2026-07-31 0000315700 fmr:AAShortTermInvestmentsandNetOtherAssetsLiabilitiesMember fmr:C000205006Member 2026-07-31 0000315700 fmr:C000205006Member country:US 2026-07-31 0000315700 fmr:C000205006Member country:NL 2026-07-31 0000315700 fmr:C000205006Member country:DK 2026-07-31 0000315700 fmr:C000205006Member country:BE 2026-07-31 0000315700 fmr:C000205006Member country:CA 2026-07-31 0000315700 fmr:C000205006Member country:FR 2026-07-31 0000315700 fmr:C000205006Member country:GB 2026-07-31 0000315700 fmr:C000205006Member country:IL 2026-07-31 0000315700 fmr:C000205006Member country:AU 2026-07-31 0000315700 fmr:C000205006Member country:CN 2026-07-31 0000315700 fmr:C000205006Member fmr:TH0Member 2026-07-31 0000315700 fmr:C000205006Member fmr:TH1Member 2026-07-31 0000315700 fmr:C000205006Member fmr:TH2Member 2026-07-31 0000315700 fmr:C000205006Member fmr:TH3Member 2026-07-31 0000315700 fmr:C000205006Member fmr:TH4Member 2026-07-31 0000315700 fmr:C000205006Member fmr:TH5Member 2026-07-31 0000315700 fmr:C000205006Member fmr:TH6Member 2026-07-31 0000315700 fmr:C000205006Member fmr:TH7Member 2026-07-31 0000315700 fmr:C000205006Member fmr:TH8Member 2026-07-31 0000315700 fmr:C000205006Member fmr:TH9Member 2026-07-31 0000315700 fmr:C000014562Member 2025-07-31 2026-07-31 0000315700 fmr:C000014562_LG_ClassMember_11YRMember 2015-07-31 2026-07-31 0000315700 fmr:C000014562_ClassMember_AsOf_2016Member 2025-07-31 2026-07-31 0000315700 fmr:C000014562_ClassMember_AsOf_2017Member 2025-07-31 2026-07-31 0000315700 fmr:C000014562_ClassMember_AsOf_2018Member 2025-07-31 2026-07-31 0000315700 fmr:C000014562_ClassMember_AsOf_2019Member 2025-07-31 2026-07-31 0000315700 fmr:C000014562_ClassMember_AsOf_2020Member 2025-07-31 2026-07-31 0000315700 fmr:C000014562_ClassMember_AsOf_2021Member 2025-07-31 2026-07-31 0000315700 fmr:C000014562_ClassMember_AsOf_2022Member 2025-07-31 2026-07-31 0000315700 fmr:C000014562_ClassMember_AsOf_2023Member 2025-07-31 2026-07-31 0000315700 fmr:C000014562_ClassMember_AsOf_2024Member 2025-07-31 2026-07-31 0000315700 fmr:C000014562_ClassMember_AsOf_2025Member 2025-07-31 2026-07-31 0000315700 fmr:C000014562_ClassMember_AsOf_2026Member 2025-07-31 2026-07-31 0000315700 fmr:C000014562_LG_1_AdditionalIndexMember_11YRMember 2015-07-31 2026-07-31 0000315700 fmr:C000014562_1_AdditionalIndexMember_AsOf_2016Member 2025-07-31 2026-07-31 0000315700 fmr:C000014562_1_AdditionalIndexMember_AsOf_2017Member 2025-07-31 2026-07-31 0000315700 fmr:C000014562_1_AdditionalIndexMember_AsOf_2018Member 2025-07-31 2026-07-31 0000315700 fmr:C000014562_1_AdditionalIndexMember_AsOf_2019Member 2025-07-31 2026-07-31 0000315700 fmr:C000014562_1_AdditionalIndexMember_AsOf_2020Member 2025-07-31 2026-07-31 0000315700 fmr:C000014562_1_AdditionalIndexMember_AsOf_2021Member 2025-07-31 2026-07-31 0000315700 fmr:C000014562_1_AdditionalIndexMember_AsOf_2022Member 2025-07-31 2026-07-31 0000315700 fmr:C000014562_1_AdditionalIndexMember_AsOf_2023Member 2025-07-31 2026-07-31 0000315700 fmr:C000014562_1_AdditionalIndexMember_AsOf_2024Member 2025-07-31 2026-07-31 0000315700 fmr:C000014562_1_AdditionalIndexMember_AsOf_2025Member 2025-07-31 2026-07-31 0000315700 fmr:C000014562_1_AdditionalIndexMember_AsOf_2026Member 2025-07-31 2026-07-31 0000315700 fmr:C000014562_LG_2_AdditionalIndexMember_11YRMember 2015-07-31 2026-07-31 0000315700 fmr:C000014562_2_AdditionalIndexMember_AsOf_2016Member 2025-07-31 2026-07-31 0000315700 fmr:C000014562_2_AdditionalIndexMember_AsOf_2017Member 2025-07-31 2026-07-31 0000315700 fmr:C000014562_2_AdditionalIndexMember_AsOf_2018Member 2025-07-31 2026-07-31 0000315700 fmr:C000014562_2_AdditionalIndexMember_AsOf_2019Member 2025-07-31 2026-07-31 0000315700 fmr:C000014562_2_AdditionalIndexMember_AsOf_2020Member 2025-07-31 2026-07-31 0000315700 fmr:C000014562_2_AdditionalIndexMember_AsOf_2021Member 2025-07-31 2026-07-31 0000315700 fmr:C000014562_2_AdditionalIndexMember_AsOf_2022Member 2025-07-31 2026-07-31 0000315700 fmr:C000014562_2_AdditionalIndexMember_AsOf_2023Member 2025-07-31 2026-07-31 0000315700 fmr:C000014562_2_AdditionalIndexMember_AsOf_2024Member 2025-07-31 2026-07-31 0000315700 fmr:C000014562_2_AdditionalIndexMember_AsOf_2025Member 2025-07-31 2026-07-31 0000315700 fmr:C000014562_2_AdditionalIndexMember_AsOf_2026Member 2025-07-31 2026-07-31 0000315700 fmr:C000014562_ClassMember_1YRMember 2025-07-31 2026-07-31 0000315700 fmr:C000014562_ClassMember_5YRMember 2021-07-31 2026-07-31 0000315700 fmr:C000014562_ClassMember_10YRMember 2016-07-31 2026-07-31 0000315700 fmr:C000014562_NoLoadClassMember_1YRMember 2025-07-31 2026-07-31 0000315700 fmr:C000014562_NoLoadClassMember_5YRMember 2021-07-31 2026-07-31 0000315700 fmr:C000014562_NoLoadClassMember_10YRMember 2016-07-31 2026-07-31 0000315700 fmr:C000014562_0_AdditionalIndexMember_1YRMember 2025-07-31 2026-07-31 0000315700 fmr:C000014562_0_AdditionalIndexMember_5YRMember 2021-07-31 2026-07-31 0000315700 fmr:C000014562_0_AdditionalIndexMember_10YRMember 2016-07-31 2026-07-31 0000315700 fmr:C000014562_1_BBIndexMember_1YRMember 2025-07-31 2026-07-31 0000315700 fmr:C000014562_1_BBIndexMember_5YRMember 2021-07-31 2026-07-31 0000315700 fmr:C000014562_1_BBIndexMember_10YRMember 2016-07-31 2026-07-31 0000315700 fmr:C000014562Member 2026-07-31 0000315700 fmr:C000014562Member fmr:TI0Member 2026-07-31 0000315700 fmr:C000014562Member fmr:TI1Member 2026-07-31 0000315700 fmr:C000014562Member fmr:TI2Member 2026-07-31 0000315700 fmr:C000014562Member fmr:TI3Member 2026-07-31 0000315700 fmr:C000014562Member fmr:TI4Member 2026-07-31 0000315700 fmr:C000014562Member fmr:TI5Member 2026-07-31 0000315700 fmr:C000014562Member fmr:TI6Member 2026-07-31 0000315700 fmr:C000014562Member fmr:TI7Member 2026-07-31 0000315700 fmr:AACommonStocksMember fmr:C000014562Member 2026-07-31 0000315700 fmr:AAPreferredStocksMember fmr:C000014562Member 2026-07-31 0000315700 fmr:AABondsMember fmr:C000014562Member 2026-07-31 0000315700 fmr:AAShortTermInvestmentsandNetOtherAssetsLiabilitiesMember fmr:C000014562Member 2026-07-31 0000315700 fmr:C000014562Member country:US 2026-07-31 0000315700 fmr:C000014562Member country:NL 2026-07-31 0000315700 fmr:C000014562Member country:DK 2026-07-31 0000315700 fmr:C000014562Member country:BE 2026-07-31 0000315700 fmr:C000014562Member country:CA 2026-07-31 0000315700 fmr:C000014562Member country:FR 2026-07-31 0000315700 fmr:C000014562Member country:GB 2026-07-31 0000315700 fmr:C000014562Member country:IL 2026-07-31 0000315700 fmr:C000014562Member country:AU 2026-07-31 0000315700 fmr:C000014562Member country:CN 2026-07-31 0000315700 fmr:C000014562Member fmr:TH0Member 2026-07-31 0000315700 fmr:C000014562Member fmr:TH1Member 2026-07-31 0000315700 fmr:C000014562Member fmr:TH2Member 2026-07-31 0000315700 fmr:C000014562Member fmr:TH3Member 2026-07-31 0000315700 fmr:C000014562Member fmr:TH4Member 2026-07-31 0000315700 fmr:C000014562Member fmr:TH5Member 2026-07-31 0000315700 fmr:C000014562Member fmr:TH6Member 2026-07-31 0000315700 fmr:C000014562Member fmr:TH7Member 2026-07-31 0000315700 fmr:C000014562Member fmr:TH8Member 2026-07-31 0000315700 fmr:C000014562Member fmr:TH9Member 2026-07-31 0000315700 fmr:C000014563Member 2025-07-31 2026-07-31 0000315700 fmr:C000014563_LG_ClassMember_11YRMember 2015-07-31 2026-07-31 0000315700 fmr:C000014563_ClassMember_AsOf_2016Member 2025-07-31 2026-07-31 0000315700 fmr:C000014563_ClassMember_AsOf_2017Member 2025-07-31 2026-07-31 0000315700 fmr:C000014563_ClassMember_AsOf_2018Member 2025-07-31 2026-07-31 0000315700 fmr:C000014563_ClassMember_AsOf_2019Member 2025-07-31 2026-07-31 0000315700 fmr:C000014563_ClassMember_AsOf_2020Member 2025-07-31 2026-07-31 0000315700 fmr:C000014563_ClassMember_AsOf_2021Member 2025-07-31 2026-07-31 0000315700 fmr:C000014563_ClassMember_AsOf_2022Member 2025-07-31 2026-07-31 0000315700 fmr:C000014563_ClassMember_AsOf_2023Member 2025-07-31 2026-07-31 0000315700 fmr:C000014563_ClassMember_AsOf_2024Member 2025-07-31 2026-07-31 0000315700 fmr:C000014563_ClassMember_AsOf_2025Member 2025-07-31 2026-07-31 0000315700 fmr:C000014563_ClassMember_AsOf_2026Member 2025-07-31 2026-07-31 0000315700 fmr:C000014563_LG_1_AdditionalIndexMember_11YRMember 2015-07-31 2026-07-31 0000315700 fmr:C000014563_1_AdditionalIndexMember_AsOf_2016Member 2025-07-31 2026-07-31 0000315700 fmr:C000014563_1_AdditionalIndexMember_AsOf_2017Member 2025-07-31 2026-07-31 0000315700 fmr:C000014563_1_AdditionalIndexMember_AsOf_2018Member 2025-07-31 2026-07-31 0000315700 fmr:C000014563_1_AdditionalIndexMember_AsOf_2019Member 2025-07-31 2026-07-31 0000315700 fmr:C000014563_1_AdditionalIndexMember_AsOf_2020Member 2025-07-31 2026-07-31 0000315700 fmr:C000014563_1_AdditionalIndexMember_AsOf_2021Member 2025-07-31 2026-07-31 0000315700 fmr:C000014563_1_AdditionalIndexMember_AsOf_2022Member 2025-07-31 2026-07-31 0000315700 fmr:C000014563_1_AdditionalIndexMember_AsOf_2023Member 2025-07-31 2026-07-31 0000315700 fmr:C000014563_1_AdditionalIndexMember_AsOf_2024Member 2025-07-31 2026-07-31 0000315700 fmr:C000014563_1_AdditionalIndexMember_AsOf_2025Member 2025-07-31 2026-07-31 0000315700 fmr:C000014563_1_AdditionalIndexMember_AsOf_2026Member 2025-07-31 2026-07-31 0000315700 fmr:C000014563_LG_2_AdditionalIndexMember_11YRMember 2015-07-31 2026-07-31 0000315700 fmr:C000014563_2_AdditionalIndexMember_AsOf_2016Member 2025-07-31 2026-07-31 0000315700 fmr:C000014563_2_AdditionalIndexMember_AsOf_2017Member 2025-07-31 2026-07-31 0000315700 fmr:C000014563_2_AdditionalIndexMember_AsOf_2018Member 2025-07-31 2026-07-31 0000315700 fmr:C000014563_2_AdditionalIndexMember_AsOf_2019Member 2025-07-31 2026-07-31 0000315700 fmr:C000014563_2_AdditionalIndexMember_AsOf_2020Member 2025-07-31 2026-07-31 0000315700 fmr:C000014563_2_AdditionalIndexMember_AsOf_2021Member 2025-07-31 2026-07-31 0000315700 fmr:C000014563_2_AdditionalIndexMember_AsOf_2022Member 2025-07-31 2026-07-31 0000315700 fmr:C000014563_2_AdditionalIndexMember_AsOf_2023Member 2025-07-31 2026-07-31 0000315700 fmr:C000014563_2_AdditionalIndexMember_AsOf_2024Member 2025-07-31 2026-07-31 0000315700 fmr:C000014563_2_AdditionalIndexMember_AsOf_2025Member 2025-07-31 2026-07-31 0000315700 fmr:C000014563_2_AdditionalIndexMember_AsOf_2026Member 2025-07-31 2026-07-31 0000315700 fmr:C000014563_NoLoadClassMember_1YRMember 2025-07-31 2026-07-31 0000315700 fmr:C000014563_NoLoadClassMember_5YRMember 2021-07-31 2026-07-31 0000315700 fmr:C000014563_NoLoadClassMember_10YRMember 2016-07-31 2026-07-31 0000315700 fmr:C000014563_0_AdditionalIndexMember_1YRMember 2025-07-31 2026-07-31 0000315700 fmr:C000014563_0_AdditionalIndexMember_5YRMember 2021-07-31 2026-07-31 0000315700 fmr:C000014563_0_AdditionalIndexMember_10YRMember 2016-07-31 2026-07-31 0000315700 fmr:C000014563_1_BBIndexMember_1YRMember 2025-07-31 2026-07-31 0000315700 fmr:C000014563_1_BBIndexMember_5YRMember 2021-07-31 2026-07-31 0000315700 fmr:C000014563_1_BBIndexMember_10YRMember 2016-07-31 2026-07-31 0000315700 fmr:C000014563Member 2026-07-31 0000315700 fmr:C000014563Member fmr:TI0Member 2026-07-31 0000315700 fmr:C000014563Member fmr:TI1Member 2026-07-31 0000315700 fmr:C000014563Member fmr:TI2Member 2026-07-31 0000315700 fmr:C000014563Member fmr:TI3Member 2026-07-31 0000315700 fmr:C000014563Member fmr:TI4Member 2026-07-31 0000315700 fmr:C000014563Member fmr:TI5Member 2026-07-31 0000315700 fmr:C000014563Member fmr:TI6Member 2026-07-31 0000315700 fmr:C000014563Member fmr:TI7Member 2026-07-31 0000315700 fmr:AACommonStocksMember fmr:C000014563Member 2026-07-31 0000315700 fmr:AAPreferredStocksMember fmr:C000014563Member 2026-07-31 0000315700 fmr:AABondsMember fmr:C000014563Member 2026-07-31 0000315700 fmr:AAShortTermInvestmentsandNetOtherAssetsLiabilitiesMember fmr:C000014563Member 2026-07-31 0000315700 fmr:C000014563Member country:US 2026-07-31 0000315700 fmr:C000014563Member country:NL 2026-07-31 0000315700 fmr:C000014563Member country:DK 2026-07-31 0000315700 fmr:C000014563Member country:BE 2026-07-31 0000315700 fmr:C000014563Member country:CA 2026-07-31 0000315700 fmr:C000014563Member country:FR 2026-07-31 0000315700 fmr:C000014563Member country:GB 2026-07-31 0000315700 fmr:C000014563Member country:IL 2026-07-31 0000315700 fmr:C000014563Member country:AU 2026-07-31 0000315700 fmr:C000014563Member country:CN 2026-07-31 0000315700 fmr:C000014563Member fmr:TH0Member 2026-07-31 0000315700 fmr:C000014563Member fmr:TH1Member 2026-07-31 0000315700 fmr:C000014563Member fmr:TH2Member 2026-07-31 0000315700 fmr:C000014563Member fmr:TH3Member 2026-07-31 0000315700 fmr:C000014563Member fmr:TH4Member 2026-07-31 0000315700 fmr:C000014563Member fmr:TH5Member 2026-07-31 0000315700 fmr:C000014563Member fmr:TH6Member 2026-07-31 0000315700 fmr:C000014563Member fmr:TH7Member 2026-07-31 0000315700 fmr:C000014563Member fmr:TH8Member 2026-07-31 0000315700 fmr:C000014563Member fmr:TH9Member 2026-07-31 0000315700 fmr:C000014561Member 2025-07-31 2026-07-31 0000315700 fmr:C000014561_LG_ClassMember_11YRMember 2015-07-31 2026-07-31 0000315700 fmr:C000014561_ClassMember_AsOf_2016Member 2025-07-31 2026-07-31 0000315700 fmr:C000014561_ClassMember_AsOf_2017Member 2025-07-31 2026-07-31 0000315700 fmr:C000014561_ClassMember_AsOf_2018Member 2025-07-31 2026-07-31 0000315700 fmr:C000014561_ClassMember_AsOf_2019Member 2025-07-31 2026-07-31 0000315700 fmr:C000014561_ClassMember_AsOf_2020Member 2025-07-31 2026-07-31 0000315700 fmr:C000014561_ClassMember_AsOf_2021Member 2025-07-31 2026-07-31 0000315700 fmr:C000014561_ClassMember_AsOf_2022Member 2025-07-31 2026-07-31 0000315700 fmr:C000014561_ClassMember_AsOf_2023Member 2025-07-31 2026-07-31 0000315700 fmr:C000014561_ClassMember_AsOf_2024Member 2025-07-31 2026-07-31 0000315700 fmr:C000014561_ClassMember_AsOf_2025Member 2025-07-31 2026-07-31 0000315700 fmr:C000014561_ClassMember_AsOf_2026Member 2025-07-31 2026-07-31 0000315700 fmr:C000014561_LG_1_AdditionalIndexMember_11YRMember 2015-07-31 2026-07-31 0000315700 fmr:C000014561_1_AdditionalIndexMember_AsOf_2016Member 2025-07-31 2026-07-31 0000315700 fmr:C000014561_1_AdditionalIndexMember_AsOf_2017Member 2025-07-31 2026-07-31 0000315700 fmr:C000014561_1_AdditionalIndexMember_AsOf_2018Member 2025-07-31 2026-07-31 0000315700 fmr:C000014561_1_AdditionalIndexMember_AsOf_2019Member 2025-07-31 2026-07-31 0000315700 fmr:C000014561_1_AdditionalIndexMember_AsOf_2020Member 2025-07-31 2026-07-31 0000315700 fmr:C000014561_1_AdditionalIndexMember_AsOf_2021Member 2025-07-31 2026-07-31 0000315700 fmr:C000014561_1_AdditionalIndexMember_AsOf_2022Member 2025-07-31 2026-07-31 0000315700 fmr:C000014561_1_AdditionalIndexMember_AsOf_2023Member 2025-07-31 2026-07-31 0000315700 fmr:C000014561_1_AdditionalIndexMember_AsOf_2024Member 2025-07-31 2026-07-31 0000315700 fmr:C000014561_1_AdditionalIndexMember_AsOf_2025Member 2025-07-31 2026-07-31 0000315700 fmr:C000014561_1_AdditionalIndexMember_AsOf_2026Member 2025-07-31 2026-07-31 0000315700 fmr:C000014561_LG_2_AdditionalIndexMember_11YRMember 2015-07-31 2026-07-31 0000315700 fmr:C000014561_2_AdditionalIndexMember_AsOf_2016Member 2025-07-31 2026-07-31 0000315700 fmr:C000014561_2_AdditionalIndexMember_AsOf_2017Member 2025-07-31 2026-07-31 0000315700 fmr:C000014561_2_AdditionalIndexMember_AsOf_2018Member 2025-07-31 2026-07-31 0000315700 fmr:C000014561_2_AdditionalIndexMember_AsOf_2019Member 2025-07-31 2026-07-31 0000315700 fmr:C000014561_2_AdditionalIndexMember_AsOf_2020Member 2025-07-31 2026-07-31 0000315700 fmr:C000014561_2_AdditionalIndexMember_AsOf_2021Member 2025-07-31 2026-07-31 0000315700 fmr:C000014561_2_AdditionalIndexMember_AsOf_2022Member 2025-07-31 2026-07-31 0000315700 fmr:C000014561_2_AdditionalIndexMember_AsOf_2023Member 2025-07-31 2026-07-31 0000315700 fmr:C000014561_2_AdditionalIndexMember_AsOf_2024Member 2025-07-31 2026-07-31 0000315700 fmr:C000014561_2_AdditionalIndexMember_AsOf_2025Member 2025-07-31 2026-07-31 0000315700 fmr:C000014561_2_AdditionalIndexMember_AsOf_2026Member 2025-07-31 2026-07-31 0000315700 fmr:C000014561_ClassMember_1YRMember 2025-07-31 2026-07-31 0000315700 fmr:C000014561_ClassMember_5YRMember 2021-07-31 2026-07-31 0000315700 fmr:C000014561_ClassMember_10YRMember 2016-07-31 2026-07-31 0000315700 fmr:C000014561_NoLoadClassMember_1YRMember 2025-07-31 2026-07-31 0000315700 fmr:C000014561_NoLoadClassMember_5YRMember 2021-07-31 2026-07-31 0000315700 fmr:C000014561_NoLoadClassMember_10YRMember 2016-07-31 2026-07-31 0000315700 fmr:C000014561_0_AdditionalIndexMember_1YRMember 2025-07-31 2026-07-31 0000315700 fmr:C000014561_0_AdditionalIndexMember_5YRMember 2021-07-31 2026-07-31 0000315700 fmr:C000014561_0_AdditionalIndexMember_10YRMember 2016-07-31 2026-07-31 0000315700 fmr:C000014561_1_BBIndexMember_1YRMember 2025-07-31 2026-07-31 0000315700 fmr:C000014561_1_BBIndexMember_5YRMember 2021-07-31 2026-07-31 0000315700 fmr:C000014561_1_BBIndexMember_10YRMember 2016-07-31 2026-07-31 0000315700 fmr:C000014561Member 2026-07-31 0000315700 fmr:C000014561Member fmr:TI0Member 2026-07-31 0000315700 fmr:C000014561Member fmr:TI1Member 2026-07-31 0000315700 fmr:C000014561Member fmr:TI2Member 2026-07-31 0000315700 fmr:C000014561Member fmr:TI3Member 2026-07-31 0000315700 fmr:C000014561Member fmr:TI4Member 2026-07-31 0000315700 fmr:C000014561Member fmr:TI5Member 2026-07-31 0000315700 fmr:C000014561Member fmr:TI6Member 2026-07-31 0000315700 fmr:C000014561Member fmr:TI7Member 2026-07-31 0000315700 fmr:AACommonStocksMember fmr:C000014561Member 2026-07-31 0000315700 fmr:AAPreferredStocksMember fmr:C000014561Member 2026-07-31 0000315700 fmr:AABondsMember fmr:C000014561Member 2026-07-31 0000315700 fmr:AAShortTermInvestmentsandNetOtherAssetsLiabilitiesMember fmr:C000014561Member 2026-07-31 0000315700 fmr:C000014561Member country:US 2026-07-31 0000315700 fmr:C000014561Member country:NL 2026-07-31 0000315700 fmr:C000014561Member country:DK 2026-07-31 0000315700 fmr:C000014561Member country:BE 2026-07-31 0000315700 fmr:C000014561Member country:CA 2026-07-31 0000315700 fmr:C000014561Member country:FR 2026-07-31 0000315700 fmr:C000014561Member country:GB 2026-07-31 0000315700 fmr:C000014561Member country:IL 2026-07-31 0000315700 fmr:C000014561Member country:AU 2026-07-31 0000315700 fmr:C000014561Member country:CN 2026-07-31 0000315700 fmr:C000014561Member fmr:TH0Member 2026-07-31 0000315700 fmr:C000014561Member fmr:TH1Member 2026-07-31 0000315700 fmr:C000014561Member fmr:TH2Member 2026-07-31 0000315700 fmr:C000014561Member fmr:TH3Member 2026-07-31 0000315700 fmr:C000014561Member fmr:TH4Member 2026-07-31 0000315700 fmr:C000014561Member fmr:TH5Member 2026-07-31 0000315700 fmr:C000014561Member fmr:TH6Member 2026-07-31 0000315700 fmr:C000014561Member fmr:TH7Member 2026-07-31 0000315700 fmr:C000014561Member fmr:TH8Member 2026-07-31 0000315700 fmr:C000014561Member fmr:TH9Member 2026-07-31 0000315700 fmr:C000014559Member 2025-07-31 2026-07-31 0000315700 fmr:C000014559_LG_ClassMember_11YRMember 2015-07-31 2026-07-31 0000315700 fmr:C000014559_ClassMember_AsOf_2016Member 2025-07-31 2026-07-31 0000315700 fmr:C000014559_ClassMember_AsOf_2017Member 2025-07-31 2026-07-31 0000315700 fmr:C000014559_ClassMember_AsOf_2018Member 2025-07-31 2026-07-31 0000315700 fmr:C000014559_ClassMember_AsOf_2019Member 2025-07-31 2026-07-31 0000315700 fmr:C000014559_ClassMember_AsOf_2020Member 2025-07-31 2026-07-31 0000315700 fmr:C000014559_ClassMember_AsOf_2021Member 2025-07-31 2026-07-31 0000315700 fmr:C000014559_ClassMember_AsOf_2022Member 2025-07-31 2026-07-31 0000315700 fmr:C000014559_ClassMember_AsOf_2023Member 2025-07-31 2026-07-31 0000315700 fmr:C000014559_ClassMember_AsOf_2024Member 2025-07-31 2026-07-31 0000315700 fmr:C000014559_ClassMember_AsOf_2025Member 2025-07-31 2026-07-31 0000315700 fmr:C000014559_ClassMember_AsOf_2026Member 2025-07-31 2026-07-31 0000315700 fmr:C000014559_LG_1_AdditionalIndexMember_11YRMember 2015-07-31 2026-07-31 0000315700 fmr:C000014559_1_AdditionalIndexMember_AsOf_2016Member 2025-07-31 2026-07-31 0000315700 fmr:C000014559_1_AdditionalIndexMember_AsOf_2017Member 2025-07-31 2026-07-31 0000315700 fmr:C000014559_1_AdditionalIndexMember_AsOf_2018Member 2025-07-31 2026-07-31 0000315700 fmr:C000014559_1_AdditionalIndexMember_AsOf_2019Member 2025-07-31 2026-07-31 0000315700 fmr:C000014559_1_AdditionalIndexMember_AsOf_2020Member 2025-07-31 2026-07-31 0000315700 fmr:C000014559_1_AdditionalIndexMember_AsOf_2021Member 2025-07-31 2026-07-31 0000315700 fmr:C000014559_1_AdditionalIndexMember_AsOf_2022Member 2025-07-31 2026-07-31 0000315700 fmr:C000014559_1_AdditionalIndexMember_AsOf_2023Member 2025-07-31 2026-07-31 0000315700 fmr:C000014559_1_AdditionalIndexMember_AsOf_2024Member 2025-07-31 2026-07-31 0000315700 fmr:C000014559_1_AdditionalIndexMember_AsOf_2025Member 2025-07-31 2026-07-31 0000315700 fmr:C000014559_1_AdditionalIndexMember_AsOf_2026Member 2025-07-31 2026-07-31 0000315700 fmr:C000014559_LG_2_AdditionalIndexMember_11YRMember 2015-07-31 2026-07-31 0000315700 fmr:C000014559_2_AdditionalIndexMember_AsOf_2016Member 2025-07-31 2026-07-31 0000315700 fmr:C000014559_2_AdditionalIndexMember_AsOf_2017Member 2025-07-31 2026-07-31 0000315700 fmr:C000014559_2_AdditionalIndexMember_AsOf_2018Member 2025-07-31 2026-07-31 0000315700 fmr:C000014559_2_AdditionalIndexMember_AsOf_2019Member 2025-07-31 2026-07-31 0000315700 fmr:C000014559_2_AdditionalIndexMember_AsOf_2020Member 2025-07-31 2026-07-31 0000315700 fmr:C000014559_2_AdditionalIndexMember_AsOf_2021Member 2025-07-31 2026-07-31 0000315700 fmr:C000014559_2_AdditionalIndexMember_AsOf_2022Member 2025-07-31 2026-07-31 0000315700 fmr:C000014559_2_AdditionalIndexMember_AsOf_2023Member 2025-07-31 2026-07-31 0000315700 fmr:C000014559_2_AdditionalIndexMember_AsOf_2024Member 2025-07-31 2026-07-31 0000315700 fmr:C000014559_2_AdditionalIndexMember_AsOf_2025Member 2025-07-31 2026-07-31 0000315700 fmr:C000014559_2_AdditionalIndexMember_AsOf_2026Member 2025-07-31 2026-07-31 0000315700 fmr:C000014559_ClassMember_1YRMember 2025-07-31 2026-07-31 0000315700 fmr:C000014559_ClassMember_5YRMember 2021-07-31 2026-07-31 0000315700 fmr:C000014559_ClassMember_10YRMember 2016-07-31 2026-07-31 0000315700 fmr:C000014559_NoLoadClassMember_1YRMember 2025-07-31 2026-07-31 0000315700 fmr:C000014559_NoLoadClassMember_5YRMember 2021-07-31 2026-07-31 0000315700 fmr:C000014559_NoLoadClassMember_10YRMember 2016-07-31 2026-07-31 0000315700 fmr:C000014559_0_AdditionalIndexMember_1YRMember 2025-07-31 2026-07-31 0000315700 fmr:C000014559_0_AdditionalIndexMember_5YRMember 2021-07-31 2026-07-31 0000315700 fmr:C000014559_0_AdditionalIndexMember_10YRMember 2016-07-31 2026-07-31 0000315700 fmr:C000014559_1_BBIndexMember_1YRMember 2025-07-31 2026-07-31 0000315700 fmr:C000014559_1_BBIndexMember_5YRMember 2021-07-31 2026-07-31 0000315700 fmr:C000014559_1_BBIndexMember_10YRMember 2016-07-31 2026-07-31 0000315700 fmr:C000014559Member 2026-07-31 0000315700 fmr:C000014559Member fmr:TI0Member 2026-07-31 0000315700 fmr:C000014559Member fmr:TI1Member 2026-07-31 0000315700 fmr:C000014559Member fmr:TI2Member 2026-07-31 0000315700 fmr:C000014559Member fmr:TI3Member 2026-07-31 0000315700 fmr:C000014559Member fmr:TI4Member 2026-07-31 0000315700 fmr:C000014559Member fmr:TI5Member 2026-07-31 0000315700 fmr:C000014559Member fmr:TI6Member 2026-07-31 0000315700 fmr:C000014559Member fmr:TI7Member 2026-07-31 0000315700 fmr:AACommonStocksMember fmr:C000014559Member 2026-07-31 0000315700 fmr:AAPreferredStocksMember fmr:C000014559Member 2026-07-31 0000315700 fmr:AABondsMember fmr:C000014559Member 2026-07-31 0000315700 fmr:AAShortTermInvestmentsandNetOtherAssetsLiabilitiesMember fmr:C000014559Member 2026-07-31 0000315700 fmr:C000014559Member country:US 2026-07-31 0000315700 fmr:C000014559Member country:NL 2026-07-31 0000315700 fmr:C000014559Member country:DK 2026-07-31 0000315700 fmr:C000014559Member country:BE 2026-07-31 0000315700 fmr:C000014559Member country:CA 2026-07-31 0000315700 fmr:C000014559Member country:FR 2026-07-31 0000315700 fmr:C000014559Member country:GB 2026-07-31 0000315700 fmr:C000014559Member country:IL 2026-07-31 0000315700 fmr:C000014559Member country:AU 2026-07-31 0000315700 fmr:C000014559Member country:CN 2026-07-31 0000315700 fmr:C000014559Member fmr:TH0Member 2026-07-31 0000315700 fmr:C000014559Member fmr:TH1Member 2026-07-31 0000315700 fmr:C000014559Member fmr:TH2Member 2026-07-31 0000315700 fmr:C000014559Member fmr:TH3Member 2026-07-31 0000315700 fmr:C000014559Member fmr:TH4Member 2026-07-31 0000315700 fmr:C000014559Member fmr:TH5Member 2026-07-31 0000315700 fmr:C000014559Member fmr:TH6Member 2026-07-31 0000315700 fmr:C000014559Member fmr:TH7Member 2026-07-31 0000315700 fmr:C000014559Member fmr:TH8Member 2026-07-31 0000315700 fmr:C000014559Member fmr:TH9Member 2026-07-31 0000315700 2025-07-31 2026-07-31 iso4217:USD pure shares N-CSR false 0000315700 N-1A Fidelity Advisor Series VII 2026-07-31 This report describes changes to the Fund that occurred during the reporting period. Fidelity Advisor® Semiconductors Fund Fidelity Advisor® Semiconductors Fund Class Z FIKGX This annual shareholder report contains information about Fidelity Advisor® Semiconductors Fund for the period August 1, 2025 to July 31, 2026. annual shareholder report You can find additional information about the Fund at fundresearch.fidelity.com/prospectus/sec. You can also request this information by contacting us at 1-877-208-0098 or by sending an e-mail to fidfunddocuments@fidelity.com. fundresearch.fidelity.com/prospectus/sec 1-877-208-0098 fidfunddocuments@fidelity.com <span style="font-family:'Fidelity Sans';font-size:16px;color:#368627;font-style:normal;font-weight:bold;">What were your Fund costs for the last year?</span> <div style="text-align:left;text-align-last:auto;"><span style="font-family:'Fidelity Sans';font-size:11px;color:#000000;font-style:normal;font-weight:normal;">(based on hypothetical $10,000 investment)</span></div> <div><span style="font-size:11px;"> </span></div><div style="text-align:left;text-align-last:auto;"></div> <div style="text-align:left;text-align-last:auto;"><span style="font-family:'Fidelity Sans';font-size:12px;color:#000000;font-style:normal;font-weight:bold;">FUND COST (PREVIOUS YEAR)</span></div> <div style="text-align:left;text-align-last:auto;"></div> <div style="text-align:left;text-align-last:auto;"><table cellpadding="0" cellspacing="0" style="border-collapse:collapse;border-style:none;" width="100%"><tr><td style="width:51%; background-color:#dfe0e4;border:1px solid #dfe0e4;padding:0px 0px 0px 0px;" valign="bottom"><div style="text-align:left;text-align-last:auto;"><span style="font-family:'Fidelity Sans';font-size:11px;color:#000000;font-style:normal;font-weight:bold;"> </span></div> </td> <td style="width:21%; background-color:#dfe0e4;border:1px solid #dfe0e4;padding:0px 0px 0px 0px;" valign="bottom"><div style="text-align:center;text-align-last:auto;"><span style="font-family:'Fidelity Sans';font-size:11px;color:#000000;font-style:normal;font-weight:bold;">Costs of a $10,000 investment</span></div> </td> <td style="width:27%; background-color:#dfe0e4;border:1px solid #dfe0e4;padding:0px 0px 0px 0px;" valign="bottom"><div style="text-align:center;text-align-last:auto;"><span style="font-family:'Fidelity Sans';font-size:11px;color:#000000;font-style:normal;font-weight:bold;">Costs paid as a percentage of a $10,000 investment </span></div> </td> <td style="width:1%; " valign="top"><span style="line-height:12px;"> </span><div style="text-align:left;text-align-last:auto;"></div> </td> </tr> <tr><td style="width:51%; border-bottom:1px solid #000000;padding:0px 0px 0px 0px;" valign="top"><div style="text-align:left;text-align-last:auto;"><span style="font-family:'Fidelity Sans';font-size:12px;color:#000000;font-style:normal;font-weight:normal;">Class Z</span><span style="font-family:'Fidelity Sans';font-size:11px;color:#000000;font-style:normal;font-weight:normal;"> </span></div> </td> <td style="width:21%; border-bottom:1px solid #000000;padding:0px 0px 0px 0px;" valign="middle"><div style="text-align:center;text-align-last:auto;"><span style="font-family:'Fidelity Sans';font-size:11px;color:#000000;font-style:normal;font-weight:normal;">$</span><span style="font-family:'Fidelity Sans';font-size:12px;color:#000000;font-style:normal;font-weight:normal;"> </span>77<span style="font-family:'Fidelity Sans';font-size:11px;color:#000000;font-style:normal;font-weight:normal;"> </span></div> </td> <td style="width:27%; border-bottom:1px solid #000000;padding:0px 0px 0px 0px;" valign="middle"><div style="text-align:center;text-align-last:auto;">0.54<span style="font-family:'Fidelity Sans';font-size:11px;color:#000000;font-style:normal;font-weight:normal;">%</span></div> </td> <td style="width:1%; " valign="top"><span style="line-height:12px;"> </span><div style="text-align:left;text-align-last:auto;"></div> </td> </tr> </table> </div> <div style="text-align:left;text-align-last:auto;"></div> 77 0.0054 <span style="font-family:'Fidelity Sans';font-size:16px;color:#368627;font-style:normal;font-weight:bold;">What affected the Fund's performance this period?</span> <div style="text-align:left;text-align-last:auto;"><span style="font-family:'Fidelity Sans';font-size:11px;color:#000000;font-style:normal;font-weight:bold;"> </span></div> <div style="text-align:left;text-align-last:auto;text-indent:-24px;margin-bottom:2px;margin-left:24px;margin-top:5px;margin-right:0px;"><span style="font-family:'Fidelity Sans';font-size:12px;color:#000000;font-style:normal;font-weight:normal;">•<span style="padding-right:10px"></span>U.S. stocks achieved a strong gain for the 12 months ending July 31, 2026, reflecting enthusiasm for artificial intelligence, strong corporate fundamentals, a resilient economy and, beginning in September, the Federal Reserve's first interest-rate reductions since December 2024.</span></div> <div style="text-align:left;text-align-last:auto;text-indent:-24px;margin-bottom:2px;margin-left:24px;margin-top:5px;margin-right:0px;"><span style="font-family:'Fidelity Sans';font-size:12px;color:#000000;font-style:normal;font-weight:normal;">•<span style="padding-right:10px"></span>Against this backdrop, security selection was the primary contributor to the fund's performance versus the MSCI US IMI Semiconductors &amp; Semiconductor Equipment 25/50 Index for the fiscal year, especially within technology hardware, storage &amp; peripherals. Stock picking in semiconductors and electronic components also boosted the fund's relative performance.</span></div> <div style="text-align:left;text-align-last:auto;text-indent:-24px;margin-bottom:2px;margin-left:24px;margin-top:5px;margin-right:0px;"><span style="font-family:'Fidelity Sans';font-size:12px;color:#000000;font-style:normal;font-weight:normal;">•<span style="padding-right:10px"></span>The top individual relative contributor was our non-index stake in Western Digital (+581%). This period we decreased our stake in Western Digital. A second notable relative contributor was an overweight in Marvell Technology (+133%). The company was among our biggest holdings. Another notable relative contributor was an underweight in Qualcomm (+3%).</span></div> <div style="text-align:left;text-align-last:auto;text-indent:-24px;margin-bottom:2px;margin-left:24px;margin-top:5px;margin-right:0px;"><span style="font-family:'Fidelity Sans';font-size:12px;color:#000000;font-style:normal;font-weight:normal;">•<span style="padding-right:10px"></span>In contrast, the biggest detractors from performance versus the industry index were picks and an underweight in semiconductor materials &amp; equipment. An overweight in semiconductors also hampered the fund's result. Lastly, the fund's position in cash detracted.</span></div> <div style="text-align:left;text-align-last:auto;text-indent:-24px;margin-bottom:2px;margin-left:24px;margin-top:5px;margin-right:0px;"><span style="font-family:'Fidelity Sans';font-size:12px;color:#000000;font-style:normal;font-weight:normal;">•<span style="padding-right:10px"></span>The biggest individual relative detractor was an underweight in Intel (+356%). This period we decreased our stake in Intel. A second notable relative detractor was an underweight in Advanced Micro Devices (+170%). This period we increased our position in Advanced Micro Devices. Another notable relative detractor was an underweight in Applied Materials (+184%).</span></div> <div style="text-align:left;text-align-last:auto;text-indent:-24px;margin-bottom:2px;margin-left:24px;margin-top:5px;margin-right:0px;"><span style="font-family:'Fidelity Sans';font-size:12px;color:#000000;font-style:normal;font-weight:normal;">•<span style="padding-right:10px"></span>Notable changes in positioning include higher allocations to the semiconductor materials &amp; equipment and technology hardware, storage &amp; peripherals industries.</span></div> <div style="text-align:left;text-align-last:auto;"></div> How did the Fund perform over the life of Fund?    CUMULATIVE PERFORMANCE October 2, 2018 through July 31, 2026. Initial investment of $10,000. Class Z $10,000 $11,203 $14,700 $23,970 $23,292 $34,912 $48,893 $60,206 $111,242 MSCI U.S. IMI Semiconductors & Semiconductor Equipment 25-50 Index $10,000 $10,992 $14,816 $23,440 $22,253 $33,233 $49,556 $57,990 $106,315 S&P 500® Index $10,000 $10,365 $11,604 $15,833 $15,098 $17,064 $20,843 $24,247 $28,991   2018 2019 2020 2021 2022 2023 2024 2025 2026   <span style="font-family:'Fidelity Sans';font-size:9px;color:#000000;font-style:normal;font-weight:normal;">Class Z</span> 10000 11203 14700 23970 23292 34912 48893 60206 111242 <span style="font-family:'Fidelity Sans';font-size:9px;color:#000000;font-style:normal;font-weight:normal;">MSCI U.S. IMI Semiconductors &amp; Semiconductor Equipment 25-50 Index</span> 10000 10992 14816 23440 22253 33233 49556 57990 106315 <span style="font-family:'Fidelity Sans';font-size:9px;color:#000000;font-style:normal;font-weight:normal;">S&amp;P 500® Index</span> 10000 10365 11604 15833 15098 17064 20843 24247 28991 AVERAGE ANNUAL TOTAL RETURNS:   1 Year 5 Year Life of Fund A Class Z 84.77% 35.93% 36.01% MSCI U.S. IMI Semiconductors & Semiconductor Equipment 25-50 Index 83.33% 35.31% 35.23% S&P 500® Index 19.56% 12.86% 14.56% A   From October 2, 2018   Visit institutional.fidelity.com for more recent performance information.    The Fund's past performance is not a good predictor of the Fund's future performance.  The graph and table do not reflect the deduction of taxes that a shareholder would pay on fund distributions or redemption of fund shares. 0.8477 0.3593 0.3601 0.8333 0.3531 0.3523 0.1956 0.1286 0.1456 2018-10-02 <span style="font-family:'Fidelity Sans';font-size:11px;color:#000000;font-style:normal;font-weight:normal;">Visit </span><span style="font-family:'Fidelity Sans';font-size:11px;color:#000000;font-style:normal;font-weight:bold;">institutional.fidelity.com</span><span style="font-family:'Fidelity Sans';font-size:11px;color:#000000;font-style:normal;font-weight:normal;"> for more recent performance information.</span> <span style="font-family:'Fidelity Sans';font-size:11px;color:#000000;font-style:italic;font-weight:normal;">The Fund's past performance is not a good predictor of the Fund's future performance.</span> <span style="font-family:'Fidelity Sans';font-size:11px;color:#000000;font-style:normal;font-weight:normal;">The graph and table do not reflect the deduction of taxes that a shareholder would pay on fund distributions or redemption of fund shares.</span> <span style="font-family:'Fidelity Sans';font-size:16px;color:#368627;font-style:normal;font-weight:bold;">Key Fund Statistics</span> <div style="text-align:left;text-align-last:auto;"></div> <div style="text-align:left;text-align-last:auto;"><span style="font-family:'Fidelity Sans';font-size:11px;color:#000000;font-style:normal;font-weight:normal;">(as of July 31, 2026)</span></div> <div><span style="font-size:11px;"> </span></div><div style="text-align:left;text-align-last:auto;"></div> <div style="text-align:right;text-align-last:auto;"><table cellpadding="0" cellspacing="1" style="border-collapse:separate;border-style:none;margin:auto;" width="100%"><tr><td style="width:63%; " valign="top"><div style="text-align:left;text-align-last:auto;"><span style="font-family:'Fidelity Sans';font-size:12px;color:#000000;font-style:normal;font-weight:bold;">KEY FACTS</span></div> <div style="text-align:left;text-align-last:auto;"></div> <div style="text-align:left;text-align-last:auto;"><span style="font-family:'Fidelity Sans';font-size:11px;color:#000000;font-style:normal;font-weight:bold;"> <span> </span></span></div> <div style="text-align:left;text-align-last:auto;"></div> </td> <td style="width:32%; " valign="top"><span style="line-height:12px;"> </span><div style="text-align:left;text-align-last:auto;"></div> </td> <td style="width:5%; " valign="top"><span style="line-height:12px;"> </span><div style="text-align:left;text-align-last:auto;"></div> </td> </tr> <tr><td style="width:63%; border-bottom:1px dashed #000000;padding:0px 0px 0px 0px;" valign="middle"><div style="text-align:left;text-align-last:auto;"><span style="font-family:'Fidelity Sans';font-size:11px;color:#000000;font-style:normal;font-weight:normal;">Fund Size</span></div> </td> <td style="width:32%; border-bottom:1px dashed #000000;padding:0px 0px 0px 0px;" valign="middle"><div style="text-align:right;text-align-last:auto;"><span style="font-family:'Fidelity Sans';font-size:11px;color:#000000;font-style:normal;font-weight:normal;">$</span>7,203,754,194</div> <div style="text-align:right;text-align-last:auto;"></div> </td> <td style="width:5%; " valign="top"><span style="line-height:11px;"> </span><div style="text-align:left;text-align-last:auto;"></div> </td> </tr> <tr><td style="width:63%; border-bottom:1px dashed #000000;padding:0px 0px 0px 0px;" valign="middle"><div style="text-align:left;text-align-last:auto;"><span style="font-family:'Fidelity Sans';font-size:11px;color:#000000;font-style:normal;font-weight:normal;">Number of Holdings</span></div> </td> <td style="width:32%; border-bottom:1px dashed #000000;padding:0px 0px 0px 0px;" valign="middle"><div style="text-align:right;text-align-last:auto;">76</div> <div style="text-align:right;text-align-last:auto;"></div> </td> <td style="width:5%; " valign="top"><span style="line-height:11px;"> </span><div style="text-align:left;text-align-last:auto;"></div> </td> </tr> <tr><td style="width:63%; border-bottom:1px dashed #000000;padding:0px 0px 0px 0px;" valign="middle"><div style="text-align:left;text-align-last:auto;"><span style="font-family:'Fidelity Sans';font-size:11px;color:#000000;font-style:normal;font-weight:normal;">Total Advisory Fee</span></div> </td> <td style="width:32%; border-bottom:1px dashed #000000;padding:0px 0px 0px 0px;" valign="middle"><div style="text-align:right;text-align-last:auto;"><span style="font-family:'Fidelity Sans';font-size:11px;color:#000000;font-style:normal;font-weight:normal;">$</span>35,292,988</div> <div style="text-align:right;text-align-last:auto;"></div> </td> <td style="width:5%; " valign="middle"><span style="line-height:11px;"> </span><div style="text-align:left;text-align-last:auto;"></div> </td> </tr> <tr><td style="width:63%; border-bottom:1px dashed #000000;padding:0px 0px 0px 0px;" valign="middle"><div style="text-align:left;text-align-last:auto;"><span style="font-family:'Fidelity Sans';font-size:11px;color:#000000;font-style:normal;font-weight:normal;">Portfolio Turnover</span></div> </td> <td style="width:32%; border-bottom:1px dashed #000000;padding:0px 0px 0px 0px;" valign="middle"><div style="text-align:right;text-align-last:auto;">99<span style="font-family:'Fidelity Sans';font-size:11px;color:#000000;font-style:normal;font-weight:normal;">%</span></div> <div style="text-align:left;text-align-last:auto;"></div> </td> <td style="width:5%; " valign="top"><span style="line-height:11px;"> </span><div style="text-align:left;text-align-last:auto;"></div> </td> </tr> </table> </div> <div style="text-align:left;text-align-last:auto;"></div> 7203754194 76 35292988 0.99       TOP INDUSTRIES (% of Fund's net assets) Semiconductors & Semiconductor Equipment 93.8   Technology Hardware, Storage & Peripherals 4.5   Electronic Equipment, Instruments & Components 0.7   Electrical Equipment 0.3   Software 0.2   Financial Services 0.0   Metals & Mining 0.0       Common Stocks 98.5 Preferred Stocks 1.0 Preferred Securities 0.0 Bonds 0.0 Short-Term Investments and Net Other Assets (Liabilities) 0.5 ASSET ALLOCATION (% of Fund's net assets)     Common Stocks - 98.5                       Preferred Stocks - 1.0                     Preferred Securities - 0.0                 Bonds - 0.0                                Short-Term Investments and Net Other Assets (Liabilities) - 0.5   United States 85.1 Netherlands 9.1 Japan 2.3 Israel 2.0 Taiwan 1.3 Korea (South) 0.2 Canada 0.0 GEOGRAPHIC DIVERSIFICATION (% of Fund's net assets)     United States - 85.1                       Netherlands - 9.1                          Japan - 2.3                                Israel - 2.0                               Taiwan - 1.3                               Korea (South) - 0.2                        Canada - 0.0                                   0.938 0.045 0.007 0.003 0.002 0.000 0.000 0.985 0.010 0.000 0.000 0.005 0.851 0.091 0.023 0.020 0.013 0.002 0.000 TOP HOLDINGS(% of Fund's net assets)     NVIDIA Corp 24.4   Broadcom Inc 15.4   Marvell Technology Inc 6.2   Astera Labs Inc 4.9   Monolithic Power Systems Inc 4.8   ASML Holding NV depository receipt 4.8   ON Semiconductor Corp 4.2   NXP Semiconductors NV 4.1   Micron Technology Inc 4.1   Lam Research Corp 3.7     76.6   0.244 0.154 0.062 0.049 0.048 0.048 0.042 0.041 0.041 0.037 <div style="text-align:left;text-align-last:auto;"><span style="font-family:'Fidelity Sans';font-size:16px;color:#368627;font-style:normal;font-weight:bold;">How has the Fund changed?</span></div> <div style="text-align:left;text-align-last:auto;"><span style="font-family:'Fidelity Sans';font-size:11px;color:#000000;font-style:normal;font-weight:normal;"> </span></div> <div style="text-align:left;text-align-last:auto;"><span style="font-family:'Fidelity Sans';font-size:11px;color:#000000;font-style:normal;font-weight:normal;">This is a summary of certain changes to the Fund since August 1, 2025. For more complete information, you may review the Fund's next prospectus, which we expect to be available by September 29, 2026 at </span><span style="font-family:'Fidelity Sans';font-size:11px;color:#000000;font-style:normal;font-weight:bold;">fundresearch.fidelity.com/prospectus/sec</span><span style="font-family:'Fidelity Sans';font-size:11px;color:#000000;font-style:normal;font-weight:normal;"> or upon request at </span><span style="font-family:'Fidelity Sans';font-size:11px;color:#000000;font-style:normal;font-weight:normal;">1-877-208-0098</span><span style="font-family:'Fidelity Sans';font-size:0px;color:#000000;font-style:normal;font-weight:normal;"> </span><span style="font-family:'Fidelity Sans';font-size:11px;color:#000000;font-style:normal;font-weight:normal;"> or by sending an e-mail to </span><span style="font-family:'Fidelity Sans';font-size:11px;color:#000000;font-style:normal;font-weight:normal;">fidfunddocuments@fidelity.com</span><span style="font-family:'Fidelity Sans';font-size:11px;color:#000000;font-style:normal;font-weight:normal;">.</span></div> <div style="text-align:left;text-align-last:auto;"></div> <span style="line-height:11px;"> </span><div style="text-align:left;text-align-last:auto;"></div> <div style="text-align:left;text-align-last:auto;"><table cellpadding="0" cellspacing="0" style="border-collapse:collapse;border-style:none;" width="100%"><tr><td style="width:50%; background-color:#ebf3e9;border-right:2px dashed #368627;padding:19px 19px 19px 19px;" valign="top"><div style="text-align:left;text-align-last:auto;"> <div style="text-align:left;text-align-last:auto;"><span style="font-family:'Fidelity Sans';font-size:11px;color:#000000;font-style:normal;font-weight:normal;">The fees associated with this class changed during the reporting year. The variations in class fees are primarily the result of the following changes:</span></div> <ul style="color:#000000;list-style-type:disc;margin:0px 0px 0px 25px;padding:0px;"><li style="margin:5px 0px 2px 24px;padding:0px 0px 0px 0px;"><span style="font-family:'Fidelity Sans';font-size:11px;color:#000000;font-style:normal;font-weight:normal;">Management fee</span></li></ul> <span style="line-height:12px;"> </span><div style="text-align:left;text-align-last:auto;"></div> <div style="text-align:left;text-align-last:auto;"></div></div> <div style="text-align:left;text-align-last:auto;"></div> </td> <td style="width:50%; background-color:#ebf3e9;padding:19px 19px 19px 19px;" valign="top"><div style="text-align:left;text-align-last:auto;"></div> </td> </tr> </table> </div> <div style="text-align:left;text-align-last:auto;"></div> <span style="font-family:'Fidelity Sans';font-size:11px;color:#000000;font-style:normal;font-weight:normal;">This is a summary of certain changes to the Fund since August 1, 2025. For more complete information, you may review the Fund's next prospectus, which we expect to be available by September 29, 2026 at </span><span style="font-family:'Fidelity Sans';font-size:11px;color:#000000;font-style:normal;font-weight:bold;">fundresearch.fidelity.com/prospectus/sec</span><span style="font-family:'Fidelity Sans';font-size:11px;color:#000000;font-style:normal;font-weight:normal;"> or upon request at </span><span style="font-family:'Fidelity Sans';font-size:11px;color:#000000;font-style:normal;font-weight:normal;">1-877-208-0098</span><span style="font-family:'Fidelity Sans';font-size:0px;color:#000000;font-style:normal;font-weight:normal;"> </span><span style="font-family:'Fidelity Sans';font-size:11px;color:#000000;font-style:normal;font-weight:normal;"> or by sending an e-mail to </span><span style="font-family:'Fidelity Sans';font-size:11px;color:#000000;font-style:normal;font-weight:normal;">fidfunddocuments@fidelity.com</span><span style="font-family:'Fidelity Sans';font-size:11px;color:#000000;font-style:normal;font-weight:normal;">.</span> <span style="font-family:'Fidelity Sans';font-size:11px;color:#000000;font-style:normal;font-weight:bold;">fundresearch.fidelity.com/prospectus/sec</span> <span style="font-family:'Fidelity Sans';font-size:11px;color:#000000;font-style:normal;font-weight:normal;">1-877-208-0098</span> <span style="font-family:'Fidelity Sans';font-size:11px;color:#000000;font-style:normal;font-weight:normal;">fidfunddocuments@fidelity.com</span> <div style="text-align:left;text-align-last:auto;"><span style="font-family:'Fidelity Sans';font-size:11px;color:#000000;font-style:normal;font-weight:normal;">The fees associated with this class changed during the reporting year. The variations in class fees are primarily the result of the following changes:</span></div> <ul style="color:#000000;list-style-type:disc;margin:0px 0px 0px 25px;padding:0px;"><li style="margin:5px 0px 2px 24px;padding:0px 0px 0px 0px;"><span style="font-family:'Fidelity Sans';font-size:11px;color:#000000;font-style:normal;font-weight:normal;">Management fee</span></li></ul> <span style="line-height:12px;"> </span><div style="text-align:left;text-align-last:auto;"></div> <div style="text-align:left;text-align-last:auto;"></div> 2026-07-31 Fidelity Advisor® Semiconductors Fund Fidelity Advisor® Semiconductors Fund Class M FELTX This annual shareholder report contains information about Fidelity Advisor® Semiconductors Fund for the period August 1, 2025 to July 31, 2026. annual shareholder report You can find additional information about the Fund at fundresearch.fidelity.com/prospectus/sec. You can also request this information by contacting us at 1-877-208-0098 or by sending an e-mail to fidfunddocuments@fidelity.com. fundresearch.fidelity.com/prospectus/sec 1-877-208-0098 fidfunddocuments@fidelity.com <span style="font-family:'Fidelity Sans';font-size:16px;color:#368627;font-style:normal;font-weight:bold;">What were your Fund costs for the last year?</span> <div style="text-align:left;text-align-last:auto;"><span style="font-family:'Fidelity Sans';font-size:11px;color:#000000;font-style:normal;font-weight:normal;">(based on hypothetical $10,000 investment)</span></div> <div><span style="font-size:11px;"> </span></div><div style="text-align:left;text-align-last:auto;"></div> <div style="text-align:left;text-align-last:auto;"><span style="font-family:'Fidelity Sans';font-size:12px;color:#000000;font-style:normal;font-weight:bold;">FUND COST (PREVIOUS YEAR)</span></div> <div style="text-align:left;text-align-last:auto;"></div> <div style="text-align:left;text-align-last:auto;"><table cellpadding="0" cellspacing="0" style="border-collapse:collapse;border-style:none;" width="100%"><tr><td style="width:51%; background-color:#dfe0e4;border:1px solid #dfe0e4;padding:0px 0px 0px 0px;" valign="bottom"><div style="text-align:left;text-align-last:auto;"><span style="font-family:'Fidelity Sans';font-size:11px;color:#000000;font-style:normal;font-weight:bold;"> </span></div> </td> <td style="width:21%; background-color:#dfe0e4;border:1px solid #dfe0e4;padding:0px 0px 0px 0px;" valign="bottom"><div style="text-align:center;text-align-last:auto;"><span style="font-family:'Fidelity Sans';font-size:11px;color:#000000;font-style:normal;font-weight:bold;">Costs of a $10,000 investment</span></div> </td> <td style="width:27%; background-color:#dfe0e4;border:1px solid #dfe0e4;padding:0px 0px 0px 0px;" valign="bottom"><div style="text-align:center;text-align-last:auto;"><span style="font-family:'Fidelity Sans';font-size:11px;color:#000000;font-style:normal;font-weight:bold;">Costs paid as a percentage of a $10,000 investment </span></div> </td> <td style="width:1%; " valign="top"><span style="line-height:12px;"> </span><div style="text-align:left;text-align-last:auto;"></div> </td> </tr> <tr><td style="width:51%; border-bottom:1px solid #000000;padding:0px 0px 0px 0px;" valign="top"><div style="text-align:left;text-align-last:auto;"><span style="font-family:'Fidelity Sans';font-size:12px;color:#000000;font-style:normal;font-weight:normal;">Class M</span><span style="font-family:'Fidelity Sans';font-size:11px;color:#000000;font-style:normal;font-weight:normal;"> </span></div> </td> <td style="width:21%; border-bottom:1px solid #000000;padding:0px 0px 0px 0px;" valign="middle"><div style="text-align:center;text-align-last:auto;"><span style="font-family:'Fidelity Sans';font-size:11px;color:#000000;font-style:normal;font-weight:normal;">$</span><span style="font-family:'Fidelity Sans';font-size:12px;color:#000000;font-style:normal;font-weight:normal;"> </span>164<span style="font-family:'Fidelity Sans';font-size:11px;color:#000000;font-style:normal;font-weight:normal;"> </span></div> </td> <td style="width:27%; border-bottom:1px solid #000000;padding:0px 0px 0px 0px;" valign="middle"><div style="text-align:center;text-align-last:auto;">1.16<span style="font-family:'Fidelity Sans';font-size:11px;color:#000000;font-style:normal;font-weight:normal;">%</span></div> </td> <td style="width:1%; " valign="top"><span style="line-height:12px;"> </span><div style="text-align:left;text-align-last:auto;"></div> </td> </tr> </table> </div> <div style="text-align:left;text-align-last:auto;"></div> 164 0.0116 <span style="font-family:'Fidelity Sans';font-size:16px;color:#368627;font-style:normal;font-weight:bold;">What affected the Fund's performance this period?</span> <div style="text-align:left;text-align-last:auto;"><span style="font-family:'Fidelity Sans';font-size:11px;color:#000000;font-style:normal;font-weight:bold;"> </span></div> <div style="text-align:left;text-align-last:auto;text-indent:-24px;margin-bottom:2px;margin-left:24px;margin-top:5px;margin-right:0px;"><span style="font-family:'Fidelity Sans';font-size:12px;color:#000000;font-style:normal;font-weight:normal;">•<span style="padding-right:10px"></span>U.S. stocks achieved a strong gain for the 12 months ending July 31, 2026, reflecting enthusiasm for artificial intelligence, strong corporate fundamentals, a resilient economy and, beginning in September, the Federal Reserve's first interest-rate reductions since December 2024.</span></div> <div style="text-align:left;text-align-last:auto;text-indent:-24px;margin-bottom:2px;margin-left:24px;margin-top:5px;margin-right:0px;"><span style="font-family:'Fidelity Sans';font-size:12px;color:#000000;font-style:normal;font-weight:normal;">•<span style="padding-right:10px"></span>Against this backdrop, security selection was the primary contributor to the fund's performance versus the MSCI US IMI Semiconductors &amp; Semiconductor Equipment 25/50 Index for the fiscal year, especially within technology hardware, storage &amp; peripherals. Stock picking in semiconductors and electronic components also boosted the fund's relative performance.</span></div> <div style="text-align:left;text-align-last:auto;text-indent:-24px;margin-bottom:2px;margin-left:24px;margin-top:5px;margin-right:0px;"><span style="font-family:'Fidelity Sans';font-size:12px;color:#000000;font-style:normal;font-weight:normal;">•<span style="padding-right:10px"></span>The top individual relative contributor was our non-index stake in Western Digital (+581%). This period we decreased our stake in Western Digital. A second notable relative contributor was an overweight in Marvell Technology (+133%). The company was among our biggest holdings. Another notable relative contributor was an underweight in Qualcomm (+3%).</span></div> <div style="text-align:left;text-align-last:auto;text-indent:-24px;margin-bottom:2px;margin-left:24px;margin-top:5px;margin-right:0px;"><span style="font-family:'Fidelity Sans';font-size:12px;color:#000000;font-style:normal;font-weight:normal;">•<span style="padding-right:10px"></span>In contrast, the biggest detractors from performance versus the industry index were picks and an underweight in semiconductor materials &amp; equipment. An overweight in semiconductors also hampered the fund's result. Lastly, the fund's position in cash detracted.</span></div> <div style="text-align:left;text-align-last:auto;text-indent:-24px;margin-bottom:2px;margin-left:24px;margin-top:5px;margin-right:0px;"><span style="font-family:'Fidelity Sans';font-size:12px;color:#000000;font-style:normal;font-weight:normal;">•<span style="padding-right:10px"></span>The biggest individual relative detractor was an underweight in Intel (+356%). This period we decreased our stake in Intel. A second notable relative detractor was an underweight in Advanced Micro Devices (+170%). This period we increased our position in Advanced Micro Devices. Another notable relative detractor was an underweight in Applied Materials (+184%).</span></div> <div style="text-align:left;text-align-last:auto;text-indent:-24px;margin-bottom:2px;margin-left:24px;margin-top:5px;margin-right:0px;"><span style="font-family:'Fidelity Sans';font-size:12px;color:#000000;font-style:normal;font-weight:normal;">•<span style="padding-right:10px"></span>Notable changes in positioning include higher allocations to the semiconductor materials &amp; equipment and technology hardware, storage &amp; peripherals industries.</span></div> <div style="text-align:left;text-align-last:auto;"></div> How did the Fund perform over the past 10 years?    CUMULATIVE PERFORMANCE July 31, 2016 through July 31, 2026. Initial investment of $10,000 and the current sales charge was paid. Class M $9,650 $12,614 $16,014 $17,590 $22,917 $37,122 $35,847 $53,395 $74,314 $90,944 $167,009 MSCI U.S. IMI Semiconductors & Semiconductor Equipment 25-50 Index $10,000 $13,272 $16,695 $18,382 $24,778 $39,200 $37,215 $55,578 $82,876 $96,980 $177,796 S&P 500® Index $10,000 $11,604 $13,489 $14,566 $16,308 $22,251 $21,219 $23,980 $29,292 $34,076 $40,742   2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026   <span style="font-family:'Fidelity Sans';font-size:9px;color:#000000;font-style:normal;font-weight:normal;">Class M</span> 9650 12614 16014 17590 22917 37122 35847 53395 74314 90944 167009 <span style="font-family:'Fidelity Sans';font-size:9px;color:#000000;font-style:normal;font-weight:normal;">MSCI U.S. IMI Semiconductors &amp; Semiconductor Equipment 25-50 Index</span> 10000 13272 16695 18382 24778 39200 37215 55578 82876 96980 177796 <span style="font-family:'Fidelity Sans';font-size:9px;color:#000000;font-style:normal;font-weight:normal;">S&amp;P 500® Index</span> 10000 11604 13489 14566 16308 22251 21219 23980 29292 34076 40742 AVERAGE ANNUAL TOTAL RETURNS:   1 Year 5 Year 10 Year Class M (incl. 3.50% sales charge)   77.21% 34.13% 32.52% Class M (without 3.50% sales charge) 83.64% 35.09% 32.99% MSCI U.S. IMI Semiconductors & Semiconductor Equipment 25-50 Index 83.33% 35.31% 33.35% S&P 500® Index 19.56% 12.86% 15.08%     Visit institutional.fidelity.com for more recent performance information.    The Fund's past performance is not a good predictor of the Fund's future performance.  The graph and table do not reflect the deduction of taxes that a shareholder would pay on fund distributions or redemption of fund shares. 0.7721 0.3413 0.3252 0.8364 0.3509 0.3299 0.8333 0.3531 0.3335 0.1956 0.1286 0.1508 <span style="font-family:'Fidelity Sans';font-size:11px;color:#000000;font-style:normal;font-weight:normal;">Visit </span><span style="font-family:'Fidelity Sans';font-size:11px;color:#000000;font-style:normal;font-weight:bold;">institutional.fidelity.com</span><span style="font-family:'Fidelity Sans';font-size:11px;color:#000000;font-style:normal;font-weight:normal;"> for more recent performance information.</span> <span style="font-family:'Fidelity Sans';font-size:11px;color:#000000;font-style:italic;font-weight:normal;">The Fund's past performance is not a good predictor of the Fund's future performance.</span> <span style="font-family:'Fidelity Sans';font-size:11px;color:#000000;font-style:normal;font-weight:normal;">The graph and table do not reflect the deduction of taxes that a shareholder would pay on fund distributions or redemption of fund shares.</span> <span style="font-family:'Fidelity Sans';font-size:16px;color:#368627;font-style:normal;font-weight:bold;">Key Fund Statistics</span> <div style="text-align:left;text-align-last:auto;"></div> <div style="text-align:left;text-align-last:auto;"><span style="font-family:'Fidelity Sans';font-size:11px;color:#000000;font-style:normal;font-weight:normal;">(as of July 31, 2026)</span></div> <div><span style="font-size:11px;"> </span></div><div style="text-align:left;text-align-last:auto;"></div> <div style="text-align:right;text-align-last:auto;"><table cellpadding="0" cellspacing="1" style="border-collapse:separate;border-style:none;margin:auto;" width="100%"><tr><td style="width:63%; " valign="top"><div style="text-align:left;text-align-last:auto;"><span style="font-family:'Fidelity Sans';font-size:12px;color:#000000;font-style:normal;font-weight:bold;">KEY FACTS</span></div> <div style="text-align:left;text-align-last:auto;"></div> <div style="text-align:left;text-align-last:auto;"><span style="font-family:'Fidelity Sans';font-size:11px;color:#000000;font-style:normal;font-weight:bold;"> <span> </span></span></div> <div style="text-align:left;text-align-last:auto;"></div> </td> <td style="width:32%; " valign="top"><span style="line-height:12px;"> </span><div style="text-align:left;text-align-last:auto;"></div> </td> <td style="width:5%; " valign="top"><span style="line-height:12px;"> </span><div style="text-align:left;text-align-last:auto;"></div> </td> </tr> <tr><td style="width:63%; border-bottom:1px dashed #000000;padding:0px 0px 0px 0px;" valign="middle"><div style="text-align:left;text-align-last:auto;"><span style="font-family:'Fidelity Sans';font-size:11px;color:#000000;font-style:normal;font-weight:normal;">Fund Size</span></div> </td> <td style="width:32%; border-bottom:1px dashed #000000;padding:0px 0px 0px 0px;" valign="middle"><div style="text-align:right;text-align-last:auto;"><span style="font-family:'Fidelity Sans';font-size:11px;color:#000000;font-style:normal;font-weight:normal;">$</span>7,203,754,194</div> <div style="text-align:right;text-align-last:auto;"></div> </td> <td style="width:5%; " valign="top"><span style="line-height:11px;"> </span><div style="text-align:left;text-align-last:auto;"></div> </td> </tr> <tr><td style="width:63%; border-bottom:1px dashed #000000;padding:0px 0px 0px 0px;" valign="middle"><div style="text-align:left;text-align-last:auto;"><span style="font-family:'Fidelity Sans';font-size:11px;color:#000000;font-style:normal;font-weight:normal;">Number of Holdings</span></div> </td> <td style="width:32%; border-bottom:1px dashed #000000;padding:0px 0px 0px 0px;" valign="middle"><div style="text-align:right;text-align-last:auto;">76</div> <div style="text-align:right;text-align-last:auto;"></div> </td> <td style="width:5%; " valign="top"><span style="line-height:11px;"> </span><div style="text-align:left;text-align-last:auto;"></div> </td> </tr> <tr><td style="width:63%; border-bottom:1px dashed #000000;padding:0px 0px 0px 0px;" valign="middle"><div style="text-align:left;text-align-last:auto;"><span style="font-family:'Fidelity Sans';font-size:11px;color:#000000;font-style:normal;font-weight:normal;">Total Advisory Fee</span></div> </td> <td style="width:32%; border-bottom:1px dashed #000000;padding:0px 0px 0px 0px;" valign="middle"><div style="text-align:right;text-align-last:auto;"><span style="font-family:'Fidelity Sans';font-size:11px;color:#000000;font-style:normal;font-weight:normal;">$</span>35,292,988</div> <div style="text-align:right;text-align-last:auto;"></div> </td> <td style="width:5%; " valign="middle"><span style="line-height:11px;"> </span><div style="text-align:left;text-align-last:auto;"></div> </td> </tr> <tr><td style="width:63%; border-bottom:1px dashed #000000;padding:0px 0px 0px 0px;" valign="middle"><div style="text-align:left;text-align-last:auto;"><span style="font-family:'Fidelity Sans';font-size:11px;color:#000000;font-style:normal;font-weight:normal;">Portfolio Turnover</span></div> </td> <td style="width:32%; border-bottom:1px dashed #000000;padding:0px 0px 0px 0px;" valign="middle"><div style="text-align:right;text-align-last:auto;">99<span style="font-family:'Fidelity Sans';font-size:11px;color:#000000;font-style:normal;font-weight:normal;">%</span></div> <div style="text-align:left;text-align-last:auto;"></div> </td> <td style="width:5%; " valign="top"><span style="line-height:11px;"> </span><div style="text-align:left;text-align-last:auto;"></div> </td> </tr> </table> </div> <div style="text-align:left;text-align-last:auto;"></div> 7203754194 76 35292988 0.99       TOP INDUSTRIES (% of Fund's net assets) Semiconductors & Semiconductor Equipment 93.8   Technology Hardware, Storage & Peripherals 4.5   Electronic Equipment, Instruments & Components 0.7   Electrical Equipment 0.3   Software 0.2   Financial Services 0.0   Metals & Mining 0.0       Common Stocks 98.5 Preferred Stocks 1.0 Preferred Securities 0.0 Bonds 0.0 Short-Term Investments and Net Other Assets (Liabilities) 0.5 ASSET ALLOCATION (% of Fund's net assets)     Common Stocks - 98.5                       Preferred Stocks - 1.0                     Preferred Securities - 0.0                 Bonds - 0.0                                Short-Term Investments and Net Other Assets (Liabilities) - 0.5   United States 85.1 Netherlands 9.1 Japan 2.3 Israel 2.0 Taiwan 1.3 Korea (South) 0.2 Canada 0.0 GEOGRAPHIC DIVERSIFICATION (% of Fund's net assets)     United States - 85.1                       Netherlands - 9.1                          Japan - 2.3                                Israel - 2.0                               Taiwan - 1.3                               Korea (South) - 0.2                        Canada - 0.0                                   0.938 0.045 0.007 0.003 0.002 0.000 0.000 0.985 0.010 0.000 0.000 0.005 0.851 0.091 0.023 0.020 0.013 0.002 0.000 TOP HOLDINGS(% of Fund's net assets)     NVIDIA Corp 24.4   Broadcom Inc 15.4   Marvell Technology Inc 6.2   Astera Labs Inc 4.9   Monolithic Power Systems Inc 4.8   ASML Holding NV depository receipt 4.8   ON Semiconductor Corp 4.2   NXP Semiconductors NV 4.1   Micron Technology Inc 4.1   Lam Research Corp 3.7     76.6   0.244 0.154 0.062 0.049 0.048 0.048 0.042 0.041 0.041 0.037 2026-07-31 Fidelity Advisor® Semiconductors Fund Fidelity Advisor® Semiconductors Fund Class I FELIX This annual shareholder report contains information about Fidelity Advisor® Semiconductors Fund for the period August 1, 2025 to July 31, 2026. annual shareholder report You can find additional information about the Fund at fundresearch.fidelity.com/prospectus/sec. You can also request this information by contacting us at 1-877-208-0098 or by sending an e-mail to fidfunddocuments@fidelity.com. fundresearch.fidelity.com/prospectus/sec 1-877-208-0098 fidfunddocuments@fidelity.com <span style="font-family:'Fidelity Sans';font-size:16px;color:#368627;font-style:normal;font-weight:bold;">What were your Fund costs for the last year?</span> <div style="text-align:left;text-align-last:auto;"><span style="font-family:'Fidelity Sans';font-size:11px;color:#000000;font-style:normal;font-weight:normal;">(based on hypothetical $10,000 investment)</span></div> <div><span style="font-size:11px;"> </span></div><div style="text-align:left;text-align-last:auto;"></div> <div style="text-align:left;text-align-last:auto;"><span style="font-family:'Fidelity Sans';font-size:12px;color:#000000;font-style:normal;font-weight:bold;">FUND COST (PREVIOUS YEAR)</span></div> <div style="text-align:left;text-align-last:auto;"></div> <div style="text-align:left;text-align-last:auto;"><table cellpadding="0" cellspacing="0" style="border-collapse:collapse;border-style:none;" width="100%"><tr><td style="width:51%; background-color:#dfe0e4;border:1px solid #dfe0e4;padding:0px 0px 0px 0px;" valign="bottom"><div style="text-align:left;text-align-last:auto;"><span style="font-family:'Fidelity Sans';font-size:11px;color:#000000;font-style:normal;font-weight:bold;"> </span></div> </td> <td style="width:21%; background-color:#dfe0e4;border:1px solid #dfe0e4;padding:0px 0px 0px 0px;" valign="bottom"><div style="text-align:center;text-align-last:auto;"><span style="font-family:'Fidelity Sans';font-size:11px;color:#000000;font-style:normal;font-weight:bold;">Costs of a $10,000 investment</span></div> </td> <td style="width:27%; background-color:#dfe0e4;border:1px solid #dfe0e4;padding:0px 0px 0px 0px;" valign="bottom"><div style="text-align:center;text-align-last:auto;"><span style="font-family:'Fidelity Sans';font-size:11px;color:#000000;font-style:normal;font-weight:bold;">Costs paid as a percentage of a $10,000 investment </span></div> </td> <td style="width:1%; " valign="top"><span style="line-height:12px;"> </span><div style="text-align:left;text-align-last:auto;"></div> </td> </tr> <tr><td style="width:51%; border-bottom:1px solid #000000;padding:0px 0px 0px 0px;" valign="top"><div style="text-align:left;text-align-last:auto;"><span style="font-family:'Fidelity Sans';font-size:12px;color:#000000;font-style:normal;font-weight:normal;">Class I</span><span style="font-family:'Fidelity Sans';font-size:11px;color:#000000;font-style:normal;font-weight:normal;"> </span></div> </td> <td style="width:21%; border-bottom:1px solid #000000;padding:0px 0px 0px 0px;" valign="middle"><div style="text-align:center;text-align-last:auto;"><span style="font-family:'Fidelity Sans';font-size:11px;color:#000000;font-style:normal;font-weight:normal;">$</span><span style="font-family:'Fidelity Sans';font-size:12px;color:#000000;font-style:normal;font-weight:normal;"> </span>93<span style="font-family:'Fidelity Sans';font-size:11px;color:#000000;font-style:normal;font-weight:normal;"> </span></div> </td> <td style="width:27%; border-bottom:1px solid #000000;padding:0px 0px 0px 0px;" valign="middle"><div style="text-align:center;text-align-last:auto;">0.66<span style="font-family:'Fidelity Sans';font-size:11px;color:#000000;font-style:normal;font-weight:normal;">%</span></div> </td> <td style="width:1%; " valign="top"><span style="line-height:12px;"> </span><div style="text-align:left;text-align-last:auto;"></div> </td> </tr> </table> </div> <div style="text-align:left;text-align-last:auto;"></div> 93 0.0066 <span style="font-family:'Fidelity Sans';font-size:16px;color:#368627;font-style:normal;font-weight:bold;">What affected the Fund's performance this period?</span> <div style="text-align:left;text-align-last:auto;"><span style="font-family:'Fidelity Sans';font-size:11px;color:#000000;font-style:normal;font-weight:bold;"> </span></div> <div style="text-align:left;text-align-last:auto;text-indent:-24px;margin-bottom:2px;margin-left:24px;margin-top:5px;margin-right:0px;"><span style="font-family:'Fidelity Sans';font-size:12px;color:#000000;font-style:normal;font-weight:normal;">•<span style="padding-right:10px"></span>U.S. stocks achieved a strong gain for the 12 months ending July 31, 2026, reflecting enthusiasm for artificial intelligence, strong corporate fundamentals, a resilient economy and, beginning in September, the Federal Reserve's first interest-rate reductions since December 2024.</span></div> <div style="text-align:left;text-align-last:auto;text-indent:-24px;margin-bottom:2px;margin-left:24px;margin-top:5px;margin-right:0px;"><span style="font-family:'Fidelity Sans';font-size:12px;color:#000000;font-style:normal;font-weight:normal;">•<span style="padding-right:10px"></span>Against this backdrop, security selection was the primary contributor to the fund's performance versus the MSCI US IMI Semiconductors &amp; Semiconductor Equipment 25/50 Index for the fiscal year, especially within technology hardware, storage &amp; peripherals. Stock picking in semiconductors and electronic components also boosted the fund's relative performance.</span></div> <div style="text-align:left;text-align-last:auto;text-indent:-24px;margin-bottom:2px;margin-left:24px;margin-top:5px;margin-right:0px;"><span style="font-family:'Fidelity Sans';font-size:12px;color:#000000;font-style:normal;font-weight:normal;">•<span style="padding-right:10px"></span>The top individual relative contributor was our non-index stake in Western Digital (+581%). This period we decreased our stake in Western Digital. A second notable relative contributor was an overweight in Marvell Technology (+133%). The company was among our biggest holdings. Another notable relative contributor was an underweight in Qualcomm (+3%).</span></div> <div style="text-align:left;text-align-last:auto;text-indent:-24px;margin-bottom:2px;margin-left:24px;margin-top:5px;margin-right:0px;"><span style="font-family:'Fidelity Sans';font-size:12px;color:#000000;font-style:normal;font-weight:normal;">•<span style="padding-right:10px"></span>In contrast, the biggest detractors from performance versus the industry index were picks and an underweight in semiconductor materials &amp; equipment. An overweight in semiconductors also hampered the fund's result. Lastly, the fund's position in cash detracted.</span></div> <div style="text-align:left;text-align-last:auto;text-indent:-24px;margin-bottom:2px;margin-left:24px;margin-top:5px;margin-right:0px;"><span style="font-family:'Fidelity Sans';font-size:12px;color:#000000;font-style:normal;font-weight:normal;">•<span style="padding-right:10px"></span>The biggest individual relative detractor was an underweight in Intel (+356%). This period we decreased our stake in Intel. A second notable relative detractor was an underweight in Advanced Micro Devices (+170%). This period we increased our position in Advanced Micro Devices. Another notable relative detractor was an underweight in Applied Materials (+184%).</span></div> <div style="text-align:left;text-align-last:auto;text-indent:-24px;margin-bottom:2px;margin-left:24px;margin-top:5px;margin-right:0px;"><span style="font-family:'Fidelity Sans';font-size:12px;color:#000000;font-style:normal;font-weight:normal;">•<span style="padding-right:10px"></span>Notable changes in positioning include higher allocations to the semiconductor materials &amp; equipment and technology hardware, storage &amp; peripherals industries.</span></div> <div style="text-align:left;text-align-last:auto;"></div> How did the Fund perform over the past 10 years?    CUMULATIVE PERFORMANCE July 31, 2016 through July 31, 2026. Initial investment of $10,000. Class I $10,000 $13,162 $16,813 $18,571 $24,342 $39,644 $38,472 $57,597 $80,560 $99,092 $182,873 MSCI U.S. IMI Semiconductors & Semiconductor Equipment 25-50 Index $10,000 $13,272 $16,695 $18,382 $24,778 $39,200 $37,215 $55,578 $82,876 $96,980 $177,796 S&P 500® Index $10,000 $11,604 $13,489 $14,566 $16,308 $22,251 $21,219 $23,980 $29,292 $34,076 $40,742   2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026   <span style="font-family:'Fidelity Sans';font-size:9px;color:#000000;font-style:normal;font-weight:normal;">Class I</span> 10000 13162 16813 18571 24342 39644 38472 57597 80560 99092 182873 <span style="font-family:'Fidelity Sans';font-size:9px;color:#000000;font-style:normal;font-weight:normal;">MSCI U.S. IMI Semiconductors &amp; Semiconductor Equipment 25-50 Index</span> 10000 13272 16695 18382 24778 39200 37215 55578 82876 96980 177796 <span style="font-family:'Fidelity Sans';font-size:9px;color:#000000;font-style:normal;font-weight:normal;">S&amp;P 500® Index</span> 10000 11604 13489 14566 16308 22251 21219 23980 29292 34076 40742 AVERAGE ANNUAL TOTAL RETURNS:   1 Year 5 Year 10 Year Class I 84.55% 35.77% 33.73% MSCI U.S. IMI Semiconductors & Semiconductor Equipment 25-50 Index 83.33% 35.31% 33.35% S&P 500® Index 19.56% 12.86% 15.08%     Visit institutional.fidelity.com for more recent performance information.    The Fund's past performance is not a good predictor of the Fund's future performance.  The graph and table do not reflect the deduction of taxes that a shareholder would pay on fund distributions or redemption of fund shares. 0.8455 0.3577 0.3373 0.8333 0.3531 0.3335 0.1956 0.1286 0.1508 <span style="font-family:'Fidelity Sans';font-size:11px;color:#000000;font-style:normal;font-weight:normal;">Visit </span><span style="font-family:'Fidelity Sans';font-size:11px;color:#000000;font-style:normal;font-weight:bold;">institutional.fidelity.com</span><span style="font-family:'Fidelity Sans';font-size:11px;color:#000000;font-style:normal;font-weight:normal;"> for more recent performance information.</span> <span style="font-family:'Fidelity Sans';font-size:11px;color:#000000;font-style:italic;font-weight:normal;">The Fund's past performance is not a good predictor of the Fund's future performance.</span> <span style="font-family:'Fidelity Sans';font-size:11px;color:#000000;font-style:normal;font-weight:normal;">The graph and table do not reflect the deduction of taxes that a shareholder would pay on fund distributions or redemption of fund shares.</span> <span style="font-family:'Fidelity Sans';font-size:16px;color:#368627;font-style:normal;font-weight:bold;">Key Fund Statistics</span> <div style="text-align:left;text-align-last:auto;"></div> <div style="text-align:left;text-align-last:auto;"><span style="font-family:'Fidelity Sans';font-size:11px;color:#000000;font-style:normal;font-weight:normal;">(as of July 31, 2026)</span></div> <div><span style="font-size:11px;"> </span></div><div style="text-align:left;text-align-last:auto;"></div> <div style="text-align:right;text-align-last:auto;"><table cellpadding="0" cellspacing="1" style="border-collapse:separate;border-style:none;margin:auto;" width="100%"><tr><td style="width:63%; " valign="top"><div style="text-align:left;text-align-last:auto;"><span style="font-family:'Fidelity Sans';font-size:12px;color:#000000;font-style:normal;font-weight:bold;">KEY FACTS</span></div> <div style="text-align:left;text-align-last:auto;"></div> <div style="text-align:left;text-align-last:auto;"><span style="font-family:'Fidelity Sans';font-size:11px;color:#000000;font-style:normal;font-weight:bold;"> <span> </span></span></div> <div style="text-align:left;text-align-last:auto;"></div> </td> <td style="width:32%; " valign="top"><span style="line-height:12px;"> </span><div style="text-align:left;text-align-last:auto;"></div> </td> <td style="width:5%; " valign="top"><span style="line-height:12px;"> </span><div style="text-align:left;text-align-last:auto;"></div> </td> </tr> <tr><td style="width:63%; border-bottom:1px dashed #000000;padding:0px 0px 0px 0px;" valign="middle"><div style="text-align:left;text-align-last:auto;"><span style="font-family:'Fidelity Sans';font-size:11px;color:#000000;font-style:normal;font-weight:normal;">Fund Size</span></div> </td> <td style="width:32%; border-bottom:1px dashed #000000;padding:0px 0px 0px 0px;" valign="middle"><div style="text-align:right;text-align-last:auto;"><span style="font-family:'Fidelity Sans';font-size:11px;color:#000000;font-style:normal;font-weight:normal;">$</span>7,203,754,194</div> <div style="text-align:right;text-align-last:auto;"></div> </td> <td style="width:5%; " valign="top"><span style="line-height:11px;"> </span><div style="text-align:left;text-align-last:auto;"></div> </td> </tr> <tr><td style="width:63%; border-bottom:1px dashed #000000;padding:0px 0px 0px 0px;" valign="middle"><div style="text-align:left;text-align-last:auto;"><span style="font-family:'Fidelity Sans';font-size:11px;color:#000000;font-style:normal;font-weight:normal;">Number of Holdings</span></div> </td> <td style="width:32%; border-bottom:1px dashed #000000;padding:0px 0px 0px 0px;" valign="middle"><div style="text-align:right;text-align-last:auto;">76</div> <div style="text-align:right;text-align-last:auto;"></div> </td> <td style="width:5%; " valign="top"><span style="line-height:11px;"> </span><div style="text-align:left;text-align-last:auto;"></div> </td> </tr> <tr><td style="width:63%; border-bottom:1px dashed #000000;padding:0px 0px 0px 0px;" valign="middle"><div style="text-align:left;text-align-last:auto;"><span style="font-family:'Fidelity Sans';font-size:11px;color:#000000;font-style:normal;font-weight:normal;">Total Advisory Fee</span></div> </td> <td style="width:32%; border-bottom:1px dashed #000000;padding:0px 0px 0px 0px;" valign="middle"><div style="text-align:right;text-align-last:auto;"><span style="font-family:'Fidelity Sans';font-size:11px;color:#000000;font-style:normal;font-weight:normal;">$</span>35,292,988</div> <div style="text-align:right;text-align-last:auto;"></div> </td> <td style="width:5%; " valign="middle"><span style="line-height:11px;"> </span><div style="text-align:left;text-align-last:auto;"></div> </td> </tr> <tr><td style="width:63%; border-bottom:1px dashed #000000;padding:0px 0px 0px 0px;" valign="middle"><div style="text-align:left;text-align-last:auto;"><span style="font-family:'Fidelity Sans';font-size:11px;color:#000000;font-style:normal;font-weight:normal;">Portfolio Turnover</span></div> </td> <td style="width:32%; border-bottom:1px dashed #000000;padding:0px 0px 0px 0px;" valign="middle"><div style="text-align:right;text-align-last:auto;">99<span style="font-family:'Fidelity Sans';font-size:11px;color:#000000;font-style:normal;font-weight:normal;">%</span></div> <div style="text-align:left;text-align-last:auto;"></div> </td> <td style="width:5%; " valign="top"><span style="line-height:11px;"> </span><div style="text-align:left;text-align-last:auto;"></div> </td> </tr> </table> </div> <div style="text-align:left;text-align-last:auto;"></div> 7203754194 76 35292988 0.99       TOP INDUSTRIES (% of Fund's net assets) Semiconductors & Semiconductor Equipment 93.8   Technology Hardware, Storage & Peripherals 4.5   Electronic Equipment, Instruments & Components 0.7   Electrical Equipment 0.3   Software 0.2   Financial Services 0.0   Metals & Mining 0.0       Common Stocks 98.5 Preferred Stocks 1.0 Preferred Securities 0.0 Bonds 0.0 Short-Term Investments and Net Other Assets (Liabilities) 0.5 ASSET ALLOCATION (% of Fund's net assets)     Common Stocks - 98.5                       Preferred Stocks - 1.0                     Preferred Securities - 0.0                 Bonds - 0.0                                Short-Term Investments and Net Other Assets (Liabilities) - 0.5   United States 85.1 Netherlands 9.1 Japan 2.3 Israel 2.0 Taiwan 1.3 Korea (South) 0.2 Canada 0.0 GEOGRAPHIC DIVERSIFICATION (% of Fund's net assets)     United States - 85.1                       Netherlands - 9.1                          Japan - 2.3                                Israel - 2.0                               Taiwan - 1.3                               Korea (South) - 0.2                        Canada - 0.0                                   0.938 0.045 0.007 0.003 0.002 0.000 0.000 0.985 0.010 0.000 0.000 0.005 0.851 0.091 0.023 0.020 0.013 0.002 0.000 TOP HOLDINGS(% of Fund's net assets)     NVIDIA Corp 24.4   Broadcom Inc 15.4   Marvell Technology Inc 6.2   Astera Labs Inc 4.9   Monolithic Power Systems Inc 4.8   ASML Holding NV depository receipt 4.8   ON Semiconductor Corp 4.2   NXP Semiconductors NV 4.1   Micron Technology Inc 4.1   Lam Research Corp 3.7     76.6   0.244 0.154 0.062 0.049 0.048 0.048 0.042 0.041 0.041 0.037 2026-07-31 Fidelity Advisor® Semiconductors Fund Fidelity Advisor® Semiconductors Fund Class C FELCX This annual shareholder report contains information about Fidelity Advisor® Semiconductors Fund for the period August 1, 2025 to July 31, 2026. annual shareholder report You can find additional information about the Fund at fundresearch.fidelity.com/prospectus/sec. You can also request this information by contacting us at 1-877-208-0098 or by sending an e-mail to fidfunddocuments@fidelity.com. fundresearch.fidelity.com/prospectus/sec 1-877-208-0098 fidfunddocuments@fidelity.com <span style="font-family:'Fidelity Sans';font-size:16px;color:#368627;font-style:normal;font-weight:bold;">What were your Fund costs for the last year?</span> <div style="text-align:left;text-align-last:auto;"><span style="font-family:'Fidelity Sans';font-size:11px;color:#000000;font-style:normal;font-weight:normal;">(based on hypothetical $10,000 investment)</span></div> <div><span style="font-size:11px;"> </span></div><div style="text-align:left;text-align-last:auto;"></div> <div style="text-align:left;text-align-last:auto;"><span style="font-family:'Fidelity Sans';font-size:12px;color:#000000;font-style:normal;font-weight:bold;">FUND COST (PREVIOUS YEAR)</span></div> <div style="text-align:left;text-align-last:auto;"></div> <div style="text-align:left;text-align-last:auto;"><table cellpadding="0" cellspacing="0" style="border-collapse:collapse;border-style:none;" width="100%"><tr><td style="width:51%; background-color:#dfe0e4;border:1px solid #dfe0e4;padding:0px 0px 0px 0px;" valign="bottom"><div style="text-align:left;text-align-last:auto;"><span style="font-family:'Fidelity Sans';font-size:11px;color:#000000;font-style:normal;font-weight:bold;"> </span></div> </td> <td style="width:21%; background-color:#dfe0e4;border:1px solid #dfe0e4;padding:0px 0px 0px 0px;" valign="bottom"><div style="text-align:center;text-align-last:auto;"><span style="font-family:'Fidelity Sans';font-size:11px;color:#000000;font-style:normal;font-weight:bold;">Costs of a $10,000 investment</span></div> </td> <td style="width:27%; background-color:#dfe0e4;border:1px solid #dfe0e4;padding:0px 0px 0px 0px;" valign="bottom"><div style="text-align:center;text-align-last:auto;"><span style="font-family:'Fidelity Sans';font-size:11px;color:#000000;font-style:normal;font-weight:bold;">Costs paid as a percentage of a $10,000 investment </span></div> </td> <td style="width:1%; " valign="top"><span style="line-height:12px;"> </span><div style="text-align:left;text-align-last:auto;"></div> </td> </tr> <tr><td style="width:51%; border-bottom:1px solid #000000;padding:0px 0px 0px 0px;" valign="top"><div style="text-align:left;text-align-last:auto;"><span style="font-family:'Fidelity Sans';font-size:12px;color:#000000;font-style:normal;font-weight:normal;">Class C</span><span style="font-family:'Fidelity Sans';font-size:11px;color:#000000;font-style:normal;font-weight:normal;"> </span></div> </td> <td style="width:21%; border-bottom:1px solid #000000;padding:0px 0px 0px 0px;" valign="middle"><div style="text-align:center;text-align-last:auto;"><span style="font-family:'Fidelity Sans';font-size:11px;color:#000000;font-style:normal;font-weight:normal;">$</span><span style="font-family:'Fidelity Sans';font-size:12px;color:#000000;font-style:normal;font-weight:normal;"> </span>234<span style="font-family:'Fidelity Sans';font-size:11px;color:#000000;font-style:normal;font-weight:normal;"> </span></div> </td> <td style="width:27%; border-bottom:1px solid #000000;padding:0px 0px 0px 0px;" valign="middle"><div style="text-align:center;text-align-last:auto;">1.66<span style="font-family:'Fidelity Sans';font-size:11px;color:#000000;font-style:normal;font-weight:normal;">%</span></div> </td> <td style="width:1%; " valign="top"><span style="line-height:12px;"> </span><div style="text-align:left;text-align-last:auto;"></div> </td> </tr> </table> </div> <div style="text-align:left;text-align-last:auto;"></div> 234 0.0166 <span style="font-family:'Fidelity Sans';font-size:16px;color:#368627;font-style:normal;font-weight:bold;">What affected the Fund's performance this period?</span> <div style="text-align:left;text-align-last:auto;"><span style="font-family:'Fidelity Sans';font-size:11px;color:#000000;font-style:normal;font-weight:bold;"> </span></div> <div style="text-align:left;text-align-last:auto;text-indent:-24px;margin-bottom:2px;margin-left:24px;margin-top:5px;margin-right:0px;"><span style="font-family:'Fidelity Sans';font-size:12px;color:#000000;font-style:normal;font-weight:normal;">•<span style="padding-right:10px"></span>U.S. stocks achieved a strong gain for the 12 months ending July 31, 2026, reflecting enthusiasm for artificial intelligence, strong corporate fundamentals, a resilient economy and, beginning in September, the Federal Reserve's first interest-rate reductions since December 2024.</span></div> <div style="text-align:left;text-align-last:auto;text-indent:-24px;margin-bottom:2px;margin-left:24px;margin-top:5px;margin-right:0px;"><span style="font-family:'Fidelity Sans';font-size:12px;color:#000000;font-style:normal;font-weight:normal;">•<span style="padding-right:10px"></span>Against this backdrop, security selection was the primary contributor to the fund's performance versus the MSCI US IMI Semiconductors &amp; Semiconductor Equipment 25/50 Index for the fiscal year, especially within technology hardware, storage &amp; peripherals. Stock picking in semiconductors and electronic components also boosted the fund's relative performance.</span></div> <div style="text-align:left;text-align-last:auto;text-indent:-24px;margin-bottom:2px;margin-left:24px;margin-top:5px;margin-right:0px;"><span style="font-family:'Fidelity Sans';font-size:12px;color:#000000;font-style:normal;font-weight:normal;">•<span style="padding-right:10px"></span>The top individual relative contributor was our non-index stake in Western Digital (+581%). This period we decreased our stake in Western Digital. A second notable relative contributor was an overweight in Marvell Technology (+133%). The company was among our biggest holdings. Another notable relative contributor was an underweight in Qualcomm (+3%).</span></div> <div style="text-align:left;text-align-last:auto;text-indent:-24px;margin-bottom:2px;margin-left:24px;margin-top:5px;margin-right:0px;"><span style="font-family:'Fidelity Sans';font-size:12px;color:#000000;font-style:normal;font-weight:normal;">•<span style="padding-right:10px"></span>In contrast, the biggest detractors from performance versus the industry index were picks and an underweight in semiconductor materials &amp; equipment. An overweight in semiconductors also hampered the fund's result. Lastly, the fund's position in cash detracted.</span></div> <div style="text-align:left;text-align-last:auto;text-indent:-24px;margin-bottom:2px;margin-left:24px;margin-top:5px;margin-right:0px;"><span style="font-family:'Fidelity Sans';font-size:12px;color:#000000;font-style:normal;font-weight:normal;">•<span style="padding-right:10px"></span>The biggest individual relative detractor was an underweight in Intel (+356%). This period we decreased our stake in Intel. A second notable relative detractor was an underweight in Advanced Micro Devices (+170%). This period we increased our position in Advanced Micro Devices. Another notable relative detractor was an underweight in Applied Materials (+184%).</span></div> <div style="text-align:left;text-align-last:auto;text-indent:-24px;margin-bottom:2px;margin-left:24px;margin-top:5px;margin-right:0px;"><span style="font-family:'Fidelity Sans';font-size:12px;color:#000000;font-style:normal;font-weight:normal;">•<span style="padding-right:10px"></span>Notable changes in positioning include higher allocations to the semiconductor materials &amp; equipment and technology hardware, storage &amp; peripherals industries.</span></div> <div style="text-align:left;text-align-last:auto;"></div> How did the Fund perform over the past 10 years?    CUMULATIVE PERFORMANCE July 31, 2016 through July 31, 2026. Initial investment of $10,000. Class C $10,000 $13,021 $16,456 $17,991 $23,340 $37,617 $36,140 $53,554 $74,153 $90,979 $167,487 MSCI U.S. IMI Semiconductors & Semiconductor Equipment 25-50 Index $10,000 $13,272 $16,695 $18,382 $24,778 $39,200 $37,215 $55,578 $82,876 $96,980 $177,796 S&P 500® Index $10,000 $11,604 $13,489 $14,566 $16,308 $22,251 $21,219 $23,980 $29,292 $34,076 $40,742   2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026   <span style="font-family:'Fidelity Sans';font-size:9px;color:#000000;font-style:normal;font-weight:normal;">Class C</span> 10000 13021 16456 17991 23340 37617 36140 53554 74153 90979 167487 <span style="font-family:'Fidelity Sans';font-size:9px;color:#000000;font-style:normal;font-weight:normal;">MSCI U.S. IMI Semiconductors &amp; Semiconductor Equipment 25-50 Index</span> 10000 13272 16695 18382 24778 39200 37215 55578 82876 96980 177796 <span style="font-family:'Fidelity Sans';font-size:9px;color:#000000;font-style:normal;font-weight:normal;">S&amp;P 500® Index</span> 10000 11604 13489 14566 16308 22251 21219 23980 29292 34076 40742 AVERAGE ANNUAL TOTAL RETURNS:   1 Year 5 Year 10 Year Class C  (incl. contingent deferred sales charge) 81.71% 34.41% 32.56% Class C 82.71% 34.41% 32.56% MSCI U.S. IMI Semiconductors & Semiconductor Equipment 25-50 Index 83.33% 35.31% 33.35% S&P 500® Index 19.56% 12.86% 15.08%     Visit institutional.fidelity.com for more recent performance information.    The Fund's past performance is not a good predictor of the Fund's future performance.  The graph and table do not reflect the deduction of taxes that a shareholder would pay on fund distributions or redemption of fund shares. 0.8171 0.3441 0.3256 0.8271 0.3441 0.3256 0.8333 0.3531 0.3335 0.1956 0.1286 0.1508 <span style="font-family:'Fidelity Sans';font-size:11px;color:#000000;font-style:normal;font-weight:normal;">Visit </span><span style="font-family:'Fidelity Sans';font-size:11px;color:#000000;font-style:normal;font-weight:bold;">institutional.fidelity.com</span><span style="font-family:'Fidelity Sans';font-size:11px;color:#000000;font-style:normal;font-weight:normal;"> for more recent performance information.</span> <span style="font-family:'Fidelity Sans';font-size:11px;color:#000000;font-style:italic;font-weight:normal;">The Fund's past performance is not a good predictor of the Fund's future performance.</span> <span style="font-family:'Fidelity Sans';font-size:11px;color:#000000;font-style:normal;font-weight:normal;">The graph and table do not reflect the deduction of taxes that a shareholder would pay on fund distributions or redemption of fund shares.</span> <span style="font-family:'Fidelity Sans';font-size:16px;color:#368627;font-style:normal;font-weight:bold;">Key Fund Statistics</span> <div style="text-align:left;text-align-last:auto;"></div> <div style="text-align:left;text-align-last:auto;"><span style="font-family:'Fidelity Sans';font-size:11px;color:#000000;font-style:normal;font-weight:normal;">(as of July 31, 2026)</span></div> <div><span style="font-size:11px;"> </span></div><div style="text-align:left;text-align-last:auto;"></div> <div style="text-align:right;text-align-last:auto;"><table cellpadding="0" cellspacing="1" style="border-collapse:separate;border-style:none;margin:auto;" width="100%"><tr><td style="width:63%; " valign="top"><div style="text-align:left;text-align-last:auto;"><span style="font-family:'Fidelity Sans';font-size:12px;color:#000000;font-style:normal;font-weight:bold;">KEY FACTS</span></div> <div style="text-align:left;text-align-last:auto;"></div> <div style="text-align:left;text-align-last:auto;"><span style="font-family:'Fidelity Sans';font-size:11px;color:#000000;font-style:normal;font-weight:bold;"> <span> </span></span></div> <div style="text-align:left;text-align-last:auto;"></div> </td> <td style="width:32%; " valign="top"><span style="line-height:12px;"> </span><div style="text-align:left;text-align-last:auto;"></div> </td> <td style="width:5%; " valign="top"><span style="line-height:12px;"> </span><div style="text-align:left;text-align-last:auto;"></div> </td> </tr> <tr><td style="width:63%; border-bottom:1px dashed #000000;padding:0px 0px 0px 0px;" valign="middle"><div style="text-align:left;text-align-last:auto;"><span style="font-family:'Fidelity Sans';font-size:11px;color:#000000;font-style:normal;font-weight:normal;">Fund Size</span></div> </td> <td style="width:32%; border-bottom:1px dashed #000000;padding:0px 0px 0px 0px;" valign="middle"><div style="text-align:right;text-align-last:auto;"><span style="font-family:'Fidelity Sans';font-size:11px;color:#000000;font-style:normal;font-weight:normal;">$</span>7,203,754,194</div> <div style="text-align:right;text-align-last:auto;"></div> </td> <td style="width:5%; " valign="top"><span style="line-height:11px;"> </span><div style="text-align:left;text-align-last:auto;"></div> </td> </tr> <tr><td style="width:63%; border-bottom:1px dashed #000000;padding:0px 0px 0px 0px;" valign="middle"><div style="text-align:left;text-align-last:auto;"><span style="font-family:'Fidelity Sans';font-size:11px;color:#000000;font-style:normal;font-weight:normal;">Number of Holdings</span></div> </td> <td style="width:32%; border-bottom:1px dashed #000000;padding:0px 0px 0px 0px;" valign="middle"><div style="text-align:right;text-align-last:auto;">76</div> <div style="text-align:right;text-align-last:auto;"></div> </td> <td style="width:5%; " valign="top"><span style="line-height:11px;"> </span><div style="text-align:left;text-align-last:auto;"></div> </td> </tr> <tr><td style="width:63%; border-bottom:1px dashed #000000;padding:0px 0px 0px 0px;" valign="middle"><div style="text-align:left;text-align-last:auto;"><span style="font-family:'Fidelity Sans';font-size:11px;color:#000000;font-style:normal;font-weight:normal;">Total Advisory Fee</span></div> </td> <td style="width:32%; border-bottom:1px dashed #000000;padding:0px 0px 0px 0px;" valign="middle"><div style="text-align:right;text-align-last:auto;"><span style="font-family:'Fidelity Sans';font-size:11px;color:#000000;font-style:normal;font-weight:normal;">$</span>35,292,988</div> <div style="text-align:right;text-align-last:auto;"></div> </td> <td style="width:5%; " valign="middle"><span style="line-height:11px;"> </span><div style="text-align:left;text-align-last:auto;"></div> </td> </tr> <tr><td style="width:63%; border-bottom:1px dashed #000000;padding:0px 0px 0px 0px;" valign="middle"><div style="text-align:left;text-align-last:auto;"><span style="font-family:'Fidelity Sans';font-size:11px;color:#000000;font-style:normal;font-weight:normal;">Portfolio Turnover</span></div> </td> <td style="width:32%; border-bottom:1px dashed #000000;padding:0px 0px 0px 0px;" valign="middle"><div style="text-align:right;text-align-last:auto;">99<span style="font-family:'Fidelity Sans';font-size:11px;color:#000000;font-style:normal;font-weight:normal;">%</span></div> <div style="text-align:left;text-align-last:auto;"></div> </td> <td style="width:5%; " valign="top"><span style="line-height:11px;"> </span><div style="text-align:left;text-align-last:auto;"></div> </td> </tr> </table> </div> <div style="text-align:left;text-align-last:auto;"></div> 7203754194 76 35292988 0.99       TOP INDUSTRIES (% of Fund's net assets) Semiconductors & Semiconductor Equipment 93.8   Technology Hardware, Storage & Peripherals 4.5   Electronic Equipment, Instruments & Components 0.7   Electrical Equipment 0.3   Software 0.2   Financial Services 0.0   Metals & Mining 0.0       Common Stocks 98.5 Preferred Stocks 1.0 Preferred Securities 0.0 Bonds 0.0 Short-Term Investments and Net Other Assets (Liabilities) 0.5 ASSET ALLOCATION (% of Fund's net assets)     Common Stocks - 98.5                       Preferred Stocks - 1.0                     Preferred Securities - 0.0                 Bonds - 0.0                                Short-Term Investments and Net Other Assets (Liabilities) - 0.5   United States 85.1 Netherlands 9.1 Japan 2.3 Israel 2.0 Taiwan 1.3 Korea (South) 0.2 Canada 0.0 GEOGRAPHIC DIVERSIFICATION (% of Fund's net assets)     United States - 85.1                       Netherlands - 9.1                          Japan - 2.3                                Israel - 2.0                               Taiwan - 1.3                               Korea (South) - 0.2                        Canada - 0.0                                   0.938 0.045 0.007 0.003 0.002 0.000 0.000 0.985 0.010 0.000 0.000 0.005 0.851 0.091 0.023 0.020 0.013 0.002 0.000 TOP HOLDINGS(% of Fund's net assets)     NVIDIA Corp 24.4   Broadcom Inc 15.4   Marvell Technology Inc 6.2   Astera Labs Inc 4.9   Monolithic Power Systems Inc 4.8   ASML Holding NV depository receipt 4.8   ON Semiconductor Corp 4.2   NXP Semiconductors NV 4.1   Micron Technology Inc 4.1   Lam Research Corp 3.7     76.6   0.244 0.154 0.062 0.049 0.048 0.048 0.042 0.041 0.041 0.037 2026-07-31 Fidelity Advisor® Semiconductors Fund Fidelity Advisor® Semiconductors Fund Class A FELAX This annual shareholder report contains information about Fidelity Advisor® Semiconductors Fund for the period August 1, 2025 to July 31, 2026. annual shareholder report You can find additional information about the Fund at fundresearch.fidelity.com/prospectus/sec. You can also request this information by contacting us at 1-877-208-0098 or by sending an e-mail to fidfunddocuments@fidelity.com. fundresearch.fidelity.com/prospectus/sec 1-877-208-0098 fidfunddocuments@fidelity.com <span style="font-family:'Fidelity Sans';font-size:16px;color:#368627;font-style:normal;font-weight:bold;">What were your Fund costs for the last year?</span> <div style="text-align:left;text-align-last:auto;"><span style="font-family:'Fidelity Sans';font-size:11px;color:#000000;font-style:normal;font-weight:normal;">(based on hypothetical $10,000 investment)</span></div> <div><span style="font-size:11px;"> </span></div><div style="text-align:left;text-align-last:auto;"></div> <div style="text-align:left;text-align-last:auto;"><span style="font-family:'Fidelity Sans';font-size:12px;color:#000000;font-style:normal;font-weight:bold;">FUND COST (PREVIOUS YEAR)</span></div> <div style="text-align:left;text-align-last:auto;"></div> <div style="text-align:left;text-align-last:auto;"><table cellpadding="0" cellspacing="0" style="border-collapse:collapse;border-style:none;" width="100%"><tr><td style="width:51%; background-color:#dfe0e4;border:1px solid #dfe0e4;padding:0px 0px 0px 0px;" valign="bottom"><div style="text-align:left;text-align-last:auto;"><span style="font-family:'Fidelity Sans';font-size:11px;color:#000000;font-style:normal;font-weight:bold;"> </span></div> </td> <td style="width:21%; background-color:#dfe0e4;border:1px solid #dfe0e4;padding:0px 0px 0px 0px;" valign="bottom"><div style="text-align:center;text-align-last:auto;"><span style="font-family:'Fidelity Sans';font-size:11px;color:#000000;font-style:normal;font-weight:bold;">Costs of a $10,000 investment</span></div> </td> <td style="width:27%; background-color:#dfe0e4;border:1px solid #dfe0e4;padding:0px 0px 0px 0px;" valign="bottom"><div style="text-align:center;text-align-last:auto;"><span style="font-family:'Fidelity Sans';font-size:11px;color:#000000;font-style:normal;font-weight:bold;">Costs paid as a percentage of a $10,000 investment </span></div> </td> <td style="width:1%; " valign="top"><span style="line-height:12px;"> </span><div style="text-align:left;text-align-last:auto;"></div> </td> </tr> <tr><td style="width:51%; border-bottom:1px solid #000000;padding:0px 0px 0px 0px;" valign="top"><div style="text-align:left;text-align-last:auto;"><span style="font-family:'Fidelity Sans';font-size:12px;color:#000000;font-style:normal;font-weight:normal;">Class A</span><span style="font-family:'Fidelity Sans';font-size:11px;color:#000000;font-style:normal;font-weight:normal;"> </span></div> </td> <td style="width:21%; border-bottom:1px solid #000000;padding:0px 0px 0px 0px;" valign="middle"><div style="text-align:center;text-align-last:auto;"><span style="font-family:'Fidelity Sans';font-size:11px;color:#000000;font-style:normal;font-weight:normal;">$</span><span style="font-family:'Fidelity Sans';font-size:12px;color:#000000;font-style:normal;font-weight:normal;"> </span>129<span style="font-family:'Fidelity Sans';font-size:11px;color:#000000;font-style:normal;font-weight:normal;"> </span></div> </td> <td style="width:27%; border-bottom:1px solid #000000;padding:0px 0px 0px 0px;" valign="middle"><div style="text-align:center;text-align-last:auto;">0.91<span style="font-family:'Fidelity Sans';font-size:11px;color:#000000;font-style:normal;font-weight:normal;">%</span></div> </td> <td style="width:1%; " valign="top"><span style="line-height:12px;"> </span><div style="text-align:left;text-align-last:auto;"></div> </td> </tr> </table> </div> <div style="text-align:left;text-align-last:auto;"></div> 129 0.0091 <span style="font-family:'Fidelity Sans';font-size:16px;color:#368627;font-style:normal;font-weight:bold;">What affected the Fund's performance this period?</span> <div style="text-align:left;text-align-last:auto;"><span style="font-family:'Fidelity Sans';font-size:11px;color:#000000;font-style:normal;font-weight:bold;"> </span></div> <div style="text-align:left;text-align-last:auto;text-indent:-24px;margin-bottom:2px;margin-left:24px;margin-top:5px;margin-right:0px;"><span style="font-family:'Fidelity Sans';font-size:12px;color:#000000;font-style:normal;font-weight:normal;">•<span style="padding-right:10px"></span>U.S. stocks achieved a strong gain for the 12 months ending July 31, 2026, reflecting enthusiasm for artificial intelligence, strong corporate fundamentals, a resilient economy and, beginning in September, the Federal Reserve's first interest-rate reductions since December 2024.</span></div> <div style="text-align:left;text-align-last:auto;text-indent:-24px;margin-bottom:2px;margin-left:24px;margin-top:5px;margin-right:0px;"><span style="font-family:'Fidelity Sans';font-size:12px;color:#000000;font-style:normal;font-weight:normal;">•<span style="padding-right:10px"></span>Against this backdrop, security selection was the primary contributor to the fund's performance versus the MSCI US IMI Semiconductors &amp; Semiconductor Equipment 25/50 Index for the fiscal year, especially within technology hardware, storage &amp; peripherals. Stock picking in semiconductors and electronic components also boosted the fund's relative performance.</span></div> <div style="text-align:left;text-align-last:auto;text-indent:-24px;margin-bottom:2px;margin-left:24px;margin-top:5px;margin-right:0px;"><span style="font-family:'Fidelity Sans';font-size:12px;color:#000000;font-style:normal;font-weight:normal;">•<span style="padding-right:10px"></span>The top individual relative contributor was our non-index stake in Western Digital (+581%). This period we decreased our stake in Western Digital. A second notable relative contributor was an overweight in Marvell Technology (+133%). The company was among our biggest holdings. Another notable relative contributor was an underweight in Qualcomm (+3%).</span></div> <div style="text-align:left;text-align-last:auto;text-indent:-24px;margin-bottom:2px;margin-left:24px;margin-top:5px;margin-right:0px;"><span style="font-family:'Fidelity Sans';font-size:12px;color:#000000;font-style:normal;font-weight:normal;">•<span style="padding-right:10px"></span>In contrast, the biggest detractors from performance versus the industry index were picks and an underweight in semiconductor materials &amp; equipment. An overweight in semiconductors also hampered the fund's result. Lastly, the fund's position in cash detracted.</span></div> <div style="text-align:left;text-align-last:auto;text-indent:-24px;margin-bottom:2px;margin-left:24px;margin-top:5px;margin-right:0px;"><span style="font-family:'Fidelity Sans';font-size:12px;color:#000000;font-style:normal;font-weight:normal;">•<span style="padding-right:10px"></span>The biggest individual relative detractor was an underweight in Intel (+356%). This period we decreased our stake in Intel. A second notable relative detractor was an underweight in Advanced Micro Devices (+170%). This period we increased our position in Advanced Micro Devices. Another notable relative detractor was an underweight in Applied Materials (+184%).</span></div> <div style="text-align:left;text-align-last:auto;text-indent:-24px;margin-bottom:2px;margin-left:24px;margin-top:5px;margin-right:0px;"><span style="font-family:'Fidelity Sans';font-size:12px;color:#000000;font-style:normal;font-weight:normal;">•<span style="padding-right:10px"></span>Notable changes in positioning include higher allocations to the semiconductor materials &amp; equipment and technology hardware, storage &amp; peripherals industries.</span></div> <div style="text-align:left;text-align-last:auto;"></div> How did the Fund perform over the past 10 years?    CUMULATIVE PERFORMANCE July 31, 2016 through July 31, 2026. Initial investment of $10,000 and the current sales charge was paid. Class A $9,425 $12,367 $15,750 $17,353 $22,671 $36,830 $35,648 $53,227 $74,260 $91,111 $167,728 MSCI U.S. IMI Semiconductors & Semiconductor Equipment 25-50 Index $10,000 $13,272 $16,695 $18,382 $24,778 $39,200 $37,215 $55,578 $82,876 $96,980 $177,796 S&P 500® Index $10,000 $11,604 $13,489 $14,566 $16,308 $22,251 $21,219 $23,980 $29,292 $34,076 $40,742   2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026   <span style="font-family:'Fidelity Sans';font-size:9px;color:#000000;font-style:normal;font-weight:normal;">Class A</span> 9425 12367 15750 17353 22671 36830 35648 53227 74260 91111 167728 <span style="font-family:'Fidelity Sans';font-size:9px;color:#000000;font-style:normal;font-weight:normal;">MSCI U.S. IMI Semiconductors &amp; Semiconductor Equipment 25-50 Index</span> 10000 13272 16695 18382 24778 39200 37215 55578 82876 96980 177796 <span style="font-family:'Fidelity Sans';font-size:9px;color:#000000;font-style:normal;font-weight:normal;">S&amp;P 500® Index</span> 10000 11604 13489 14566 16308 22251 21219 23980 29292 34076 40742 AVERAGE ANNUAL TOTAL RETURNS:   1 Year 5 Year 10 Year Class A (incl. 5.75% sales charge)   73.51% 33.83% 32.57% Class A (without 5.75% sales charge) 84.09% 35.42% 33.36% MSCI U.S. IMI Semiconductors & Semiconductor Equipment 25-50 Index 83.33% 35.31% 33.35% S&P 500® Index 19.56% 12.86% 15.08%     Visit institutional.fidelity.com for more recent performance information.    The Fund's past performance is not a good predictor of the Fund's future performance.  The graph and table do not reflect the deduction of taxes that a shareholder would pay on fund distributions or redemption of fund shares. 0.7351 0.3383 0.3257 0.8409 0.3542 0.3336 0.8333 0.3531 0.3335 0.1956 0.1286 0.1508 <span style="font-family:'Fidelity Sans';font-size:11px;color:#000000;font-style:normal;font-weight:normal;">Visit </span><span style="font-family:'Fidelity Sans';font-size:11px;color:#000000;font-style:normal;font-weight:bold;">institutional.fidelity.com</span><span style="font-family:'Fidelity Sans';font-size:11px;color:#000000;font-style:normal;font-weight:normal;"> for more recent performance information.</span> <span style="font-family:'Fidelity Sans';font-size:11px;color:#000000;font-style:italic;font-weight:normal;">The Fund's past performance is not a good predictor of the Fund's future performance.</span> <span style="font-family:'Fidelity Sans';font-size:11px;color:#000000;font-style:normal;font-weight:normal;">The graph and table do not reflect the deduction of taxes that a shareholder would pay on fund distributions or redemption of fund shares.</span> <span style="font-family:'Fidelity Sans';font-size:16px;color:#368627;font-style:normal;font-weight:bold;">Key Fund Statistics</span> <div style="text-align:left;text-align-last:auto;"></div> <div style="text-align:left;text-align-last:auto;"><span style="font-family:'Fidelity Sans';font-size:11px;color:#000000;font-style:normal;font-weight:normal;">(as of July 31, 2026)</span></div> <div><span style="font-size:11px;"> </span></div><div style="text-align:left;text-align-last:auto;"></div> <div style="text-align:right;text-align-last:auto;"><table cellpadding="0" cellspacing="1" style="border-collapse:separate;border-style:none;margin:auto;" width="100%"><tr><td style="width:63%; " valign="top"><div style="text-align:left;text-align-last:auto;"><span style="font-family:'Fidelity Sans';font-size:12px;color:#000000;font-style:normal;font-weight:bold;">KEY FACTS</span></div> <div style="text-align:left;text-align-last:auto;"></div> <div style="text-align:left;text-align-last:auto;"><span style="font-family:'Fidelity Sans';font-size:11px;color:#000000;font-style:normal;font-weight:bold;"> <span> </span></span></div> <div style="text-align:left;text-align-last:auto;"></div> </td> <td style="width:32%; " valign="top"><span style="line-height:12px;"> </span><div style="text-align:left;text-align-last:auto;"></div> </td> <td style="width:5%; " valign="top"><span style="line-height:12px;"> </span><div style="text-align:left;text-align-last:auto;"></div> </td> </tr> <tr><td style="width:63%; border-bottom:1px dashed #000000;padding:0px 0px 0px 0px;" valign="middle"><div style="text-align:left;text-align-last:auto;"><span style="font-family:'Fidelity Sans';font-size:11px;color:#000000;font-style:normal;font-weight:normal;">Fund Size</span></div> </td> <td style="width:32%; border-bottom:1px dashed #000000;padding:0px 0px 0px 0px;" valign="middle"><div style="text-align:right;text-align-last:auto;"><span style="font-family:'Fidelity Sans';font-size:11px;color:#000000;font-style:normal;font-weight:normal;">$</span>7,203,754,194</div> <div style="text-align:right;text-align-last:auto;"></div> </td> <td style="width:5%; " valign="top"><span style="line-height:11px;"> </span><div style="text-align:left;text-align-last:auto;"></div> </td> </tr> <tr><td style="width:63%; border-bottom:1px dashed #000000;padding:0px 0px 0px 0px;" valign="middle"><div style="text-align:left;text-align-last:auto;"><span style="font-family:'Fidelity Sans';font-size:11px;color:#000000;font-style:normal;font-weight:normal;">Number of Holdings</span></div> </td> <td style="width:32%; border-bottom:1px dashed #000000;padding:0px 0px 0px 0px;" valign="middle"><div style="text-align:right;text-align-last:auto;">76</div> <div style="text-align:right;text-align-last:auto;"></div> </td> <td style="width:5%; " valign="top"><span style="line-height:11px;"> </span><div style="text-align:left;text-align-last:auto;"></div> </td> </tr> <tr><td style="width:63%; border-bottom:1px dashed #000000;padding:0px 0px 0px 0px;" valign="middle"><div style="text-align:left;text-align-last:auto;"><span style="font-family:'Fidelity Sans';font-size:11px;color:#000000;font-style:normal;font-weight:normal;">Total Advisory Fee</span></div> </td> <td style="width:32%; border-bottom:1px dashed #000000;padding:0px 0px 0px 0px;" valign="middle"><div style="text-align:right;text-align-last:auto;"><span style="font-family:'Fidelity Sans';font-size:11px;color:#000000;font-style:normal;font-weight:normal;">$</span>35,292,988</div> <div style="text-align:right;text-align-last:auto;"></div> </td> <td style="width:5%; " valign="middle"><span style="line-height:11px;"> </span><div style="text-align:left;text-align-last:auto;"></div> </td> </tr> <tr><td style="width:63%; border-bottom:1px dashed #000000;padding:0px 0px 0px 0px;" valign="middle"><div style="text-align:left;text-align-last:auto;"><span style="font-family:'Fidelity Sans';font-size:11px;color:#000000;font-style:normal;font-weight:normal;">Portfolio Turnover</span></div> </td> <td style="width:32%; border-bottom:1px dashed #000000;padding:0px 0px 0px 0px;" valign="middle"><div style="text-align:right;text-align-last:auto;">99<span style="font-family:'Fidelity Sans';font-size:11px;color:#000000;font-style:normal;font-weight:normal;">%</span></div> <div style="text-align:left;text-align-last:auto;"></div> </td> <td style="width:5%; " valign="top"><span style="line-height:11px;"> </span><div style="text-align:left;text-align-last:auto;"></div> </td> </tr> </table> </div> <div style="text-align:left;text-align-last:auto;"></div> 7203754194 76 35292988 0.99       TOP INDUSTRIES (% of Fund's net assets) Semiconductors & Semiconductor Equipment 93.8   Technology Hardware, Storage & Peripherals 4.5   Electronic Equipment, Instruments & Components 0.7   Electrical Equipment 0.3   Software 0.2   Financial Services 0.0   Metals & Mining 0.0       Common Stocks 98.5 Preferred Stocks 1.0 Preferred Securities 0.0 Bonds 0.0 Short-Term Investments and Net Other Assets (Liabilities) 0.5 ASSET ALLOCATION (% of Fund's net assets)     Common Stocks - 98.5                       Preferred Stocks - 1.0                     Preferred Securities - 0.0                 Bonds - 0.0                                Short-Term Investments and Net Other Assets (Liabilities) - 0.5   United States 85.1 Netherlands 9.1 Japan 2.3 Israel 2.0 Taiwan 1.3 Korea (South) 0.2 Canada 0.0 GEOGRAPHIC DIVERSIFICATION (% of Fund's net assets)     United States - 85.1                       Netherlands - 9.1                          Japan - 2.3                                Israel - 2.0                               Taiwan - 1.3                               Korea (South) - 0.2                        Canada - 0.0                                   0.938 0.045 0.007 0.003 0.002 0.000 0.000 0.985 0.010 0.000 0.000 0.005 0.851 0.091 0.023 0.020 0.013 0.002 0.000 TOP HOLDINGS(% of Fund's net assets)     NVIDIA Corp 24.4   Broadcom Inc 15.4   Marvell Technology Inc 6.2   Astera Labs Inc 4.9   Monolithic Power Systems Inc 4.8   ASML Holding NV depository receipt 4.8   ON Semiconductor Corp 4.2   NXP Semiconductors NV 4.1   Micron Technology Inc 4.1   Lam Research Corp 3.7     76.6   0.244 0.154 0.062 0.049 0.048 0.048 0.042 0.041 0.041 0.037 2026-07-31 This report describes changes to the Fund that occurred during the reporting period. Fidelity Advisor® Industrials Fund Fidelity Advisor® Industrials Fund Class Z FIKEX This annual shareholder report contains information about Fidelity Advisor® Industrials Fund for the period August 1, 2025 to July 31, 2026. annual shareholder report You can find additional information about the Fund at fundresearch.fidelity.com/prospectus/sec. You can also request this information by contacting us at 1-877-208-0098 or by sending an e-mail to fidfunddocuments@fidelity.com. fundresearch.fidelity.com/prospectus/sec 1-877-208-0098 fidfunddocuments@fidelity.com <span style="font-family:'Fidelity Sans';font-size:16px;color:#368627;font-style:normal;font-weight:bold;">What were your Fund costs for the last year?</span> <div style="text-align:left;text-align-last:auto;"><span style="font-family:'Fidelity Sans';font-size:11px;color:#000000;font-style:normal;font-weight:normal;">(based on hypothetical $10,000 investment)</span></div> <div><span style="font-size:11px;"> </span></div><div style="text-align:left;text-align-last:auto;"></div> <div style="text-align:left;text-align-last:auto;"><span style="font-family:'Fidelity Sans';font-size:12px;color:#000000;font-style:normal;font-weight:bold;">FUND COST (PREVIOUS YEAR)</span></div> <div style="text-align:left;text-align-last:auto;"></div> <div style="text-align:left;text-align-last:auto;"><table cellpadding="0" cellspacing="0" style="border-collapse:collapse;border-style:none;" width="100%"><tr><td style="width:51%; background-color:#dfe0e4;border:1px solid #dfe0e4;padding:0px 0px 0px 0px;" valign="bottom"><div style="text-align:left;text-align-last:auto;"><span style="font-family:'Fidelity Sans';font-size:11px;color:#000000;font-style:normal;font-weight:bold;"> </span></div> </td> <td style="width:21%; background-color:#dfe0e4;border:1px solid #dfe0e4;padding:0px 0px 0px 0px;" valign="bottom"><div style="text-align:center;text-align-last:auto;"><span style="font-family:'Fidelity Sans';font-size:11px;color:#000000;font-style:normal;font-weight:bold;">Costs of a $10,000 investment</span></div> </td> <td style="width:27%; background-color:#dfe0e4;border:1px solid #dfe0e4;padding:0px 0px 0px 0px;" valign="bottom"><div style="text-align:center;text-align-last:auto;"><span style="font-family:'Fidelity Sans';font-size:11px;color:#000000;font-style:normal;font-weight:bold;">Costs paid as a percentage of a $10,000 investment </span></div> </td> <td style="width:1%; " valign="top"><span style="line-height:12px;"> </span><div style="text-align:left;text-align-last:auto;"></div> </td> </tr> <tr><td style="width:51%; border-bottom:1px solid #000000;padding:0px 0px 0px 0px;" valign="top"><div style="text-align:left;text-align-last:auto;"><span style="font-family:'Fidelity Sans';font-size:12px;color:#000000;font-style:normal;font-weight:normal;">Class Z</span><span style="font-family:'Fidelity Sans';font-size:11px;color:#000000;font-style:normal;font-weight:normal;"> </span></div> </td> <td style="width:21%; border-bottom:1px solid #000000;padding:0px 0px 0px 0px;" valign="middle"><div style="text-align:center;text-align-last:auto;"><span style="font-family:'Fidelity Sans';font-size:11px;color:#000000;font-style:normal;font-weight:normal;">$</span><span style="font-family:'Fidelity Sans';font-size:12px;color:#000000;font-style:normal;font-weight:normal;"> </span>64<span style="font-family:'Fidelity Sans';font-size:11px;color:#000000;font-style:normal;font-weight:normal;"> </span></div> </td> <td style="width:27%; border-bottom:1px solid #000000;padding:0px 0px 0px 0px;" valign="middle"><div style="text-align:center;text-align-last:auto;">0.57<span style="font-family:'Fidelity Sans';font-size:11px;color:#000000;font-style:normal;font-weight:normal;">%</span></div> </td> <td style="width:1%; " valign="top"><span style="line-height:12px;"> </span><div style="text-align:left;text-align-last:auto;"></div> </td> </tr> </table> </div> <div style="text-align:left;text-align-last:auto;"></div> 64 0.0057 <span style="font-family:'Fidelity Sans';font-size:16px;color:#368627;font-style:normal;font-weight:bold;">What affected the Fund's performance this period?</span> <div style="text-align:left;text-align-last:auto;"><span style="font-family:'Fidelity Sans';font-size:11px;color:#000000;font-style:normal;font-weight:bold;"> </span></div> <div style="text-align:left;text-align-last:auto;text-indent:-24px;margin-bottom:2px;margin-left:24px;margin-top:5px;margin-right:0px;"><span style="font-family:'Fidelity Sans';font-size:12px;color:#000000;font-style:normal;font-weight:normal;">•<span style="padding-right:10px"></span>U.S. stocks achieved a strong gain for the 12 months ending July 31, 2026, reflecting enthusiasm for artificial intelligence, strong corporate fundamentals, a resilient economy and, beginning in September, the Federal Reserve's first interest-rate reductions since December 2024.</span></div> <div style="text-align:left;text-align-last:auto;text-indent:-24px;margin-bottom:2px;margin-left:24px;margin-top:5px;margin-right:0px;"><span style="font-family:'Fidelity Sans';font-size:12px;color:#000000;font-style:normal;font-weight:normal;">•<span style="padding-right:10px"></span>Against this backdrop, market selection was the primary contributor to the fund's performance versus the MSCI US IMI Industrials 25/50 Linked Index for the fiscal year, especially an underweight in human resource &amp; employment services. Picks in construction &amp; engineering also boosted the fund's relative performance. Also helping our relative result was an overweight in heavy electrical equipment.</span></div> <div style="text-align:left;text-align-last:auto;text-indent:-24px;margin-bottom:2px;margin-left:24px;margin-top:5px;margin-right:0px;"><span style="font-family:'Fidelity Sans';font-size:12px;color:#000000;font-style:normal;font-weight:normal;">•<span style="padding-right:10px"></span>The top individual relative contributor was an overweight in Howmet Aerospace (+60%). The company was one of our biggest holdings. A second notable relative contributor was an overweight in Cummins (+74%). This was a position we established this period. The company was one of the fund's biggest holdings this period. An overweight in GE Vernova (+49%) also helped. The stock was one of the fund's biggest holdings.</span></div> <div style="text-align:left;text-align-last:auto;text-indent:-24px;margin-bottom:2px;margin-left:24px;margin-top:5px;margin-right:0px;"><span style="font-family:'Fidelity Sans';font-size:12px;color:#000000;font-style:normal;font-weight:normal;">•<span style="padding-right:10px"></span>In contrast, the biggest detractor from performance versus the sector index was security selection in aerospace &amp; defense. Also hurting our result was stock picking in electrical components &amp; equipment and heavy electrical equipment.</span></div> <div style="text-align:left;text-align-last:auto;text-indent:-24px;margin-bottom:2px;margin-left:24px;margin-top:5px;margin-right:0px;"><span style="font-family:'Fidelity Sans';font-size:12px;color:#000000;font-style:normal;font-weight:normal;">•<span style="padding-right:10px"></span>The biggest individual relative detractor was an underweight in Caterpillar (+88%). This period we increased our stake in Caterpillar. A second notable relative detractor was an overweight in Boeing (-2%). This period we increased our stake in Boeing. The company was among our largest holdings. An overweight in Ingersoll Rand (-2%) also detracted. This period we increased our stake in Ingersoll Rand. The stock was one of the fund's biggest holdings this period.</span></div> <div style="text-align:left;text-align-last:auto;text-indent:-24px;margin-bottom:2px;margin-left:24px;margin-top:5px;margin-right:0px;"><span style="font-family:'Fidelity Sans';font-size:12px;color:#000000;font-style:normal;font-weight:normal;">•<span style="padding-right:10px"></span>Notable changes in positioning include increased exposure to the construction machinery &amp; heavy transportation equipment and construction &amp; engineering industries.</span></div> <div style="text-align:left;text-align-last:auto;"></div> How did the Fund perform over the life of Fund?    CUMULATIVE PERFORMANCE October 2, 2018 through July 31, 2026. Initial investment of $10,000. Class Z $10,000 $9,808 $9,199 $12,525 $11,596 $13,816 $17,564 $22,165 $26,996 MSCI U.S. IMI Industrials 25-50 Index $10,000 $10,039 $9,457 $13,947 $12,942 $15,447 $18,353 $21,730 $26,086 S&P 500® Index $10,000 $10,365 $11,604 $15,833 $15,098 $17,064 $20,843 $24,247 $28,991   2018 2019 2020 2021 2022 2023 2024 2025 2026   <span style="font-family:'Fidelity Sans';font-size:9px;color:#000000;font-style:normal;font-weight:normal;">Class Z</span> 10000 9808 9199 12525 11596 13816 17564 22165 26996 <span style="font-family:'Fidelity Sans';font-size:9px;color:#000000;font-style:normal;font-weight:normal;">MSCI U.S. IMI Industrials 25-50 Index</span> 10000 10039 9457 13947 12942 15447 18353 21730 26086 <span style="font-family:'Fidelity Sans';font-size:9px;color:#000000;font-style:normal;font-weight:normal;">S&amp;P 500® Index</span> 10000 10365 11604 15833 15098 17064 20843 24247 28991 AVERAGE ANNUAL TOTAL RETURNS:   1 Year 5 Year Life of Fund A Class Z 21.79% 16.60% 13.52% MSCI U.S. IMI Industrials 25-50 Index 20.05% 13.34% 13.02% S&P 500® Index 19.56% 12.86% 14.56% A   From October 2, 2018   Visit institutional.fidelity.com for more recent performance information.    The Fund's past performance is not a good predictor of the Fund's future performance.  The graph and table do not reflect the deduction of taxes that a shareholder would pay on fund distributions or redemption of fund shares. 0.2179 0.1660 0.1352 0.2005 0.1334 0.1302 0.1956 0.1286 0.1456 2018-10-02 <span style="font-family:'Fidelity Sans';font-size:11px;color:#000000;font-style:normal;font-weight:normal;">Visit </span><span style="font-family:'Fidelity Sans';font-size:11px;color:#000000;font-style:normal;font-weight:bold;">institutional.fidelity.com</span><span style="font-family:'Fidelity Sans';font-size:11px;color:#000000;font-style:normal;font-weight:normal;"> for more recent performance information.</span> <span style="font-family:'Fidelity Sans';font-size:11px;color:#000000;font-style:italic;font-weight:normal;">The Fund's past performance is not a good predictor of the Fund's future performance.</span> <span style="font-family:'Fidelity Sans';font-size:11px;color:#000000;font-style:normal;font-weight:normal;">The graph and table do not reflect the deduction of taxes that a shareholder would pay on fund distributions or redemption of fund shares.</span> <span style="font-family:'Fidelity Sans';font-size:16px;color:#368627;font-style:normal;font-weight:bold;">Key Fund Statistics</span> <div style="text-align:left;text-align-last:auto;"></div> <div style="text-align:left;text-align-last:auto;"><span style="font-family:'Fidelity Sans';font-size:11px;color:#000000;font-style:normal;font-weight:normal;">(as of July 31, 2026)</span></div> <div><span style="font-size:11px;"> </span></div><div style="text-align:left;text-align-last:auto;"></div> <div style="text-align:right;text-align-last:auto;"><table cellpadding="0" cellspacing="1" style="border-collapse:separate;border-style:none;margin:auto;" width="100%"><tr><td style="width:63%; " valign="top"><div style="text-align:left;text-align-last:auto;"><span style="font-family:'Fidelity Sans';font-size:12px;color:#000000;font-style:normal;font-weight:bold;">KEY FACTS</span></div> <div style="text-align:left;text-align-last:auto;"></div> <div style="text-align:left;text-align-last:auto;"><span style="font-family:'Fidelity Sans';font-size:11px;color:#000000;font-style:normal;font-weight:bold;"> <span> </span></span></div> <div style="text-align:left;text-align-last:auto;"></div> </td> <td style="width:32%; " valign="top"><span style="line-height:12px;"> </span><div style="text-align:left;text-align-last:auto;"></div> </td> <td style="width:5%; " valign="top"><span style="line-height:12px;"> </span><div style="text-align:left;text-align-last:auto;"></div> </td> </tr> <tr><td style="width:63%; border-bottom:1px dashed #000000;padding:0px 0px 0px 0px;" valign="middle"><div style="text-align:left;text-align-last:auto;"><span style="font-family:'Fidelity Sans';font-size:11px;color:#000000;font-style:normal;font-weight:normal;">Fund Size</span></div> </td> <td style="width:32%; border-bottom:1px dashed #000000;padding:0px 0px 0px 0px;" valign="middle"><div style="text-align:right;text-align-last:auto;"><span style="font-family:'Fidelity Sans';font-size:11px;color:#000000;font-style:normal;font-weight:normal;">$</span>2,161,544,746</div> <div style="text-align:right;text-align-last:auto;"></div> </td> <td style="width:5%; " valign="top"><span style="line-height:11px;"> </span><div style="text-align:left;text-align-last:auto;"></div> </td> </tr> <tr><td style="width:63%; border-bottom:1px dashed #000000;padding:0px 0px 0px 0px;" valign="middle"><div style="text-align:left;text-align-last:auto;"><span style="font-family:'Fidelity Sans';font-size:11px;color:#000000;font-style:normal;font-weight:normal;">Number of Holdings</span></div> </td> <td style="width:32%; border-bottom:1px dashed #000000;padding:0px 0px 0px 0px;" valign="middle"><div style="text-align:right;text-align-last:auto;">50</div> <div style="text-align:right;text-align-last:auto;"></div> </td> <td style="width:5%; " valign="top"><span style="line-height:11px;"> </span><div style="text-align:left;text-align-last:auto;"></div> </td> </tr> <tr><td style="width:63%; border-bottom:1px dashed #000000;padding:0px 0px 0px 0px;" valign="middle"><div style="text-align:left;text-align-last:auto;"><span style="font-family:'Fidelity Sans';font-size:11px;color:#000000;font-style:normal;font-weight:normal;">Total Advisory Fee</span></div> </td> <td style="width:32%; border-bottom:1px dashed #000000;padding:0px 0px 0px 0px;" valign="middle"><div style="text-align:right;text-align-last:auto;"><span style="font-family:'Fidelity Sans';font-size:11px;color:#000000;font-style:normal;font-weight:normal;">$</span>10,611,345</div> <div style="text-align:right;text-align-last:auto;"></div> </td> <td style="width:5%; " valign="middle"><span style="line-height:11px;"> </span><div style="text-align:left;text-align-last:auto;"></div> </td> </tr> <tr><td style="width:63%; border-bottom:1px dashed #000000;padding:0px 0px 0px 0px;" valign="middle"><div style="text-align:left;text-align-last:auto;"><span style="font-family:'Fidelity Sans';font-size:11px;color:#000000;font-style:normal;font-weight:normal;">Portfolio Turnover</span></div> </td> <td style="width:32%; border-bottom:1px dashed #000000;padding:0px 0px 0px 0px;" valign="middle"><div style="text-align:right;text-align-last:auto;">34<span style="font-family:'Fidelity Sans';font-size:11px;color:#000000;font-style:normal;font-weight:normal;">%</span></div> <div style="text-align:left;text-align-last:auto;"></div> </td> <td style="width:5%; " valign="top"><span style="line-height:11px;"> </span><div style="text-align:left;text-align-last:auto;"></div> </td> </tr> </table> </div> <div style="text-align:left;text-align-last:auto;"></div> 2161544746 50 10611345 0.34       TOP INDUSTRIES (% of Fund's net assets) Aerospace & Defense 30.9   Machinery 24.3   Electrical Equipment 13.6   Building Products 8.8   Ground Transportation 5.6   Construction & Engineering 5.0   Commercial Services & Supplies 3.2   Trading Companies & Distributors 3.0   Industrial Conglomerates 1.8   Others 2.5       Common Stocks 98.7 Short-Term Investments and Net Other Assets (Liabilities) 1.3 ASSET ALLOCATION (% of Fund's net assets)     Common Stocks - 98.7                       Short-Term Investments and Net Other Assets (Liabilities) - 1.3   United States 100.0 GEOGRAPHIC DIVERSIFICATION (% of Fund's net assets)     United States - 100.0                          0.309 0.243 0.136 0.088 0.056 0.050 0.032 0.030 0.018 0.025 0.987 0.013 1.000 TOP HOLDINGS(% of Fund's net assets)     GE Aerospace 8.1   GE Vernova Inc 6.3   Boeing Co 6.2   Trane Technologies PLC 4.6   Howmet Aerospace Inc 4.5   Parker-Hannifin Corp 4.4   Eaton Corp PLC 3.5   RTX Corp 3.5   PACCAR Inc 2.9   Quanta Services Inc 2.9     46.9   0.081 0.063 0.062 0.046 0.045 0.044 0.035 0.035 0.029 0.029 <div style="text-align:left;text-align-last:auto;"><span style="font-family:'Fidelity Sans';font-size:16px;color:#368627;font-style:normal;font-weight:bold;">How has the Fund changed?</span></div> <div style="text-align:left;text-align-last:auto;"><span style="font-family:'Fidelity Sans';font-size:11px;color:#000000;font-style:normal;font-weight:normal;"> </span></div> <div style="text-align:left;text-align-last:auto;"><span style="font-family:'Fidelity Sans';font-size:11px;color:#000000;font-style:normal;font-weight:normal;">This is a summary of certain changes to the Fund since August 1, 2025. For more complete information, you may review the Fund's next prospectus, which we expect to be available by September 29, 2026 at </span><span style="font-family:'Fidelity Sans';font-size:11px;color:#000000;font-style:normal;font-weight:bold;">fundresearch.fidelity.com/prospectus/sec</span><span style="font-family:'Fidelity Sans';font-size:11px;color:#000000;font-style:normal;font-weight:normal;"> or upon request at </span><span style="font-family:'Fidelity Sans';font-size:11px;color:#000000;font-style:normal;font-weight:normal;">1-877-208-0098</span><span style="font-family:'Fidelity Sans';font-size:0px;color:#000000;font-style:normal;font-weight:normal;"> </span><span style="font-family:'Fidelity Sans';font-size:11px;color:#000000;font-style:normal;font-weight:normal;"> or by sending an e-mail to </span><span style="font-family:'Fidelity Sans';font-size:11px;color:#000000;font-style:normal;font-weight:normal;">fidfunddocuments@fidelity.com</span><span style="font-family:'Fidelity Sans';font-size:11px;color:#000000;font-style:normal;font-weight:normal;">.</span></div> <div style="text-align:left;text-align-last:auto;"></div> <span style="line-height:11px;"> </span><div style="text-align:left;text-align-last:auto;"></div> <div style="text-align:left;text-align-last:auto;"><table cellpadding="0" cellspacing="0" style="border-collapse:collapse;border-style:none;" width="100%"><tr><td style="width:50%; background-color:#ebf3e9;border-right:2px dashed #368627;padding:19px 19px 19px 19px;" valign="top"><div style="text-align:left;text-align-last:auto;"><span style="font-family:'Fidelity Sans';font-size:11px;color:#000000;font-style:normal;font-weight:normal;">Industrials Portfolio merged into Fidelity Advisor® Industrials Fund on October 17, 2025.</span></div> <div style="text-align:left;text-align-last:auto;"></div> </td> <td style="width:50%; background-color:#ebf3e9;padding:19px 19px 19px 19px;" valign="top"><div style="text-align:left;text-align-last:auto;"></div> </td> </tr> </table> </div> <div style="text-align:left;text-align-last:auto;"></div> <span style="font-family:'Fidelity Sans';font-size:11px;color:#000000;font-style:normal;font-weight:normal;">This is a summary of certain changes to the Fund since August 1, 2025. For more complete information, you may review the Fund's next prospectus, which we expect to be available by September 29, 2026 at </span><span style="font-family:'Fidelity Sans';font-size:11px;color:#000000;font-style:normal;font-weight:bold;">fundresearch.fidelity.com/prospectus/sec</span><span style="font-family:'Fidelity Sans';font-size:11px;color:#000000;font-style:normal;font-weight:normal;"> or upon request at </span><span style="font-family:'Fidelity Sans';font-size:11px;color:#000000;font-style:normal;font-weight:normal;">1-877-208-0098</span><span style="font-family:'Fidelity Sans';font-size:0px;color:#000000;font-style:normal;font-weight:normal;"> </span><span style="font-family:'Fidelity Sans';font-size:11px;color:#000000;font-style:normal;font-weight:normal;"> or by sending an e-mail to </span><span style="font-family:'Fidelity Sans';font-size:11px;color:#000000;font-style:normal;font-weight:normal;">fidfunddocuments@fidelity.com</span><span style="font-family:'Fidelity Sans';font-size:11px;color:#000000;font-style:normal;font-weight:normal;">.</span> <span style="font-family:'Fidelity Sans';font-size:11px;color:#000000;font-style:normal;font-weight:bold;">fundresearch.fidelity.com/prospectus/sec</span> <span style="font-family:'Fidelity Sans';font-size:11px;color:#000000;font-style:normal;font-weight:normal;">1-877-208-0098</span> <span style="font-family:'Fidelity Sans';font-size:11px;color:#000000;font-style:normal;font-weight:normal;">fidfunddocuments@fidelity.com</span> 2026-07-31 This report describes changes to the Fund that occurred during the reporting period. Fidelity Advisor® Industrials Fund Fidelity Advisor® Industrials Fund Class M FCLTX This annual shareholder report contains information about Fidelity Advisor® Industrials Fund for the period August 1, 2025 to July 31, 2026. annual shareholder report You can find additional information about the Fund at fundresearch.fidelity.com/prospectus/sec. You can also request this information by contacting us at 1-877-208-0098 or by sending an e-mail to fidfunddocuments@fidelity.com. fundresearch.fidelity.com/prospectus/sec 1-877-208-0098 fidfunddocuments@fidelity.com <span style="font-family:'Fidelity Sans';font-size:16px;color:#368627;font-style:normal;font-weight:bold;">What were your Fund costs for the last year?</span> <div style="text-align:left;text-align-last:auto;"><span style="font-family:'Fidelity Sans';font-size:11px;color:#000000;font-style:normal;font-weight:normal;">(based on hypothetical $10,000 investment)</span></div> <div><span style="font-size:11px;"> </span></div><div style="text-align:left;text-align-last:auto;"></div> <div style="text-align:left;text-align-last:auto;"><span style="font-family:'Fidelity Sans';font-size:12px;color:#000000;font-style:normal;font-weight:bold;">FUND COST (PREVIOUS YEAR)</span></div> <div style="text-align:left;text-align-last:auto;"></div> <div style="text-align:left;text-align-last:auto;"><table cellpadding="0" cellspacing="0" style="border-collapse:collapse;border-style:none;" width="100%"><tr><td style="width:51%; background-color:#dfe0e4;border:1px solid #dfe0e4;padding:0px 0px 0px 0px;" valign="bottom"><div style="text-align:left;text-align-last:auto;"><span style="font-family:'Fidelity Sans';font-size:11px;color:#000000;font-style:normal;font-weight:bold;"> </span></div> </td> <td style="width:21%; background-color:#dfe0e4;border:1px solid #dfe0e4;padding:0px 0px 0px 0px;" valign="bottom"><div style="text-align:center;text-align-last:auto;"><span style="font-family:'Fidelity Sans';font-size:11px;color:#000000;font-style:normal;font-weight:bold;">Costs of a $10,000 investment</span></div> </td> <td style="width:27%; background-color:#dfe0e4;border:1px solid #dfe0e4;padding:0px 0px 0px 0px;" valign="bottom"><div style="text-align:center;text-align-last:auto;"><span style="font-family:'Fidelity Sans';font-size:11px;color:#000000;font-style:normal;font-weight:bold;">Costs paid as a percentage of a $10,000 investment </span></div> </td> <td style="width:1%; " valign="top"><span style="line-height:12px;"> </span><div style="text-align:left;text-align-last:auto;"></div> </td> </tr> <tr><td style="width:51%; border-bottom:1px solid #000000;padding:0px 0px 0px 0px;" valign="top"><div style="text-align:left;text-align-last:auto;"><span style="font-family:'Fidelity Sans';font-size:12px;color:#000000;font-style:normal;font-weight:normal;">Class M</span><span style="font-family:'Fidelity Sans';font-size:11px;color:#000000;font-style:normal;font-weight:normal;"> </span></div> </td> <td style="width:21%; border-bottom:1px solid #000000;padding:0px 0px 0px 0px;" valign="middle"><div style="text-align:center;text-align-last:auto;"><span style="font-family:'Fidelity Sans';font-size:11px;color:#000000;font-style:normal;font-weight:normal;">$</span><span style="font-family:'Fidelity Sans';font-size:12px;color:#000000;font-style:normal;font-weight:normal;"> </span>132<span style="font-family:'Fidelity Sans';font-size:11px;color:#000000;font-style:normal;font-weight:normal;"> </span></div> </td> <td style="width:27%; border-bottom:1px solid #000000;padding:0px 0px 0px 0px;" valign="middle"><div style="text-align:center;text-align-last:auto;">1.20<span style="font-family:'Fidelity Sans';font-size:11px;color:#000000;font-style:normal;font-weight:normal;">%</span></div> </td> <td style="width:1%; " valign="top"><span style="line-height:12px;"> </span><div style="text-align:left;text-align-last:auto;"></div> </td> </tr> </table> </div> <div style="text-align:left;text-align-last:auto;"></div> 132 0.0120 <span style="font-family:'Fidelity Sans';font-size:16px;color:#368627;font-style:normal;font-weight:bold;">What affected the Fund's performance this period?</span> <div style="text-align:left;text-align-last:auto;"><span style="font-family:'Fidelity Sans';font-size:11px;color:#000000;font-style:normal;font-weight:bold;"> </span></div> <div style="text-align:left;text-align-last:auto;text-indent:-24px;margin-bottom:2px;margin-left:24px;margin-top:5px;margin-right:0px;"><span style="font-family:'Fidelity Sans';font-size:12px;color:#000000;font-style:normal;font-weight:normal;">•<span style="padding-right:10px"></span>U.S. stocks achieved a strong gain for the 12 months ending July 31, 2026, reflecting enthusiasm for artificial intelligence, strong corporate fundamentals, a resilient economy and, beginning in September, the Federal Reserve's first interest-rate reductions since December 2024.</span></div> <div style="text-align:left;text-align-last:auto;text-indent:-24px;margin-bottom:2px;margin-left:24px;margin-top:5px;margin-right:0px;"><span style="font-family:'Fidelity Sans';font-size:12px;color:#000000;font-style:normal;font-weight:normal;">•<span style="padding-right:10px"></span>Against this backdrop, market selection was the primary contributor to the fund's performance versus the MSCI US IMI Industrials 25/50 Linked Index for the fiscal year, especially an underweight in human resource &amp; employment services. Picks in construction &amp; engineering also boosted the fund's relative performance. Also helping our relative result was an overweight in heavy electrical equipment.</span></div> <div style="text-align:left;text-align-last:auto;text-indent:-24px;margin-bottom:2px;margin-left:24px;margin-top:5px;margin-right:0px;"><span style="font-family:'Fidelity Sans';font-size:12px;color:#000000;font-style:normal;font-weight:normal;">•<span style="padding-right:10px"></span>The top individual relative contributor was an overweight in Howmet Aerospace (+60%). The company was one of our biggest holdings. A second notable relative contributor was an overweight in Cummins (+74%). This was a position we established this period. The company was one of the fund's biggest holdings this period. An overweight in GE Vernova (+49%) also helped. The stock was one of the fund's biggest holdings.</span></div> <div style="text-align:left;text-align-last:auto;text-indent:-24px;margin-bottom:2px;margin-left:24px;margin-top:5px;margin-right:0px;"><span style="font-family:'Fidelity Sans';font-size:12px;color:#000000;font-style:normal;font-weight:normal;">•<span style="padding-right:10px"></span>In contrast, the biggest detractor from performance versus the sector index was security selection in aerospace &amp; defense. Also hurting our result was stock picking in electrical components &amp; equipment and heavy electrical equipment.</span></div> <div style="text-align:left;text-align-last:auto;text-indent:-24px;margin-bottom:2px;margin-left:24px;margin-top:5px;margin-right:0px;"><span style="font-family:'Fidelity Sans';font-size:12px;color:#000000;font-style:normal;font-weight:normal;">•<span style="padding-right:10px"></span>The biggest individual relative detractor was an underweight in Caterpillar (+88%). This period we increased our stake in Caterpillar. A second notable relative detractor was an overweight in Boeing (-2%). This period we increased our stake in Boeing. The company was among our largest holdings. An overweight in Ingersoll Rand (-2%) also detracted. This period we increased our stake in Ingersoll Rand. The stock was one of the fund's biggest holdings this period.</span></div> <div style="text-align:left;text-align-last:auto;text-indent:-24px;margin-bottom:2px;margin-left:24px;margin-top:5px;margin-right:0px;"><span style="font-family:'Fidelity Sans';font-size:12px;color:#000000;font-style:normal;font-weight:normal;">•<span style="padding-right:10px"></span>Notable changes in positioning include increased exposure to the construction machinery &amp; heavy transportation equipment and construction &amp; engineering industries.</span></div> <div style="text-align:left;text-align-last:auto;"></div> How did the Fund perform over the past 10 years?    CUMULATIVE PERFORMANCE July 31, 2016 through July 31, 2026. Initial investment of $10,000 and the current sales charge was paid. Class M $9,650 $10,840 $12,542 $12,765 $11,895 $16,088 $14,797 $17,518 $22,125 $27,746 $33,583 MSCI U.S. IMI Industrials 25-50 Index $10,000 $11,882 $13,626 $14,063 $13,248 $19,538 $18,129 $21,639 $25,709 $30,439 $36,542 S&P 500® Index $10,000 $11,604 $13,489 $14,566 $16,308 $22,251 $21,219 $23,980 $29,292 $34,076 $40,742   2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026   <span style="font-family:'Fidelity Sans';font-size:9px;color:#000000;font-style:normal;font-weight:normal;">Class M</span> 9650 10840 12542 12765 11895 16088 14797 17518 22125 27746 33583 <span style="font-family:'Fidelity Sans';font-size:9px;color:#000000;font-style:normal;font-weight:normal;">MSCI U.S. IMI Industrials 25-50 Index</span> 10000 11882 13626 14063 13248 19538 18129 21639 25709 30439 36542 <span style="font-family:'Fidelity Sans';font-size:9px;color:#000000;font-style:normal;font-weight:normal;">S&amp;P 500® Index</span> 10000 11604 13489 14566 16308 22251 21219 23980 29292 34076 40742 AVERAGE ANNUAL TOTAL RETURNS:   1 Year 5 Year 10 Year Class M (incl. 3.50% sales charge)   16.80% 15.03% 12.88% Class M (without 3.50% sales charge) 21.04% 15.86% 13.28% MSCI U.S. IMI Industrials 25-50 Index 20.05% 13.34% 13.84% S&P 500® Index 19.56% 12.86% 15.08%     Visit institutional.fidelity.com for more recent performance information.    The Fund's past performance is not a good predictor of the Fund's future performance.  The graph and table do not reflect the deduction of taxes that a shareholder would pay on fund distributions or redemption of fund shares. 0.1680 0.1503 0.1288 0.2104 0.1586 0.1328 0.2005 0.1334 0.1384 0.1956 0.1286 0.1508 <span style="font-family:'Fidelity Sans';font-size:11px;color:#000000;font-style:normal;font-weight:normal;">Visit </span><span style="font-family:'Fidelity Sans';font-size:11px;color:#000000;font-style:normal;font-weight:bold;">institutional.fidelity.com</span><span style="font-family:'Fidelity Sans';font-size:11px;color:#000000;font-style:normal;font-weight:normal;"> for more recent performance information.</span> <span style="font-family:'Fidelity Sans';font-size:11px;color:#000000;font-style:italic;font-weight:normal;">The Fund's past performance is not a good predictor of the Fund's future performance.</span> <span style="font-family:'Fidelity Sans';font-size:11px;color:#000000;font-style:normal;font-weight:normal;">The graph and table do not reflect the deduction of taxes that a shareholder would pay on fund distributions or redemption of fund shares.</span> <span style="font-family:'Fidelity Sans';font-size:16px;color:#368627;font-style:normal;font-weight:bold;">Key Fund Statistics</span> <div style="text-align:left;text-align-last:auto;"></div> <div style="text-align:left;text-align-last:auto;"><span style="font-family:'Fidelity Sans';font-size:11px;color:#000000;font-style:normal;font-weight:normal;">(as of July 31, 2026)</span></div> <div><span style="font-size:11px;"> </span></div><div style="text-align:left;text-align-last:auto;"></div> <div style="text-align:right;text-align-last:auto;"><table cellpadding="0" cellspacing="1" style="border-collapse:separate;border-style:none;margin:auto;" width="100%"><tr><td style="width:63%; " valign="top"><div style="text-align:left;text-align-last:auto;"><span style="font-family:'Fidelity Sans';font-size:12px;color:#000000;font-style:normal;font-weight:bold;">KEY FACTS</span></div> <div style="text-align:left;text-align-last:auto;"></div> <div style="text-align:left;text-align-last:auto;"><span style="font-family:'Fidelity Sans';font-size:11px;color:#000000;font-style:normal;font-weight:bold;"> <span> </span></span></div> <div style="text-align:left;text-align-last:auto;"></div> </td> <td style="width:32%; " valign="top"><span style="line-height:12px;"> </span><div style="text-align:left;text-align-last:auto;"></div> </td> <td style="width:5%; " valign="top"><span style="line-height:12px;"> </span><div style="text-align:left;text-align-last:auto;"></div> </td> </tr> <tr><td style="width:63%; border-bottom:1px dashed #000000;padding:0px 0px 0px 0px;" valign="middle"><div style="text-align:left;text-align-last:auto;"><span style="font-family:'Fidelity Sans';font-size:11px;color:#000000;font-style:normal;font-weight:normal;">Fund Size</span></div> </td> <td style="width:32%; border-bottom:1px dashed #000000;padding:0px 0px 0px 0px;" valign="middle"><div style="text-align:right;text-align-last:auto;"><span style="font-family:'Fidelity Sans';font-size:11px;color:#000000;font-style:normal;font-weight:normal;">$</span>2,161,544,746</div> <div style="text-align:right;text-align-last:auto;"></div> </td> <td style="width:5%; " valign="top"><span style="line-height:11px;"> </span><div style="text-align:left;text-align-last:auto;"></div> </td> </tr> <tr><td style="width:63%; border-bottom:1px dashed #000000;padding:0px 0px 0px 0px;" valign="middle"><div style="text-align:left;text-align-last:auto;"><span style="font-family:'Fidelity Sans';font-size:11px;color:#000000;font-style:normal;font-weight:normal;">Number of Holdings</span></div> </td> <td style="width:32%; border-bottom:1px dashed #000000;padding:0px 0px 0px 0px;" valign="middle"><div style="text-align:right;text-align-last:auto;">50</div> <div style="text-align:right;text-align-last:auto;"></div> </td> <td style="width:5%; " valign="top"><span style="line-height:11px;"> </span><div style="text-align:left;text-align-last:auto;"></div> </td> </tr> <tr><td style="width:63%; border-bottom:1px dashed #000000;padding:0px 0px 0px 0px;" valign="middle"><div style="text-align:left;text-align-last:auto;"><span style="font-family:'Fidelity Sans';font-size:11px;color:#000000;font-style:normal;font-weight:normal;">Total Advisory Fee</span></div> </td> <td style="width:32%; border-bottom:1px dashed #000000;padding:0px 0px 0px 0px;" valign="middle"><div style="text-align:right;text-align-last:auto;"><span style="font-family:'Fidelity Sans';font-size:11px;color:#000000;font-style:normal;font-weight:normal;">$</span>10,611,345</div> <div style="text-align:right;text-align-last:auto;"></div> </td> <td style="width:5%; " valign="middle"><span style="line-height:11px;"> </span><div style="text-align:left;text-align-last:auto;"></div> </td> </tr> <tr><td style="width:63%; border-bottom:1px dashed #000000;padding:0px 0px 0px 0px;" valign="middle"><div style="text-align:left;text-align-last:auto;"><span style="font-family:'Fidelity Sans';font-size:11px;color:#000000;font-style:normal;font-weight:normal;">Portfolio Turnover</span></div> </td> <td style="width:32%; border-bottom:1px dashed #000000;padding:0px 0px 0px 0px;" valign="middle"><div style="text-align:right;text-align-last:auto;">34<span style="font-family:'Fidelity Sans';font-size:11px;color:#000000;font-style:normal;font-weight:normal;">%</span></div> <div style="text-align:left;text-align-last:auto;"></div> </td> <td style="width:5%; " valign="top"><span style="line-height:11px;"> </span><div style="text-align:left;text-align-last:auto;"></div> </td> </tr> </table> </div> <div style="text-align:left;text-align-last:auto;"></div> 2161544746 50 10611345 0.34       TOP INDUSTRIES (% of Fund's net assets) Aerospace & Defense 30.9   Machinery 24.3   Electrical Equipment 13.6   Building Products 8.8   Ground Transportation 5.6   Construction & Engineering 5.0   Commercial Services & Supplies 3.2   Trading Companies & Distributors 3.0   Industrial Conglomerates 1.8   Others 2.5       Common Stocks 98.7 Short-Term Investments and Net Other Assets (Liabilities) 1.3 ASSET ALLOCATION (% of Fund's net assets)     Common Stocks - 98.7                       Short-Term Investments and Net Other Assets (Liabilities) - 1.3   United States 100.0 GEOGRAPHIC DIVERSIFICATION (% of Fund's net assets)     United States - 100.0                          0.309 0.243 0.136 0.088 0.056 0.050 0.032 0.030 0.018 0.025 0.987 0.013 1.000 TOP HOLDINGS(% of Fund's net assets)     GE Aerospace 8.1   GE Vernova Inc 6.3   Boeing Co 6.2   Trane Technologies PLC 4.6   Howmet Aerospace Inc 4.5   Parker-Hannifin Corp 4.4   Eaton Corp PLC 3.5   RTX Corp 3.5   PACCAR Inc 2.9   Quanta Services Inc 2.9     46.9   0.081 0.063 0.062 0.046 0.045 0.044 0.035 0.035 0.029 0.029 <div style="text-align:left;text-align-last:auto;"><span style="font-family:'Fidelity Sans';font-size:16px;color:#368627;font-style:normal;font-weight:bold;">How has the Fund changed?</span></div> <div style="text-align:left;text-align-last:auto;"><span style="font-family:'Fidelity Sans';font-size:11px;color:#000000;font-style:normal;font-weight:normal;"> </span></div> <div style="text-align:left;text-align-last:auto;"><span style="font-family:'Fidelity Sans';font-size:11px;color:#000000;font-style:normal;font-weight:normal;">This is a summary of certain changes to the Fund since August 1, 2025. For more complete information, you may review the Fund's next prospectus, which we expect to be available by September 29, 2026 at </span><span style="font-family:'Fidelity Sans';font-size:11px;color:#000000;font-style:normal;font-weight:bold;">fundresearch.fidelity.com/prospectus/sec</span><span style="font-family:'Fidelity Sans';font-size:11px;color:#000000;font-style:normal;font-weight:normal;"> or upon request at </span><span style="font-family:'Fidelity Sans';font-size:11px;color:#000000;font-style:normal;font-weight:normal;">1-877-208-0098</span><span style="font-family:'Fidelity Sans';font-size:0px;color:#000000;font-style:normal;font-weight:normal;"> </span><span style="font-family:'Fidelity Sans';font-size:11px;color:#000000;font-style:normal;font-weight:normal;"> or by sending an e-mail to </span><span style="font-family:'Fidelity Sans';font-size:11px;color:#000000;font-style:normal;font-weight:normal;">fidfunddocuments@fidelity.com</span><span style="font-family:'Fidelity Sans';font-size:11px;color:#000000;font-style:normal;font-weight:normal;">.</span></div> <div style="text-align:left;text-align-last:auto;"></div> <span style="line-height:11px;"> </span><div style="text-align:left;text-align-last:auto;"></div> <div style="text-align:left;text-align-last:auto;"><table cellpadding="0" cellspacing="0" style="border-collapse:collapse;border-style:none;" width="100%"><tr><td style="width:50%; background-color:#ebf3e9;border-right:2px dashed #368627;padding:19px 19px 19px 19px;" valign="top"><div style="text-align:left;text-align-last:auto;"><span style="font-family:'Fidelity Sans';font-size:11px;color:#000000;font-style:normal;font-weight:normal;">Industrials Portfolio merged into Fidelity Advisor® Industrials Fund on October 17, 2025.</span></div> <div style="text-align:left;text-align-last:auto;"></div> </td> <td style="width:50%; background-color:#ebf3e9;padding:19px 19px 19px 19px;" valign="top"><div style="text-align:left;text-align-last:auto;"></div> </td> </tr> </table> </div> <div style="text-align:left;text-align-last:auto;"></div> <span style="font-family:'Fidelity Sans';font-size:11px;color:#000000;font-style:normal;font-weight:normal;">This is a summary of certain changes to the Fund since August 1, 2025. For more complete information, you may review the Fund's next prospectus, which we expect to be available by September 29, 2026 at </span><span style="font-family:'Fidelity Sans';font-size:11px;color:#000000;font-style:normal;font-weight:bold;">fundresearch.fidelity.com/prospectus/sec</span><span style="font-family:'Fidelity Sans';font-size:11px;color:#000000;font-style:normal;font-weight:normal;"> or upon request at </span><span style="font-family:'Fidelity Sans';font-size:11px;color:#000000;font-style:normal;font-weight:normal;">1-877-208-0098</span><span style="font-family:'Fidelity Sans';font-size:0px;color:#000000;font-style:normal;font-weight:normal;"> </span><span style="font-family:'Fidelity Sans';font-size:11px;color:#000000;font-style:normal;font-weight:normal;"> or by sending an e-mail to </span><span style="font-family:'Fidelity Sans';font-size:11px;color:#000000;font-style:normal;font-weight:normal;">fidfunddocuments@fidelity.com</span><span style="font-family:'Fidelity Sans';font-size:11px;color:#000000;font-style:normal;font-weight:normal;">.</span> <span style="font-family:'Fidelity Sans';font-size:11px;color:#000000;font-style:normal;font-weight:bold;">fundresearch.fidelity.com/prospectus/sec</span> <span style="font-family:'Fidelity Sans';font-size:11px;color:#000000;font-style:normal;font-weight:normal;">1-877-208-0098</span> <span style="font-family:'Fidelity Sans';font-size:11px;color:#000000;font-style:normal;font-weight:normal;">fidfunddocuments@fidelity.com</span> 2026-07-31 This report describes changes to the Fund that occurred during the reporting period. Fidelity Advisor® Industrials Fund Fidelity Advisor® Industrials Fund Class I FCLIX This annual shareholder report contains information about Fidelity Advisor® Industrials Fund for the period August 1, 2025 to July 31, 2026. annual shareholder report You can find additional information about the Fund at fundresearch.fidelity.com/prospectus/sec. You can also request this information by contacting us at 1-877-208-0098 or by sending an e-mail to fidfunddocuments@fidelity.com. fundresearch.fidelity.com/prospectus/sec 1-877-208-0098 fidfunddocuments@fidelity.com <span style="font-family:'Fidelity Sans';font-size:16px;color:#368627;font-style:normal;font-weight:bold;">What were your Fund costs for the last year?</span> <div style="text-align:left;text-align-last:auto;"><span style="font-family:'Fidelity Sans';font-size:11px;color:#000000;font-style:normal;font-weight:normal;">(based on hypothetical $10,000 investment)</span></div> <div><span style="font-size:11px;"> </span></div><div style="text-align:left;text-align-last:auto;"></div> <div style="text-align:left;text-align-last:auto;"><span style="font-family:'Fidelity Sans';font-size:12px;color:#000000;font-style:normal;font-weight:bold;">FUND COST (PREVIOUS YEAR)</span></div> <div style="text-align:left;text-align-last:auto;"></div> <div style="text-align:left;text-align-last:auto;"><table cellpadding="0" cellspacing="0" style="border-collapse:collapse;border-style:none;" width="100%"><tr><td style="width:51%; background-color:#dfe0e4;border:1px solid #dfe0e4;padding:0px 0px 0px 0px;" valign="bottom"><div style="text-align:left;text-align-last:auto;"><span style="font-family:'Fidelity Sans';font-size:11px;color:#000000;font-style:normal;font-weight:bold;"> </span></div> </td> <td style="width:21%; background-color:#dfe0e4;border:1px solid #dfe0e4;padding:0px 0px 0px 0px;" valign="bottom"><div style="text-align:center;text-align-last:auto;"><span style="font-family:'Fidelity Sans';font-size:11px;color:#000000;font-style:normal;font-weight:bold;">Costs of a $10,000 investment</span></div> </td> <td style="width:27%; background-color:#dfe0e4;border:1px solid #dfe0e4;padding:0px 0px 0px 0px;" valign="bottom"><div style="text-align:center;text-align-last:auto;"><span style="font-family:'Fidelity Sans';font-size:11px;color:#000000;font-style:normal;font-weight:bold;">Costs paid as a percentage of a $10,000 investment </span></div> </td> <td style="width:1%; " valign="top"><span style="line-height:12px;"> </span><div style="text-align:left;text-align-last:auto;"></div> </td> </tr> <tr><td style="width:51%; border-bottom:1px solid #000000;padding:0px 0px 0px 0px;" valign="top"><div style="text-align:left;text-align-last:auto;"><span style="font-family:'Fidelity Sans';font-size:12px;color:#000000;font-style:normal;font-weight:normal;">Class I</span><span style="font-family:'Fidelity Sans';font-size:11px;color:#000000;font-style:normal;font-weight:normal;"> </span></div> </td> <td style="width:21%; border-bottom:1px solid #000000;padding:0px 0px 0px 0px;" valign="middle"><div style="text-align:center;text-align-last:auto;"><span style="font-family:'Fidelity Sans';font-size:11px;color:#000000;font-style:normal;font-weight:normal;">$</span><span style="font-family:'Fidelity Sans';font-size:12px;color:#000000;font-style:normal;font-weight:normal;"> </span>77<span style="font-family:'Fidelity Sans';font-size:11px;color:#000000;font-style:normal;font-weight:normal;"> </span></div> </td> <td style="width:27%; border-bottom:1px solid #000000;padding:0px 0px 0px 0px;" valign="middle"><div style="text-align:center;text-align-last:auto;">0.69<span style="font-family:'Fidelity Sans';font-size:11px;color:#000000;font-style:normal;font-weight:normal;">%</span></div> </td> <td style="width:1%; " valign="top"><span style="line-height:12px;"> </span><div style="text-align:left;text-align-last:auto;"></div> </td> </tr> </table> </div> <div style="text-align:left;text-align-last:auto;"></div> 77 0.0069 <span style="font-family:'Fidelity Sans';font-size:16px;color:#368627;font-style:normal;font-weight:bold;">What affected the Fund's performance this period?</span> <div style="text-align:left;text-align-last:auto;"><span style="font-family:'Fidelity Sans';font-size:11px;color:#000000;font-style:normal;font-weight:bold;"> </span></div> <div style="text-align:left;text-align-last:auto;text-indent:-24px;margin-bottom:2px;margin-left:24px;margin-top:5px;margin-right:0px;"><span style="font-family:'Fidelity Sans';font-size:12px;color:#000000;font-style:normal;font-weight:normal;">•<span style="padding-right:10px"></span>U.S. stocks achieved a strong gain for the 12 months ending July 31, 2026, reflecting enthusiasm for artificial intelligence, strong corporate fundamentals, a resilient economy and, beginning in September, the Federal Reserve's first interest-rate reductions since December 2024.</span></div> <div style="text-align:left;text-align-last:auto;text-indent:-24px;margin-bottom:2px;margin-left:24px;margin-top:5px;margin-right:0px;"><span style="font-family:'Fidelity Sans';font-size:12px;color:#000000;font-style:normal;font-weight:normal;">•<span style="padding-right:10px"></span>Against this backdrop, market selection was the primary contributor to the fund's performance versus the MSCI US IMI Industrials 25/50 Linked Index for the fiscal year, especially an underweight in human resource &amp; employment services. Picks in construction &amp; engineering also boosted the fund's relative performance. Also helping our relative result was an overweight in heavy electrical equipment.</span></div> <div style="text-align:left;text-align-last:auto;text-indent:-24px;margin-bottom:2px;margin-left:24px;margin-top:5px;margin-right:0px;"><span style="font-family:'Fidelity Sans';font-size:12px;color:#000000;font-style:normal;font-weight:normal;">•<span style="padding-right:10px"></span>The top individual relative contributor was an overweight in Howmet Aerospace (+60%). The company was one of our biggest holdings. A second notable relative contributor was an overweight in Cummins (+74%). This was a position we established this period. The company was one of the fund's biggest holdings this period. An overweight in GE Vernova (+49%) also helped. The stock was one of the fund's biggest holdings.</span></div> <div style="text-align:left;text-align-last:auto;text-indent:-24px;margin-bottom:2px;margin-left:24px;margin-top:5px;margin-right:0px;"><span style="font-family:'Fidelity Sans';font-size:12px;color:#000000;font-style:normal;font-weight:normal;">•<span style="padding-right:10px"></span>In contrast, the biggest detractor from performance versus the sector index was security selection in aerospace &amp; defense. Also hurting our result was stock picking in electrical components &amp; equipment and heavy electrical equipment.</span></div> <div style="text-align:left;text-align-last:auto;text-indent:-24px;margin-bottom:2px;margin-left:24px;margin-top:5px;margin-right:0px;"><span style="font-family:'Fidelity Sans';font-size:12px;color:#000000;font-style:normal;font-weight:normal;">•<span style="padding-right:10px"></span>The biggest individual relative detractor was an underweight in Caterpillar (+88%). This period we increased our stake in Caterpillar. A second notable relative detractor was an overweight in Boeing (-2%). This period we increased our stake in Boeing. The company was among our largest holdings. An overweight in Ingersoll Rand (-2%) also detracted. This period we increased our stake in Ingersoll Rand. The stock was one of the fund's biggest holdings this period.</span></div> <div style="text-align:left;text-align-last:auto;text-indent:-24px;margin-bottom:2px;margin-left:24px;margin-top:5px;margin-right:0px;"><span style="font-family:'Fidelity Sans';font-size:12px;color:#000000;font-style:normal;font-weight:normal;">•<span style="padding-right:10px"></span>Notable changes in positioning include increased exposure to the construction machinery &amp; heavy transportation equipment and construction &amp; engineering industries.</span></div> <div style="text-align:left;text-align-last:auto;"></div> How did the Fund perform over the past 10 years?    CUMULATIVE PERFORMANCE July 31, 2016 through July 31, 2026. Initial investment of $10,000. Class I $10,000 $11,291 $13,132 $13,436 $12,588 $17,116 $15,824 $18,834 $23,912 $30,142 $36,665 MSCI U.S. IMI Industrials 25-50 Index $10,000 $11,882 $13,626 $14,063 $13,248 $19,538 $18,129 $21,639 $25,709 $30,439 $36,542 S&P 500® Index $10,000 $11,604 $13,489 $14,566 $16,308 $22,251 $21,219 $23,980 $29,292 $34,076 $40,742   2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026   <span style="font-family:'Fidelity Sans';font-size:9px;color:#000000;font-style:normal;font-weight:normal;">Class I</span> 10000 11291 13132 13436 12588 17116 15824 18834 23912 30142 36665 <span style="font-family:'Fidelity Sans';font-size:9px;color:#000000;font-style:normal;font-weight:normal;">MSCI U.S. IMI Industrials 25-50 Index</span> 10000 11882 13626 14063 13248 19538 18129 21639 25709 30439 36542 <span style="font-family:'Fidelity Sans';font-size:9px;color:#000000;font-style:normal;font-weight:normal;">S&amp;P 500® Index</span> 10000 11604 13489 14566 16308 22251 21219 23980 29292 34076 40742 AVERAGE ANNUAL TOTAL RETURNS:   1 Year 5 Year 10 Year Class I 21.64% 16.46% 13.87% MSCI U.S. IMI Industrials 25-50 Index 20.05% 13.34% 13.84% S&P 500® Index 19.56% 12.86% 15.08%     Visit institutional.fidelity.com for more recent performance information.    The Fund's past performance is not a good predictor of the Fund's future performance.  The graph and table do not reflect the deduction of taxes that a shareholder would pay on fund distributions or redemption of fund shares. 0.2164 0.1646 0.1387 0.2005 0.1334 0.1384 0.1956 0.1286 0.1508 <span style="font-family:'Fidelity Sans';font-size:11px;color:#000000;font-style:normal;font-weight:normal;">Visit </span><span style="font-family:'Fidelity Sans';font-size:11px;color:#000000;font-style:normal;font-weight:bold;">institutional.fidelity.com</span><span style="font-family:'Fidelity Sans';font-size:11px;color:#000000;font-style:normal;font-weight:normal;"> for more recent performance information.</span> <span style="font-family:'Fidelity Sans';font-size:11px;color:#000000;font-style:italic;font-weight:normal;">The Fund's past performance is not a good predictor of the Fund's future performance.</span> <span style="font-family:'Fidelity Sans';font-size:11px;color:#000000;font-style:normal;font-weight:normal;">The graph and table do not reflect the deduction of taxes that a shareholder would pay on fund distributions or redemption of fund shares.</span> <span style="font-family:'Fidelity Sans';font-size:16px;color:#368627;font-style:normal;font-weight:bold;">Key Fund Statistics</span> <div style="text-align:left;text-align-last:auto;"></div> <div style="text-align:left;text-align-last:auto;"><span style="font-family:'Fidelity Sans';font-size:11px;color:#000000;font-style:normal;font-weight:normal;">(as of July 31, 2026)</span></div> <div><span style="font-size:11px;"> </span></div><div style="text-align:left;text-align-last:auto;"></div> <div style="text-align:right;text-align-last:auto;"><table cellpadding="0" cellspacing="1" style="border-collapse:separate;border-style:none;margin:auto;" width="100%"><tr><td style="width:63%; " valign="top"><div style="text-align:left;text-align-last:auto;"><span style="font-family:'Fidelity Sans';font-size:12px;color:#000000;font-style:normal;font-weight:bold;">KEY FACTS</span></div> <div style="text-align:left;text-align-last:auto;"></div> <div style="text-align:left;text-align-last:auto;"><span style="font-family:'Fidelity Sans';font-size:11px;color:#000000;font-style:normal;font-weight:bold;"> <span> </span></span></div> <div style="text-align:left;text-align-last:auto;"></div> </td> <td style="width:32%; " valign="top"><span style="line-height:12px;"> </span><div style="text-align:left;text-align-last:auto;"></div> </td> <td style="width:5%; " valign="top"><span style="line-height:12px;"> </span><div style="text-align:left;text-align-last:auto;"></div> </td> </tr> <tr><td style="width:63%; border-bottom:1px dashed #000000;padding:0px 0px 0px 0px;" valign="middle"><div style="text-align:left;text-align-last:auto;"><span style="font-family:'Fidelity Sans';font-size:11px;color:#000000;font-style:normal;font-weight:normal;">Fund Size</span></div> </td> <td style="width:32%; border-bottom:1px dashed #000000;padding:0px 0px 0px 0px;" valign="middle"><div style="text-align:right;text-align-last:auto;"><span style="font-family:'Fidelity Sans';font-size:11px;color:#000000;font-style:normal;font-weight:normal;">$</span>2,161,544,746</div> <div style="text-align:right;text-align-last:auto;"></div> </td> <td style="width:5%; " valign="top"><span style="line-height:11px;"> </span><div style="text-align:left;text-align-last:auto;"></div> </td> </tr> <tr><td style="width:63%; border-bottom:1px dashed #000000;padding:0px 0px 0px 0px;" valign="middle"><div style="text-align:left;text-align-last:auto;"><span style="font-family:'Fidelity Sans';font-size:11px;color:#000000;font-style:normal;font-weight:normal;">Number of Holdings</span></div> </td> <td style="width:32%; border-bottom:1px dashed #000000;padding:0px 0px 0px 0px;" valign="middle"><div style="text-align:right;text-align-last:auto;">50</div> <div style="text-align:right;text-align-last:auto;"></div> </td> <td style="width:5%; " valign="top"><span style="line-height:11px;"> </span><div style="text-align:left;text-align-last:auto;"></div> </td> </tr> <tr><td style="width:63%; border-bottom:1px dashed #000000;padding:0px 0px 0px 0px;" valign="middle"><div style="text-align:left;text-align-last:auto;"><span style="font-family:'Fidelity Sans';font-size:11px;color:#000000;font-style:normal;font-weight:normal;">Total Advisory Fee</span></div> </td> <td style="width:32%; border-bottom:1px dashed #000000;padding:0px 0px 0px 0px;" valign="middle"><div style="text-align:right;text-align-last:auto;"><span style="font-family:'Fidelity Sans';font-size:11px;color:#000000;font-style:normal;font-weight:normal;">$</span>10,611,345</div> <div style="text-align:right;text-align-last:auto;"></div> </td> <td style="width:5%; " valign="middle"><span style="line-height:11px;"> </span><div style="text-align:left;text-align-last:auto;"></div> </td> </tr> <tr><td style="width:63%; border-bottom:1px dashed #000000;padding:0px 0px 0px 0px;" valign="middle"><div style="text-align:left;text-align-last:auto;"><span style="font-family:'Fidelity Sans';font-size:11px;color:#000000;font-style:normal;font-weight:normal;">Portfolio Turnover</span></div> </td> <td style="width:32%; border-bottom:1px dashed #000000;padding:0px 0px 0px 0px;" valign="middle"><div style="text-align:right;text-align-last:auto;">34<span style="font-family:'Fidelity Sans';font-size:11px;color:#000000;font-style:normal;font-weight:normal;">%</span></div> <div style="text-align:left;text-align-last:auto;"></div> </td> <td style="width:5%; " valign="top"><span style="line-height:11px;"> </span><div style="text-align:left;text-align-last:auto;"></div> </td> </tr> </table> </div> <div style="text-align:left;text-align-last:auto;"></div> 2161544746 50 10611345 0.34       TOP INDUSTRIES (% of Fund's net assets) Aerospace & Defense 30.9   Machinery 24.3   Electrical Equipment 13.6   Building Products 8.8   Ground Transportation 5.6   Construction & Engineering 5.0   Commercial Services & Supplies 3.2   Trading Companies & Distributors 3.0   Industrial Conglomerates 1.8   Others 2.5       Common Stocks 98.7 Short-Term Investments and Net Other Assets (Liabilities) 1.3 ASSET ALLOCATION (% of Fund's net assets)     Common Stocks - 98.7                       Short-Term Investments and Net Other Assets (Liabilities) - 1.3   United States 100.0 GEOGRAPHIC DIVERSIFICATION (% of Fund's net assets)     United States - 100.0                          0.309 0.243 0.136 0.088 0.056 0.050 0.032 0.030 0.018 0.025 0.987 0.013 1.000 TOP HOLDINGS(% of Fund's net assets)     GE Aerospace 8.1   GE Vernova Inc 6.3   Boeing Co 6.2   Trane Technologies PLC 4.6   Howmet Aerospace Inc 4.5   Parker-Hannifin Corp 4.4   Eaton Corp PLC 3.5   RTX Corp 3.5   PACCAR Inc 2.9   Quanta Services Inc 2.9     46.9   0.081 0.063 0.062 0.046 0.045 0.044 0.035 0.035 0.029 0.029 <div style="text-align:left;text-align-last:auto;"><span style="font-family:'Fidelity Sans';font-size:16px;color:#368627;font-style:normal;font-weight:bold;">How has the Fund changed?</span></div> <div style="text-align:left;text-align-last:auto;"><span style="font-family:'Fidelity Sans';font-size:11px;color:#000000;font-style:normal;font-weight:normal;"> </span></div> <div style="text-align:left;text-align-last:auto;"><span style="font-family:'Fidelity Sans';font-size:11px;color:#000000;font-style:normal;font-weight:normal;">This is a summary of certain changes to the Fund since August 1, 2025. For more complete information, you may review the Fund's next prospectus, which we expect to be available by September 29, 2026 at </span><span style="font-family:'Fidelity Sans';font-size:11px;color:#000000;font-style:normal;font-weight:bold;">fundresearch.fidelity.com/prospectus/sec</span><span style="font-family:'Fidelity Sans';font-size:11px;color:#000000;font-style:normal;font-weight:normal;"> or upon request at </span><span style="font-family:'Fidelity Sans';font-size:11px;color:#000000;font-style:normal;font-weight:normal;">1-877-208-0098</span><span style="font-family:'Fidelity Sans';font-size:0px;color:#000000;font-style:normal;font-weight:normal;"> </span><span style="font-family:'Fidelity Sans';font-size:11px;color:#000000;font-style:normal;font-weight:normal;"> or by sending an e-mail to </span><span style="font-family:'Fidelity Sans';font-size:11px;color:#000000;font-style:normal;font-weight:normal;">fidfunddocuments@fidelity.com</span><span style="font-family:'Fidelity Sans';font-size:11px;color:#000000;font-style:normal;font-weight:normal;">.</span></div> <div style="text-align:left;text-align-last:auto;"></div> <span style="line-height:11px;"> </span><div style="text-align:left;text-align-last:auto;"></div> <div style="text-align:left;text-align-last:auto;"><table cellpadding="0" cellspacing="0" style="border-collapse:collapse;border-style:none;" width="100%"><tr><td style="width:50%; background-color:#ebf3e9;border-right:2px dashed #368627;padding:19px 19px 19px 19px;" valign="top"><div style="text-align:left;text-align-last:auto;"><span style="font-family:'Fidelity Sans';font-size:11px;color:#000000;font-style:normal;font-weight:normal;">Industrials Portfolio merged into Fidelity Advisor® Industrials Fund on October 17, 2025.</span></div> <div style="text-align:left;text-align-last:auto;"></div> </td> <td style="width:50%; background-color:#ebf3e9;padding:19px 19px 19px 19px;" valign="top"><div style="text-align:left;text-align-last:auto;"></div> </td> </tr> </table> </div> <div style="text-align:left;text-align-last:auto;"></div> <span style="font-family:'Fidelity Sans';font-size:11px;color:#000000;font-style:normal;font-weight:normal;">This is a summary of certain changes to the Fund since August 1, 2025. For more complete information, you may review the Fund's next prospectus, which we expect to be available by September 29, 2026 at </span><span style="font-family:'Fidelity Sans';font-size:11px;color:#000000;font-style:normal;font-weight:bold;">fundresearch.fidelity.com/prospectus/sec</span><span style="font-family:'Fidelity Sans';font-size:11px;color:#000000;font-style:normal;font-weight:normal;"> or upon request at </span><span style="font-family:'Fidelity Sans';font-size:11px;color:#000000;font-style:normal;font-weight:normal;">1-877-208-0098</span><span style="font-family:'Fidelity Sans';font-size:0px;color:#000000;font-style:normal;font-weight:normal;"> </span><span style="font-family:'Fidelity Sans';font-size:11px;color:#000000;font-style:normal;font-weight:normal;"> or by sending an e-mail to </span><span style="font-family:'Fidelity Sans';font-size:11px;color:#000000;font-style:normal;font-weight:normal;">fidfunddocuments@fidelity.com</span><span style="font-family:'Fidelity Sans';font-size:11px;color:#000000;font-style:normal;font-weight:normal;">.</span> <span style="font-family:'Fidelity Sans';font-size:11px;color:#000000;font-style:normal;font-weight:bold;">fundresearch.fidelity.com/prospectus/sec</span> <span style="font-family:'Fidelity Sans';font-size:11px;color:#000000;font-style:normal;font-weight:normal;">1-877-208-0098</span> <span style="font-family:'Fidelity Sans';font-size:11px;color:#000000;font-style:normal;font-weight:normal;">fidfunddocuments@fidelity.com</span> 2026-07-31 This report describes changes to the Fund that occurred during the reporting period. Fidelity Advisor® Industrials Fund Fidelity Advisor® Industrials Fund Class C FCLCX This annual shareholder report contains information about Fidelity Advisor® Industrials Fund for the period August 1, 2025 to July 31, 2026. annual shareholder report You can find additional information about the Fund at fundresearch.fidelity.com/prospectus/sec. You can also request this information by contacting us at 1-877-208-0098 or by sending an e-mail to fidfunddocuments@fidelity.com. fundresearch.fidelity.com/prospectus/sec 1-877-208-0098 fidfunddocuments@fidelity.com <span style="font-family:'Fidelity Sans';font-size:16px;color:#368627;font-style:normal;font-weight:bold;">What were your Fund costs for the last year?</span> <div style="text-align:left;text-align-last:auto;"><span style="font-family:'Fidelity Sans';font-size:11px;color:#000000;font-style:normal;font-weight:normal;">(based on hypothetical $10,000 investment)</span></div> <div><span style="font-size:11px;"> </span></div><div style="text-align:left;text-align-last:auto;"></div> <div style="text-align:left;text-align-last:auto;"><span style="font-family:'Fidelity Sans';font-size:12px;color:#000000;font-style:normal;font-weight:bold;">FUND COST (PREVIOUS YEAR)</span></div> <div style="text-align:left;text-align-last:auto;"></div> <div style="text-align:left;text-align-last:auto;"><table cellpadding="0" cellspacing="0" style="border-collapse:collapse;border-style:none;" width="100%"><tr><td style="width:51%; background-color:#dfe0e4;border:1px solid #dfe0e4;padding:0px 0px 0px 0px;" valign="bottom"><div style="text-align:left;text-align-last:auto;"><span style="font-family:'Fidelity Sans';font-size:11px;color:#000000;font-style:normal;font-weight:bold;"> </span></div> </td> <td style="width:21%; background-color:#dfe0e4;border:1px solid #dfe0e4;padding:0px 0px 0px 0px;" valign="bottom"><div style="text-align:center;text-align-last:auto;"><span style="font-family:'Fidelity Sans';font-size:11px;color:#000000;font-style:normal;font-weight:bold;">Costs of a $10,000 investment</span></div> </td> <td style="width:27%; background-color:#dfe0e4;border:1px solid #dfe0e4;padding:0px 0px 0px 0px;" valign="bottom"><div style="text-align:center;text-align-last:auto;"><span style="font-family:'Fidelity Sans';font-size:11px;color:#000000;font-style:normal;font-weight:bold;">Costs paid as a percentage of a $10,000 investment </span></div> </td> <td style="width:1%; " valign="top"><span style="line-height:12px;"> </span><div style="text-align:left;text-align-last:auto;"></div> </td> </tr> <tr><td style="width:51%; border-bottom:1px solid #000000;padding:0px 0px 0px 0px;" valign="top"><div style="text-align:left;text-align-last:auto;"><span style="font-family:'Fidelity Sans';font-size:12px;color:#000000;font-style:normal;font-weight:normal;">Class C</span><span style="font-family:'Fidelity Sans';font-size:11px;color:#000000;font-style:normal;font-weight:normal;"> </span></div> </td> <td style="width:21%; border-bottom:1px solid #000000;padding:0px 0px 0px 0px;" valign="middle"><div style="text-align:center;text-align-last:auto;"><span style="font-family:'Fidelity Sans';font-size:11px;color:#000000;font-style:normal;font-weight:normal;">$</span><span style="font-family:'Fidelity Sans';font-size:12px;color:#000000;font-style:normal;font-weight:normal;"> </span>187<span style="font-family:'Fidelity Sans';font-size:11px;color:#000000;font-style:normal;font-weight:normal;"> </span></div> </td> <td style="width:27%; border-bottom:1px solid #000000;padding:0px 0px 0px 0px;" valign="middle"><div style="text-align:center;text-align-last:auto;">1.70<span style="font-family:'Fidelity Sans';font-size:11px;color:#000000;font-style:normal;font-weight:normal;">%</span></div> </td> <td style="width:1%; " valign="top"><span style="line-height:12px;"> </span><div style="text-align:left;text-align-last:auto;"></div> </td> </tr> </table> </div> <div style="text-align:left;text-align-last:auto;"></div> 187 0.0170 <span style="font-family:'Fidelity Sans';font-size:16px;color:#368627;font-style:normal;font-weight:bold;">What affected the Fund's performance this period?</span> <div style="text-align:left;text-align-last:auto;"><span style="font-family:'Fidelity Sans';font-size:11px;color:#000000;font-style:normal;font-weight:bold;"> </span></div> <div style="text-align:left;text-align-last:auto;text-indent:-24px;margin-bottom:2px;margin-left:24px;margin-top:5px;margin-right:0px;"><span style="font-family:'Fidelity Sans';font-size:12px;color:#000000;font-style:normal;font-weight:normal;">•<span style="padding-right:10px"></span>U.S. stocks achieved a strong gain for the 12 months ending July 31, 2026, reflecting enthusiasm for artificial intelligence, strong corporate fundamentals, a resilient economy and, beginning in September, the Federal Reserve's first interest-rate reductions since December 2024.</span></div> <div style="text-align:left;text-align-last:auto;text-indent:-24px;margin-bottom:2px;margin-left:24px;margin-top:5px;margin-right:0px;"><span style="font-family:'Fidelity Sans';font-size:12px;color:#000000;font-style:normal;font-weight:normal;">•<span style="padding-right:10px"></span>Against this backdrop, market selection was the primary contributor to the fund's performance versus the MSCI US IMI Industrials 25/50 Linked Index for the fiscal year, especially an underweight in human resource &amp; employment services. Picks in construction &amp; engineering also boosted the fund's relative performance. Also helping our relative result was an overweight in heavy electrical equipment.</span></div> <div style="text-align:left;text-align-last:auto;text-indent:-24px;margin-bottom:2px;margin-left:24px;margin-top:5px;margin-right:0px;"><span style="font-family:'Fidelity Sans';font-size:12px;color:#000000;font-style:normal;font-weight:normal;">•<span style="padding-right:10px"></span>The top individual relative contributor was an overweight in Howmet Aerospace (+60%). The company was one of our biggest holdings. A second notable relative contributor was an overweight in Cummins (+74%). This was a position we established this period. The company was one of the fund's biggest holdings this period. An overweight in GE Vernova (+49%) also helped. The stock was one of the fund's biggest holdings.</span></div> <div style="text-align:left;text-align-last:auto;text-indent:-24px;margin-bottom:2px;margin-left:24px;margin-top:5px;margin-right:0px;"><span style="font-family:'Fidelity Sans';font-size:12px;color:#000000;font-style:normal;font-weight:normal;">•<span style="padding-right:10px"></span>In contrast, the biggest detractor from performance versus the sector index was security selection in aerospace &amp; defense. Also hurting our result was stock picking in electrical components &amp; equipment and heavy electrical equipment.</span></div> <div style="text-align:left;text-align-last:auto;text-indent:-24px;margin-bottom:2px;margin-left:24px;margin-top:5px;margin-right:0px;"><span style="font-family:'Fidelity Sans';font-size:12px;color:#000000;font-style:normal;font-weight:normal;">•<span style="padding-right:10px"></span>The biggest individual relative detractor was an underweight in Caterpillar (+88%). This period we increased our stake in Caterpillar. A second notable relative detractor was an overweight in Boeing (-2%). This period we increased our stake in Boeing. The company was among our largest holdings. An overweight in Ingersoll Rand (-2%) also detracted. This period we increased our stake in Ingersoll Rand. The stock was one of the fund's biggest holdings this period.</span></div> <div style="text-align:left;text-align-last:auto;text-indent:-24px;margin-bottom:2px;margin-left:24px;margin-top:5px;margin-right:0px;"><span style="font-family:'Fidelity Sans';font-size:12px;color:#000000;font-style:normal;font-weight:normal;">•<span style="padding-right:10px"></span>Notable changes in positioning include increased exposure to the construction machinery &amp; heavy transportation equipment and construction &amp; engineering industries.</span></div> <div style="text-align:left;text-align-last:auto;"></div> How did the Fund perform over the past 10 years?    CUMULATIVE PERFORMANCE July 31, 2016 through July 31, 2026. Initial investment of $10,000. Class C $10,000 $11,176 $12,866 $13,030 $12,083 $16,261 $14,882 $17,532 $22,035 $27,697 $33,611 MSCI U.S. IMI Industrials 25-50 Index $10,000 $11,882 $13,626 $14,063 $13,248 $19,538 $18,129 $21,639 $25,709 $30,439 $36,542 S&P 500® Index $10,000 $11,604 $13,489 $14,566 $16,308 $22,251 $21,219 $23,980 $29,292 $34,076 $40,742   2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026   <span style="font-family:'Fidelity Sans';font-size:9px;color:#000000;font-style:normal;font-weight:normal;">Class C</span> 10000 11176 12866 13030 12083 16261 14882 17532 22035 27697 33611 <span style="font-family:'Fidelity Sans';font-size:9px;color:#000000;font-style:normal;font-weight:normal;">MSCI U.S. IMI Industrials 25-50 Index</span> 10000 11882 13626 14063 13248 19538 18129 21639 25709 30439 36542 <span style="font-family:'Fidelity Sans';font-size:9px;color:#000000;font-style:normal;font-weight:normal;">S&amp;P 500® Index</span> 10000 11604 13489 14566 16308 22251 21219 23980 29292 34076 40742 AVERAGE ANNUAL TOTAL RETURNS:   1 Year 5 Year 10 Year Class C  (incl. contingent deferred sales charge) 19.44% 15.28% 12.89% Class C 20.44% 15.28% 12.89% MSCI U.S. IMI Industrials 25-50 Index 20.05% 13.34% 13.84% S&P 500® Index 19.56% 12.86% 15.08%     Visit institutional.fidelity.com for more recent performance information.    The Fund's past performance is not a good predictor of the Fund's future performance.  The graph and table do not reflect the deduction of taxes that a shareholder would pay on fund distributions or redemption of fund shares. 0.1944 0.1528 0.1289 0.2044 0.1528 0.1289 0.2005 0.1334 0.1384 0.1956 0.1286 0.1508 <span style="font-family:'Fidelity Sans';font-size:11px;color:#000000;font-style:normal;font-weight:normal;">Visit </span><span style="font-family:'Fidelity Sans';font-size:11px;color:#000000;font-style:normal;font-weight:bold;">institutional.fidelity.com</span><span style="font-family:'Fidelity Sans';font-size:11px;color:#000000;font-style:normal;font-weight:normal;"> for more recent performance information.</span> <span style="font-family:'Fidelity Sans';font-size:11px;color:#000000;font-style:italic;font-weight:normal;">The Fund's past performance is not a good predictor of the Fund's future performance.</span> <span style="font-family:'Fidelity Sans';font-size:11px;color:#000000;font-style:normal;font-weight:normal;">The graph and table do not reflect the deduction of taxes that a shareholder would pay on fund distributions or redemption of fund shares.</span> <span style="font-family:'Fidelity Sans';font-size:16px;color:#368627;font-style:normal;font-weight:bold;">Key Fund Statistics</span> <div style="text-align:left;text-align-last:auto;"></div> <div style="text-align:left;text-align-last:auto;"><span style="font-family:'Fidelity Sans';font-size:11px;color:#000000;font-style:normal;font-weight:normal;">(as of July 31, 2026)</span></div> <div><span style="font-size:11px;"> </span></div><div style="text-align:left;text-align-last:auto;"></div> <div style="text-align:right;text-align-last:auto;"><table cellpadding="0" cellspacing="1" style="border-collapse:separate;border-style:none;margin:auto;" width="100%"><tr><td style="width:63%; " valign="top"><div style="text-align:left;text-align-last:auto;"><span style="font-family:'Fidelity Sans';font-size:12px;color:#000000;font-style:normal;font-weight:bold;">KEY FACTS</span></div> <div style="text-align:left;text-align-last:auto;"></div> <div style="text-align:left;text-align-last:auto;"><span style="font-family:'Fidelity Sans';font-size:11px;color:#000000;font-style:normal;font-weight:bold;"> <span> </span></span></div> <div style="text-align:left;text-align-last:auto;"></div> </td> <td style="width:32%; " valign="top"><span style="line-height:12px;"> </span><div style="text-align:left;text-align-last:auto;"></div> </td> <td style="width:5%; " valign="top"><span style="line-height:12px;"> </span><div style="text-align:left;text-align-last:auto;"></div> </td> </tr> <tr><td style="width:63%; border-bottom:1px dashed #000000;padding:0px 0px 0px 0px;" valign="middle"><div style="text-align:left;text-align-last:auto;"><span style="font-family:'Fidelity Sans';font-size:11px;color:#000000;font-style:normal;font-weight:normal;">Fund Size</span></div> </td> <td style="width:32%; border-bottom:1px dashed #000000;padding:0px 0px 0px 0px;" valign="middle"><div style="text-align:right;text-align-last:auto;"><span style="font-family:'Fidelity Sans';font-size:11px;color:#000000;font-style:normal;font-weight:normal;">$</span>2,161,544,746</div> <div style="text-align:right;text-align-last:auto;"></div> </td> <td style="width:5%; " valign="top"><span style="line-height:11px;"> </span><div style="text-align:left;text-align-last:auto;"></div> </td> </tr> <tr><td style="width:63%; border-bottom:1px dashed #000000;padding:0px 0px 0px 0px;" valign="middle"><div style="text-align:left;text-align-last:auto;"><span style="font-family:'Fidelity Sans';font-size:11px;color:#000000;font-style:normal;font-weight:normal;">Number of Holdings</span></div> </td> <td style="width:32%; border-bottom:1px dashed #000000;padding:0px 0px 0px 0px;" valign="middle"><div style="text-align:right;text-align-last:auto;">50</div> <div style="text-align:right;text-align-last:auto;"></div> </td> <td style="width:5%; " valign="top"><span style="line-height:11px;"> </span><div style="text-align:left;text-align-last:auto;"></div> </td> </tr> <tr><td style="width:63%; border-bottom:1px dashed #000000;padding:0px 0px 0px 0px;" valign="middle"><div style="text-align:left;text-align-last:auto;"><span style="font-family:'Fidelity Sans';font-size:11px;color:#000000;font-style:normal;font-weight:normal;">Total Advisory Fee</span></div> </td> <td style="width:32%; border-bottom:1px dashed #000000;padding:0px 0px 0px 0px;" valign="middle"><div style="text-align:right;text-align-last:auto;"><span style="font-family:'Fidelity Sans';font-size:11px;color:#000000;font-style:normal;font-weight:normal;">$</span>10,611,345</div> <div style="text-align:right;text-align-last:auto;"></div> </td> <td style="width:5%; " valign="middle"><span style="line-height:11px;"> </span><div style="text-align:left;text-align-last:auto;"></div> </td> </tr> <tr><td style="width:63%; border-bottom:1px dashed #000000;padding:0px 0px 0px 0px;" valign="middle"><div style="text-align:left;text-align-last:auto;"><span style="font-family:'Fidelity Sans';font-size:11px;color:#000000;font-style:normal;font-weight:normal;">Portfolio Turnover</span></div> </td> <td style="width:32%; border-bottom:1px dashed #000000;padding:0px 0px 0px 0px;" valign="middle"><div style="text-align:right;text-align-last:auto;">34<span style="font-family:'Fidelity Sans';font-size:11px;color:#000000;font-style:normal;font-weight:normal;">%</span></div> <div style="text-align:left;text-align-last:auto;"></div> </td> <td style="width:5%; " valign="top"><span style="line-height:11px;"> </span><div style="text-align:left;text-align-last:auto;"></div> </td> </tr> </table> </div> <div style="text-align:left;text-align-last:auto;"></div> 2161544746 50 10611345 0.34       TOP INDUSTRIES (% of Fund's net assets) Aerospace & Defense 30.9   Machinery 24.3   Electrical Equipment 13.6   Building Products 8.8   Ground Transportation 5.6   Construction & Engineering 5.0   Commercial Services & Supplies 3.2   Trading Companies & Distributors 3.0   Industrial Conglomerates 1.8   Others 2.5       Common Stocks 98.7 Short-Term Investments and Net Other Assets (Liabilities) 1.3 ASSET ALLOCATION (% of Fund's net assets)     Common Stocks - 98.7                       Short-Term Investments and Net Other Assets (Liabilities) - 1.3   United States 100.0 GEOGRAPHIC DIVERSIFICATION (% of Fund's net assets)     United States - 100.0                          0.309 0.243 0.136 0.088 0.056 0.050 0.032 0.030 0.018 0.025 0.987 0.013 1.000 TOP HOLDINGS(% of Fund's net assets)     GE Aerospace 8.1   GE Vernova Inc 6.3   Boeing Co 6.2   Trane Technologies PLC 4.6   Howmet Aerospace Inc 4.5   Parker-Hannifin Corp 4.4   Eaton Corp PLC 3.5   RTX Corp 3.5   PACCAR Inc 2.9   Quanta Services Inc 2.9     46.9   0.081 0.063 0.062 0.046 0.045 0.044 0.035 0.035 0.029 0.029 <div style="text-align:left;text-align-last:auto;"><span style="font-family:'Fidelity Sans';font-size:16px;color:#368627;font-style:normal;font-weight:bold;">How has the Fund changed?</span></div> <div style="text-align:left;text-align-last:auto;"><span style="font-family:'Fidelity Sans';font-size:11px;color:#000000;font-style:normal;font-weight:normal;"> </span></div> <div style="text-align:left;text-align-last:auto;"><span style="font-family:'Fidelity Sans';font-size:11px;color:#000000;font-style:normal;font-weight:normal;">This is a summary of certain changes to the Fund since August 1, 2025. For more complete information, you may review the Fund's next prospectus, which we expect to be available by September 29, 2026 at </span><span style="font-family:'Fidelity Sans';font-size:11px;color:#000000;font-style:normal;font-weight:bold;">fundresearch.fidelity.com/prospectus/sec</span><span style="font-family:'Fidelity Sans';font-size:11px;color:#000000;font-style:normal;font-weight:normal;"> or upon request at </span><span style="font-family:'Fidelity Sans';font-size:11px;color:#000000;font-style:normal;font-weight:normal;">1-877-208-0098</span><span style="font-family:'Fidelity Sans';font-size:0px;color:#000000;font-style:normal;font-weight:normal;"> </span><span style="font-family:'Fidelity Sans';font-size:11px;color:#000000;font-style:normal;font-weight:normal;"> or by sending an e-mail to </span><span style="font-family:'Fidelity Sans';font-size:11px;color:#000000;font-style:normal;font-weight:normal;">fidfunddocuments@fidelity.com</span><span style="font-family:'Fidelity Sans';font-size:11px;color:#000000;font-style:normal;font-weight:normal;">.</span></div> <div style="text-align:left;text-align-last:auto;"></div> <span style="line-height:11px;"> </span><div style="text-align:left;text-align-last:auto;"></div> <div style="text-align:left;text-align-last:auto;"><table cellpadding="0" cellspacing="0" style="border-collapse:collapse;border-style:none;" width="100%"><tr><td style="width:50%; background-color:#ebf3e9;border-right:2px dashed #368627;padding:19px 19px 19px 19px;" valign="top"><div style="text-align:left;text-align-last:auto;"><span style="font-family:'Fidelity Sans';font-size:11px;color:#000000;font-style:normal;font-weight:normal;">Industrials Portfolio merged into Fidelity Advisor® Industrials Fund on October 17, 2025.</span></div> <div style="text-align:left;text-align-last:auto;"></div> </td> <td style="width:50%; background-color:#ebf3e9;padding:19px 19px 19px 19px;" valign="top"><div style="text-align:left;text-align-last:auto;"></div> </td> </tr> </table> </div> <div style="text-align:left;text-align-last:auto;"></div> <span style="font-family:'Fidelity Sans';font-size:11px;color:#000000;font-style:normal;font-weight:normal;">This is a summary of certain changes to the Fund since August 1, 2025. For more complete information, you may review the Fund's next prospectus, which we expect to be available by September 29, 2026 at </span><span style="font-family:'Fidelity Sans';font-size:11px;color:#000000;font-style:normal;font-weight:bold;">fundresearch.fidelity.com/prospectus/sec</span><span style="font-family:'Fidelity Sans';font-size:11px;color:#000000;font-style:normal;font-weight:normal;"> or upon request at </span><span style="font-family:'Fidelity Sans';font-size:11px;color:#000000;font-style:normal;font-weight:normal;">1-877-208-0098</span><span style="font-family:'Fidelity Sans';font-size:0px;color:#000000;font-style:normal;font-weight:normal;"> </span><span style="font-family:'Fidelity Sans';font-size:11px;color:#000000;font-style:normal;font-weight:normal;"> or by sending an e-mail to </span><span style="font-family:'Fidelity Sans';font-size:11px;color:#000000;font-style:normal;font-weight:normal;">fidfunddocuments@fidelity.com</span><span style="font-family:'Fidelity Sans';font-size:11px;color:#000000;font-style:normal;font-weight:normal;">.</span> <span style="font-family:'Fidelity Sans';font-size:11px;color:#000000;font-style:normal;font-weight:bold;">fundresearch.fidelity.com/prospectus/sec</span> <span style="font-family:'Fidelity Sans';font-size:11px;color:#000000;font-style:normal;font-weight:normal;">1-877-208-0098</span> <span style="font-family:'Fidelity Sans';font-size:11px;color:#000000;font-style:normal;font-weight:normal;">fidfunddocuments@fidelity.com</span> 2026-07-31 This report describes changes to the Fund that occurred during the reporting period. Fidelity Advisor® Industrials Fund Fidelity Advisor® Industrials Fund Class A FCLAX This annual shareholder report contains information about Fidelity Advisor® Industrials Fund for the period August 1, 2025 to July 31, 2026. annual shareholder report You can find additional information about the Fund at fundresearch.fidelity.com/prospectus/sec. You can also request this information by contacting us at 1-877-208-0098 or by sending an e-mail to fidfunddocuments@fidelity.com. fundresearch.fidelity.com/prospectus/sec 1-877-208-0098 fidfunddocuments@fidelity.com <span style="font-family:'Fidelity Sans';font-size:16px;color:#368627;font-style:normal;font-weight:bold;">What were your Fund costs for the last year?</span> <div style="text-align:left;text-align-last:auto;"><span style="font-family:'Fidelity Sans';font-size:11px;color:#000000;font-style:normal;font-weight:normal;">(based on hypothetical $10,000 investment)</span></div> <div><span style="font-size:11px;"> </span></div><div style="text-align:left;text-align-last:auto;"></div> <div style="text-align:left;text-align-last:auto;"><span style="font-family:'Fidelity Sans';font-size:12px;color:#000000;font-style:normal;font-weight:bold;">FUND COST (PREVIOUS YEAR)</span></div> <div style="text-align:left;text-align-last:auto;"></div> <div style="text-align:left;text-align-last:auto;"><table cellpadding="0" cellspacing="0" style="border-collapse:collapse;border-style:none;" width="100%"><tr><td style="width:51%; background-color:#dfe0e4;border:1px solid #dfe0e4;padding:0px 0px 0px 0px;" valign="bottom"><div style="text-align:left;text-align-last:auto;"><span style="font-family:'Fidelity Sans';font-size:11px;color:#000000;font-style:normal;font-weight:bold;"> </span></div> </td> <td style="width:21%; background-color:#dfe0e4;border:1px solid #dfe0e4;padding:0px 0px 0px 0px;" valign="bottom"><div style="text-align:center;text-align-last:auto;"><span style="font-family:'Fidelity Sans';font-size:11px;color:#000000;font-style:normal;font-weight:bold;">Costs of a $10,000 investment</span></div> </td> <td style="width:27%; background-color:#dfe0e4;border:1px solid #dfe0e4;padding:0px 0px 0px 0px;" valign="bottom"><div style="text-align:center;text-align-last:auto;"><span style="font-family:'Fidelity Sans';font-size:11px;color:#000000;font-style:normal;font-weight:bold;">Costs paid as a percentage of a $10,000 investment </span></div> </td> <td style="width:1%; " valign="top"><span style="line-height:12px;"> </span><div style="text-align:left;text-align-last:auto;"></div> </td> </tr> <tr><td style="width:51%; border-bottom:1px solid #000000;padding:0px 0px 0px 0px;" valign="top"><div style="text-align:left;text-align-last:auto;"><span style="font-family:'Fidelity Sans';font-size:12px;color:#000000;font-style:normal;font-weight:normal;">Class A</span><span style="font-family:'Fidelity Sans';font-size:11px;color:#000000;font-style:normal;font-weight:normal;"> </span></div> </td> <td style="width:21%; border-bottom:1px solid #000000;padding:0px 0px 0px 0px;" valign="middle"><div style="text-align:center;text-align-last:auto;"><span style="font-family:'Fidelity Sans';font-size:11px;color:#000000;font-style:normal;font-weight:normal;">$</span><span style="font-family:'Fidelity Sans';font-size:12px;color:#000000;font-style:normal;font-weight:normal;"> </span>105<span style="font-family:'Fidelity Sans';font-size:11px;color:#000000;font-style:normal;font-weight:normal;"> </span></div> </td> <td style="width:27%; border-bottom:1px solid #000000;padding:0px 0px 0px 0px;" valign="middle"><div style="text-align:center;text-align-last:auto;">0.95<span style="font-family:'Fidelity Sans';font-size:11px;color:#000000;font-style:normal;font-weight:normal;">%</span></div> </td> <td style="width:1%; " valign="top"><span style="line-height:12px;"> </span><div style="text-align:left;text-align-last:auto;"></div> </td> </tr> </table> </div> <div style="text-align:left;text-align-last:auto;"></div> 105 0.0095 <span style="font-family:'Fidelity Sans';font-size:16px;color:#368627;font-style:normal;font-weight:bold;">What affected the Fund's performance this period?</span> <div style="text-align:left;text-align-last:auto;"><span style="font-family:'Fidelity Sans';font-size:11px;color:#000000;font-style:normal;font-weight:bold;"> </span></div> <div style="text-align:left;text-align-last:auto;text-indent:-24px;margin-bottom:2px;margin-left:24px;margin-top:5px;margin-right:0px;"><span style="font-family:'Fidelity Sans';font-size:12px;color:#000000;font-style:normal;font-weight:normal;">•<span style="padding-right:10px"></span>U.S. stocks achieved a strong gain for the 12 months ending July 31, 2026, reflecting enthusiasm for artificial intelligence, strong corporate fundamentals, a resilient economy and, beginning in September, the Federal Reserve's first interest-rate reductions since December 2024.</span></div> <div style="text-align:left;text-align-last:auto;text-indent:-24px;margin-bottom:2px;margin-left:24px;margin-top:5px;margin-right:0px;"><span style="font-family:'Fidelity Sans';font-size:12px;color:#000000;font-style:normal;font-weight:normal;">•<span style="padding-right:10px"></span>Against this backdrop, market selection was the primary contributor to the fund's performance versus the MSCI US IMI Industrials 25/50 Linked Index for the fiscal year, especially an underweight in human resource &amp; employment services. Picks in construction &amp; engineering also boosted the fund's relative performance. Also helping our relative result was an overweight in heavy electrical equipment.</span></div> <div style="text-align:left;text-align-last:auto;text-indent:-24px;margin-bottom:2px;margin-left:24px;margin-top:5px;margin-right:0px;"><span style="font-family:'Fidelity Sans';font-size:12px;color:#000000;font-style:normal;font-weight:normal;">•<span style="padding-right:10px"></span>The top individual relative contributor was an overweight in Howmet Aerospace (+60%). The company was one of our biggest holdings. A second notable relative contributor was an overweight in Cummins (+74%). This was a position we established this period. The company was one of the fund's biggest holdings this period. An overweight in GE Vernova (+49%) also helped. The stock was one of the fund's biggest holdings.</span></div> <div style="text-align:left;text-align-last:auto;text-indent:-24px;margin-bottom:2px;margin-left:24px;margin-top:5px;margin-right:0px;"><span style="font-family:'Fidelity Sans';font-size:12px;color:#000000;font-style:normal;font-weight:normal;">•<span style="padding-right:10px"></span>In contrast, the biggest detractor from performance versus the sector index was security selection in aerospace &amp; defense. Also hurting our result was stock picking in electrical components &amp; equipment and heavy electrical equipment.</span></div> <div style="text-align:left;text-align-last:auto;text-indent:-24px;margin-bottom:2px;margin-left:24px;margin-top:5px;margin-right:0px;"><span style="font-family:'Fidelity Sans';font-size:12px;color:#000000;font-style:normal;font-weight:normal;">•<span style="padding-right:10px"></span>The biggest individual relative detractor was an underweight in Caterpillar (+88%). This period we increased our stake in Caterpillar. A second notable relative detractor was an overweight in Boeing (-2%). This period we increased our stake in Boeing. The company was among our largest holdings. An overweight in Ingersoll Rand (-2%) also detracted. This period we increased our stake in Ingersoll Rand. The stock was one of the fund's biggest holdings this period.</span></div> <div style="text-align:left;text-align-last:auto;text-indent:-24px;margin-bottom:2px;margin-left:24px;margin-top:5px;margin-right:0px;"><span style="font-family:'Fidelity Sans';font-size:12px;color:#000000;font-style:normal;font-weight:normal;">•<span style="padding-right:10px"></span>Notable changes in positioning include increased exposure to the construction machinery &amp; heavy transportation equipment and construction &amp; engineering industries.</span></div> <div style="text-align:left;text-align-last:auto;"></div> How did the Fund perform over the past 10 years?    CUMULATIVE PERFORMANCE July 31, 2016 through July 31, 2026. Initial investment of $10,000 and the current sales charge was paid. Class A $9,425 $10,614 $12,309 $12,563 $11,736 $15,918 $14,678 $17,419 $22,060 $27,729 $33,650 MSCI U.S. IMI Industrials 25-50 Index $10,000 $11,882 $13,626 $14,063 $13,248 $19,538 $18,129 $21,639 $25,709 $30,439 $36,542 S&P 500® Index $10,000 $11,604 $13,489 $14,566 $16,308 $22,251 $21,219 $23,980 $29,292 $34,076 $40,742   2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026   <span style="font-family:'Fidelity Sans';font-size:9px;color:#000000;font-style:normal;font-weight:normal;">Class A</span> 9425 10614 12309 12563 11736 15918 14678 17419 22060 27729 33650 <span style="font-family:'Fidelity Sans';font-size:9px;color:#000000;font-style:normal;font-weight:normal;">MSCI U.S. IMI Industrials 25-50 Index</span> 10000 11882 13626 14063 13248 19538 18129 21639 25709 30439 36542 <span style="font-family:'Fidelity Sans';font-size:9px;color:#000000;font-style:normal;font-weight:normal;">S&amp;P 500® Index</span> 10000 11604 13489 14566 16308 22251 21219 23980 29292 34076 40742 AVERAGE ANNUAL TOTAL RETURNS:   1 Year 5 Year 10 Year Class A (incl. 5.75% sales charge)   14.37% 14.78% 12.90% Class A (without 5.75% sales charge) 21.35% 16.15% 13.57% MSCI U.S. IMI Industrials 25-50 Index 20.05% 13.34% 13.84% S&P 500® Index 19.56% 12.86% 15.08%     Visit institutional.fidelity.com for more recent performance information.    The Fund's past performance is not a good predictor of the Fund's future performance.  The graph and table do not reflect the deduction of taxes that a shareholder would pay on fund distributions or redemption of fund shares. 0.1437 0.1478 0.1290 0.2135 0.1615 0.1357 0.2005 0.1334 0.1384 0.1956 0.1286 0.1508 <span style="font-family:'Fidelity Sans';font-size:11px;color:#000000;font-style:normal;font-weight:normal;">Visit </span><span style="font-family:'Fidelity Sans';font-size:11px;color:#000000;font-style:normal;font-weight:bold;">institutional.fidelity.com</span><span style="font-family:'Fidelity Sans';font-size:11px;color:#000000;font-style:normal;font-weight:normal;"> for more recent performance information.</span> <span style="font-family:'Fidelity Sans';font-size:11px;color:#000000;font-style:italic;font-weight:normal;">The Fund's past performance is not a good predictor of the Fund's future performance.</span> <span style="font-family:'Fidelity Sans';font-size:11px;color:#000000;font-style:normal;font-weight:normal;">The graph and table do not reflect the deduction of taxes that a shareholder would pay on fund distributions or redemption of fund shares.</span> <span style="font-family:'Fidelity Sans';font-size:16px;color:#368627;font-style:normal;font-weight:bold;">Key Fund Statistics</span> <div style="text-align:left;text-align-last:auto;"></div> <div style="text-align:left;text-align-last:auto;"><span style="font-family:'Fidelity Sans';font-size:11px;color:#000000;font-style:normal;font-weight:normal;">(as of July 31, 2026)</span></div> <div><span style="font-size:11px;"> </span></div><div style="text-align:left;text-align-last:auto;"></div> <div style="text-align:right;text-align-last:auto;"><table cellpadding="0" cellspacing="1" style="border-collapse:separate;border-style:none;margin:auto;" width="100%"><tr><td style="width:63%; " valign="top"><div style="text-align:left;text-align-last:auto;"><span style="font-family:'Fidelity Sans';font-size:12px;color:#000000;font-style:normal;font-weight:bold;">KEY FACTS</span></div> <div style="text-align:left;text-align-last:auto;"></div> <div style="text-align:left;text-align-last:auto;"><span style="font-family:'Fidelity Sans';font-size:11px;color:#000000;font-style:normal;font-weight:bold;"> <span> </span></span></div> <div style="text-align:left;text-align-last:auto;"></div> </td> <td style="width:32%; " valign="top"><span style="line-height:12px;"> </span><div style="text-align:left;text-align-last:auto;"></div> </td> <td style="width:5%; " valign="top"><span style="line-height:12px;"> </span><div style="text-align:left;text-align-last:auto;"></div> </td> </tr> <tr><td style="width:63%; border-bottom:1px dashed #000000;padding:0px 0px 0px 0px;" valign="middle"><div style="text-align:left;text-align-last:auto;"><span style="font-family:'Fidelity Sans';font-size:11px;color:#000000;font-style:normal;font-weight:normal;">Fund Size</span></div> </td> <td style="width:32%; border-bottom:1px dashed #000000;padding:0px 0px 0px 0px;" valign="middle"><div style="text-align:right;text-align-last:auto;"><span style="font-family:'Fidelity Sans';font-size:11px;color:#000000;font-style:normal;font-weight:normal;">$</span>2,161,544,746</div> <div style="text-align:right;text-align-last:auto;"></div> </td> <td style="width:5%; " valign="top"><span style="line-height:11px;"> </span><div style="text-align:left;text-align-last:auto;"></div> </td> </tr> <tr><td style="width:63%; border-bottom:1px dashed #000000;padding:0px 0px 0px 0px;" valign="middle"><div style="text-align:left;text-align-last:auto;"><span style="font-family:'Fidelity Sans';font-size:11px;color:#000000;font-style:normal;font-weight:normal;">Number of Holdings</span></div> </td> <td style="width:32%; border-bottom:1px dashed #000000;padding:0px 0px 0px 0px;" valign="middle"><div style="text-align:right;text-align-last:auto;">50</div> <div style="text-align:right;text-align-last:auto;"></div> </td> <td style="width:5%; " valign="top"><span style="line-height:11px;"> </span><div style="text-align:left;text-align-last:auto;"></div> </td> </tr> <tr><td style="width:63%; border-bottom:1px dashed #000000;padding:0px 0px 0px 0px;" valign="middle"><div style="text-align:left;text-align-last:auto;"><span style="font-family:'Fidelity Sans';font-size:11px;color:#000000;font-style:normal;font-weight:normal;">Total Advisory Fee</span></div> </td> <td style="width:32%; border-bottom:1px dashed #000000;padding:0px 0px 0px 0px;" valign="middle"><div style="text-align:right;text-align-last:auto;"><span style="font-family:'Fidelity Sans';font-size:11px;color:#000000;font-style:normal;font-weight:normal;">$</span>10,611,345</div> <div style="text-align:right;text-align-last:auto;"></div> </td> <td style="width:5%; " valign="middle"><span style="line-height:11px;"> </span><div style="text-align:left;text-align-last:auto;"></div> </td> </tr> <tr><td style="width:63%; border-bottom:1px dashed #000000;padding:0px 0px 0px 0px;" valign="middle"><div style="text-align:left;text-align-last:auto;"><span style="font-family:'Fidelity Sans';font-size:11px;color:#000000;font-style:normal;font-weight:normal;">Portfolio Turnover</span></div> </td> <td style="width:32%; border-bottom:1px dashed #000000;padding:0px 0px 0px 0px;" valign="middle"><div style="text-align:right;text-align-last:auto;">34<span style="font-family:'Fidelity Sans';font-size:11px;color:#000000;font-style:normal;font-weight:normal;">%</span></div> <div style="text-align:left;text-align-last:auto;"></div> </td> <td style="width:5%; " valign="top"><span style="line-height:11px;"> </span><div style="text-align:left;text-align-last:auto;"></div> </td> </tr> </table> </div> <div style="text-align:left;text-align-last:auto;"></div> 2161544746 50 10611345 0.34       TOP INDUSTRIES (% of Fund's net assets) Aerospace & Defense 30.9   Machinery 24.3   Electrical Equipment 13.6   Building Products 8.8   Ground Transportation 5.6   Construction & Engineering 5.0   Commercial Services & Supplies 3.2   Trading Companies & Distributors 3.0   Industrial Conglomerates 1.8   Others 2.5       Common Stocks 98.7 Short-Term Investments and Net Other Assets (Liabilities) 1.3 ASSET ALLOCATION (% of Fund's net assets)     Common Stocks - 98.7                       Short-Term Investments and Net Other Assets (Liabilities) - 1.3   United States 100.0 GEOGRAPHIC DIVERSIFICATION (% of Fund's net assets)     United States - 100.0                          0.309 0.243 0.136 0.088 0.056 0.050 0.032 0.030 0.018 0.025 0.987 0.013 1.000 TOP HOLDINGS(% of Fund's net assets)     GE Aerospace 8.1   GE Vernova Inc 6.3   Boeing Co 6.2   Trane Technologies PLC 4.6   Howmet Aerospace Inc 4.5   Parker-Hannifin Corp 4.4   Eaton Corp PLC 3.5   RTX Corp 3.5   PACCAR Inc 2.9   Quanta Services Inc 2.9     46.9   0.081 0.063 0.062 0.046 0.045 0.044 0.035 0.035 0.029 0.029 <div style="text-align:left;text-align-last:auto;"><span style="font-family:'Fidelity Sans';font-size:16px;color:#368627;font-style:normal;font-weight:bold;">How has the Fund changed?</span></div> <div style="text-align:left;text-align-last:auto;"><span style="font-family:'Fidelity Sans';font-size:11px;color:#000000;font-style:normal;font-weight:normal;"> </span></div> <div style="text-align:left;text-align-last:auto;"><span style="font-family:'Fidelity Sans';font-size:11px;color:#000000;font-style:normal;font-weight:normal;">This is a summary of certain changes to the Fund since August 1, 2025. For more complete information, you may review the Fund's next prospectus, which we expect to be available by September 29, 2026 at </span><span style="font-family:'Fidelity Sans';font-size:11px;color:#000000;font-style:normal;font-weight:bold;">fundresearch.fidelity.com/prospectus/sec</span><span style="font-family:'Fidelity Sans';font-size:11px;color:#000000;font-style:normal;font-weight:normal;"> or upon request at </span><span style="font-family:'Fidelity Sans';font-size:11px;color:#000000;font-style:normal;font-weight:normal;">1-877-208-0098</span><span style="font-family:'Fidelity Sans';font-size:0px;color:#000000;font-style:normal;font-weight:normal;"> </span><span style="font-family:'Fidelity Sans';font-size:11px;color:#000000;font-style:normal;font-weight:normal;"> or by sending an e-mail to </span><span style="font-family:'Fidelity Sans';font-size:11px;color:#000000;font-style:normal;font-weight:normal;">fidfunddocuments@fidelity.com</span><span style="font-family:'Fidelity Sans';font-size:11px;color:#000000;font-style:normal;font-weight:normal;">.</span></div> <div style="text-align:left;text-align-last:auto;"></div> <span style="line-height:11px;"> </span><div style="text-align:left;text-align-last:auto;"></div> <div style="text-align:left;text-align-last:auto;"><table cellpadding="0" cellspacing="0" style="border-collapse:collapse;border-style:none;" width="100%"><tr><td style="width:50%; background-color:#ebf3e9;border-right:2px dashed #368627;padding:19px 19px 19px 19px;" valign="top"><div style="text-align:left;text-align-last:auto;"><span style="font-family:'Fidelity Sans';font-size:11px;color:#000000;font-style:normal;font-weight:normal;">Industrials Portfolio merged into Fidelity Advisor® Industrials Fund on October 17, 2025.</span></div> <div style="text-align:left;text-align-last:auto;"></div> </td> <td style="width:50%; background-color:#ebf3e9;padding:19px 19px 19px 19px;" valign="top"><div style="text-align:left;text-align-last:auto;"></div> </td> </tr> </table> </div> <div style="text-align:left;text-align-last:auto;"></div> <span style="font-family:'Fidelity Sans';font-size:11px;color:#000000;font-style:normal;font-weight:normal;">This is a summary of certain changes to the Fund since August 1, 2025. For more complete information, you may review the Fund's next prospectus, which we expect to be available by September 29, 2026 at </span><span style="font-family:'Fidelity Sans';font-size:11px;color:#000000;font-style:normal;font-weight:bold;">fundresearch.fidelity.com/prospectus/sec</span><span style="font-family:'Fidelity Sans';font-size:11px;color:#000000;font-style:normal;font-weight:normal;"> or upon request at </span><span style="font-family:'Fidelity Sans';font-size:11px;color:#000000;font-style:normal;font-weight:normal;">1-877-208-0098</span><span style="font-family:'Fidelity Sans';font-size:0px;color:#000000;font-style:normal;font-weight:normal;"> </span><span style="font-family:'Fidelity Sans';font-size:11px;color:#000000;font-style:normal;font-weight:normal;"> or by sending an e-mail to </span><span style="font-family:'Fidelity Sans';font-size:11px;color:#000000;font-style:normal;font-weight:normal;">fidfunddocuments@fidelity.com</span><span style="font-family:'Fidelity Sans';font-size:11px;color:#000000;font-style:normal;font-weight:normal;">.</span> <span style="font-family:'Fidelity Sans';font-size:11px;color:#000000;font-style:normal;font-weight:bold;">fundresearch.fidelity.com/prospectus/sec</span> <span style="font-family:'Fidelity Sans';font-size:11px;color:#000000;font-style:normal;font-weight:normal;">1-877-208-0098</span> <span style="font-family:'Fidelity Sans';font-size:11px;color:#000000;font-style:normal;font-weight:normal;">fidfunddocuments@fidelity.com</span> 2026-07-31 Fidelity Advisor® Financials Fund Fidelity Advisor® Financials Fund Class Z FIKBX This annual shareholder report contains information about Fidelity Advisor® Financials Fund for the period August 1, 2025 to July 31, 2026. annual shareholder report You can find additional information about the Fund at fundresearch.fidelity.com/prospectus/sec. You can also request this information by contacting us at 1-877-208-0098 or by sending an e-mail to fidfunddocuments@fidelity.com. fundresearch.fidelity.com/prospectus/sec 1-877-208-0098 fidfunddocuments@fidelity.com <span style="font-family:'Fidelity Sans';font-size:16px;color:#368627;font-style:normal;font-weight:bold;">What were your Fund costs for the last year?</span> <div style="text-align:left;text-align-last:auto;"><span style="font-family:'Fidelity Sans';font-size:11px;color:#000000;font-style:normal;font-weight:normal;">(based on hypothetical $10,000 investment)</span></div> <div><span style="font-size:11px;"> </span></div><div style="text-align:left;text-align-last:auto;"></div> <div style="text-align:left;text-align-last:auto;"><span style="font-family:'Fidelity Sans';font-size:12px;color:#000000;font-style:normal;font-weight:bold;">FUND COST (PREVIOUS YEAR)</span></div> <div style="text-align:left;text-align-last:auto;"></div> <div style="text-align:left;text-align-last:auto;"><table cellpadding="0" cellspacing="0" style="border-collapse:collapse;border-style:none;" width="100%"><tr><td style="width:51%; background-color:#dfe0e4;border:1px solid #dfe0e4;padding:0px 0px 0px 0px;" valign="bottom"><div style="text-align:left;text-align-last:auto;"><span style="font-family:'Fidelity Sans';font-size:11px;color:#000000;font-style:normal;font-weight:bold;"> </span></div> </td> <td style="width:21%; background-color:#dfe0e4;border:1px solid #dfe0e4;padding:0px 0px 0px 0px;" valign="bottom"><div style="text-align:center;text-align-last:auto;"><span style="font-family:'Fidelity Sans';font-size:11px;color:#000000;font-style:normal;font-weight:bold;">Costs of a $10,000 investment</span></div> </td> <td style="width:27%; background-color:#dfe0e4;border:1px solid #dfe0e4;padding:0px 0px 0px 0px;" valign="bottom"><div style="text-align:center;text-align-last:auto;"><span style="font-family:'Fidelity Sans';font-size:11px;color:#000000;font-style:normal;font-weight:bold;">Costs paid as a percentage of a $10,000 investment </span></div> </td> <td style="width:1%; " valign="top"><span style="line-height:12px;"> </span><div style="text-align:left;text-align-last:auto;"></div> </td> </tr> <tr><td style="width:51%; border-bottom:1px solid #000000;padding:0px 0px 0px 0px;" valign="top"><div style="text-align:left;text-align-last:auto;"><span style="font-family:'Fidelity Sans';font-size:12px;color:#000000;font-style:normal;font-weight:normal;">Class Z</span><span style="font-family:'Fidelity Sans';font-size:11px;color:#000000;font-style:normal;font-weight:normal;"> </span></div> </td> <td style="width:21%; border-bottom:1px solid #000000;padding:0px 0px 0px 0px;" valign="middle"><div style="text-align:center;text-align-last:auto;"><span style="font-family:'Fidelity Sans';font-size:11px;color:#000000;font-style:normal;font-weight:normal;">$</span><span style="font-family:'Fidelity Sans';font-size:12px;color:#000000;font-style:normal;font-weight:normal;"> </span>64<span style="font-family:'Fidelity Sans';font-size:11px;color:#000000;font-style:normal;font-weight:normal;"> </span></div> </td> <td style="width:27%; border-bottom:1px solid #000000;padding:0px 0px 0px 0px;" valign="middle"><div style="text-align:center;text-align-last:auto;">0.59<span style="font-family:'Fidelity Sans';font-size:11px;color:#000000;font-style:normal;font-weight:normal;">%</span></div> </td> <td style="width:1%; " valign="top"><span style="line-height:12px;"> </span><div style="text-align:left;text-align-last:auto;"></div> </td> </tr> </table> </div> <div style="text-align:left;text-align-last:auto;"></div> 64 0.0059 <span style="font-family:'Fidelity Sans';font-size:16px;color:#368627;font-style:normal;font-weight:bold;">What affected the Fund's performance this period?</span> <div style="text-align:left;text-align-last:auto;"><span style="font-family:'Fidelity Sans';font-size:11px;color:#000000;font-style:normal;font-weight:bold;"> </span></div> <div style="text-align:left;text-align-last:auto;text-indent:-24px;margin-bottom:2px;margin-left:24px;margin-top:5px;margin-right:0px;"><span style="font-family:'Fidelity Sans';font-size:12px;color:#000000;font-style:normal;font-weight:normal;">•<span style="padding-right:10px"></span>U.S. stocks achieved a strong gain for the 12 months ending July 31, 2026, reflecting enthusiasm for artificial intelligence, strong corporate fundamentals, a resilient economy and, beginning in September, the Federal Reserve's first interest-rate reductions since December 2024.</span></div> <div style="text-align:left;text-align-last:auto;text-indent:-24px;margin-bottom:2px;margin-left:24px;margin-top:5px;margin-right:0px;"><span style="font-family:'Fidelity Sans';font-size:12px;color:#000000;font-style:normal;font-weight:normal;">•<span style="padding-right:10px"></span>Against this backdrop, security selection was the primary contributor to the fund's performance versus the MSCI US IMI Financials 5% Capped Linked Index for the fiscal year, led by property &amp; casualty insurance firms. Stock picks and an overweight in regional banks, along with stock selection and an underweight in the financial exchanges &amp; data category, also boosted the fund's relative performance.</span></div> <div style="text-align:left;text-align-last:auto;text-indent:-24px;margin-bottom:2px;margin-left:24px;margin-top:5px;margin-right:0px;"><span style="font-family:'Fidelity Sans';font-size:12px;color:#000000;font-style:normal;font-weight:normal;">•<span style="padding-right:10px"></span>The top individual relative contributor was an overweight in State Street (+68%). The company was among the fund's biggest holdings. Avoiding S&amp;P Global, an index component that returned -21%, also helped. Another notable relative contributor this period was avoiding Coinbase Global, an index component that returned about -61%.</span></div> <div style="text-align:left;text-align-last:auto;text-indent:-24px;margin-bottom:2px;margin-left:24px;margin-top:5px;margin-right:0px;"><span style="font-family:'Fidelity Sans';font-size:12px;color:#000000;font-style:normal;font-weight:normal;">•<span style="padding-right:10px"></span>In contrast, the primary detractor from performance versus the sector index was an underweight among life &amp; health insurance providers. Stock selection in insurance brokers also hampered the fund's result, as did an overweight in the diversified financial services industry.</span></div> <div style="text-align:left;text-align-last:auto;text-indent:-24px;margin-bottom:2px;margin-left:24px;margin-top:5px;margin-right:0px;"><span style="font-family:'Fidelity Sans';font-size:12px;color:#000000;font-style:normal;font-weight:normal;">•<span style="padding-right:10px"></span>Not owning Goldman Sachs Group, an index component that gained roughly 44%, was the biggest individual relative detractor, followed by an overweight in Blue Owl Capital (-43%). The latter was a stake we established this period. An overweight in Mastercard (+2%), the fund's biggest holding, also detracted.</span></div> <div style="text-align:left;text-align-last:auto;text-indent:-24px;margin-bottom:2px;margin-left:24px;margin-top:5px;margin-right:0px;"><span style="font-family:'Fidelity Sans';font-size:12px;color:#000000;font-style:normal;font-weight:normal;">•<span style="padding-right:10px"></span>Notable changes in positioning include increased exposure to the investment banking &amp; brokerage industry and a lower allocation to financial exchanges &amp; data stocks.</span></div> <div style="text-align:left;text-align-last:auto;"></div> How did the Fund perform over the life of Fund?    CUMULATIVE PERFORMANCE October 2, 2018 through July 31, 2026. Initial investment of $10,000. Class Z $10,000 $10,472 $8,924 $14,504 $14,065 $14,710 $19,231 $23,248 $27,298 MSCI U.S. IMI Financials 5% Capped Linked Index $10,000 $10,457 $8,858 $13,921 $13,268 $13,983 $17,897 $21,515 $24,273 S&P 500® Index $10,000 $10,365 $11,604 $15,833 $15,098 $17,064 $20,843 $24,247 $28,991   2018 2019 2020 2021 2022 2023 2024 2025 2026   <span style="font-family:'Fidelity Sans';font-size:9px;color:#000000;font-style:normal;font-weight:normal;">Class Z</span> 10000 10472 8924 14504 14065 14710 19231 23248 27298 <span style="font-family:'Fidelity Sans';font-size:9px;color:#000000;font-style:normal;font-weight:normal;">MSCI U.S. IMI Financials 5% Capped Linked Index</span> 10000 10457 8858 13921 13268 13983 17897 21515 24273 <span style="font-family:'Fidelity Sans';font-size:9px;color:#000000;font-style:normal;font-weight:normal;">S&amp;P 500® Index</span> 10000 10365 11604 15833 15098 17064 20843 24247 28991 AVERAGE ANNUAL TOTAL RETURNS:   1 Year 5 Year Life of Fund A Class Z 17.42% 13.48% 13.68% MSCI U.S. IMI Financials 5% Capped Linked Index 12.82% 11.76% 11.99% S&P 500® Index 19.56% 12.86% 14.56% A   From October 2, 2018   Visit institutional.fidelity.com for more recent performance information.    The Fund's past performance is not a good predictor of the Fund's future performance.  The graph and table do not reflect the deduction of taxes that a shareholder would pay on fund distributions or redemption of fund shares. 0.1742 0.1348 0.1368 0.1282 0.1176 0.1199 0.1956 0.1286 0.1456 2018-10-02 <span style="font-family:'Fidelity Sans';font-size:11px;color:#000000;font-style:normal;font-weight:normal;">Visit </span><span style="font-family:'Fidelity Sans';font-size:11px;color:#000000;font-style:normal;font-weight:bold;">institutional.fidelity.com</span><span style="font-family:'Fidelity Sans';font-size:11px;color:#000000;font-style:normal;font-weight:normal;"> for more recent performance information.</span> <span style="font-family:'Fidelity Sans';font-size:11px;color:#000000;font-style:italic;font-weight:normal;">The Fund's past performance is not a good predictor of the Fund's future performance.</span> <span style="font-family:'Fidelity Sans';font-size:11px;color:#000000;font-style:normal;font-weight:normal;">The graph and table do not reflect the deduction of taxes that a shareholder would pay on fund distributions or redemption of fund shares.</span> <span style="font-family:'Fidelity Sans';font-size:16px;color:#368627;font-style:normal;font-weight:bold;">Key Fund Statistics</span> <div style="text-align:left;text-align-last:auto;"></div> <div style="text-align:left;text-align-last:auto;"><span style="font-family:'Fidelity Sans';font-size:11px;color:#000000;font-style:normal;font-weight:normal;">(as of July 31, 2026)</span></div> <div><span style="font-size:11px;"> </span></div><div style="text-align:left;text-align-last:auto;"></div> <div style="text-align:right;text-align-last:auto;"><table cellpadding="0" cellspacing="1" style="border-collapse:separate;border-style:none;margin:auto;" width="100%"><tr><td style="width:63%; " valign="top"><div style="text-align:left;text-align-last:auto;"><span style="font-family:'Fidelity Sans';font-size:12px;color:#000000;font-style:normal;font-weight:bold;">KEY FACTS</span></div> <div style="text-align:left;text-align-last:auto;"></div> <div style="text-align:left;text-align-last:auto;"><span style="font-family:'Fidelity Sans';font-size:11px;color:#000000;font-style:normal;font-weight:bold;"> <span> </span></span></div> <div style="text-align:left;text-align-last:auto;"></div> </td> <td style="width:32%; " valign="top"><span style="line-height:12px;"> </span><div style="text-align:left;text-align-last:auto;"></div> </td> <td style="width:5%; " valign="top"><span style="line-height:12px;"> </span><div style="text-align:left;text-align-last:auto;"></div> </td> </tr> <tr><td style="width:63%; border-bottom:1px dashed #000000;padding:0px 0px 0px 0px;" valign="middle"><div style="text-align:left;text-align-last:auto;"><span style="font-family:'Fidelity Sans';font-size:11px;color:#000000;font-style:normal;font-weight:normal;">Fund Size</span></div> </td> <td style="width:32%; border-bottom:1px dashed #000000;padding:0px 0px 0px 0px;" valign="middle"><div style="text-align:right;text-align-last:auto;"><span style="font-family:'Fidelity Sans';font-size:11px;color:#000000;font-style:normal;font-weight:normal;">$</span>676,458,374</div> <div style="text-align:right;text-align-last:auto;"></div> </td> <td style="width:5%; " valign="top"><span style="line-height:11px;"> </span><div style="text-align:left;text-align-last:auto;"></div> </td> </tr> <tr><td style="width:63%; border-bottom:1px dashed #000000;padding:0px 0px 0px 0px;" valign="middle"><div style="text-align:left;text-align-last:auto;"><span style="font-family:'Fidelity Sans';font-size:11px;color:#000000;font-style:normal;font-weight:normal;">Number of Holdings</span></div> </td> <td style="width:32%; border-bottom:1px dashed #000000;padding:0px 0px 0px 0px;" valign="middle"><div style="text-align:right;text-align-last:auto;">64</div> <div style="text-align:right;text-align-last:auto;"></div> </td> <td style="width:5%; " valign="top"><span style="line-height:11px;"> </span><div style="text-align:left;text-align-last:auto;"></div> </td> </tr> <tr><td style="width:63%; border-bottom:1px dashed #000000;padding:0px 0px 0px 0px;" valign="middle"><div style="text-align:left;text-align-last:auto;"><span style="font-family:'Fidelity Sans';font-size:11px;color:#000000;font-style:normal;font-weight:normal;">Total Advisory Fee</span></div> </td> <td style="width:32%; border-bottom:1px dashed #000000;padding:0px 0px 0px 0px;" valign="middle"><div style="text-align:right;text-align-last:auto;"><span style="font-family:'Fidelity Sans';font-size:11px;color:#000000;font-style:normal;font-weight:normal;">$</span>4,639,325</div> <div style="text-align:right;text-align-last:auto;"></div> </td> <td style="width:5%; " valign="middle"><span style="line-height:11px;"> </span><div style="text-align:left;text-align-last:auto;"></div> </td> </tr> <tr><td style="width:63%; border-bottom:1px dashed #000000;padding:0px 0px 0px 0px;" valign="middle"><div style="text-align:left;text-align-last:auto;"><span style="font-family:'Fidelity Sans';font-size:11px;color:#000000;font-style:normal;font-weight:normal;">Portfolio Turnover</span></div> </td> <td style="width:32%; border-bottom:1px dashed #000000;padding:0px 0px 0px 0px;" valign="middle"><div style="text-align:right;text-align-last:auto;">25<span style="font-family:'Fidelity Sans';font-size:11px;color:#000000;font-style:normal;font-weight:normal;">%</span></div> <div style="text-align:left;text-align-last:auto;"></div> </td> <td style="width:5%; " valign="top"><span style="line-height:11px;"> </span><div style="text-align:left;text-align-last:auto;"></div> </td> </tr> </table> </div> <div style="text-align:left;text-align-last:auto;"></div> 676458374 64 4639325 0.25       TOP INDUSTRIES (% of Fund's net assets) Banks 34.0   Capital Markets 28.4   Insurance 17.2   Financial Services 14.6   Consumer Finance 4.5   Professional Services 1.0       Common Stocks 99.7 Short-Term Investments and Net Other Assets (Liabilities) 0.3 ASSET ALLOCATION (% of Fund's net assets)     Common Stocks - 99.7                       Short-Term Investments and Net Other Assets (Liabilities) - 0.3   United States 95.1 United Kingdom 1.6 Puerto Rico 0.8 Australia 0.7 Grand Cayman (UK Overseas Ter) 0.7 Mexico 0.6 France 0.5 GEOGRAPHIC DIVERSIFICATION (% of Fund's net assets)     United States - 95.1                       United Kingdom - 1.6                       Puerto Rico - 0.8                          Australia - 0.7                            Grand Cayman (UK Overseas Ter) - 0.7       Mexico - 0.6                               France - 0.5                                   0.340 0.284 0.172 0.146 0.045 0.010 0.997 0.003 0.951 0.016 0.008 0.007 0.007 0.006 0.005 TOP HOLDINGS(% of Fund's net assets)     Mastercard Inc Class A 8.8   Bank of America Corp 7.0   Wells Fargo & Co 6.7   Charles Schwab Corp/The 4.7   State Street Corp 3.9   Citigroup Inc 3.8   Reinsurance Group of America Inc 3.4   Morgan Stanley 2.6   Chubb Ltd 2.5   Capital One Financial Corp 2.4     45.8   0.088 0.070 0.067 0.047 0.039 0.038 0.034 0.026 0.025 0.024 2026-07-31 Fidelity Advisor® Financials Fund Fidelity Advisor® Financials Fund Class M FAFSX This annual shareholder report contains information about Fidelity Advisor® Financials Fund for the period August 1, 2025 to July 31, 2026. annual shareholder report You can find additional information about the Fund at fundresearch.fidelity.com/prospectus/sec. You can also request this information by contacting us at 1-877-208-0098 or by sending an e-mail to fidfunddocuments@fidelity.com. fundresearch.fidelity.com/prospectus/sec 1-877-208-0098 fidfunddocuments@fidelity.com <span style="font-family:'Fidelity Sans';font-size:16px;color:#368627;font-style:normal;font-weight:bold;">What were your Fund costs for the last year?</span> <div style="text-align:left;text-align-last:auto;"><span style="font-family:'Fidelity Sans';font-size:11px;color:#000000;font-style:normal;font-weight:normal;">(based on hypothetical $10,000 investment)</span></div> <div><span style="font-size:11px;"> </span></div><div style="text-align:left;text-align-last:auto;"></div> <div style="text-align:left;text-align-last:auto;"><span style="font-family:'Fidelity Sans';font-size:12px;color:#000000;font-style:normal;font-weight:bold;">FUND COST (PREVIOUS YEAR)</span></div> <div style="text-align:left;text-align-last:auto;"></div> <div style="text-align:left;text-align-last:auto;"><table cellpadding="0" cellspacing="0" style="border-collapse:collapse;border-style:none;" width="100%"><tr><td style="width:51%; background-color:#dfe0e4;border:1px solid #dfe0e4;padding:0px 0px 0px 0px;" valign="bottom"><div style="text-align:left;text-align-last:auto;"><span style="font-family:'Fidelity Sans';font-size:11px;color:#000000;font-style:normal;font-weight:bold;"> </span></div> </td> <td style="width:21%; background-color:#dfe0e4;border:1px solid #dfe0e4;padding:0px 0px 0px 0px;" valign="bottom"><div style="text-align:center;text-align-last:auto;"><span style="font-family:'Fidelity Sans';font-size:11px;color:#000000;font-style:normal;font-weight:bold;">Costs of a $10,000 investment</span></div> </td> <td style="width:27%; background-color:#dfe0e4;border:1px solid #dfe0e4;padding:0px 0px 0px 0px;" valign="bottom"><div style="text-align:center;text-align-last:auto;"><span style="font-family:'Fidelity Sans';font-size:11px;color:#000000;font-style:normal;font-weight:bold;">Costs paid as a percentage of a $10,000 investment </span></div> </td> <td style="width:1%; " valign="top"><span style="line-height:12px;"> </span><div style="text-align:left;text-align-last:auto;"></div> </td> </tr> <tr><td style="width:51%; border-bottom:1px solid #000000;padding:0px 0px 0px 0px;" valign="top"><div style="text-align:left;text-align-last:auto;"><span style="font-family:'Fidelity Sans';font-size:12px;color:#000000;font-style:normal;font-weight:normal;">Class M</span><span style="font-family:'Fidelity Sans';font-size:11px;color:#000000;font-style:normal;font-weight:normal;"> </span></div> </td> <td style="width:21%; border-bottom:1px solid #000000;padding:0px 0px 0px 0px;" valign="middle"><div style="text-align:center;text-align-last:auto;"><span style="font-family:'Fidelity Sans';font-size:11px;color:#000000;font-style:normal;font-weight:normal;">$</span><span style="font-family:'Fidelity Sans';font-size:12px;color:#000000;font-style:normal;font-weight:normal;"> </span>134<span style="font-family:'Fidelity Sans';font-size:11px;color:#000000;font-style:normal;font-weight:normal;"> </span></div> </td> <td style="width:27%; border-bottom:1px solid #000000;padding:0px 0px 0px 0px;" valign="middle"><div style="text-align:center;text-align-last:auto;">1.24<span style="font-family:'Fidelity Sans';font-size:11px;color:#000000;font-style:normal;font-weight:normal;">%</span></div> </td> <td style="width:1%; " valign="top"><span style="line-height:12px;"> </span><div style="text-align:left;text-align-last:auto;"></div> </td> </tr> </table> </div> <div style="text-align:left;text-align-last:auto;"></div> 134 0.0124 <span style="font-family:'Fidelity Sans';font-size:16px;color:#368627;font-style:normal;font-weight:bold;">What affected the Fund's performance this period?</span> <div style="text-align:left;text-align-last:auto;"><span style="font-family:'Fidelity Sans';font-size:11px;color:#000000;font-style:normal;font-weight:bold;"> </span></div> <div style="text-align:left;text-align-last:auto;text-indent:-24px;margin-bottom:2px;margin-left:24px;margin-top:5px;margin-right:0px;"><span style="font-family:'Fidelity Sans';font-size:12px;color:#000000;font-style:normal;font-weight:normal;">•<span style="padding-right:10px"></span>U.S. stocks achieved a strong gain for the 12 months ending July 31, 2026, reflecting enthusiasm for artificial intelligence, strong corporate fundamentals, a resilient economy and, beginning in September, the Federal Reserve's first interest-rate reductions since December 2024.</span></div> <div style="text-align:left;text-align-last:auto;text-indent:-24px;margin-bottom:2px;margin-left:24px;margin-top:5px;margin-right:0px;"><span style="font-family:'Fidelity Sans';font-size:12px;color:#000000;font-style:normal;font-weight:normal;">•<span style="padding-right:10px"></span>Against this backdrop, security selection was the primary contributor to the fund's performance versus the MSCI US IMI Financials 5% Capped Linked Index for the fiscal year, led by property &amp; casualty insurance firms. Stock picks and an overweight in regional banks, along with stock selection and an underweight in the financial exchanges &amp; data category, also boosted the fund's relative performance.</span></div> <div style="text-align:left;text-align-last:auto;text-indent:-24px;margin-bottom:2px;margin-left:24px;margin-top:5px;margin-right:0px;"><span style="font-family:'Fidelity Sans';font-size:12px;color:#000000;font-style:normal;font-weight:normal;">•<span style="padding-right:10px"></span>The top individual relative contributor was an overweight in State Street (+68%). The company was among the fund's biggest holdings. Avoiding S&amp;P Global, an index component that returned -21%, also helped. Another notable relative contributor this period was avoiding Coinbase Global, an index component that returned about -61%.</span></div> <div style="text-align:left;text-align-last:auto;text-indent:-24px;margin-bottom:2px;margin-left:24px;margin-top:5px;margin-right:0px;"><span style="font-family:'Fidelity Sans';font-size:12px;color:#000000;font-style:normal;font-weight:normal;">•<span style="padding-right:10px"></span>In contrast, the primary detractor from performance versus the sector index was an underweight among life &amp; health insurance providers. Stock selection in insurance brokers also hampered the fund's result, as did an overweight in the diversified financial services industry.</span></div> <div style="text-align:left;text-align-last:auto;text-indent:-24px;margin-bottom:2px;margin-left:24px;margin-top:5px;margin-right:0px;"><span style="font-family:'Fidelity Sans';font-size:12px;color:#000000;font-style:normal;font-weight:normal;">•<span style="padding-right:10px"></span>Not owning Goldman Sachs Group, an index component that gained roughly 44%, was the biggest individual relative detractor, followed by an overweight in Blue Owl Capital (-43%). The latter was a stake we established this period. An overweight in Mastercard (+2%), the fund's biggest holding, also detracted.</span></div> <div style="text-align:left;text-align-last:auto;text-indent:-24px;margin-bottom:2px;margin-left:24px;margin-top:5px;margin-right:0px;"><span style="font-family:'Fidelity Sans';font-size:12px;color:#000000;font-style:normal;font-weight:normal;">•<span style="padding-right:10px"></span>Notable changes in positioning include increased exposure to the investment banking &amp; brokerage industry and a lower allocation to financial exchanges &amp; data stocks.</span></div> <div style="text-align:left;text-align-last:auto;"></div> How did the Fund perform over the past 10 years?    CUMULATIVE PERFORMANCE July 31, 2016 through July 31, 2026. Initial investment of $10,000 and the current sales charge was paid. Class M $9,650 $12,219 $13,666 $13,908 $11,769 $19,006 $18,315 $19,026 $24,715 $29,684 $34,631 MSCI U.S. IMI Financials 5% Capped Linked Index $10,000 $13,125 $14,720 $15,196 $12,873 $20,230 $19,281 $20,321 $26,008 $31,266 $35,275 S&P 500® Index $10,000 $11,604 $13,489 $14,566 $16,308 $22,251 $21,219 $23,980 $29,292 $34,076 $40,742   2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026   <span style="font-family:'Fidelity Sans';font-size:9px;color:#000000;font-style:normal;font-weight:normal;">Class M</span> 9650 12219 13666 13908 11769 19006 18315 19026 24715 29684 34631 <span style="font-family:'Fidelity Sans';font-size:9px;color:#000000;font-style:normal;font-weight:normal;">MSCI U.S. IMI Financials 5% Capped Linked Index</span> 10000 13125 14720 15196 12873 20230 19281 20321 26008 31266 35275 <span style="font-family:'Fidelity Sans';font-size:9px;color:#000000;font-style:normal;font-weight:normal;">S&amp;P 500® Index</span> 10000 11604 13489 14566 16308 22251 21219 23980 29292 34076 40742 AVERAGE ANNUAL TOTAL RETURNS:   1 Year 5 Year 10 Year Class M (incl. 3.50% sales charge)   12.58% 11.95% 13.23% Class M (without 3.50% sales charge) 16.66% 12.75% 13.63% MSCI U.S. IMI Financials 5% Capped Linked Index 12.82% 11.76% 13.43% S&P 500® Index 19.56% 12.86% 15.08%     Visit institutional.fidelity.com for more recent performance information.    The Fund's past performance is not a good predictor of the Fund's future performance.  The graph and table do not reflect the deduction of taxes that a shareholder would pay on fund distributions or redemption of fund shares. 0.1258 0.1195 0.1323 0.1666 0.1275 0.1363 0.1282 0.1176 0.1343 0.1956 0.1286 0.1508 <span style="font-family:'Fidelity Sans';font-size:11px;color:#000000;font-style:normal;font-weight:normal;">Visit </span><span style="font-family:'Fidelity Sans';font-size:11px;color:#000000;font-style:normal;font-weight:bold;">institutional.fidelity.com</span><span style="font-family:'Fidelity Sans';font-size:11px;color:#000000;font-style:normal;font-weight:normal;"> for more recent performance information.</span> <span style="font-family:'Fidelity Sans';font-size:11px;color:#000000;font-style:italic;font-weight:normal;">The Fund's past performance is not a good predictor of the Fund's future performance.</span> <span style="font-family:'Fidelity Sans';font-size:11px;color:#000000;font-style:normal;font-weight:normal;">The graph and table do not reflect the deduction of taxes that a shareholder would pay on fund distributions or redemption of fund shares.</span> <span style="font-family:'Fidelity Sans';font-size:16px;color:#368627;font-style:normal;font-weight:bold;">Key Fund Statistics</span> <div style="text-align:left;text-align-last:auto;"></div> <div style="text-align:left;text-align-last:auto;"><span style="font-family:'Fidelity Sans';font-size:11px;color:#000000;font-style:normal;font-weight:normal;">(as of July 31, 2026)</span></div> <div><span style="font-size:11px;"> </span></div><div style="text-align:left;text-align-last:auto;"></div> <div style="text-align:right;text-align-last:auto;"><table cellpadding="0" cellspacing="1" style="border-collapse:separate;border-style:none;margin:auto;" width="100%"><tr><td style="width:63%; " valign="top"><div style="text-align:left;text-align-last:auto;"><span style="font-family:'Fidelity Sans';font-size:12px;color:#000000;font-style:normal;font-weight:bold;">KEY FACTS</span></div> <div style="text-align:left;text-align-last:auto;"></div> <div style="text-align:left;text-align-last:auto;"><span style="font-family:'Fidelity Sans';font-size:11px;color:#000000;font-style:normal;font-weight:bold;"> <span> </span></span></div> <div style="text-align:left;text-align-last:auto;"></div> </td> <td style="width:32%; " valign="top"><span style="line-height:12px;"> </span><div style="text-align:left;text-align-last:auto;"></div> </td> <td style="width:5%; " valign="top"><span style="line-height:12px;"> </span><div style="text-align:left;text-align-last:auto;"></div> </td> </tr> <tr><td style="width:63%; border-bottom:1px dashed #000000;padding:0px 0px 0px 0px;" valign="middle"><div style="text-align:left;text-align-last:auto;"><span style="font-family:'Fidelity Sans';font-size:11px;color:#000000;font-style:normal;font-weight:normal;">Fund Size</span></div> </td> <td style="width:32%; border-bottom:1px dashed #000000;padding:0px 0px 0px 0px;" valign="middle"><div style="text-align:right;text-align-last:auto;"><span style="font-family:'Fidelity Sans';font-size:11px;color:#000000;font-style:normal;font-weight:normal;">$</span>676,458,374</div> <div style="text-align:right;text-align-last:auto;"></div> </td> <td style="width:5%; " valign="top"><span style="line-height:11px;"> </span><div style="text-align:left;text-align-last:auto;"></div> </td> </tr> <tr><td style="width:63%; border-bottom:1px dashed #000000;padding:0px 0px 0px 0px;" valign="middle"><div style="text-align:left;text-align-last:auto;"><span style="font-family:'Fidelity Sans';font-size:11px;color:#000000;font-style:normal;font-weight:normal;">Number of Holdings</span></div> </td> <td style="width:32%; border-bottom:1px dashed #000000;padding:0px 0px 0px 0px;" valign="middle"><div style="text-align:right;text-align-last:auto;">64</div> <div style="text-align:right;text-align-last:auto;"></div> </td> <td style="width:5%; " valign="top"><span style="line-height:11px;"> </span><div style="text-align:left;text-align-last:auto;"></div> </td> </tr> <tr><td style="width:63%; border-bottom:1px dashed #000000;padding:0px 0px 0px 0px;" valign="middle"><div style="text-align:left;text-align-last:auto;"><span style="font-family:'Fidelity Sans';font-size:11px;color:#000000;font-style:normal;font-weight:normal;">Total Advisory Fee</span></div> </td> <td style="width:32%; border-bottom:1px dashed #000000;padding:0px 0px 0px 0px;" valign="middle"><div style="text-align:right;text-align-last:auto;"><span style="font-family:'Fidelity Sans';font-size:11px;color:#000000;font-style:normal;font-weight:normal;">$</span>4,639,325</div> <div style="text-align:right;text-align-last:auto;"></div> </td> <td style="width:5%; " valign="middle"><span style="line-height:11px;"> </span><div style="text-align:left;text-align-last:auto;"></div> </td> </tr> <tr><td style="width:63%; border-bottom:1px dashed #000000;padding:0px 0px 0px 0px;" valign="middle"><div style="text-align:left;text-align-last:auto;"><span style="font-family:'Fidelity Sans';font-size:11px;color:#000000;font-style:normal;font-weight:normal;">Portfolio Turnover</span></div> </td> <td style="width:32%; border-bottom:1px dashed #000000;padding:0px 0px 0px 0px;" valign="middle"><div style="text-align:right;text-align-last:auto;">25<span style="font-family:'Fidelity Sans';font-size:11px;color:#000000;font-style:normal;font-weight:normal;">%</span></div> <div style="text-align:left;text-align-last:auto;"></div> </td> <td style="width:5%; " valign="top"><span style="line-height:11px;"> </span><div style="text-align:left;text-align-last:auto;"></div> </td> </tr> </table> </div> <div style="text-align:left;text-align-last:auto;"></div> 676458374 64 4639325 0.25       TOP INDUSTRIES (% of Fund's net assets) Banks 34.0   Capital Markets 28.4   Insurance 17.2   Financial Services 14.6   Consumer Finance 4.5   Professional Services 1.0       Common Stocks 99.7 Short-Term Investments and Net Other Assets (Liabilities) 0.3 ASSET ALLOCATION (% of Fund's net assets)     Common Stocks - 99.7                       Short-Term Investments and Net Other Assets (Liabilities) - 0.3   United States 95.1 United Kingdom 1.6 Puerto Rico 0.8 Australia 0.7 Grand Cayman (UK Overseas Ter) 0.7 Mexico 0.6 France 0.5 GEOGRAPHIC DIVERSIFICATION (% of Fund's net assets)     United States - 95.1                       United Kingdom - 1.6                       Puerto Rico - 0.8                          Australia - 0.7                            Grand Cayman (UK Overseas Ter) - 0.7       Mexico - 0.6                               France - 0.5                                   0.340 0.284 0.172 0.146 0.045 0.010 0.997 0.003 0.951 0.016 0.008 0.007 0.007 0.006 0.005 TOP HOLDINGS(% of Fund's net assets)     Mastercard Inc Class A 8.8   Bank of America Corp 7.0   Wells Fargo & Co 6.7   Charles Schwab Corp/The 4.7   State Street Corp 3.9   Citigroup Inc 3.8   Reinsurance Group of America Inc 3.4   Morgan Stanley 2.6   Chubb Ltd 2.5   Capital One Financial Corp 2.4     45.8   0.088 0.070 0.067 0.047 0.039 0.038 0.034 0.026 0.025 0.024 2026-07-31 Fidelity Advisor® Financials Fund Fidelity Advisor® Financials Fund Class I FFSIX This annual shareholder report contains information about Fidelity Advisor® Financials Fund for the period August 1, 2025 to July 31, 2026. annual shareholder report You can find additional information about the Fund at fundresearch.fidelity.com/prospectus/sec. You can also request this information by contacting us at 1-877-208-0098 or by sending an e-mail to fidfunddocuments@fidelity.com. fundresearch.fidelity.com/prospectus/sec 1-877-208-0098 fidfunddocuments@fidelity.com <span style="font-family:'Fidelity Sans';font-size:16px;color:#368627;font-style:normal;font-weight:bold;">What were your Fund costs for the last year?</span> <div style="text-align:left;text-align-last:auto;"><span style="font-family:'Fidelity Sans';font-size:11px;color:#000000;font-style:normal;font-weight:normal;">(based on hypothetical $10,000 investment)</span></div> <div><span style="font-size:11px;"> </span></div><div style="text-align:left;text-align-last:auto;"></div> <div style="text-align:left;text-align-last:auto;"><span style="font-family:'Fidelity Sans';font-size:12px;color:#000000;font-style:normal;font-weight:bold;">FUND COST (PREVIOUS YEAR)</span></div> <div style="text-align:left;text-align-last:auto;"></div> <div style="text-align:left;text-align-last:auto;"><table cellpadding="0" cellspacing="0" style="border-collapse:collapse;border-style:none;" width="100%"><tr><td style="width:51%; background-color:#dfe0e4;border:1px solid #dfe0e4;padding:0px 0px 0px 0px;" valign="bottom"><div style="text-align:left;text-align-last:auto;"><span style="font-family:'Fidelity Sans';font-size:11px;color:#000000;font-style:normal;font-weight:bold;"> </span></div> </td> <td style="width:21%; background-color:#dfe0e4;border:1px solid #dfe0e4;padding:0px 0px 0px 0px;" valign="bottom"><div style="text-align:center;text-align-last:auto;"><span style="font-family:'Fidelity Sans';font-size:11px;color:#000000;font-style:normal;font-weight:bold;">Costs of a $10,000 investment</span></div> </td> <td style="width:27%; background-color:#dfe0e4;border:1px solid #dfe0e4;padding:0px 0px 0px 0px;" valign="bottom"><div style="text-align:center;text-align-last:auto;"><span style="font-family:'Fidelity Sans';font-size:11px;color:#000000;font-style:normal;font-weight:bold;">Costs paid as a percentage of a $10,000 investment </span></div> </td> <td style="width:1%; " valign="top"><span style="line-height:12px;"> </span><div style="text-align:left;text-align-last:auto;"></div> </td> </tr> <tr><td style="width:51%; border-bottom:1px solid #000000;padding:0px 0px 0px 0px;" valign="top"><div style="text-align:left;text-align-last:auto;"><span style="font-family:'Fidelity Sans';font-size:12px;color:#000000;font-style:normal;font-weight:normal;">Class I</span><span style="font-family:'Fidelity Sans';font-size:11px;color:#000000;font-style:normal;font-weight:normal;"> </span></div> </td> <td style="width:21%; border-bottom:1px solid #000000;padding:0px 0px 0px 0px;" valign="middle"><div style="text-align:center;text-align-last:auto;"><span style="font-family:'Fidelity Sans';font-size:11px;color:#000000;font-style:normal;font-weight:normal;">$</span><span style="font-family:'Fidelity Sans';font-size:12px;color:#000000;font-style:normal;font-weight:normal;"> </span>78<span style="font-family:'Fidelity Sans';font-size:11px;color:#000000;font-style:normal;font-weight:normal;"> </span></div> </td> <td style="width:27%; border-bottom:1px solid #000000;padding:0px 0px 0px 0px;" valign="middle"><div style="text-align:center;text-align-last:auto;">0.72<span style="font-family:'Fidelity Sans';font-size:11px;color:#000000;font-style:normal;font-weight:normal;">%</span></div> </td> <td style="width:1%; " valign="top"><span style="line-height:12px;"> </span><div style="text-align:left;text-align-last:auto;"></div> </td> </tr> </table> </div> <div style="text-align:left;text-align-last:auto;"></div> 78 0.0072 <span style="font-family:'Fidelity Sans';font-size:16px;color:#368627;font-style:normal;font-weight:bold;">What affected the Fund's performance this period?</span> <div style="text-align:left;text-align-last:auto;"><span style="font-family:'Fidelity Sans';font-size:11px;color:#000000;font-style:normal;font-weight:bold;"> </span></div> <div style="text-align:left;text-align-last:auto;text-indent:-24px;margin-bottom:2px;margin-left:24px;margin-top:5px;margin-right:0px;"><span style="font-family:'Fidelity Sans';font-size:12px;color:#000000;font-style:normal;font-weight:normal;">•<span style="padding-right:10px"></span>U.S. stocks achieved a strong gain for the 12 months ending July 31, 2026, reflecting enthusiasm for artificial intelligence, strong corporate fundamentals, a resilient economy and, beginning in September, the Federal Reserve's first interest-rate reductions since December 2024.</span></div> <div style="text-align:left;text-align-last:auto;text-indent:-24px;margin-bottom:2px;margin-left:24px;margin-top:5px;margin-right:0px;"><span style="font-family:'Fidelity Sans';font-size:12px;color:#000000;font-style:normal;font-weight:normal;">•<span style="padding-right:10px"></span>Against this backdrop, security selection was the primary contributor to the fund's performance versus the MSCI US IMI Financials 5% Capped Linked Index for the fiscal year, led by property &amp; casualty insurance firms. Stock picks and an overweight in regional banks, along with stock selection and an underweight in the financial exchanges &amp; data category, also boosted the fund's relative performance.</span></div> <div style="text-align:left;text-align-last:auto;text-indent:-24px;margin-bottom:2px;margin-left:24px;margin-top:5px;margin-right:0px;"><span style="font-family:'Fidelity Sans';font-size:12px;color:#000000;font-style:normal;font-weight:normal;">•<span style="padding-right:10px"></span>The top individual relative contributor was an overweight in State Street (+68%). The company was among the fund's biggest holdings. Avoiding S&amp;P Global, an index component that returned -21%, also helped. Another notable relative contributor this period was avoiding Coinbase Global, an index component that returned about -61%.</span></div> <div style="text-align:left;text-align-last:auto;text-indent:-24px;margin-bottom:2px;margin-left:24px;margin-top:5px;margin-right:0px;"><span style="font-family:'Fidelity Sans';font-size:12px;color:#000000;font-style:normal;font-weight:normal;">•<span style="padding-right:10px"></span>In contrast, the primary detractor from performance versus the sector index was an underweight among life &amp; health insurance providers. Stock selection in insurance brokers also hampered the fund's result, as did an overweight in the diversified financial services industry.</span></div> <div style="text-align:left;text-align-last:auto;text-indent:-24px;margin-bottom:2px;margin-left:24px;margin-top:5px;margin-right:0px;"><span style="font-family:'Fidelity Sans';font-size:12px;color:#000000;font-style:normal;font-weight:normal;">•<span style="padding-right:10px"></span>Not owning Goldman Sachs Group, an index component that gained roughly 44%, was the biggest individual relative detractor, followed by an overweight in Blue Owl Capital (-43%). The latter was a stake we established this period. An overweight in Mastercard (+2%), the fund's biggest holding, also detracted.</span></div> <div style="text-align:left;text-align-last:auto;text-indent:-24px;margin-bottom:2px;margin-left:24px;margin-top:5px;margin-right:0px;"><span style="font-family:'Fidelity Sans';font-size:12px;color:#000000;font-style:normal;font-weight:normal;">•<span style="padding-right:10px"></span>Notable changes in positioning include increased exposure to the investment banking &amp; brokerage industry and a lower allocation to financial exchanges &amp; data stocks.</span></div> <div style="text-align:left;text-align-last:auto;"></div> How did the Fund perform over the past 10 years?    CUMULATIVE PERFORMANCE July 31, 2016 through July 31, 2026. Initial investment of $10,000. Class I $10,000 $12,736 $14,319 $14,657 $12,472 $20,243 $19,610 $20,487 $26,740 $32,287 $37,858 MSCI U.S. IMI Financials 5% Capped Linked Index $10,000 $13,125 $14,720 $15,196 $12,873 $20,230 $19,281 $20,321 $26,008 $31,266 $35,275 S&P 500® Index $10,000 $11,604 $13,489 $14,566 $16,308 $22,251 $21,219 $23,980 $29,292 $34,076 $40,742   2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026   <span style="font-family:'Fidelity Sans';font-size:9px;color:#000000;font-style:normal;font-weight:normal;">Class I</span> 10000 12736 14319 14657 12472 20243 19610 20487 26740 32287 37858 <span style="font-family:'Fidelity Sans';font-size:9px;color:#000000;font-style:normal;font-weight:normal;">MSCI U.S. IMI Financials 5% Capped Linked Index</span> 10000 13125 14720 15196 12873 20230 19281 20321 26008 31266 35275 <span style="font-family:'Fidelity Sans';font-size:9px;color:#000000;font-style:normal;font-weight:normal;">S&amp;P 500® Index</span> 10000 11604 13489 14566 16308 22251 21219 23980 29292 34076 40742 AVERAGE ANNUAL TOTAL RETURNS:   1 Year 5 Year 10 Year Class I 17.25% 13.34% 14.24% MSCI U.S. IMI Financials 5% Capped Linked Index 12.82% 11.76% 13.43% S&P 500® Index 19.56% 12.86% 15.08%     Visit institutional.fidelity.com for more recent performance information.    The Fund's past performance is not a good predictor of the Fund's future performance.  The graph and table do not reflect the deduction of taxes that a shareholder would pay on fund distributions or redemption of fund shares. 0.1725 0.1334 0.1424 0.1282 0.1176 0.1343 0.1956 0.1286 0.1508 <span style="font-family:'Fidelity Sans';font-size:11px;color:#000000;font-style:normal;font-weight:normal;">Visit </span><span style="font-family:'Fidelity Sans';font-size:11px;color:#000000;font-style:normal;font-weight:bold;">institutional.fidelity.com</span><span style="font-family:'Fidelity Sans';font-size:11px;color:#000000;font-style:normal;font-weight:normal;"> for more recent performance information.</span> <span style="font-family:'Fidelity Sans';font-size:11px;color:#000000;font-style:italic;font-weight:normal;">The Fund's past performance is not a good predictor of the Fund's future performance.</span> <span style="font-family:'Fidelity Sans';font-size:11px;color:#000000;font-style:normal;font-weight:normal;">The graph and table do not reflect the deduction of taxes that a shareholder would pay on fund distributions or redemption of fund shares.</span> <span style="font-family:'Fidelity Sans';font-size:16px;color:#368627;font-style:normal;font-weight:bold;">Key Fund Statistics</span> <div style="text-align:left;text-align-last:auto;"></div> <div style="text-align:left;text-align-last:auto;"><span style="font-family:'Fidelity Sans';font-size:11px;color:#000000;font-style:normal;font-weight:normal;">(as of July 31, 2026)</span></div> <div><span style="font-size:11px;"> </span></div><div style="text-align:left;text-align-last:auto;"></div> <div style="text-align:right;text-align-last:auto;"><table cellpadding="0" cellspacing="1" style="border-collapse:separate;border-style:none;margin:auto;" width="100%"><tr><td style="width:63%; " valign="top"><div style="text-align:left;text-align-last:auto;"><span style="font-family:'Fidelity Sans';font-size:12px;color:#000000;font-style:normal;font-weight:bold;">KEY FACTS</span></div> <div style="text-align:left;text-align-last:auto;"></div> <div style="text-align:left;text-align-last:auto;"><span style="font-family:'Fidelity Sans';font-size:11px;color:#000000;font-style:normal;font-weight:bold;"> <span> </span></span></div> <div style="text-align:left;text-align-last:auto;"></div> </td> <td style="width:32%; " valign="top"><span style="line-height:12px;"> </span><div style="text-align:left;text-align-last:auto;"></div> </td> <td style="width:5%; " valign="top"><span style="line-height:12px;"> </span><div style="text-align:left;text-align-last:auto;"></div> </td> </tr> <tr><td style="width:63%; border-bottom:1px dashed #000000;padding:0px 0px 0px 0px;" valign="middle"><div style="text-align:left;text-align-last:auto;"><span style="font-family:'Fidelity Sans';font-size:11px;color:#000000;font-style:normal;font-weight:normal;">Fund Size</span></div> </td> <td style="width:32%; border-bottom:1px dashed #000000;padding:0px 0px 0px 0px;" valign="middle"><div style="text-align:right;text-align-last:auto;"><span style="font-family:'Fidelity Sans';font-size:11px;color:#000000;font-style:normal;font-weight:normal;">$</span>676,458,374</div> <div style="text-align:right;text-align-last:auto;"></div> </td> <td style="width:5%; " valign="top"><span style="line-height:11px;"> </span><div style="text-align:left;text-align-last:auto;"></div> </td> </tr> <tr><td style="width:63%; border-bottom:1px dashed #000000;padding:0px 0px 0px 0px;" valign="middle"><div style="text-align:left;text-align-last:auto;"><span style="font-family:'Fidelity Sans';font-size:11px;color:#000000;font-style:normal;font-weight:normal;">Number of Holdings</span></div> </td> <td style="width:32%; border-bottom:1px dashed #000000;padding:0px 0px 0px 0px;" valign="middle"><div style="text-align:right;text-align-last:auto;">64</div> <div style="text-align:right;text-align-last:auto;"></div> </td> <td style="width:5%; " valign="top"><span style="line-height:11px;"> </span><div style="text-align:left;text-align-last:auto;"></div> </td> </tr> <tr><td style="width:63%; border-bottom:1px dashed #000000;padding:0px 0px 0px 0px;" valign="middle"><div style="text-align:left;text-align-last:auto;"><span style="font-family:'Fidelity Sans';font-size:11px;color:#000000;font-style:normal;font-weight:normal;">Total Advisory Fee</span></div> </td> <td style="width:32%; border-bottom:1px dashed #000000;padding:0px 0px 0px 0px;" valign="middle"><div style="text-align:right;text-align-last:auto;"><span style="font-family:'Fidelity Sans';font-size:11px;color:#000000;font-style:normal;font-weight:normal;">$</span>4,639,325</div> <div style="text-align:right;text-align-last:auto;"></div> </td> <td style="width:5%; " valign="middle"><span style="line-height:11px;"> </span><div style="text-align:left;text-align-last:auto;"></div> </td> </tr> <tr><td style="width:63%; border-bottom:1px dashed #000000;padding:0px 0px 0px 0px;" valign="middle"><div style="text-align:left;text-align-last:auto;"><span style="font-family:'Fidelity Sans';font-size:11px;color:#000000;font-style:normal;font-weight:normal;">Portfolio Turnover</span></div> </td> <td style="width:32%; border-bottom:1px dashed #000000;padding:0px 0px 0px 0px;" valign="middle"><div style="text-align:right;text-align-last:auto;">25<span style="font-family:'Fidelity Sans';font-size:11px;color:#000000;font-style:normal;font-weight:normal;">%</span></div> <div style="text-align:left;text-align-last:auto;"></div> </td> <td style="width:5%; " valign="top"><span style="line-height:11px;"> </span><div style="text-align:left;text-align-last:auto;"></div> </td> </tr> </table> </div> <div style="text-align:left;text-align-last:auto;"></div> 676458374 64 4639325 0.25       TOP INDUSTRIES (% of Fund's net assets) Banks 34.0   Capital Markets 28.4   Insurance 17.2   Financial Services 14.6   Consumer Finance 4.5   Professional Services 1.0       Common Stocks 99.7 Short-Term Investments and Net Other Assets (Liabilities) 0.3 ASSET ALLOCATION (% of Fund's net assets)     Common Stocks - 99.7                       Short-Term Investments and Net Other Assets (Liabilities) - 0.3   United States 95.1 United Kingdom 1.6 Puerto Rico 0.8 Australia 0.7 Grand Cayman (UK Overseas Ter) 0.7 Mexico 0.6 France 0.5 GEOGRAPHIC DIVERSIFICATION (% of Fund's net assets)     United States - 95.1                       United Kingdom - 1.6                       Puerto Rico - 0.8                          Australia - 0.7                            Grand Cayman (UK Overseas Ter) - 0.7       Mexico - 0.6                               France - 0.5                                   0.340 0.284 0.172 0.146 0.045 0.010 0.997 0.003 0.951 0.016 0.008 0.007 0.007 0.006 0.005 TOP HOLDINGS(% of Fund's net assets)     Mastercard Inc Class A 8.8   Bank of America Corp 7.0   Wells Fargo & Co 6.7   Charles Schwab Corp/The 4.7   State Street Corp 3.9   Citigroup Inc 3.8   Reinsurance Group of America Inc 3.4   Morgan Stanley 2.6   Chubb Ltd 2.5   Capital One Financial Corp 2.4     45.8   0.088 0.070 0.067 0.047 0.039 0.038 0.034 0.026 0.025 0.024 2026-07-31 Fidelity Advisor® Financials Fund Fidelity Advisor® Financials Fund Class C FAFCX This annual shareholder report contains information about Fidelity Advisor® Financials Fund for the period August 1, 2025 to July 31, 2026. annual shareholder report You can find additional information about the Fund at fundresearch.fidelity.com/prospectus/sec. You can also request this information by contacting us at 1-877-208-0098 or by sending an e-mail to fidfunddocuments@fidelity.com. fundresearch.fidelity.com/prospectus/sec 1-877-208-0098 fidfunddocuments@fidelity.com <span style="font-family:'Fidelity Sans';font-size:16px;color:#368627;font-style:normal;font-weight:bold;">What were your Fund costs for the last year?</span> <div style="text-align:left;text-align-last:auto;"><span style="font-family:'Fidelity Sans';font-size:11px;color:#000000;font-style:normal;font-weight:normal;">(based on hypothetical $10,000 investment)</span></div> <div><span style="font-size:11px;"> </span></div><div style="text-align:left;text-align-last:auto;"></div> <div style="text-align:left;text-align-last:auto;"><span style="font-family:'Fidelity Sans';font-size:12px;color:#000000;font-style:normal;font-weight:bold;">FUND COST (PREVIOUS YEAR)</span></div> <div style="text-align:left;text-align-last:auto;"></div> <div style="text-align:left;text-align-last:auto;"><table cellpadding="0" cellspacing="0" style="border-collapse:collapse;border-style:none;" width="100%"><tr><td style="width:51%; background-color:#dfe0e4;border:1px solid #dfe0e4;padding:0px 0px 0px 0px;" valign="bottom"><div style="text-align:left;text-align-last:auto;"><span style="font-family:'Fidelity Sans';font-size:11px;color:#000000;font-style:normal;font-weight:bold;"> </span></div> </td> <td style="width:21%; background-color:#dfe0e4;border:1px solid #dfe0e4;padding:0px 0px 0px 0px;" valign="bottom"><div style="text-align:center;text-align-last:auto;"><span style="font-family:'Fidelity Sans';font-size:11px;color:#000000;font-style:normal;font-weight:bold;">Costs of a $10,000 investment</span></div> </td> <td style="width:27%; background-color:#dfe0e4;border:1px solid #dfe0e4;padding:0px 0px 0px 0px;" valign="bottom"><div style="text-align:center;text-align-last:auto;"><span style="font-family:'Fidelity Sans';font-size:11px;color:#000000;font-style:normal;font-weight:bold;">Costs paid as a percentage of a $10,000 investment </span></div> </td> <td style="width:1%; " valign="top"><span style="line-height:12px;"> </span><div style="text-align:left;text-align-last:auto;"></div> </td> </tr> <tr><td style="width:51%; border-bottom:1px solid #000000;padding:0px 0px 0px 0px;" valign="top"><div style="text-align:left;text-align-last:auto;"><span style="font-family:'Fidelity Sans';font-size:12px;color:#000000;font-style:normal;font-weight:normal;">Class C</span><span style="font-family:'Fidelity Sans';font-size:11px;color:#000000;font-style:normal;font-weight:normal;"> </span></div> </td> <td style="width:21%; border-bottom:1px solid #000000;padding:0px 0px 0px 0px;" valign="middle"><div style="text-align:center;text-align-last:auto;"><span style="font-family:'Fidelity Sans';font-size:11px;color:#000000;font-style:normal;font-weight:normal;">$</span><span style="font-family:'Fidelity Sans';font-size:12px;color:#000000;font-style:normal;font-weight:normal;"> </span>188<span style="font-family:'Fidelity Sans';font-size:11px;color:#000000;font-style:normal;font-weight:normal;"> </span></div> </td> <td style="width:27%; border-bottom:1px solid #000000;padding:0px 0px 0px 0px;" valign="middle"><div style="text-align:center;text-align-last:auto;">1.74<span style="font-family:'Fidelity Sans';font-size:11px;color:#000000;font-style:normal;font-weight:normal;">%</span></div> </td> <td style="width:1%; " valign="top"><span style="line-height:12px;"> </span><div style="text-align:left;text-align-last:auto;"></div> </td> </tr> </table> </div> <div style="text-align:left;text-align-last:auto;"></div> 188 0.0174 <span style="font-family:'Fidelity Sans';font-size:16px;color:#368627;font-style:normal;font-weight:bold;">What affected the Fund's performance this period?</span> <div style="text-align:left;text-align-last:auto;"><span style="font-family:'Fidelity Sans';font-size:11px;color:#000000;font-style:normal;font-weight:bold;"> </span></div> <div style="text-align:left;text-align-last:auto;text-indent:-24px;margin-bottom:2px;margin-left:24px;margin-top:5px;margin-right:0px;"><span style="font-family:'Fidelity Sans';font-size:12px;color:#000000;font-style:normal;font-weight:normal;">•<span style="padding-right:10px"></span>U.S. stocks achieved a strong gain for the 12 months ending July 31, 2026, reflecting enthusiasm for artificial intelligence, strong corporate fundamentals, a resilient economy and, beginning in September, the Federal Reserve's first interest-rate reductions since December 2024.</span></div> <div style="text-align:left;text-align-last:auto;text-indent:-24px;margin-bottom:2px;margin-left:24px;margin-top:5px;margin-right:0px;"><span style="font-family:'Fidelity Sans';font-size:12px;color:#000000;font-style:normal;font-weight:normal;">•<span style="padding-right:10px"></span>Against this backdrop, security selection was the primary contributor to the fund's performance versus the MSCI US IMI Financials 5% Capped Linked Index for the fiscal year, led by property &amp; casualty insurance firms. Stock picks and an overweight in regional banks, along with stock selection and an underweight in the financial exchanges &amp; data category, also boosted the fund's relative performance.</span></div> <div style="text-align:left;text-align-last:auto;text-indent:-24px;margin-bottom:2px;margin-left:24px;margin-top:5px;margin-right:0px;"><span style="font-family:'Fidelity Sans';font-size:12px;color:#000000;font-style:normal;font-weight:normal;">•<span style="padding-right:10px"></span>The top individual relative contributor was an overweight in State Street (+68%). The company was among the fund's biggest holdings. Avoiding S&amp;P Global, an index component that returned -21%, also helped. Another notable relative contributor this period was avoiding Coinbase Global, an index component that returned about -61%.</span></div> <div style="text-align:left;text-align-last:auto;text-indent:-24px;margin-bottom:2px;margin-left:24px;margin-top:5px;margin-right:0px;"><span style="font-family:'Fidelity Sans';font-size:12px;color:#000000;font-style:normal;font-weight:normal;">•<span style="padding-right:10px"></span>In contrast, the primary detractor from performance versus the sector index was an underweight among life &amp; health insurance providers. Stock selection in insurance brokers also hampered the fund's result, as did an overweight in the diversified financial services industry.</span></div> <div style="text-align:left;text-align-last:auto;text-indent:-24px;margin-bottom:2px;margin-left:24px;margin-top:5px;margin-right:0px;"><span style="font-family:'Fidelity Sans';font-size:12px;color:#000000;font-style:normal;font-weight:normal;">•<span style="padding-right:10px"></span>Not owning Goldman Sachs Group, an index component that gained roughly 44%, was the biggest individual relative detractor, followed by an overweight in Blue Owl Capital (-43%). The latter was a stake we established this period. An overweight in Mastercard (+2%), the fund's biggest holding, also detracted.</span></div> <div style="text-align:left;text-align-last:auto;text-indent:-24px;margin-bottom:2px;margin-left:24px;margin-top:5px;margin-right:0px;"><span style="font-family:'Fidelity Sans';font-size:12px;color:#000000;font-style:normal;font-weight:normal;">•<span style="padding-right:10px"></span>Notable changes in positioning include increased exposure to the investment banking &amp; brokerage industry and a lower allocation to financial exchanges &amp; data stocks.</span></div> <div style="text-align:left;text-align-last:auto;"></div> How did the Fund perform over the past 10 years?    CUMULATIVE PERFORMANCE July 31, 2016 through July 31, 2026. Initial investment of $10,000. Class C $10,000 $12,606 $14,029 $14,211 $11,966 $19,220 $18,427 $19,049 $24,618 $29,645 $34,673 MSCI U.S. IMI Financials 5% Capped Linked Index $10,000 $13,125 $14,720 $15,196 $12,873 $20,230 $19,281 $20,321 $26,008 $31,266 $35,275 S&P 500® Index $10,000 $11,604 $13,489 $14,566 $16,308 $22,251 $21,219 $23,980 $29,292 $34,076 $40,742   2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026   <span style="font-family:'Fidelity Sans';font-size:9px;color:#000000;font-style:normal;font-weight:normal;">Class C</span> 10000 12606 14029 14211 11966 19220 18427 19049 24618 29645 34673 <span style="font-family:'Fidelity Sans';font-size:9px;color:#000000;font-style:normal;font-weight:normal;">MSCI U.S. IMI Financials 5% Capped Linked Index</span> 10000 13125 14720 15196 12873 20230 19281 20321 26008 31266 35275 <span style="font-family:'Fidelity Sans';font-size:9px;color:#000000;font-style:normal;font-weight:normal;">S&amp;P 500® Index</span> 10000 11604 13489 14566 16308 22251 21219 23980 29292 34076 40742 AVERAGE ANNUAL TOTAL RETURNS:   1 Year 5 Year 10 Year Class C  (incl. contingent deferred sales charge) 15.06% 12.18% 13.24% Class C 16.06% 12.18% 13.24% MSCI U.S. IMI Financials 5% Capped Linked Index 12.82% 11.76% 13.43% S&P 500® Index 19.56% 12.86% 15.08%     Visit institutional.fidelity.com for more recent performance information.    The Fund's past performance is not a good predictor of the Fund's future performance.  The graph and table do not reflect the deduction of taxes that a shareholder would pay on fund distributions or redemption of fund shares. 0.1506 0.1218 0.1324 0.1606 0.1218 0.1324 0.1282 0.1176 0.1343 0.1956 0.1286 0.1508 <span style="font-family:'Fidelity Sans';font-size:11px;color:#000000;font-style:normal;font-weight:normal;">Visit </span><span style="font-family:'Fidelity Sans';font-size:11px;color:#000000;font-style:normal;font-weight:bold;">institutional.fidelity.com</span><span style="font-family:'Fidelity Sans';font-size:11px;color:#000000;font-style:normal;font-weight:normal;"> for more recent performance information.</span> <span style="font-family:'Fidelity Sans';font-size:11px;color:#000000;font-style:italic;font-weight:normal;">The Fund's past performance is not a good predictor of the Fund's future performance.</span> <span style="font-family:'Fidelity Sans';font-size:11px;color:#000000;font-style:normal;font-weight:normal;">The graph and table do not reflect the deduction of taxes that a shareholder would pay on fund distributions or redemption of fund shares.</span> <span style="font-family:'Fidelity Sans';font-size:16px;color:#368627;font-style:normal;font-weight:bold;">Key Fund Statistics</span> <div style="text-align:left;text-align-last:auto;"></div> <div style="text-align:left;text-align-last:auto;"><span style="font-family:'Fidelity Sans';font-size:11px;color:#000000;font-style:normal;font-weight:normal;">(as of July 31, 2026)</span></div> <div><span style="font-size:11px;"> </span></div><div style="text-align:left;text-align-last:auto;"></div> <div style="text-align:right;text-align-last:auto;"><table cellpadding="0" cellspacing="1" style="border-collapse:separate;border-style:none;margin:auto;" width="100%"><tr><td style="width:63%; " valign="top"><div style="text-align:left;text-align-last:auto;"><span style="font-family:'Fidelity Sans';font-size:12px;color:#000000;font-style:normal;font-weight:bold;">KEY FACTS</span></div> <div style="text-align:left;text-align-last:auto;"></div> <div style="text-align:left;text-align-last:auto;"><span style="font-family:'Fidelity Sans';font-size:11px;color:#000000;font-style:normal;font-weight:bold;"> <span> </span></span></div> <div style="text-align:left;text-align-last:auto;"></div> </td> <td style="width:32%; " valign="top"><span style="line-height:12px;"> </span><div style="text-align:left;text-align-last:auto;"></div> </td> <td style="width:5%; " valign="top"><span style="line-height:12px;"> </span><div style="text-align:left;text-align-last:auto;"></div> </td> </tr> <tr><td style="width:63%; border-bottom:1px dashed #000000;padding:0px 0px 0px 0px;" valign="middle"><div style="text-align:left;text-align-last:auto;"><span style="font-family:'Fidelity Sans';font-size:11px;color:#000000;font-style:normal;font-weight:normal;">Fund Size</span></div> </td> <td style="width:32%; border-bottom:1px dashed #000000;padding:0px 0px 0px 0px;" valign="middle"><div style="text-align:right;text-align-last:auto;"><span style="font-family:'Fidelity Sans';font-size:11px;color:#000000;font-style:normal;font-weight:normal;">$</span>676,458,374</div> <div style="text-align:right;text-align-last:auto;"></div> </td> <td style="width:5%; " valign="top"><span style="line-height:11px;"> </span><div style="text-align:left;text-align-last:auto;"></div> </td> </tr> <tr><td style="width:63%; border-bottom:1px dashed #000000;padding:0px 0px 0px 0px;" valign="middle"><div style="text-align:left;text-align-last:auto;"><span style="font-family:'Fidelity Sans';font-size:11px;color:#000000;font-style:normal;font-weight:normal;">Number of Holdings</span></div> </td> <td style="width:32%; border-bottom:1px dashed #000000;padding:0px 0px 0px 0px;" valign="middle"><div style="text-align:right;text-align-last:auto;">64</div> <div style="text-align:right;text-align-last:auto;"></div> </td> <td style="width:5%; " valign="top"><span style="line-height:11px;"> </span><div style="text-align:left;text-align-last:auto;"></div> </td> </tr> <tr><td style="width:63%; border-bottom:1px dashed #000000;padding:0px 0px 0px 0px;" valign="middle"><div style="text-align:left;text-align-last:auto;"><span style="font-family:'Fidelity Sans';font-size:11px;color:#000000;font-style:normal;font-weight:normal;">Total Advisory Fee</span></div> </td> <td style="width:32%; border-bottom:1px dashed #000000;padding:0px 0px 0px 0px;" valign="middle"><div style="text-align:right;text-align-last:auto;"><span style="font-family:'Fidelity Sans';font-size:11px;color:#000000;font-style:normal;font-weight:normal;">$</span>4,639,325</div> <div style="text-align:right;text-align-last:auto;"></div> </td> <td style="width:5%; " valign="middle"><span style="line-height:11px;"> </span><div style="text-align:left;text-align-last:auto;"></div> </td> </tr> <tr><td style="width:63%; border-bottom:1px dashed #000000;padding:0px 0px 0px 0px;" valign="middle"><div style="text-align:left;text-align-last:auto;"><span style="font-family:'Fidelity Sans';font-size:11px;color:#000000;font-style:normal;font-weight:normal;">Portfolio Turnover</span></div> </td> <td style="width:32%; border-bottom:1px dashed #000000;padding:0px 0px 0px 0px;" valign="middle"><div style="text-align:right;text-align-last:auto;">25<span style="font-family:'Fidelity Sans';font-size:11px;color:#000000;font-style:normal;font-weight:normal;">%</span></div> <div style="text-align:left;text-align-last:auto;"></div> </td> <td style="width:5%; " valign="top"><span style="line-height:11px;"> </span><div style="text-align:left;text-align-last:auto;"></div> </td> </tr> </table> </div> <div style="text-align:left;text-align-last:auto;"></div> 676458374 64 4639325 0.25       TOP INDUSTRIES (% of Fund's net assets) Banks 34.0   Capital Markets 28.4   Insurance 17.2   Financial Services 14.6   Consumer Finance 4.5   Professional Services 1.0       Common Stocks 99.7 Short-Term Investments and Net Other Assets (Liabilities) 0.3 ASSET ALLOCATION (% of Fund's net assets)     Common Stocks - 99.7                       Short-Term Investments and Net Other Assets (Liabilities) - 0.3   United States 95.1 United Kingdom 1.6 Puerto Rico 0.8 Australia 0.7 Grand Cayman (UK Overseas Ter) 0.7 Mexico 0.6 France 0.5 GEOGRAPHIC DIVERSIFICATION (% of Fund's net assets)     United States - 95.1                       United Kingdom - 1.6                       Puerto Rico - 0.8                          Australia - 0.7                            Grand Cayman (UK Overseas Ter) - 0.7       Mexico - 0.6                               France - 0.5                                   0.340 0.284 0.172 0.146 0.045 0.010 0.997 0.003 0.951 0.016 0.008 0.007 0.007 0.006 0.005 TOP HOLDINGS(% of Fund's net assets)     Mastercard Inc Class A 8.8   Bank of America Corp 7.0   Wells Fargo & Co 6.7   Charles Schwab Corp/The 4.7   State Street Corp 3.9   Citigroup Inc 3.8   Reinsurance Group of America Inc 3.4   Morgan Stanley 2.6   Chubb Ltd 2.5   Capital One Financial Corp 2.4     45.8   0.088 0.070 0.067 0.047 0.039 0.038 0.034 0.026 0.025 0.024 2026-07-31 Fidelity Advisor® Financials Fund Fidelity Advisor® Financials Fund Class A FAFDX This annual shareholder report contains information about Fidelity Advisor® Financials Fund for the period August 1, 2025 to July 31, 2026. annual shareholder report You can find additional information about the Fund at fundresearch.fidelity.com/prospectus/sec. You can also request this information by contacting us at 1-877-208-0098 or by sending an e-mail to fidfunddocuments@fidelity.com. fundresearch.fidelity.com/prospectus/sec 1-877-208-0098 fidfunddocuments@fidelity.com <span style="font-family:'Fidelity Sans';font-size:16px;color:#368627;font-style:normal;font-weight:bold;">What were your Fund costs for the last year?</span> <div style="text-align:left;text-align-last:auto;"><span style="font-family:'Fidelity Sans';font-size:11px;color:#000000;font-style:normal;font-weight:normal;">(based on hypothetical $10,000 investment)</span></div> <div><span style="font-size:11px;"> </span></div><div style="text-align:left;text-align-last:auto;"></div> <div style="text-align:left;text-align-last:auto;"><span style="font-family:'Fidelity Sans';font-size:12px;color:#000000;font-style:normal;font-weight:bold;">FUND COST (PREVIOUS YEAR)</span></div> <div style="text-align:left;text-align-last:auto;"></div> <div style="text-align:left;text-align-last:auto;"><table cellpadding="0" cellspacing="0" style="border-collapse:collapse;border-style:none;" width="100%"><tr><td style="width:51%; background-color:#dfe0e4;border:1px solid #dfe0e4;padding:0px 0px 0px 0px;" valign="bottom"><div style="text-align:left;text-align-last:auto;"><span style="font-family:'Fidelity Sans';font-size:11px;color:#000000;font-style:normal;font-weight:bold;"> </span></div> </td> <td style="width:21%; background-color:#dfe0e4;border:1px solid #dfe0e4;padding:0px 0px 0px 0px;" valign="bottom"><div style="text-align:center;text-align-last:auto;"><span style="font-family:'Fidelity Sans';font-size:11px;color:#000000;font-style:normal;font-weight:bold;">Costs of a $10,000 investment</span></div> </td> <td style="width:27%; background-color:#dfe0e4;border:1px solid #dfe0e4;padding:0px 0px 0px 0px;" valign="bottom"><div style="text-align:center;text-align-last:auto;"><span style="font-family:'Fidelity Sans';font-size:11px;color:#000000;font-style:normal;font-weight:bold;">Costs paid as a percentage of a $10,000 investment </span></div> </td> <td style="width:1%; " valign="top"><span style="line-height:12px;"> </span><div style="text-align:left;text-align-last:auto;"></div> </td> </tr> <tr><td style="width:51%; border-bottom:1px solid #000000;padding:0px 0px 0px 0px;" valign="top"><div style="text-align:left;text-align-last:auto;"><span style="font-family:'Fidelity Sans';font-size:12px;color:#000000;font-style:normal;font-weight:normal;">Class A</span><span style="font-family:'Fidelity Sans';font-size:11px;color:#000000;font-style:normal;font-weight:normal;"> </span></div> </td> <td style="width:21%; border-bottom:1px solid #000000;padding:0px 0px 0px 0px;" valign="middle"><div style="text-align:center;text-align-last:auto;"><span style="font-family:'Fidelity Sans';font-size:11px;color:#000000;font-style:normal;font-weight:normal;">$</span><span style="font-family:'Fidelity Sans';font-size:12px;color:#000000;font-style:normal;font-weight:normal;"> </span>107<span style="font-family:'Fidelity Sans';font-size:11px;color:#000000;font-style:normal;font-weight:normal;"> </span></div> </td> <td style="width:27%; border-bottom:1px solid #000000;padding:0px 0px 0px 0px;" valign="middle"><div style="text-align:center;text-align-last:auto;">0.99<span style="font-family:'Fidelity Sans';font-size:11px;color:#000000;font-style:normal;font-weight:normal;">%</span></div> </td> <td style="width:1%; " valign="top"><span style="line-height:12px;"> </span><div style="text-align:left;text-align-last:auto;"></div> </td> </tr> </table> </div> <div style="text-align:left;text-align-last:auto;"></div> 107 0.0099 <span style="font-family:'Fidelity Sans';font-size:16px;color:#368627;font-style:normal;font-weight:bold;">What affected the Fund's performance this period?</span> <div style="text-align:left;text-align-last:auto;"><span style="font-family:'Fidelity Sans';font-size:11px;color:#000000;font-style:normal;font-weight:bold;"> </span></div> <div style="text-align:left;text-align-last:auto;text-indent:-24px;margin-bottom:2px;margin-left:24px;margin-top:5px;margin-right:0px;"><span style="font-family:'Fidelity Sans';font-size:12px;color:#000000;font-style:normal;font-weight:normal;">•<span style="padding-right:10px"></span>U.S. stocks achieved a strong gain for the 12 months ending July 31, 2026, reflecting enthusiasm for artificial intelligence, strong corporate fundamentals, a resilient economy and, beginning in September, the Federal Reserve's first interest-rate reductions since December 2024.</span></div> <div style="text-align:left;text-align-last:auto;text-indent:-24px;margin-bottom:2px;margin-left:24px;margin-top:5px;margin-right:0px;"><span style="font-family:'Fidelity Sans';font-size:12px;color:#000000;font-style:normal;font-weight:normal;">•<span style="padding-right:10px"></span>Against this backdrop, security selection was the primary contributor to the fund's performance versus the MSCI US IMI Financials 5% Capped Linked Index for the fiscal year, led by property &amp; casualty insurance firms. Stock picks and an overweight in regional banks, along with stock selection and an underweight in the financial exchanges &amp; data category, also boosted the fund's relative performance.</span></div> <div style="text-align:left;text-align-last:auto;text-indent:-24px;margin-bottom:2px;margin-left:24px;margin-top:5px;margin-right:0px;"><span style="font-family:'Fidelity Sans';font-size:12px;color:#000000;font-style:normal;font-weight:normal;">•<span style="padding-right:10px"></span>The top individual relative contributor was an overweight in State Street (+68%). The company was among the fund's biggest holdings. Avoiding S&amp;P Global, an index component that returned -21%, also helped. Another notable relative contributor this period was avoiding Coinbase Global, an index component that returned about -61%.</span></div> <div style="text-align:left;text-align-last:auto;text-indent:-24px;margin-bottom:2px;margin-left:24px;margin-top:5px;margin-right:0px;"><span style="font-family:'Fidelity Sans';font-size:12px;color:#000000;font-style:normal;font-weight:normal;">•<span style="padding-right:10px"></span>In contrast, the primary detractor from performance versus the sector index was an underweight among life &amp; health insurance providers. Stock selection in insurance brokers also hampered the fund's result, as did an overweight in the diversified financial services industry.</span></div> <div style="text-align:left;text-align-last:auto;text-indent:-24px;margin-bottom:2px;margin-left:24px;margin-top:5px;margin-right:0px;"><span style="font-family:'Fidelity Sans';font-size:12px;color:#000000;font-style:normal;font-weight:normal;">•<span style="padding-right:10px"></span>Not owning Goldman Sachs Group, an index component that gained roughly 44%, was the biggest individual relative detractor, followed by an overweight in Blue Owl Capital (-43%). The latter was a stake we established this period. An overweight in Mastercard (+2%), the fund's biggest holding, also detracted.</span></div> <div style="text-align:left;text-align-last:auto;text-indent:-24px;margin-bottom:2px;margin-left:24px;margin-top:5px;margin-right:0px;"><span style="font-family:'Fidelity Sans';font-size:12px;color:#000000;font-style:normal;font-weight:normal;">•<span style="padding-right:10px"></span>Notable changes in positioning include increased exposure to the investment banking &amp; brokerage industry and a lower allocation to financial exchanges &amp; data stocks.</span></div> <div style="text-align:left;text-align-last:auto;"></div> How did the Fund perform over the past 10 years?    CUMULATIVE PERFORMANCE July 31, 2016 through July 31, 2026. Initial investment of $10,000 and the current sales charge was paid. Class A $9,425 $11,967 $13,418 $13,693 $11,619 $18,803 $18,164 $18,922 $24,632 $29,662 $34,693 MSCI U.S. IMI Financials 5% Capped Linked Index $10,000 $13,125 $14,720 $15,196 $12,873 $20,230 $19,281 $20,321 $26,008 $31,266 $35,275 S&P 500® Index $10,000 $11,604 $13,489 $14,566 $16,308 $22,251 $21,219 $23,980 $29,292 $34,076 $40,742   2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026   <span style="font-family:'Fidelity Sans';font-size:9px;color:#000000;font-style:normal;font-weight:normal;">Class A</span> 9425 11967 13418 13693 11619 18803 18164 18922 24632 29662 34693 <span style="font-family:'Fidelity Sans';font-size:9px;color:#000000;font-style:normal;font-weight:normal;">MSCI U.S. IMI Financials 5% Capped Linked Index</span> 10000 13125 14720 15196 12873 20230 19281 20321 26008 31266 35275 <span style="font-family:'Fidelity Sans';font-size:9px;color:#000000;font-style:normal;font-weight:normal;">S&amp;P 500® Index</span> 10000 11604 13489 14566 16308 22251 21219 23980 29292 34076 40742 AVERAGE ANNUAL TOTAL RETURNS:   1 Year 5 Year 10 Year Class A (incl. 5.75% sales charge)   10.24% 11.70% 13.25% Class A (without 5.75% sales charge) 16.96% 13.03% 13.92% MSCI U.S. IMI Financials 5% Capped Linked Index 12.82% 11.76% 13.43% S&P 500® Index 19.56% 12.86% 15.08%     Visit institutional.fidelity.com for more recent performance information.    The Fund's past performance is not a good predictor of the Fund's future performance.  The graph and table do not reflect the deduction of taxes that a shareholder would pay on fund distributions or redemption of fund shares. 0.1024 0.1170 0.1325 0.1696 0.1303 0.1392 0.1282 0.1176 0.1343 0.1956 0.1286 0.1508 <span style="font-family:'Fidelity Sans';font-size:11px;color:#000000;font-style:normal;font-weight:normal;">Visit </span><span style="font-family:'Fidelity Sans';font-size:11px;color:#000000;font-style:normal;font-weight:bold;">institutional.fidelity.com</span><span style="font-family:'Fidelity Sans';font-size:11px;color:#000000;font-style:normal;font-weight:normal;"> for more recent performance information.</span> <span style="font-family:'Fidelity Sans';font-size:11px;color:#000000;font-style:italic;font-weight:normal;">The Fund's past performance is not a good predictor of the Fund's future performance.</span> <span style="font-family:'Fidelity Sans';font-size:11px;color:#000000;font-style:normal;font-weight:normal;">The graph and table do not reflect the deduction of taxes that a shareholder would pay on fund distributions or redemption of fund shares.</span> <span style="font-family:'Fidelity Sans';font-size:16px;color:#368627;font-style:normal;font-weight:bold;">Key Fund Statistics</span> <div style="text-align:left;text-align-last:auto;"></div> <div style="text-align:left;text-align-last:auto;"><span style="font-family:'Fidelity Sans';font-size:11px;color:#000000;font-style:normal;font-weight:normal;">(as of July 31, 2026)</span></div> <div><span style="font-size:11px;"> </span></div><div style="text-align:left;text-align-last:auto;"></div> <div style="text-align:right;text-align-last:auto;"><table cellpadding="0" cellspacing="1" style="border-collapse:separate;border-style:none;margin:auto;" width="100%"><tr><td style="width:63%; " valign="top"><div style="text-align:left;text-align-last:auto;"><span style="font-family:'Fidelity Sans';font-size:12px;color:#000000;font-style:normal;font-weight:bold;">KEY FACTS</span></div> <div style="text-align:left;text-align-last:auto;"></div> <div style="text-align:left;text-align-last:auto;"><span style="font-family:'Fidelity Sans';font-size:11px;color:#000000;font-style:normal;font-weight:bold;"> <span> </span></span></div> <div style="text-align:left;text-align-last:auto;"></div> </td> <td style="width:32%; " valign="top"><span style="line-height:12px;"> </span><div style="text-align:left;text-align-last:auto;"></div> </td> <td style="width:5%; " valign="top"><span style="line-height:12px;"> </span><div style="text-align:left;text-align-last:auto;"></div> </td> </tr> <tr><td style="width:63%; border-bottom:1px dashed #000000;padding:0px 0px 0px 0px;" valign="middle"><div style="text-align:left;text-align-last:auto;"><span style="font-family:'Fidelity Sans';font-size:11px;color:#000000;font-style:normal;font-weight:normal;">Fund Size</span></div> </td> <td style="width:32%; border-bottom:1px dashed #000000;padding:0px 0px 0px 0px;" valign="middle"><div style="text-align:right;text-align-last:auto;"><span style="font-family:'Fidelity Sans';font-size:11px;color:#000000;font-style:normal;font-weight:normal;">$</span>676,458,374</div> <div style="text-align:right;text-align-last:auto;"></div> </td> <td style="width:5%; " valign="top"><span style="line-height:11px;"> </span><div style="text-align:left;text-align-last:auto;"></div> </td> </tr> <tr><td style="width:63%; border-bottom:1px dashed #000000;padding:0px 0px 0px 0px;" valign="middle"><div style="text-align:left;text-align-last:auto;"><span style="font-family:'Fidelity Sans';font-size:11px;color:#000000;font-style:normal;font-weight:normal;">Number of Holdings</span></div> </td> <td style="width:32%; border-bottom:1px dashed #000000;padding:0px 0px 0px 0px;" valign="middle"><div style="text-align:right;text-align-last:auto;">64</div> <div style="text-align:right;text-align-last:auto;"></div> </td> <td style="width:5%; " valign="top"><span style="line-height:11px;"> </span><div style="text-align:left;text-align-last:auto;"></div> </td> </tr> <tr><td style="width:63%; border-bottom:1px dashed #000000;padding:0px 0px 0px 0px;" valign="middle"><div style="text-align:left;text-align-last:auto;"><span style="font-family:'Fidelity Sans';font-size:11px;color:#000000;font-style:normal;font-weight:normal;">Total Advisory Fee</span></div> </td> <td style="width:32%; border-bottom:1px dashed #000000;padding:0px 0px 0px 0px;" valign="middle"><div style="text-align:right;text-align-last:auto;"><span style="font-family:'Fidelity Sans';font-size:11px;color:#000000;font-style:normal;font-weight:normal;">$</span>4,639,325</div> <div style="text-align:right;text-align-last:auto;"></div> </td> <td style="width:5%; " valign="middle"><span style="line-height:11px;"> </span><div style="text-align:left;text-align-last:auto;"></div> </td> </tr> <tr><td style="width:63%; border-bottom:1px dashed #000000;padding:0px 0px 0px 0px;" valign="middle"><div style="text-align:left;text-align-last:auto;"><span style="font-family:'Fidelity Sans';font-size:11px;color:#000000;font-style:normal;font-weight:normal;">Portfolio Turnover</span></div> </td> <td style="width:32%; border-bottom:1px dashed #000000;padding:0px 0px 0px 0px;" valign="middle"><div style="text-align:right;text-align-last:auto;">25<span style="font-family:'Fidelity Sans';font-size:11px;color:#000000;font-style:normal;font-weight:normal;">%</span></div> <div style="text-align:left;text-align-last:auto;"></div> </td> <td style="width:5%; " valign="top"><span style="line-height:11px;"> </span><div style="text-align:left;text-align-last:auto;"></div> </td> </tr> </table> </div> <div style="text-align:left;text-align-last:auto;"></div> 676458374 64 4639325 0.25       TOP INDUSTRIES (% of Fund's net assets) Banks 34.0   Capital Markets 28.4   Insurance 17.2   Financial Services 14.6   Consumer Finance 4.5   Professional Services 1.0       Common Stocks 99.7 Short-Term Investments and Net Other Assets (Liabilities) 0.3 ASSET ALLOCATION (% of Fund's net assets)     Common Stocks - 99.7                       Short-Term Investments and Net Other Assets (Liabilities) - 0.3   United States 95.1 United Kingdom 1.6 Puerto Rico 0.8 Australia 0.7 Grand Cayman (UK Overseas Ter) 0.7 Mexico 0.6 France 0.5 GEOGRAPHIC DIVERSIFICATION (% of Fund's net assets)     United States - 95.1                       United Kingdom - 1.6                       Puerto Rico - 0.8                          Australia - 0.7                            Grand Cayman (UK Overseas Ter) - 0.7       Mexico - 0.6                               France - 0.5                                   0.340 0.284 0.172 0.146 0.045 0.010 0.997 0.003 0.951 0.016 0.008 0.007 0.007 0.006 0.005 TOP HOLDINGS(% of Fund's net assets)     Mastercard Inc Class A 8.8   Bank of America Corp 7.0   Wells Fargo & Co 6.7   Charles Schwab Corp/The 4.7   State Street Corp 3.9   Citigroup Inc 3.8   Reinsurance Group of America Inc 3.4   Morgan Stanley 2.6   Chubb Ltd 2.5   Capital One Financial Corp 2.4     45.8   0.088 0.070 0.067 0.047 0.039 0.038 0.034 0.026 0.025 0.024 2026-07-31 Fidelity Advisor® Biotechnology Fund Fidelity Advisor® Biotechnology Fund Class Z FIJYX This annual shareholder report contains information about Fidelity Advisor® Biotechnology Fund for the period August 1, 2025 to July 31, 2026. annual shareholder report You can find additional information about the Fund at fundresearch.fidelity.com/prospectus/sec. You can also request this information by contacting us at 1-877-208-0098 or by sending an e-mail to fidfunddocuments@fidelity.com. fundresearch.fidelity.com/prospectus/sec 1-877-208-0098 fidfunddocuments@fidelity.com <span style="font-family:'Fidelity Sans';font-size:16px;color:#368627;font-style:normal;font-weight:bold;">What were your Fund costs for the last year?</span> <div style="text-align:left;text-align-last:auto;"><span style="font-family:'Fidelity Sans';font-size:11px;color:#000000;font-style:normal;font-weight:normal;">(based on hypothetical $10,000 investment)</span></div> <div><span style="font-size:11px;"> </span></div><div style="text-align:left;text-align-last:auto;"></div> <div style="text-align:left;text-align-last:auto;"><span style="font-family:'Fidelity Sans';font-size:12px;color:#000000;font-style:normal;font-weight:bold;">FUND COST (PREVIOUS YEAR)</span></div> <div style="text-align:left;text-align-last:auto;"></div> <div style="text-align:left;text-align-last:auto;"><table cellpadding="0" cellspacing="0" style="border-collapse:collapse;border-style:none;" width="100%"><tr><td style="width:51%; background-color:#dfe0e4;border:1px solid #dfe0e4;padding:0px 0px 0px 0px;" valign="bottom"><div style="text-align:left;text-align-last:auto;"><span style="font-family:'Fidelity Sans';font-size:11px;color:#000000;font-style:normal;font-weight:bold;"> </span></div> </td> <td style="width:21%; background-color:#dfe0e4;border:1px solid #dfe0e4;padding:0px 0px 0px 0px;" valign="bottom"><div style="text-align:center;text-align-last:auto;"><span style="font-family:'Fidelity Sans';font-size:11px;color:#000000;font-style:normal;font-weight:bold;">Costs of a $10,000 investment</span></div> </td> <td style="width:27%; background-color:#dfe0e4;border:1px solid #dfe0e4;padding:0px 0px 0px 0px;" valign="bottom"><div style="text-align:center;text-align-last:auto;"><span style="font-family:'Fidelity Sans';font-size:11px;color:#000000;font-style:normal;font-weight:bold;">Costs paid as a percentage of a $10,000 investment </span></div> </td> <td style="width:1%; " valign="top"><span style="line-height:12px;"> </span><div style="text-align:left;text-align-last:auto;"></div> </td> </tr> <tr><td style="width:51%; border-bottom:1px solid #000000;padding:0px 0px 0px 0px;" valign="top"><div style="text-align:left;text-align-last:auto;"><span style="font-family:'Fidelity Sans';font-size:12px;color:#000000;font-style:normal;font-weight:normal;">Class Z</span><span style="font-family:'Fidelity Sans';font-size:11px;color:#000000;font-style:normal;font-weight:normal;"> </span></div> </td> <td style="width:21%; border-bottom:1px solid #000000;padding:0px 0px 0px 0px;" valign="middle"><div style="text-align:center;text-align-last:auto;"><span style="font-family:'Fidelity Sans';font-size:11px;color:#000000;font-style:normal;font-weight:normal;">$</span><span style="font-family:'Fidelity Sans';font-size:12px;color:#000000;font-style:normal;font-weight:normal;"> </span>74<span style="font-family:'Fidelity Sans';font-size:11px;color:#000000;font-style:normal;font-weight:normal;"> </span></div> </td> <td style="width:27%; border-bottom:1px solid #000000;padding:0px 0px 0px 0px;" valign="middle"><div style="text-align:center;text-align-last:auto;">0.57<span style="font-family:'Fidelity Sans';font-size:11px;color:#000000;font-style:normal;font-weight:normal;">%</span></div> </td> <td style="width:1%; " valign="top"><span style="line-height:12px;"> </span><div style="text-align:left;text-align-last:auto;"></div> </td> </tr> </table> </div> <div style="text-align:left;text-align-last:auto;"></div> 74 0.0057 <span style="font-family:'Fidelity Sans';font-size:16px;color:#368627;font-style:normal;font-weight:bold;">What affected the Fund's performance this period?</span> <div style="text-align:left;text-align-last:auto;"><span style="font-family:'Fidelity Sans';font-size:11px;color:#000000;font-style:normal;font-weight:bold;"> </span></div> <div style="text-align:left;text-align-last:auto;text-indent:-24px;margin-bottom:2px;margin-left:24px;margin-top:5px;margin-right:0px;"><span style="font-family:'Fidelity Sans';font-size:12px;color:#000000;font-style:normal;font-weight:normal;">•<span style="padding-right:10px"></span>U.S. stocks achieved a strong gain for the 12 months ending July 31, 2026, reflecting enthusiasm for artificial intelligence, strong corporate fundamentals, a resilient economy and, beginning in September, the Federal Reserve's first interest-rate reductions since December 2024.</span></div> <div style="text-align:left;text-align-last:auto;text-indent:-24px;margin-bottom:2px;margin-left:24px;margin-top:5px;margin-right:0px;"><span style="font-family:'Fidelity Sans';font-size:12px;color:#000000;font-style:normal;font-weight:normal;">•<span style="padding-right:10px"></span>Against this backdrop, security selection was the primary contributor to the fund's performance versus the MSCI US IMI Biotechnology 25/50 Index for the fiscal year, especially within biotechnology. Security selection in pharmaceuticals and health care technology, most of which were out-of-index positions, also boosted the fund's relative performance.</span></div> <div style="text-align:left;text-align-last:auto;text-indent:-24px;margin-bottom:2px;margin-left:24px;margin-top:5px;margin-right:0px;"><span style="font-family:'Fidelity Sans';font-size:12px;color:#000000;font-style:normal;font-weight:normal;">•<span style="padding-right:10px"></span>The top individual relative contributor was an overweight in Oruka Therapeutics (+612%). The company was among the fund's biggest holdings at period end. A second notable relative contributor was an overweight in Spyre Therapeutics (+484%). The company was one of the fund's largest holdings at period end. An overweight in Cogent Biosciences (+240%) also helped. The company was one of the fund's biggest holdings.</span></div> <div style="text-align:left;text-align-last:auto;text-indent:-24px;margin-bottom:2px;margin-left:24px;margin-top:5px;margin-right:0px;"><span style="font-family:'Fidelity Sans';font-size:12px;color:#000000;font-style:normal;font-weight:normal;">•<span style="padding-right:10px"></span>The largest individual relative detractor was an overweight in Alnylam Pharmaceuticals (-48%). The stock was among our biggest holdings. A second notable relative detractor was our stake in Soleno Therapeutics (-53%). The stock was not held at period end. Untimely positioning in uniQure (+17%) also hurt. This was a position we established this period.</span></div> <div style="text-align:left;text-align-last:auto;text-indent:-24px;margin-bottom:2px;margin-left:24px;margin-top:5px;margin-right:0px;"><span style="font-family:'Fidelity Sans';font-size:12px;color:#000000;font-style:normal;font-weight:normal;">•<span style="padding-right:10px"></span>Notable changes in positioning include a higher allocation to pharmaceuticals and lower exposure to biotechnology.</span></div> <div style="text-align:left;text-align-last:auto;"></div> How did the Fund perform over the life of Fund?    CUMULATIVE PERFORMANCE October 2, 2018 through July 31, 2026. Initial investment of $10,000. Class Z $10,000 $9,217 $12,031 $13,774 $11,207 $12,965 $16,814 $15,597 $25,394 MSCI U.S. IMI Biotechnology 25-50 Index $10,000 $8,683 $11,477 $13,581 $12,037 $13,159 $16,701 $15,512 $22,429 S&P 500® Index $10,000 $10,365 $11,604 $15,833 $15,098 $17,064 $20,843 $24,247 $28,991   2018 2019 2020 2021 2022 2023 2024 2025 2026   <span style="font-family:'Fidelity Sans';font-size:9px;color:#000000;font-style:normal;font-weight:normal;">Class Z</span> 10000 9217 12031 13774 11207 12965 16814 15597 25394 <span style="font-family:'Fidelity Sans';font-size:9px;color:#000000;font-style:normal;font-weight:normal;">MSCI U.S. IMI Biotechnology 25-50 Index</span> 10000 8683 11477 13581 12037 13159 16701 15512 22429 <span style="font-family:'Fidelity Sans';font-size:9px;color:#000000;font-style:normal;font-weight:normal;">S&amp;P 500® Index</span> 10000 10365 11604 15833 15098 17064 20843 24247 28991 AVERAGE ANNUAL TOTAL RETURNS:   1 Year 5 Year Life of Fund A Class Z 62.81% 13.01% 12.63% MSCI U.S. IMI Biotechnology 25-50 Index 44.59% 10.55% 10.86% S&P 500® Index 19.56% 12.86% 14.56% A   From October 2, 2018   Visit institutional.fidelity.com for more recent performance information.    The Fund's past performance is not a good predictor of the Fund's future performance.  The graph and table do not reflect the deduction of taxes that a shareholder would pay on fund distributions or redemption of fund shares. 0.6281 0.1301 0.1263 0.4459 0.1055 0.1086 0.1956 0.1286 0.1456 2018-10-02 <span style="font-family:'Fidelity Sans';font-size:11px;color:#000000;font-style:normal;font-weight:normal;">Visit </span><span style="font-family:'Fidelity Sans';font-size:11px;color:#000000;font-style:normal;font-weight:bold;">institutional.fidelity.com</span><span style="font-family:'Fidelity Sans';font-size:11px;color:#000000;font-style:normal;font-weight:normal;"> for more recent performance information.</span> <span style="font-family:'Fidelity Sans';font-size:11px;color:#000000;font-style:italic;font-weight:normal;">The Fund's past performance is not a good predictor of the Fund's future performance.</span> <span style="font-family:'Fidelity Sans';font-size:11px;color:#000000;font-style:normal;font-weight:normal;">The graph and table do not reflect the deduction of taxes that a shareholder would pay on fund distributions or redemption of fund shares.</span> <span style="font-family:'Fidelity Sans';font-size:16px;color:#368627;font-style:normal;font-weight:bold;">Key Fund Statistics</span> <div style="text-align:left;text-align-last:auto;"></div> <div style="text-align:left;text-align-last:auto;"><span style="font-family:'Fidelity Sans';font-size:11px;color:#000000;font-style:normal;font-weight:normal;">(as of July 31, 2026)</span></div> <div><span style="font-size:11px;"> </span></div><div style="text-align:left;text-align-last:auto;"></div> <div style="text-align:right;text-align-last:auto;"><table cellpadding="0" cellspacing="1" style="border-collapse:separate;border-style:none;margin:auto;" width="100%"><tr><td style="width:63%; " valign="top"><div style="text-align:left;text-align-last:auto;"><span style="font-family:'Fidelity Sans';font-size:12px;color:#000000;font-style:normal;font-weight:bold;">KEY FACTS</span></div> <div style="text-align:left;text-align-last:auto;"></div> <div style="text-align:left;text-align-last:auto;"><span style="font-family:'Fidelity Sans';font-size:11px;color:#000000;font-style:normal;font-weight:bold;"> <span> </span></span></div> <div style="text-align:left;text-align-last:auto;"></div> </td> <td style="width:32%; " valign="top"><span style="line-height:12px;"> </span><div style="text-align:left;text-align-last:auto;"></div> </td> <td style="width:5%; " valign="top"><span style="line-height:12px;"> </span><div style="text-align:left;text-align-last:auto;"></div> </td> </tr> <tr><td style="width:63%; border-bottom:1px dashed #000000;padding:0px 0px 0px 0px;" valign="middle"><div style="text-align:left;text-align-last:auto;"><span style="font-family:'Fidelity Sans';font-size:11px;color:#000000;font-style:normal;font-weight:normal;">Fund Size</span></div> </td> <td style="width:32%; border-bottom:1px dashed #000000;padding:0px 0px 0px 0px;" valign="middle"><div style="text-align:right;text-align-last:auto;"><span style="font-family:'Fidelity Sans';font-size:11px;color:#000000;font-style:normal;font-weight:normal;">$</span>2,204,320,575</div> <div style="text-align:right;text-align-last:auto;"></div> </td> <td style="width:5%; " valign="top"><span style="line-height:11px;"> </span><div style="text-align:left;text-align-last:auto;"></div> </td> </tr> <tr><td style="width:63%; border-bottom:1px dashed #000000;padding:0px 0px 0px 0px;" valign="middle"><div style="text-align:left;text-align-last:auto;"><span style="font-family:'Fidelity Sans';font-size:11px;color:#000000;font-style:normal;font-weight:normal;">Number of Holdings</span></div> </td> <td style="width:32%; border-bottom:1px dashed #000000;padding:0px 0px 0px 0px;" valign="middle"><div style="text-align:right;text-align-last:auto;">116</div> <div style="text-align:right;text-align-last:auto;"></div> </td> <td style="width:5%; " valign="top"><span style="line-height:11px;"> </span><div style="text-align:left;text-align-last:auto;"></div> </td> </tr> <tr><td style="width:63%; border-bottom:1px dashed #000000;padding:0px 0px 0px 0px;" valign="middle"><div style="text-align:left;text-align-last:auto;"><span style="font-family:'Fidelity Sans';font-size:11px;color:#000000;font-style:normal;font-weight:normal;">Total Advisory Fee</span></div> </td> <td style="width:32%; border-bottom:1px dashed #000000;padding:0px 0px 0px 0px;" valign="middle"><div style="text-align:right;text-align-last:auto;"><span style="font-family:'Fidelity Sans';font-size:11px;color:#000000;font-style:normal;font-weight:normal;">$</span>12,169,643</div> <div style="text-align:right;text-align-last:auto;"></div> </td> <td style="width:5%; " valign="middle"><span style="line-height:11px;"> </span><div style="text-align:left;text-align-last:auto;"></div> </td> </tr> <tr><td style="width:63%; border-bottom:1px dashed #000000;padding:0px 0px 0px 0px;" valign="middle"><div style="text-align:left;text-align-last:auto;"><span style="font-family:'Fidelity Sans';font-size:11px;color:#000000;font-style:normal;font-weight:normal;">Portfolio Turnover</span></div> </td> <td style="width:32%; border-bottom:1px dashed #000000;padding:0px 0px 0px 0px;" valign="middle"><div style="text-align:right;text-align-last:auto;">54<span style="font-family:'Fidelity Sans';font-size:11px;color:#000000;font-style:normal;font-weight:normal;">%</span></div> <div style="text-align:left;text-align-last:auto;"></div> </td> <td style="width:5%; " valign="top"><span style="line-height:11px;"> </span><div style="text-align:left;text-align-last:auto;"></div> </td> </tr> </table> </div> <div style="text-align:left;text-align-last:auto;"></div> 2204320575 116 12169643 0.54       TOP INDUSTRIES (% of Fund's net assets) Biotechnology 88.4   Pharmaceuticals 10.6   Health Care Technology 0.0       Common Stocks 97.5 Preferred Stocks 1.5 Bonds 0.1 Preferred Securities 0.0 Short-Term Investments and Net Other Assets (Liabilities) 0.9 ASSET ALLOCATION (% of Fund's net assets)     Common Stocks - 97.5                       Preferred Stocks - 1.5                     Bonds - 0.1                                Preferred Securities - 0.0                 Short-Term Investments and Net Other Assets (Liabilities) - 0.9   United States 90.6 Netherlands 4.0 Denmark 3.0 Canada 1.0 France 0.4 Belgium 0.4 United Kingdom 0.3 Germany 0.2 Australia 0.1 GEOGRAPHIC DIVERSIFICATION (% of Fund's net assets)     United States - 90.6                       Netherlands - 4.0                          Denmark - 3.0                              Canada - 1.0                               France - 0.4                               Belgium - 0.4                              United Kingdom - 0.3                       Germany - 0.2                              Australia - 0.1                                0.884 0.106 0.000 0.975 0.015 0.001 0.000 0.009 0.906 0.040 0.030 0.010 0.004 0.004 0.003 0.002 0.001 TOP HOLDINGS(% of Fund's net assets)     AbbVie Inc 14.8   Gilead Sciences Inc 5.8   Spyre Therapeutics Inc 3.8   Alnylam Pharmaceuticals Inc 3.6   Dianthus Therapeutics Inc 3.5   Cogent Biosciences Inc 3.2   Oruka Therapeutics Inc 3.2   Insmed Inc 3.0   Revolution Medicines Inc 3.0   Argenx SE ADR 3.0     46.9   0.148 0.058 0.038 0.036 0.035 0.032 0.032 0.030 0.030 0.030 2026-07-31 Fidelity Advisor® Biotechnology Fund Fidelity Advisor® Biotechnology Fund Class M FBTTX This annual shareholder report contains information about Fidelity Advisor® Biotechnology Fund for the period August 1, 2025 to July 31, 2026. annual shareholder report You can find additional information about the Fund at fundresearch.fidelity.com/prospectus/sec. You can also request this information by contacting us at 1-877-208-0098 or by sending an e-mail to fidfunddocuments@fidelity.com. fundresearch.fidelity.com/prospectus/sec 1-877-208-0098 fidfunddocuments@fidelity.com <span style="font-family:'Fidelity Sans';font-size:16px;color:#368627;font-style:normal;font-weight:bold;">What were your Fund costs for the last year?</span> <div style="text-align:left;text-align-last:auto;"><span style="font-family:'Fidelity Sans';font-size:11px;color:#000000;font-style:normal;font-weight:normal;">(based on hypothetical $10,000 investment)</span></div> <div><span style="font-size:11px;"> </span></div><div style="text-align:left;text-align-last:auto;"></div> <div style="text-align:left;text-align-last:auto;"><span style="font-family:'Fidelity Sans';font-size:12px;color:#000000;font-style:normal;font-weight:bold;">FUND COST (PREVIOUS YEAR)</span></div> <div style="text-align:left;text-align-last:auto;"></div> <div style="text-align:left;text-align-last:auto;"><table cellpadding="0" cellspacing="0" style="border-collapse:collapse;border-style:none;" width="100%"><tr><td style="width:51%; background-color:#dfe0e4;border:1px solid #dfe0e4;padding:0px 0px 0px 0px;" valign="bottom"><div style="text-align:left;text-align-last:auto;"><span style="font-family:'Fidelity Sans';font-size:11px;color:#000000;font-style:normal;font-weight:bold;"> </span></div> </td> <td style="width:21%; background-color:#dfe0e4;border:1px solid #dfe0e4;padding:0px 0px 0px 0px;" valign="bottom"><div style="text-align:center;text-align-last:auto;"><span style="font-family:'Fidelity Sans';font-size:11px;color:#000000;font-style:normal;font-weight:bold;">Costs of a $10,000 investment</span></div> </td> <td style="width:27%; background-color:#dfe0e4;border:1px solid #dfe0e4;padding:0px 0px 0px 0px;" valign="bottom"><div style="text-align:center;text-align-last:auto;"><span style="font-family:'Fidelity Sans';font-size:11px;color:#000000;font-style:normal;font-weight:bold;">Costs paid as a percentage of a $10,000 investment </span></div> </td> <td style="width:1%; " valign="top"><span style="line-height:12px;"> </span><div style="text-align:left;text-align-last:auto;"></div> </td> </tr> <tr><td style="width:51%; border-bottom:1px solid #000000;padding:0px 0px 0px 0px;" valign="top"><div style="text-align:left;text-align-last:auto;"><span style="font-family:'Fidelity Sans';font-size:12px;color:#000000;font-style:normal;font-weight:normal;">Class M</span><span style="font-family:'Fidelity Sans';font-size:11px;color:#000000;font-style:normal;font-weight:normal;"> </span></div> </td> <td style="width:21%; border-bottom:1px solid #000000;padding:0px 0px 0px 0px;" valign="middle"><div style="text-align:center;text-align-last:auto;"><span style="font-family:'Fidelity Sans';font-size:11px;color:#000000;font-style:normal;font-weight:normal;">$</span><span style="font-family:'Fidelity Sans';font-size:12px;color:#000000;font-style:normal;font-weight:normal;"> </span>155<span style="font-family:'Fidelity Sans';font-size:11px;color:#000000;font-style:normal;font-weight:normal;"> </span></div> </td> <td style="width:27%; border-bottom:1px solid #000000;padding:0px 0px 0px 0px;" valign="middle"><div style="text-align:center;text-align-last:auto;">1.19<span style="font-family:'Fidelity Sans';font-size:11px;color:#000000;font-style:normal;font-weight:normal;">%</span></div> </td> <td style="width:1%; " valign="top"><span style="line-height:12px;"> </span><div style="text-align:left;text-align-last:auto;"></div> </td> </tr> </table> </div> <div style="text-align:left;text-align-last:auto;"></div> 155 0.0119 <span style="font-family:'Fidelity Sans';font-size:16px;color:#368627;font-style:normal;font-weight:bold;">What affected the Fund's performance this period?</span> <div style="text-align:left;text-align-last:auto;"><span style="font-family:'Fidelity Sans';font-size:11px;color:#000000;font-style:normal;font-weight:bold;"> </span></div> <div style="text-align:left;text-align-last:auto;text-indent:-24px;margin-bottom:2px;margin-left:24px;margin-top:5px;margin-right:0px;"><span style="font-family:'Fidelity Sans';font-size:12px;color:#000000;font-style:normal;font-weight:normal;">•<span style="padding-right:10px"></span>U.S. stocks achieved a strong gain for the 12 months ending July 31, 2026, reflecting enthusiasm for artificial intelligence, strong corporate fundamentals, a resilient economy and, beginning in September, the Federal Reserve's first interest-rate reductions since December 2024.</span></div> <div style="text-align:left;text-align-last:auto;text-indent:-24px;margin-bottom:2px;margin-left:24px;margin-top:5px;margin-right:0px;"><span style="font-family:'Fidelity Sans';font-size:12px;color:#000000;font-style:normal;font-weight:normal;">•<span style="padding-right:10px"></span>Against this backdrop, security selection was the primary contributor to the fund's performance versus the MSCI US IMI Biotechnology 25/50 Index for the fiscal year, especially within biotechnology. Security selection in pharmaceuticals and health care technology, most of which were out-of-index positions, also boosted the fund's relative performance.</span></div> <div style="text-align:left;text-align-last:auto;text-indent:-24px;margin-bottom:2px;margin-left:24px;margin-top:5px;margin-right:0px;"><span style="font-family:'Fidelity Sans';font-size:12px;color:#000000;font-style:normal;font-weight:normal;">•<span style="padding-right:10px"></span>The top individual relative contributor was an overweight in Oruka Therapeutics (+612%). The company was among the fund's biggest holdings at period end. A second notable relative contributor was an overweight in Spyre Therapeutics (+484%). The company was one of the fund's largest holdings at period end. An overweight in Cogent Biosciences (+240%) also helped. The company was one of the fund's biggest holdings.</span></div> <div style="text-align:left;text-align-last:auto;text-indent:-24px;margin-bottom:2px;margin-left:24px;margin-top:5px;margin-right:0px;"><span style="font-family:'Fidelity Sans';font-size:12px;color:#000000;font-style:normal;font-weight:normal;">•<span style="padding-right:10px"></span>The largest individual relative detractor was an overweight in Alnylam Pharmaceuticals (-48%). The stock was among our biggest holdings. A second notable relative detractor was our stake in Soleno Therapeutics (-53%). The stock was not held at period end. Untimely positioning in uniQure (+17%) also hurt. This was a position we established this period.</span></div> <div style="text-align:left;text-align-last:auto;text-indent:-24px;margin-bottom:2px;margin-left:24px;margin-top:5px;margin-right:0px;"><span style="font-family:'Fidelity Sans';font-size:12px;color:#000000;font-style:normal;font-weight:normal;">•<span style="padding-right:10px"></span>Notable changes in positioning include a higher allocation to pharmaceuticals and lower exposure to biotechnology.</span></div> <div style="text-align:left;text-align-last:auto;"></div> How did the Fund perform over the past 10 years?    CUMULATIVE PERFORMANCE July 31, 2016 through July 31, 2026. Initial investment of $10,000 and the current sales charge was paid. Class M $9,650 $10,989 $12,456 $11,654 $15,109 $17,177 $13,883 $15,948 $20,552 $18,947 $30,651 MSCI U.S. IMI Biotechnology 25-50 Index $10,000 $11,625 $12,983 $11,564 $15,286 $18,089 $16,032 $17,526 $22,245 $20,661 $29,874 S&P 500® Index $10,000 $11,604 $13,489 $14,566 $16,308 $22,251 $21,219 $23,980 $29,292 $34,076 $40,742   2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026   <span style="font-family:'Fidelity Sans';font-size:9px;color:#000000;font-style:normal;font-weight:normal;">Class M</span> 9650 10989 12456 11654 15109 17177 13883 15948 20552 18947 30651 <span style="font-family:'Fidelity Sans';font-size:9px;color:#000000;font-style:normal;font-weight:normal;">MSCI U.S. IMI Biotechnology 25-50 Index</span> 10000 11625 12983 11564 15286 18089 16032 17526 22245 20661 29874 <span style="font-family:'Fidelity Sans';font-size:9px;color:#000000;font-style:normal;font-weight:normal;">S&amp;P 500® Index</span> 10000 11604 13489 14566 16308 22251 21219 23980 29292 34076 40742 AVERAGE ANNUAL TOTAL RETURNS:   1 Year 5 Year 10 Year Class M (incl. 3.50% sales charge)   56.11% 11.48% 11.85% Class M (without 3.50% sales charge) 61.77% 12.28% 12.25% MSCI U.S. IMI Biotechnology 25-50 Index 44.59% 10.55% 11.57% S&P 500® Index 19.56% 12.86% 15.08%     Visit institutional.fidelity.com for more recent performance information.    The Fund's past performance is not a good predictor of the Fund's future performance.  The graph and table do not reflect the deduction of taxes that a shareholder would pay on fund distributions or redemption of fund shares. 0.5611 0.1148 0.1185 0.6177 0.1228 0.1225 0.4459 0.1055 0.1157 0.1956 0.1286 0.1508 <span style="font-family:'Fidelity Sans';font-size:11px;color:#000000;font-style:normal;font-weight:normal;">Visit </span><span style="font-family:'Fidelity Sans';font-size:11px;color:#000000;font-style:normal;font-weight:bold;">institutional.fidelity.com</span><span style="font-family:'Fidelity Sans';font-size:11px;color:#000000;font-style:normal;font-weight:normal;"> for more recent performance information.</span> <span style="font-family:'Fidelity Sans';font-size:11px;color:#000000;font-style:italic;font-weight:normal;">The Fund's past performance is not a good predictor of the Fund's future performance.</span> <span style="font-family:'Fidelity Sans';font-size:11px;color:#000000;font-style:normal;font-weight:normal;">The graph and table do not reflect the deduction of taxes that a shareholder would pay on fund distributions or redemption of fund shares.</span> <span style="font-family:'Fidelity Sans';font-size:16px;color:#368627;font-style:normal;font-weight:bold;">Key Fund Statistics</span> <div style="text-align:left;text-align-last:auto;"></div> <div style="text-align:left;text-align-last:auto;"><span style="font-family:'Fidelity Sans';font-size:11px;color:#000000;font-style:normal;font-weight:normal;">(as of July 31, 2026)</span></div> <div><span style="font-size:11px;"> </span></div><div style="text-align:left;text-align-last:auto;"></div> <div style="text-align:right;text-align-last:auto;"><table cellpadding="0" cellspacing="1" style="border-collapse:separate;border-style:none;margin:auto;" width="100%"><tr><td style="width:63%; " valign="top"><div style="text-align:left;text-align-last:auto;"><span style="font-family:'Fidelity Sans';font-size:12px;color:#000000;font-style:normal;font-weight:bold;">KEY FACTS</span></div> <div style="text-align:left;text-align-last:auto;"></div> <div style="text-align:left;text-align-last:auto;"><span style="font-family:'Fidelity Sans';font-size:11px;color:#000000;font-style:normal;font-weight:bold;"> <span> </span></span></div> <div style="text-align:left;text-align-last:auto;"></div> </td> <td style="width:32%; " valign="top"><span style="line-height:12px;"> </span><div style="text-align:left;text-align-last:auto;"></div> </td> <td style="width:5%; " valign="top"><span style="line-height:12px;"> </span><div style="text-align:left;text-align-last:auto;"></div> </td> </tr> <tr><td style="width:63%; border-bottom:1px dashed #000000;padding:0px 0px 0px 0px;" valign="middle"><div style="text-align:left;text-align-last:auto;"><span style="font-family:'Fidelity Sans';font-size:11px;color:#000000;font-style:normal;font-weight:normal;">Fund Size</span></div> </td> <td style="width:32%; border-bottom:1px dashed #000000;padding:0px 0px 0px 0px;" valign="middle"><div style="text-align:right;text-align-last:auto;"><span style="font-family:'Fidelity Sans';font-size:11px;color:#000000;font-style:normal;font-weight:normal;">$</span>2,204,320,575</div> <div style="text-align:right;text-align-last:auto;"></div> </td> <td style="width:5%; " valign="top"><span style="line-height:11px;"> </span><div style="text-align:left;text-align-last:auto;"></div> </td> </tr> <tr><td style="width:63%; border-bottom:1px dashed #000000;padding:0px 0px 0px 0px;" valign="middle"><div style="text-align:left;text-align-last:auto;"><span style="font-family:'Fidelity Sans';font-size:11px;color:#000000;font-style:normal;font-weight:normal;">Number of Holdings</span></div> </td> <td style="width:32%; border-bottom:1px dashed #000000;padding:0px 0px 0px 0px;" valign="middle"><div style="text-align:right;text-align-last:auto;">116</div> <div style="text-align:right;text-align-last:auto;"></div> </td> <td style="width:5%; " valign="top"><span style="line-height:11px;"> </span><div style="text-align:left;text-align-last:auto;"></div> </td> </tr> <tr><td style="width:63%; border-bottom:1px dashed #000000;padding:0px 0px 0px 0px;" valign="middle"><div style="text-align:left;text-align-last:auto;"><span style="font-family:'Fidelity Sans';font-size:11px;color:#000000;font-style:normal;font-weight:normal;">Total Advisory Fee</span></div> </td> <td style="width:32%; border-bottom:1px dashed #000000;padding:0px 0px 0px 0px;" valign="middle"><div style="text-align:right;text-align-last:auto;"><span style="font-family:'Fidelity Sans';font-size:11px;color:#000000;font-style:normal;font-weight:normal;">$</span>12,169,643</div> <div style="text-align:right;text-align-last:auto;"></div> </td> <td style="width:5%; " valign="middle"><span style="line-height:11px;"> </span><div style="text-align:left;text-align-last:auto;"></div> </td> </tr> <tr><td style="width:63%; border-bottom:1px dashed #000000;padding:0px 0px 0px 0px;" valign="middle"><div style="text-align:left;text-align-last:auto;"><span style="font-family:'Fidelity Sans';font-size:11px;color:#000000;font-style:normal;font-weight:normal;">Portfolio Turnover</span></div> </td> <td style="width:32%; border-bottom:1px dashed #000000;padding:0px 0px 0px 0px;" valign="middle"><div style="text-align:right;text-align-last:auto;">54<span style="font-family:'Fidelity Sans';font-size:11px;color:#000000;font-style:normal;font-weight:normal;">%</span></div> <div style="text-align:left;text-align-last:auto;"></div> </td> <td style="width:5%; " valign="top"><span style="line-height:11px;"> </span><div style="text-align:left;text-align-last:auto;"></div> </td> </tr> </table> </div> <div style="text-align:left;text-align-last:auto;"></div> 2204320575 116 12169643 0.54       TOP INDUSTRIES (% of Fund's net assets) Biotechnology 88.4   Pharmaceuticals 10.6   Health Care Technology 0.0       Common Stocks 97.5 Preferred Stocks 1.5 Bonds 0.1 Preferred Securities 0.0 Short-Term Investments and Net Other Assets (Liabilities) 0.9 ASSET ALLOCATION (% of Fund's net assets)     Common Stocks - 97.5                       Preferred Stocks - 1.5                     Bonds - 0.1                                Preferred Securities - 0.0                 Short-Term Investments and Net Other Assets (Liabilities) - 0.9   United States 90.6 Netherlands 4.0 Denmark 3.0 Canada 1.0 France 0.4 Belgium 0.4 United Kingdom 0.3 Germany 0.2 Australia 0.1 GEOGRAPHIC DIVERSIFICATION (% of Fund's net assets)     United States - 90.6                       Netherlands - 4.0                          Denmark - 3.0                              Canada - 1.0                               France - 0.4                               Belgium - 0.4                              United Kingdom - 0.3                       Germany - 0.2                              Australia - 0.1                                0.884 0.106 0.000 0.975 0.015 0.001 0.000 0.009 0.906 0.040 0.030 0.010 0.004 0.004 0.003 0.002 0.001 TOP HOLDINGS(% of Fund's net assets)     AbbVie Inc 14.8   Gilead Sciences Inc 5.8   Spyre Therapeutics Inc 3.8   Alnylam Pharmaceuticals Inc 3.6   Dianthus Therapeutics Inc 3.5   Cogent Biosciences Inc 3.2   Oruka Therapeutics Inc 3.2   Insmed Inc 3.0   Revolution Medicines Inc 3.0   Argenx SE ADR 3.0     46.9   0.148 0.058 0.038 0.036 0.035 0.032 0.032 0.030 0.030 0.030 2026-07-31 Fidelity Advisor® Biotechnology Fund Fidelity Advisor® Biotechnology Fund Class I FBTIX This annual shareholder report contains information about Fidelity Advisor® Biotechnology Fund for the period August 1, 2025 to July 31, 2026. annual shareholder report You can find additional information about the Fund at fundresearch.fidelity.com/prospectus/sec. You can also request this information by contacting us at 1-877-208-0098 or by sending an e-mail to fidfunddocuments@fidelity.com. fundresearch.fidelity.com/prospectus/sec 1-877-208-0098 fidfunddocuments@fidelity.com <span style="font-family:'Fidelity Sans';font-size:16px;color:#368627;font-style:normal;font-weight:bold;">What were your Fund costs for the last year?</span> <div style="text-align:left;text-align-last:auto;"><span style="font-family:'Fidelity Sans';font-size:11px;color:#000000;font-style:normal;font-weight:normal;">(based on hypothetical $10,000 investment)</span></div> <div><span style="font-size:11px;"> </span></div><div style="text-align:left;text-align-last:auto;"></div> <div style="text-align:left;text-align-last:auto;"><span style="font-family:'Fidelity Sans';font-size:12px;color:#000000;font-style:normal;font-weight:bold;">FUND COST (PREVIOUS YEAR)</span></div> <div style="text-align:left;text-align-last:auto;"></div> <div style="text-align:left;text-align-last:auto;"><table cellpadding="0" cellspacing="0" style="border-collapse:collapse;border-style:none;" width="100%"><tr><td style="width:51%; background-color:#dfe0e4;border:1px solid #dfe0e4;padding:0px 0px 0px 0px;" valign="bottom"><div style="text-align:left;text-align-last:auto;"><span style="font-family:'Fidelity Sans';font-size:11px;color:#000000;font-style:normal;font-weight:bold;"> </span></div> </td> <td style="width:21%; background-color:#dfe0e4;border:1px solid #dfe0e4;padding:0px 0px 0px 0px;" valign="bottom"><div style="text-align:center;text-align-last:auto;"><span style="font-family:'Fidelity Sans';font-size:11px;color:#000000;font-style:normal;font-weight:bold;">Costs of a $10,000 investment</span></div> </td> <td style="width:27%; background-color:#dfe0e4;border:1px solid #dfe0e4;padding:0px 0px 0px 0px;" valign="bottom"><div style="text-align:center;text-align-last:auto;"><span style="font-family:'Fidelity Sans';font-size:11px;color:#000000;font-style:normal;font-weight:bold;">Costs paid as a percentage of a $10,000 investment </span></div> </td> <td style="width:1%; " valign="top"><span style="line-height:12px;"> </span><div style="text-align:left;text-align-last:auto;"></div> </td> </tr> <tr><td style="width:51%; border-bottom:1px solid #000000;padding:0px 0px 0px 0px;" valign="top"><div style="text-align:left;text-align-last:auto;"><span style="font-family:'Fidelity Sans';font-size:12px;color:#000000;font-style:normal;font-weight:normal;">Class I</span><span style="font-family:'Fidelity Sans';font-size:11px;color:#000000;font-style:normal;font-weight:normal;"> </span></div> </td> <td style="width:21%; border-bottom:1px solid #000000;padding:0px 0px 0px 0px;" valign="middle"><div style="text-align:center;text-align-last:auto;"><span style="font-family:'Fidelity Sans';font-size:11px;color:#000000;font-style:normal;font-weight:normal;">$</span><span style="font-family:'Fidelity Sans';font-size:12px;color:#000000;font-style:normal;font-weight:normal;"> </span>90<span style="font-family:'Fidelity Sans';font-size:11px;color:#000000;font-style:normal;font-weight:normal;"> </span></div> </td> <td style="width:27%; border-bottom:1px solid #000000;padding:0px 0px 0px 0px;" valign="middle"><div style="text-align:center;text-align-last:auto;">0.69<span style="font-family:'Fidelity Sans';font-size:11px;color:#000000;font-style:normal;font-weight:normal;">%</span></div> </td> <td style="width:1%; " valign="top"><span style="line-height:12px;"> </span><div style="text-align:left;text-align-last:auto;"></div> </td> </tr> </table> </div> <div style="text-align:left;text-align-last:auto;"></div> 90 0.0069 <span style="font-family:'Fidelity Sans';font-size:16px;color:#368627;font-style:normal;font-weight:bold;">What affected the Fund's performance this period?</span> <div style="text-align:left;text-align-last:auto;"><span style="font-family:'Fidelity Sans';font-size:11px;color:#000000;font-style:normal;font-weight:bold;"> </span></div> <div style="text-align:left;text-align-last:auto;text-indent:-24px;margin-bottom:2px;margin-left:24px;margin-top:5px;margin-right:0px;"><span style="font-family:'Fidelity Sans';font-size:12px;color:#000000;font-style:normal;font-weight:normal;">•<span style="padding-right:10px"></span>U.S. stocks achieved a strong gain for the 12 months ending July 31, 2026, reflecting enthusiasm for artificial intelligence, strong corporate fundamentals, a resilient economy and, beginning in September, the Federal Reserve's first interest-rate reductions since December 2024.</span></div> <div style="text-align:left;text-align-last:auto;text-indent:-24px;margin-bottom:2px;margin-left:24px;margin-top:5px;margin-right:0px;"><span style="font-family:'Fidelity Sans';font-size:12px;color:#000000;font-style:normal;font-weight:normal;">•<span style="padding-right:10px"></span>Against this backdrop, security selection was the primary contributor to the fund's performance versus the MSCI US IMI Biotechnology 25/50 Index for the fiscal year, especially within biotechnology. Security selection in pharmaceuticals and health care technology, most of which were out-of-index positions, also boosted the fund's relative performance.</span></div> <div style="text-align:left;text-align-last:auto;text-indent:-24px;margin-bottom:2px;margin-left:24px;margin-top:5px;margin-right:0px;"><span style="font-family:'Fidelity Sans';font-size:12px;color:#000000;font-style:normal;font-weight:normal;">•<span style="padding-right:10px"></span>The top individual relative contributor was an overweight in Oruka Therapeutics (+612%). The company was among the fund's biggest holdings at period end. A second notable relative contributor was an overweight in Spyre Therapeutics (+484%). The company was one of the fund's largest holdings at period end. An overweight in Cogent Biosciences (+240%) also helped. The company was one of the fund's biggest holdings.</span></div> <div style="text-align:left;text-align-last:auto;text-indent:-24px;margin-bottom:2px;margin-left:24px;margin-top:5px;margin-right:0px;"><span style="font-family:'Fidelity Sans';font-size:12px;color:#000000;font-style:normal;font-weight:normal;">•<span style="padding-right:10px"></span>The largest individual relative detractor was an overweight in Alnylam Pharmaceuticals (-48%). The stock was among our biggest holdings. A second notable relative detractor was our stake in Soleno Therapeutics (-53%). The stock was not held at period end. Untimely positioning in uniQure (+17%) also hurt. This was a position we established this period.</span></div> <div style="text-align:left;text-align-last:auto;text-indent:-24px;margin-bottom:2px;margin-left:24px;margin-top:5px;margin-right:0px;"><span style="font-family:'Fidelity Sans';font-size:12px;color:#000000;font-style:normal;font-weight:normal;">•<span style="padding-right:10px"></span>Notable changes in positioning include a higher allocation to pharmaceuticals and lower exposure to biotechnology.</span></div> <div style="text-align:left;text-align-last:auto;"></div> How did the Fund perform over the past 10 years?    CUMULATIVE PERFORMANCE July 31, 2016 through July 31, 2026. Initial investment of $10,000. Class I $10,000 $11,456 $13,064 $12,294 $16,023 $18,320 $14,887 $17,195 $22,272 $20,642 $33,560 MSCI U.S. IMI Biotechnology 25-50 Index $10,000 $11,625 $12,983 $11,564 $15,286 $18,089 $16,032 $17,526 $22,245 $20,661 $29,874 S&P 500® Index $10,000 $11,604 $13,489 $14,566 $16,308 $22,251 $21,219 $23,980 $29,292 $34,076 $40,742   2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026   <span style="font-family:'Fidelity Sans';font-size:9px;color:#000000;font-style:normal;font-weight:normal;">Class I</span> 10000 11456 13064 12294 16023 18320 14887 17195 22272 20642 33560 <span style="font-family:'Fidelity Sans';font-size:9px;color:#000000;font-style:normal;font-weight:normal;">MSCI U.S. IMI Biotechnology 25-50 Index</span> 10000 11625 12983 11564 15286 18089 16032 17526 22245 20661 29874 <span style="font-family:'Fidelity Sans';font-size:9px;color:#000000;font-style:normal;font-weight:normal;">S&amp;P 500® Index</span> 10000 11604 13489 14566 16308 22251 21219 23980 29292 34076 40742 AVERAGE ANNUAL TOTAL RETURNS:   1 Year 5 Year 10 Year Class I 62.58% 12.87% 12.87% MSCI U.S. IMI Biotechnology 25-50 Index 44.59% 10.55% 11.57% S&P 500® Index 19.56% 12.86% 15.08%     Visit institutional.fidelity.com for more recent performance information.    The Fund's past performance is not a good predictor of the Fund's future performance.  The graph and table do not reflect the deduction of taxes that a shareholder would pay on fund distributions or redemption of fund shares. 0.6258 0.1287 0.1287 0.4459 0.1055 0.1157 0.1956 0.1286 0.1508 <span style="font-family:'Fidelity Sans';font-size:11px;color:#000000;font-style:normal;font-weight:normal;">Visit </span><span style="font-family:'Fidelity Sans';font-size:11px;color:#000000;font-style:normal;font-weight:bold;">institutional.fidelity.com</span><span style="font-family:'Fidelity Sans';font-size:11px;color:#000000;font-style:normal;font-weight:normal;"> for more recent performance information.</span> <span style="font-family:'Fidelity Sans';font-size:11px;color:#000000;font-style:italic;font-weight:normal;">The Fund's past performance is not a good predictor of the Fund's future performance.</span> <span style="font-family:'Fidelity Sans';font-size:11px;color:#000000;font-style:normal;font-weight:normal;">The graph and table do not reflect the deduction of taxes that a shareholder would pay on fund distributions or redemption of fund shares.</span> <span style="font-family:'Fidelity Sans';font-size:16px;color:#368627;font-style:normal;font-weight:bold;">Key Fund Statistics</span> <div style="text-align:left;text-align-last:auto;"></div> <div style="text-align:left;text-align-last:auto;"><span style="font-family:'Fidelity Sans';font-size:11px;color:#000000;font-style:normal;font-weight:normal;">(as of July 31, 2026)</span></div> <div><span style="font-size:11px;"> </span></div><div style="text-align:left;text-align-last:auto;"></div> <div style="text-align:right;text-align-last:auto;"><table cellpadding="0" cellspacing="1" style="border-collapse:separate;border-style:none;margin:auto;" width="100%"><tr><td style="width:63%; " valign="top"><div style="text-align:left;text-align-last:auto;"><span style="font-family:'Fidelity Sans';font-size:12px;color:#000000;font-style:normal;font-weight:bold;">KEY FACTS</span></div> <div style="text-align:left;text-align-last:auto;"></div> <div style="text-align:left;text-align-last:auto;"><span style="font-family:'Fidelity Sans';font-size:11px;color:#000000;font-style:normal;font-weight:bold;"> <span> </span></span></div> <div style="text-align:left;text-align-last:auto;"></div> </td> <td style="width:32%; " valign="top"><span style="line-height:12px;"> </span><div style="text-align:left;text-align-last:auto;"></div> </td> <td style="width:5%; " valign="top"><span style="line-height:12px;"> </span><div style="text-align:left;text-align-last:auto;"></div> </td> </tr> <tr><td style="width:63%; border-bottom:1px dashed #000000;padding:0px 0px 0px 0px;" valign="middle"><div style="text-align:left;text-align-last:auto;"><span style="font-family:'Fidelity Sans';font-size:11px;color:#000000;font-style:normal;font-weight:normal;">Fund Size</span></div> </td> <td style="width:32%; border-bottom:1px dashed #000000;padding:0px 0px 0px 0px;" valign="middle"><div style="text-align:right;text-align-last:auto;"><span style="font-family:'Fidelity Sans';font-size:11px;color:#000000;font-style:normal;font-weight:normal;">$</span>2,204,320,575</div> <div style="text-align:right;text-align-last:auto;"></div> </td> <td style="width:5%; " valign="top"><span style="line-height:11px;"> </span><div style="text-align:left;text-align-last:auto;"></div> </td> </tr> <tr><td style="width:63%; border-bottom:1px dashed #000000;padding:0px 0px 0px 0px;" valign="middle"><div style="text-align:left;text-align-last:auto;"><span style="font-family:'Fidelity Sans';font-size:11px;color:#000000;font-style:normal;font-weight:normal;">Number of Holdings</span></div> </td> <td style="width:32%; border-bottom:1px dashed #000000;padding:0px 0px 0px 0px;" valign="middle"><div style="text-align:right;text-align-last:auto;">116</div> <div style="text-align:right;text-align-last:auto;"></div> </td> <td style="width:5%; " valign="top"><span style="line-height:11px;"> </span><div style="text-align:left;text-align-last:auto;"></div> </td> </tr> <tr><td style="width:63%; border-bottom:1px dashed #000000;padding:0px 0px 0px 0px;" valign="middle"><div style="text-align:left;text-align-last:auto;"><span style="font-family:'Fidelity Sans';font-size:11px;color:#000000;font-style:normal;font-weight:normal;">Total Advisory Fee</span></div> </td> <td style="width:32%; border-bottom:1px dashed #000000;padding:0px 0px 0px 0px;" valign="middle"><div style="text-align:right;text-align-last:auto;"><span style="font-family:'Fidelity Sans';font-size:11px;color:#000000;font-style:normal;font-weight:normal;">$</span>12,169,643</div> <div style="text-align:right;text-align-last:auto;"></div> </td> <td style="width:5%; " valign="middle"><span style="line-height:11px;"> </span><div style="text-align:left;text-align-last:auto;"></div> </td> </tr> <tr><td style="width:63%; border-bottom:1px dashed #000000;padding:0px 0px 0px 0px;" valign="middle"><div style="text-align:left;text-align-last:auto;"><span style="font-family:'Fidelity Sans';font-size:11px;color:#000000;font-style:normal;font-weight:normal;">Portfolio Turnover</span></div> </td> <td style="width:32%; border-bottom:1px dashed #000000;padding:0px 0px 0px 0px;" valign="middle"><div style="text-align:right;text-align-last:auto;">54<span style="font-family:'Fidelity Sans';font-size:11px;color:#000000;font-style:normal;font-weight:normal;">%</span></div> <div style="text-align:left;text-align-last:auto;"></div> </td> <td style="width:5%; " valign="top"><span style="line-height:11px;"> </span><div style="text-align:left;text-align-last:auto;"></div> </td> </tr> </table> </div> <div style="text-align:left;text-align-last:auto;"></div> 2204320575 116 12169643 0.54       TOP INDUSTRIES (% of Fund's net assets) Biotechnology 88.4   Pharmaceuticals 10.6   Health Care Technology 0.0       Common Stocks 97.5 Preferred Stocks 1.5 Bonds 0.1 Preferred Securities 0.0 Short-Term Investments and Net Other Assets (Liabilities) 0.9 ASSET ALLOCATION (% of Fund's net assets)     Common Stocks - 97.5                       Preferred Stocks - 1.5                     Bonds - 0.1                                Preferred Securities - 0.0                 Short-Term Investments and Net Other Assets (Liabilities) - 0.9   United States 90.6 Netherlands 4.0 Denmark 3.0 Canada 1.0 France 0.4 Belgium 0.4 United Kingdom 0.3 Germany 0.2 Australia 0.1 GEOGRAPHIC DIVERSIFICATION (% of Fund's net assets)     United States - 90.6                       Netherlands - 4.0                          Denmark - 3.0                              Canada - 1.0                               France - 0.4                               Belgium - 0.4                              United Kingdom - 0.3                       Germany - 0.2                              Australia - 0.1                                0.884 0.106 0.000 0.975 0.015 0.001 0.000 0.009 0.906 0.040 0.030 0.010 0.004 0.004 0.003 0.002 0.001 TOP HOLDINGS(% of Fund's net assets)     AbbVie Inc 14.8   Gilead Sciences Inc 5.8   Spyre Therapeutics Inc 3.8   Alnylam Pharmaceuticals Inc 3.6   Dianthus Therapeutics Inc 3.5   Cogent Biosciences Inc 3.2   Oruka Therapeutics Inc 3.2   Insmed Inc 3.0   Revolution Medicines Inc 3.0   Argenx SE ADR 3.0     46.9   0.148 0.058 0.038 0.036 0.035 0.032 0.032 0.030 0.030 0.030 2026-07-31 Fidelity Advisor® Biotechnology Fund Fidelity Advisor® Biotechnology Fund Class C FBTCX This annual shareholder report contains information about Fidelity Advisor® Biotechnology Fund for the period August 1, 2025 to July 31, 2026. annual shareholder report You can find additional information about the Fund at fundresearch.fidelity.com/prospectus/sec. You can also request this information by contacting us at 1-877-208-0098 or by sending an e-mail to fidfunddocuments@fidelity.com. fundresearch.fidelity.com/prospectus/sec 1-877-208-0098 fidfunddocuments@fidelity.com <span style="font-family:'Fidelity Sans';font-size:16px;color:#368627;font-style:normal;font-weight:bold;">What were your Fund costs for the last year?</span> <div style="text-align:left;text-align-last:auto;"><span style="font-family:'Fidelity Sans';font-size:11px;color:#000000;font-style:normal;font-weight:normal;">(based on hypothetical $10,000 investment)</span></div> <div><span style="font-size:11px;"> </span></div><div style="text-align:left;text-align-last:auto;"></div> <div style="text-align:left;text-align-last:auto;"><span style="font-family:'Fidelity Sans';font-size:12px;color:#000000;font-style:normal;font-weight:bold;">FUND COST (PREVIOUS YEAR)</span></div> <div style="text-align:left;text-align-last:auto;"></div> <div style="text-align:left;text-align-last:auto;"><table cellpadding="0" cellspacing="0" style="border-collapse:collapse;border-style:none;" width="100%"><tr><td style="width:51%; background-color:#dfe0e4;border:1px solid #dfe0e4;padding:0px 0px 0px 0px;" valign="bottom"><div style="text-align:left;text-align-last:auto;"><span style="font-family:'Fidelity Sans';font-size:11px;color:#000000;font-style:normal;font-weight:bold;"> </span></div> </td> <td style="width:21%; background-color:#dfe0e4;border:1px solid #dfe0e4;padding:0px 0px 0px 0px;" valign="bottom"><div style="text-align:center;text-align-last:auto;"><span style="font-family:'Fidelity Sans';font-size:11px;color:#000000;font-style:normal;font-weight:bold;">Costs of a $10,000 investment</span></div> </td> <td style="width:27%; background-color:#dfe0e4;border:1px solid #dfe0e4;padding:0px 0px 0px 0px;" valign="bottom"><div style="text-align:center;text-align-last:auto;"><span style="font-family:'Fidelity Sans';font-size:11px;color:#000000;font-style:normal;font-weight:bold;">Costs paid as a percentage of a $10,000 investment </span></div> </td> <td style="width:1%; " valign="top"><span style="line-height:12px;"> </span><div style="text-align:left;text-align-last:auto;"></div> </td> </tr> <tr><td style="width:51%; border-bottom:1px solid #000000;padding:0px 0px 0px 0px;" valign="top"><div style="text-align:left;text-align-last:auto;"><span style="font-family:'Fidelity Sans';font-size:12px;color:#000000;font-style:normal;font-weight:normal;">Class C</span><span style="font-family:'Fidelity Sans';font-size:11px;color:#000000;font-style:normal;font-weight:normal;"> </span></div> </td> <td style="width:21%; border-bottom:1px solid #000000;padding:0px 0px 0px 0px;" valign="middle"><div style="text-align:center;text-align-last:auto;"><span style="font-family:'Fidelity Sans';font-size:11px;color:#000000;font-style:normal;font-weight:normal;">$</span><span style="font-family:'Fidelity Sans';font-size:12px;color:#000000;font-style:normal;font-weight:normal;"> </span>220<span style="font-family:'Fidelity Sans';font-size:11px;color:#000000;font-style:normal;font-weight:normal;"> </span></div> </td> <td style="width:27%; border-bottom:1px solid #000000;padding:0px 0px 0px 0px;" valign="middle"><div style="text-align:center;text-align-last:auto;">1.69<span style="font-family:'Fidelity Sans';font-size:11px;color:#000000;font-style:normal;font-weight:normal;">%</span></div> </td> <td style="width:1%; " valign="top"><span style="line-height:12px;"> </span><div style="text-align:left;text-align-last:auto;"></div> </td> </tr> </table> </div> <div style="text-align:left;text-align-last:auto;"></div> 220 0.0169 <span style="font-family:'Fidelity Sans';font-size:16px;color:#368627;font-style:normal;font-weight:bold;">What affected the Fund's performance this period?</span> <div style="text-align:left;text-align-last:auto;"><span style="font-family:'Fidelity Sans';font-size:11px;color:#000000;font-style:normal;font-weight:bold;"> </span></div> <div style="text-align:left;text-align-last:auto;text-indent:-24px;margin-bottom:2px;margin-left:24px;margin-top:5px;margin-right:0px;"><span style="font-family:'Fidelity Sans';font-size:12px;color:#000000;font-style:normal;font-weight:normal;">•<span style="padding-right:10px"></span>U.S. stocks achieved a strong gain for the 12 months ending July 31, 2026, reflecting enthusiasm for artificial intelligence, strong corporate fundamentals, a resilient economy and, beginning in September, the Federal Reserve's first interest-rate reductions since December 2024.</span></div> <div style="text-align:left;text-align-last:auto;text-indent:-24px;margin-bottom:2px;margin-left:24px;margin-top:5px;margin-right:0px;"><span style="font-family:'Fidelity Sans';font-size:12px;color:#000000;font-style:normal;font-weight:normal;">•<span style="padding-right:10px"></span>Against this backdrop, security selection was the primary contributor to the fund's performance versus the MSCI US IMI Biotechnology 25/50 Index for the fiscal year, especially within biotechnology. Security selection in pharmaceuticals and health care technology, most of which were out-of-index positions, also boosted the fund's relative performance.</span></div> <div style="text-align:left;text-align-last:auto;text-indent:-24px;margin-bottom:2px;margin-left:24px;margin-top:5px;margin-right:0px;"><span style="font-family:'Fidelity Sans';font-size:12px;color:#000000;font-style:normal;font-weight:normal;">•<span style="padding-right:10px"></span>The top individual relative contributor was an overweight in Oruka Therapeutics (+612%). The company was among the fund's biggest holdings at period end. A second notable relative contributor was an overweight in Spyre Therapeutics (+484%). The company was one of the fund's largest holdings at period end. An overweight in Cogent Biosciences (+240%) also helped. The company was one of the fund's biggest holdings.</span></div> <div style="text-align:left;text-align-last:auto;text-indent:-24px;margin-bottom:2px;margin-left:24px;margin-top:5px;margin-right:0px;"><span style="font-family:'Fidelity Sans';font-size:12px;color:#000000;font-style:normal;font-weight:normal;">•<span style="padding-right:10px"></span>The largest individual relative detractor was an overweight in Alnylam Pharmaceuticals (-48%). The stock was among our biggest holdings. A second notable relative detractor was our stake in Soleno Therapeutics (-53%). The stock was not held at period end. Untimely positioning in uniQure (+17%) also hurt. This was a position we established this period.</span></div> <div style="text-align:left;text-align-last:auto;text-indent:-24px;margin-bottom:2px;margin-left:24px;margin-top:5px;margin-right:0px;"><span style="font-family:'Fidelity Sans';font-size:12px;color:#000000;font-style:normal;font-weight:normal;">•<span style="padding-right:10px"></span>Notable changes in positioning include a higher allocation to pharmaceuticals and lower exposure to biotechnology.</span></div> <div style="text-align:left;text-align-last:auto;"></div> How did the Fund perform over the past 10 years?    CUMULATIVE PERFORMANCE July 31, 2016 through July 31, 2026. Initial investment of $10,000. Class C $10,000 $11,347 $12,806 $11,926 $15,393 $17,417 $14,014 $16,026 $20,538 $18,976 $30,782 MSCI U.S. IMI Biotechnology 25-50 Index $10,000 $11,625 $12,983 $11,564 $15,286 $18,089 $16,032 $17,526 $22,245 $20,661 $29,874 S&P 500® Index $10,000 $11,604 $13,489 $14,566 $16,308 $22,251 $21,219 $23,980 $29,292 $34,076 $40,742   2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026   <span style="font-family:'Fidelity Sans';font-size:9px;color:#000000;font-style:normal;font-weight:normal;">Class C</span> 10000 11347 12806 11926 15393 17417 14014 16026 20538 18976 30782 <span style="font-family:'Fidelity Sans';font-size:9px;color:#000000;font-style:normal;font-weight:normal;">MSCI U.S. IMI Biotechnology 25-50 Index</span> 10000 11625 12983 11564 15286 18089 16032 17526 22245 20661 29874 <span style="font-family:'Fidelity Sans';font-size:9px;color:#000000;font-style:normal;font-weight:normal;">S&amp;P 500® Index</span> 10000 11604 13489 14566 16308 22251 21219 23980 29292 34076 40742 AVERAGE ANNUAL TOTAL RETURNS:   1 Year 5 Year 10 Year Class C  (incl. contingent deferred sales charge) 59.99% 11.74% 11.90% Class C 60.99% 11.74% 11.90% MSCI U.S. IMI Biotechnology 25-50 Index 44.59% 10.55% 11.57% S&P 500® Index 19.56% 12.86% 15.08%     Visit institutional.fidelity.com for more recent performance information.    The Fund's past performance is not a good predictor of the Fund's future performance.  The graph and table do not reflect the deduction of taxes that a shareholder would pay on fund distributions or redemption of fund shares. 0.5999 0.1174 0.1190 0.6099 0.1174 0.1190 0.4459 0.1055 0.1157 0.1956 0.1286 0.1508 <span style="font-family:'Fidelity Sans';font-size:11px;color:#000000;font-style:normal;font-weight:normal;">Visit </span><span style="font-family:'Fidelity Sans';font-size:11px;color:#000000;font-style:normal;font-weight:bold;">institutional.fidelity.com</span><span style="font-family:'Fidelity Sans';font-size:11px;color:#000000;font-style:normal;font-weight:normal;"> for more recent performance information.</span> <span style="font-family:'Fidelity Sans';font-size:11px;color:#000000;font-style:italic;font-weight:normal;">The Fund's past performance is not a good predictor of the Fund's future performance.</span> <span style="font-family:'Fidelity Sans';font-size:11px;color:#000000;font-style:normal;font-weight:normal;">The graph and table do not reflect the deduction of taxes that a shareholder would pay on fund distributions or redemption of fund shares.</span> <span style="font-family:'Fidelity Sans';font-size:16px;color:#368627;font-style:normal;font-weight:bold;">Key Fund Statistics</span> <div style="text-align:left;text-align-last:auto;"></div> <div style="text-align:left;text-align-last:auto;"><span style="font-family:'Fidelity Sans';font-size:11px;color:#000000;font-style:normal;font-weight:normal;">(as of July 31, 2026)</span></div> <div><span style="font-size:11px;"> </span></div><div style="text-align:left;text-align-last:auto;"></div> <div style="text-align:right;text-align-last:auto;"><table cellpadding="0" cellspacing="1" style="border-collapse:separate;border-style:none;margin:auto;" width="100%"><tr><td style="width:63%; " valign="top"><div style="text-align:left;text-align-last:auto;"><span style="font-family:'Fidelity Sans';font-size:12px;color:#000000;font-style:normal;font-weight:bold;">KEY FACTS</span></div> <div style="text-align:left;text-align-last:auto;"></div> <div style="text-align:left;text-align-last:auto;"><span style="font-family:'Fidelity Sans';font-size:11px;color:#000000;font-style:normal;font-weight:bold;"> <span> </span></span></div> <div style="text-align:left;text-align-last:auto;"></div> </td> <td style="width:32%; " valign="top"><span style="line-height:12px;"> </span><div style="text-align:left;text-align-last:auto;"></div> </td> <td style="width:5%; " valign="top"><span style="line-height:12px;"> </span><div style="text-align:left;text-align-last:auto;"></div> </td> </tr> <tr><td style="width:63%; border-bottom:1px dashed #000000;padding:0px 0px 0px 0px;" valign="middle"><div style="text-align:left;text-align-last:auto;"><span style="font-family:'Fidelity Sans';font-size:11px;color:#000000;font-style:normal;font-weight:normal;">Fund Size</span></div> </td> <td style="width:32%; border-bottom:1px dashed #000000;padding:0px 0px 0px 0px;" valign="middle"><div style="text-align:right;text-align-last:auto;"><span style="font-family:'Fidelity Sans';font-size:11px;color:#000000;font-style:normal;font-weight:normal;">$</span>2,204,320,575</div> <div style="text-align:right;text-align-last:auto;"></div> </td> <td style="width:5%; " valign="top"><span style="line-height:11px;"> </span><div style="text-align:left;text-align-last:auto;"></div> </td> </tr> <tr><td style="width:63%; border-bottom:1px dashed #000000;padding:0px 0px 0px 0px;" valign="middle"><div style="text-align:left;text-align-last:auto;"><span style="font-family:'Fidelity Sans';font-size:11px;color:#000000;font-style:normal;font-weight:normal;">Number of Holdings</span></div> </td> <td style="width:32%; border-bottom:1px dashed #000000;padding:0px 0px 0px 0px;" valign="middle"><div style="text-align:right;text-align-last:auto;">116</div> <div style="text-align:right;text-align-last:auto;"></div> </td> <td style="width:5%; " valign="top"><span style="line-height:11px;"> </span><div style="text-align:left;text-align-last:auto;"></div> </td> </tr> <tr><td style="width:63%; border-bottom:1px dashed #000000;padding:0px 0px 0px 0px;" valign="middle"><div style="text-align:left;text-align-last:auto;"><span style="font-family:'Fidelity Sans';font-size:11px;color:#000000;font-style:normal;font-weight:normal;">Total Advisory Fee</span></div> </td> <td style="width:32%; border-bottom:1px dashed #000000;padding:0px 0px 0px 0px;" valign="middle"><div style="text-align:right;text-align-last:auto;"><span style="font-family:'Fidelity Sans';font-size:11px;color:#000000;font-style:normal;font-weight:normal;">$</span>12,169,643</div> <div style="text-align:right;text-align-last:auto;"></div> </td> <td style="width:5%; " valign="middle"><span style="line-height:11px;"> </span><div style="text-align:left;text-align-last:auto;"></div> </td> </tr> <tr><td style="width:63%; border-bottom:1px dashed #000000;padding:0px 0px 0px 0px;" valign="middle"><div style="text-align:left;text-align-last:auto;"><span style="font-family:'Fidelity Sans';font-size:11px;color:#000000;font-style:normal;font-weight:normal;">Portfolio Turnover</span></div> </td> <td style="width:32%; border-bottom:1px dashed #000000;padding:0px 0px 0px 0px;" valign="middle"><div style="text-align:right;text-align-last:auto;">54<span style="font-family:'Fidelity Sans';font-size:11px;color:#000000;font-style:normal;font-weight:normal;">%</span></div> <div style="text-align:left;text-align-last:auto;"></div> </td> <td style="width:5%; " valign="top"><span style="line-height:11px;"> </span><div style="text-align:left;text-align-last:auto;"></div> </td> </tr> </table> </div> <div style="text-align:left;text-align-last:auto;"></div> 2204320575 116 12169643 0.54       TOP INDUSTRIES (% of Fund's net assets) Biotechnology 88.4   Pharmaceuticals 10.6   Health Care Technology 0.0       Common Stocks 97.5 Preferred Stocks 1.5 Bonds 0.1 Preferred Securities 0.0 Short-Term Investments and Net Other Assets (Liabilities) 0.9 ASSET ALLOCATION (% of Fund's net assets)     Common Stocks - 97.5                       Preferred Stocks - 1.5                     Bonds - 0.1                                Preferred Securities - 0.0                 Short-Term Investments and Net Other Assets (Liabilities) - 0.9   United States 90.6 Netherlands 4.0 Denmark 3.0 Canada 1.0 France 0.4 Belgium 0.4 United Kingdom 0.3 Germany 0.2 Australia 0.1 GEOGRAPHIC DIVERSIFICATION (% of Fund's net assets)     United States - 90.6                       Netherlands - 4.0                          Denmark - 3.0                              Canada - 1.0                               France - 0.4                               Belgium - 0.4                              United Kingdom - 0.3                       Germany - 0.2                              Australia - 0.1                                0.884 0.106 0.000 0.975 0.015 0.001 0.000 0.009 0.906 0.040 0.030 0.010 0.004 0.004 0.003 0.002 0.001 TOP HOLDINGS(% of Fund's net assets)     AbbVie Inc 14.8   Gilead Sciences Inc 5.8   Spyre Therapeutics Inc 3.8   Alnylam Pharmaceuticals Inc 3.6   Dianthus Therapeutics Inc 3.5   Cogent Biosciences Inc 3.2   Oruka Therapeutics Inc 3.2   Insmed Inc 3.0   Revolution Medicines Inc 3.0   Argenx SE ADR 3.0     46.9   0.148 0.058 0.038 0.036 0.035 0.032 0.032 0.030 0.030 0.030 2026-07-31 Fidelity Advisor® Biotechnology Fund Fidelity Advisor® Biotechnology Fund Class A FBTAX This annual shareholder report contains information about Fidelity Advisor® Biotechnology Fund for the period August 1, 2025 to July 31, 2026. annual shareholder report You can find additional information about the Fund at fundresearch.fidelity.com/prospectus/sec. You can also request this information by contacting us at 1-877-208-0098 or by sending an e-mail to fidfunddocuments@fidelity.com. fundresearch.fidelity.com/prospectus/sec 1-877-208-0098 fidfunddocuments@fidelity.com <span style="font-family:'Fidelity Sans';font-size:16px;color:#368627;font-style:normal;font-weight:bold;">What were your Fund costs for the last year?</span> <div style="text-align:left;text-align-last:auto;"><span style="font-family:'Fidelity Sans';font-size:11px;color:#000000;font-style:normal;font-weight:normal;">(based on hypothetical $10,000 investment)</span></div> <div><span style="font-size:11px;"> </span></div><div style="text-align:left;text-align-last:auto;"></div> <div style="text-align:left;text-align-last:auto;"><span style="font-family:'Fidelity Sans';font-size:12px;color:#000000;font-style:normal;font-weight:bold;">FUND COST (PREVIOUS YEAR)</span></div> <div style="text-align:left;text-align-last:auto;"></div> <div style="text-align:left;text-align-last:auto;"><table cellpadding="0" cellspacing="0" style="border-collapse:collapse;border-style:none;" width="100%"><tr><td style="width:51%; background-color:#dfe0e4;border:1px solid #dfe0e4;padding:0px 0px 0px 0px;" valign="bottom"><div style="text-align:left;text-align-last:auto;"><span style="font-family:'Fidelity Sans';font-size:11px;color:#000000;font-style:normal;font-weight:bold;"> </span></div> </td> <td style="width:21%; background-color:#dfe0e4;border:1px solid #dfe0e4;padding:0px 0px 0px 0px;" valign="bottom"><div style="text-align:center;text-align-last:auto;"><span style="font-family:'Fidelity Sans';font-size:11px;color:#000000;font-style:normal;font-weight:bold;">Costs of a $10,000 investment</span></div> </td> <td style="width:27%; background-color:#dfe0e4;border:1px solid #dfe0e4;padding:0px 0px 0px 0px;" valign="bottom"><div style="text-align:center;text-align-last:auto;"><span style="font-family:'Fidelity Sans';font-size:11px;color:#000000;font-style:normal;font-weight:bold;">Costs paid as a percentage of a $10,000 investment </span></div> </td> <td style="width:1%; " valign="top"><span style="line-height:12px;"> </span><div style="text-align:left;text-align-last:auto;"></div> </td> </tr> <tr><td style="width:51%; border-bottom:1px solid #000000;padding:0px 0px 0px 0px;" valign="top"><div style="text-align:left;text-align-last:auto;"><span style="font-family:'Fidelity Sans';font-size:12px;color:#000000;font-style:normal;font-weight:normal;">Class A</span><span style="font-family:'Fidelity Sans';font-size:11px;color:#000000;font-style:normal;font-weight:normal;"> </span></div> </td> <td style="width:21%; border-bottom:1px solid #000000;padding:0px 0px 0px 0px;" valign="middle"><div style="text-align:center;text-align-last:auto;"><span style="font-family:'Fidelity Sans';font-size:11px;color:#000000;font-style:normal;font-weight:normal;">$</span><span style="font-family:'Fidelity Sans';font-size:12px;color:#000000;font-style:normal;font-weight:normal;"> </span>123<span style="font-family:'Fidelity Sans';font-size:11px;color:#000000;font-style:normal;font-weight:normal;"> </span></div> </td> <td style="width:27%; border-bottom:1px solid #000000;padding:0px 0px 0px 0px;" valign="middle"><div style="text-align:center;text-align-last:auto;">0.94<span style="font-family:'Fidelity Sans';font-size:11px;color:#000000;font-style:normal;font-weight:normal;">%</span></div> </td> <td style="width:1%; " valign="top"><span style="line-height:12px;"> </span><div style="text-align:left;text-align-last:auto;"></div> </td> </tr> </table> </div> <div style="text-align:left;text-align-last:auto;"></div> 123 0.0094 <span style="font-family:'Fidelity Sans';font-size:16px;color:#368627;font-style:normal;font-weight:bold;">What affected the Fund's performance this period?</span> <div style="text-align:left;text-align-last:auto;"><span style="font-family:'Fidelity Sans';font-size:11px;color:#000000;font-style:normal;font-weight:bold;"> </span></div> <div style="text-align:left;text-align-last:auto;text-indent:-24px;margin-bottom:2px;margin-left:24px;margin-top:5px;margin-right:0px;"><span style="font-family:'Fidelity Sans';font-size:12px;color:#000000;font-style:normal;font-weight:normal;">•<span style="padding-right:10px"></span>U.S. stocks achieved a strong gain for the 12 months ending July 31, 2026, reflecting enthusiasm for artificial intelligence, strong corporate fundamentals, a resilient economy and, beginning in September, the Federal Reserve's first interest-rate reductions since December 2024.</span></div> <div style="text-align:left;text-align-last:auto;text-indent:-24px;margin-bottom:2px;margin-left:24px;margin-top:5px;margin-right:0px;"><span style="font-family:'Fidelity Sans';font-size:12px;color:#000000;font-style:normal;font-weight:normal;">•<span style="padding-right:10px"></span>Against this backdrop, security selection was the primary contributor to the fund's performance versus the MSCI US IMI Biotechnology 25/50 Index for the fiscal year, especially within biotechnology. Security selection in pharmaceuticals and health care technology, most of which were out-of-index positions, also boosted the fund's relative performance.</span></div> <div style="text-align:left;text-align-last:auto;text-indent:-24px;margin-bottom:2px;margin-left:24px;margin-top:5px;margin-right:0px;"><span style="font-family:'Fidelity Sans';font-size:12px;color:#000000;font-style:normal;font-weight:normal;">•<span style="padding-right:10px"></span>The top individual relative contributor was an overweight in Oruka Therapeutics (+612%). The company was among the fund's biggest holdings at period end. A second notable relative contributor was an overweight in Spyre Therapeutics (+484%). The company was one of the fund's largest holdings at period end. An overweight in Cogent Biosciences (+240%) also helped. The company was one of the fund's biggest holdings.</span></div> <div style="text-align:left;text-align-last:auto;text-indent:-24px;margin-bottom:2px;margin-left:24px;margin-top:5px;margin-right:0px;"><span style="font-family:'Fidelity Sans';font-size:12px;color:#000000;font-style:normal;font-weight:normal;">•<span style="padding-right:10px"></span>The largest individual relative detractor was an overweight in Alnylam Pharmaceuticals (-48%). The stock was among our biggest holdings. A second notable relative detractor was our stake in Soleno Therapeutics (-53%). The stock was not held at period end. Untimely positioning in uniQure (+17%) also hurt. This was a position we established this period.</span></div> <div style="text-align:left;text-align-last:auto;text-indent:-24px;margin-bottom:2px;margin-left:24px;margin-top:5px;margin-right:0px;"><span style="font-family:'Fidelity Sans';font-size:12px;color:#000000;font-style:normal;font-weight:normal;">•<span style="padding-right:10px"></span>Notable changes in positioning include a higher allocation to pharmaceuticals and lower exposure to biotechnology.</span></div> <div style="text-align:left;text-align-last:auto;"></div> How did the Fund perform over the past 10 years?    CUMULATIVE PERFORMANCE July 31, 2016 through July 31, 2026. Initial investment of $10,000 and the current sales charge was paid. Class A $9,425 $10,773 $12,249 $11,494 $14,943 $17,040 $13,811 $15,908 $20,555 $18,992 $30,807 MSCI U.S. IMI Biotechnology 25-50 Index $10,000 $11,625 $12,983 $11,564 $15,286 $18,089 $16,032 $17,526 $22,245 $20,661 $29,874 S&P 500® Index $10,000 $11,604 $13,489 $14,566 $16,308 $22,251 $21,219 $23,980 $29,292 $34,076 $40,742   2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026   <span style="font-family:'Fidelity Sans';font-size:9px;color:#000000;font-style:normal;font-weight:normal;">Class A</span> 9425 10773 12249 11494 14943 17040 13811 15908 20555 18992 30807 <span style="font-family:'Fidelity Sans';font-size:9px;color:#000000;font-style:normal;font-weight:normal;">MSCI U.S. IMI Biotechnology 25-50 Index</span> 10000 11625 12983 11564 15286 18089 16032 17526 22245 20661 29874 <span style="font-family:'Fidelity Sans';font-size:9px;color:#000000;font-style:normal;font-weight:normal;">S&amp;P 500® Index</span> 10000 11604 13489 14566 16308 22251 21219 23980 29292 34076 40742 AVERAGE ANNUAL TOTAL RETURNS:   1 Year 5 Year 10 Year Class A (incl. 5.75% sales charge)   52.88% 11.25% 11.91% Class A (without 5.75% sales charge) 62.21% 12.57% 12.57% MSCI U.S. IMI Biotechnology 25-50 Index 44.59% 10.55% 11.57% S&P 500® Index 19.56% 12.86% 15.08%     Visit institutional.fidelity.com for more recent performance information.    The Fund's past performance is not a good predictor of the Fund's future performance.  The graph and table do not reflect the deduction of taxes that a shareholder would pay on fund distributions or redemption of fund shares. 0.5288 0.1125 0.1191 0.6221 0.1257 0.1257 0.4459 0.1055 0.1157 0.1956 0.1286 0.1508 <span style="font-family:'Fidelity Sans';font-size:11px;color:#000000;font-style:normal;font-weight:normal;">Visit </span><span style="font-family:'Fidelity Sans';font-size:11px;color:#000000;font-style:normal;font-weight:bold;">institutional.fidelity.com</span><span style="font-family:'Fidelity Sans';font-size:11px;color:#000000;font-style:normal;font-weight:normal;"> for more recent performance information.</span> <span style="font-family:'Fidelity Sans';font-size:11px;color:#000000;font-style:italic;font-weight:normal;">The Fund's past performance is not a good predictor of the Fund's future performance.</span> <span style="font-family:'Fidelity Sans';font-size:11px;color:#000000;font-style:normal;font-weight:normal;">The graph and table do not reflect the deduction of taxes that a shareholder would pay on fund distributions or redemption of fund shares.</span> <span style="font-family:'Fidelity Sans';font-size:16px;color:#368627;font-style:normal;font-weight:bold;">Key Fund Statistics</span> <div style="text-align:left;text-align-last:auto;"></div> <div style="text-align:left;text-align-last:auto;"><span style="font-family:'Fidelity Sans';font-size:11px;color:#000000;font-style:normal;font-weight:normal;">(as of July 31, 2026)</span></div> <div><span style="font-size:11px;"> </span></div><div style="text-align:left;text-align-last:auto;"></div> <div style="text-align:right;text-align-last:auto;"><table cellpadding="0" cellspacing="1" style="border-collapse:separate;border-style:none;margin:auto;" width="100%"><tr><td style="width:63%; " valign="top"><div style="text-align:left;text-align-last:auto;"><span style="font-family:'Fidelity Sans';font-size:12px;color:#000000;font-style:normal;font-weight:bold;">KEY FACTS</span></div> <div style="text-align:left;text-align-last:auto;"></div> <div style="text-align:left;text-align-last:auto;"><span style="font-family:'Fidelity Sans';font-size:11px;color:#000000;font-style:normal;font-weight:bold;"> <span> </span></span></div> <div style="text-align:left;text-align-last:auto;"></div> </td> <td style="width:32%; " valign="top"><span style="line-height:12px;"> </span><div style="text-align:left;text-align-last:auto;"></div> </td> <td style="width:5%; " valign="top"><span style="line-height:12px;"> </span><div style="text-align:left;text-align-last:auto;"></div> </td> </tr> <tr><td style="width:63%; border-bottom:1px dashed #000000;padding:0px 0px 0px 0px;" valign="middle"><div style="text-align:left;text-align-last:auto;"><span style="font-family:'Fidelity Sans';font-size:11px;color:#000000;font-style:normal;font-weight:normal;">Fund Size</span></div> </td> <td style="width:32%; border-bottom:1px dashed #000000;padding:0px 0px 0px 0px;" valign="middle"><div style="text-align:right;text-align-last:auto;"><span style="font-family:'Fidelity Sans';font-size:11px;color:#000000;font-style:normal;font-weight:normal;">$</span>2,204,320,575</div> <div style="text-align:right;text-align-last:auto;"></div> </td> <td style="width:5%; " valign="top"><span style="line-height:11px;"> </span><div style="text-align:left;text-align-last:auto;"></div> </td> </tr> <tr><td style="width:63%; border-bottom:1px dashed #000000;padding:0px 0px 0px 0px;" valign="middle"><div style="text-align:left;text-align-last:auto;"><span style="font-family:'Fidelity Sans';font-size:11px;color:#000000;font-style:normal;font-weight:normal;">Number of Holdings</span></div> </td> <td style="width:32%; border-bottom:1px dashed #000000;padding:0px 0px 0px 0px;" valign="middle"><div style="text-align:right;text-align-last:auto;">116</div> <div style="text-align:right;text-align-last:auto;"></div> </td> <td style="width:5%; " valign="top"><span style="line-height:11px;"> </span><div style="text-align:left;text-align-last:auto;"></div> </td> </tr> <tr><td style="width:63%; border-bottom:1px dashed #000000;padding:0px 0px 0px 0px;" valign="middle"><div style="text-align:left;text-align-last:auto;"><span style="font-family:'Fidelity Sans';font-size:11px;color:#000000;font-style:normal;font-weight:normal;">Total Advisory Fee</span></div> </td> <td style="width:32%; border-bottom:1px dashed #000000;padding:0px 0px 0px 0px;" valign="middle"><div style="text-align:right;text-align-last:auto;"><span style="font-family:'Fidelity Sans';font-size:11px;color:#000000;font-style:normal;font-weight:normal;">$</span>12,169,643</div> <div style="text-align:right;text-align-last:auto;"></div> </td> <td style="width:5%; " valign="middle"><span style="line-height:11px;"> </span><div style="text-align:left;text-align-last:auto;"></div> </td> </tr> <tr><td style="width:63%; border-bottom:1px dashed #000000;padding:0px 0px 0px 0px;" valign="middle"><div style="text-align:left;text-align-last:auto;"><span style="font-family:'Fidelity Sans';font-size:11px;color:#000000;font-style:normal;font-weight:normal;">Portfolio Turnover</span></div> </td> <td style="width:32%; border-bottom:1px dashed #000000;padding:0px 0px 0px 0px;" valign="middle"><div style="text-align:right;text-align-last:auto;">54<span style="font-family:'Fidelity Sans';font-size:11px;color:#000000;font-style:normal;font-weight:normal;">%</span></div> <div style="text-align:left;text-align-last:auto;"></div> </td> <td style="width:5%; " valign="top"><span style="line-height:11px;"> </span><div style="text-align:left;text-align-last:auto;"></div> </td> </tr> </table> </div> <div style="text-align:left;text-align-last:auto;"></div> 2204320575 116 12169643 0.54       TOP INDUSTRIES (% of Fund's net assets) Biotechnology 88.4   Pharmaceuticals 10.6   Health Care Technology 0.0       Common Stocks 97.5 Preferred Stocks 1.5 Bonds 0.1 Preferred Securities 0.0 Short-Term Investments and Net Other Assets (Liabilities) 0.9 ASSET ALLOCATION (% of Fund's net assets)     Common Stocks - 97.5                       Preferred Stocks - 1.5                     Bonds - 0.1                                Preferred Securities - 0.0                 Short-Term Investments and Net Other Assets (Liabilities) - 0.9   United States 90.6 Netherlands 4.0 Denmark 3.0 Canada 1.0 France 0.4 Belgium 0.4 United Kingdom 0.3 Germany 0.2 Australia 0.1 GEOGRAPHIC DIVERSIFICATION (% of Fund's net assets)     United States - 90.6                       Netherlands - 4.0                          Denmark - 3.0                              Canada - 1.0                               France - 0.4                               Belgium - 0.4                              United Kingdom - 0.3                       Germany - 0.2                              Australia - 0.1                                0.884 0.106 0.000 0.975 0.015 0.001 0.000 0.009 0.906 0.040 0.030 0.010 0.004 0.004 0.003 0.002 0.001 TOP HOLDINGS(% of Fund's net assets)     AbbVie Inc 14.8   Gilead Sciences Inc 5.8   Spyre Therapeutics Inc 3.8   Alnylam Pharmaceuticals Inc 3.6   Dianthus Therapeutics Inc 3.5   Cogent Biosciences Inc 3.2   Oruka Therapeutics Inc 3.2   Insmed Inc 3.0   Revolution Medicines Inc 3.0   Argenx SE ADR 3.0     46.9   0.148 0.058 0.038 0.036 0.035 0.032 0.032 0.030 0.030 0.030 2026-07-31 This report describes changes to the Fund that occurred during the reporting period. Fidelity Advisor® Industrials Fund Industrials Portfolio FIDRX This annual shareholder report contains information about Fidelity Advisor® Industrials Fund for the period October 9, 2025 to July 31, 2026. annual shareholder report You can find additional information about the Fund at fundresearch.fidelity.com/prospectus/sec. You can also request this information by contacting us at 1-800-544-8544 or by sending an e-mail to fidfunddocuments@fidelity.com. fundresearch.fidelity.com/prospectus/sec 1-800-544-8544 fidfunddocuments@fidelity.com <span style="font-family:'Fidelity Sans';font-size:16px;color:#368627;font-style:normal;font-weight:bold;">What were your Fund costs for the last year?</span> <div style="text-align:left;text-align-last:auto;"><span style="font-family:'Fidelity Sans';font-size:11px;color:#000000;font-style:normal;font-weight:normal;">(based on hypothetical $10,000 investment)</span></div> <div><span style="font-size:11px;"> </span></div><div style="text-align:left;text-align-last:auto;"></div> <div style="text-align:left;text-align-last:auto;"><span style="font-family:'Fidelity Sans';font-size:12px;color:#000000;font-style:normal;font-weight:bold;">FUND COST (PREVIOUS YEAR)</span></div> <div style="text-align:left;text-align-last:auto;"></div> <div style="text-align:left;text-align-last:auto;"><table cellpadding="0" cellspacing="0" style="border-collapse:collapse;border-style:none;" width="100%"><tr><td style="width:51%; background-color:#dfe0e4;border:1px solid #dfe0e4;padding:0px 0px 0px 0px;" valign="bottom"><div style="text-align:left;text-align-last:auto;"><span style="font-family:'Fidelity Sans';font-size:11px;color:#000000;font-style:normal;font-weight:bold;"> </span></div> </td> <td style="width:21%; background-color:#dfe0e4;border:1px solid #dfe0e4;padding:0px 0px 0px 0px;" valign="bottom"><div style="text-align:center;text-align-last:auto;"><span style="font-family:'Fidelity Sans';font-size:11px;color:#000000;font-style:normal;font-weight:bold;">Costs of a $10,000 investment</span></div> </td> <td style="width:27%; background-color:#dfe0e4;border:1px solid #dfe0e4;padding:0px 0px 0px 0px;" valign="bottom"><div style="text-align:center;text-align-last:auto;"><span style="font-family:'Fidelity Sans';font-size:11px;color:#000000;font-style:normal;font-weight:bold;">Costs paid as a percentage of a $10,000 investment </span></div> </td> <td style="width:1%; " valign="top"><span style="line-height:12px;"> </span><div style="text-align:left;text-align-last:auto;"></div> </td> </tr> <tr><td style="width:51%; border-bottom:1px solid #000000;padding:0px 0px 0px 0px;" valign="top"><div style="text-align:left;text-align-last:auto;"><span style="font-family:'Fidelity Sans';font-size:12px;color:#000000;font-style:normal;font-weight:normal;">Industrials Portfolio</span><span style="font-family:'Fidelity Sans';font-size:6px;color:#000000;font-style:normal;vertical-align:4px;font-weight:normal;">A</span><span style="font-family:'Fidelity Sans';font-size:11px;color:#000000;font-style:normal;font-weight:normal;"> </span></div> </td> <td style="width:21%; border-bottom:1px solid #000000;padding:0px 0px 0px 0px;" valign="middle"><div style="text-align:center;text-align-last:auto;"><span style="font-family:'Fidelity Sans';font-size:11px;color:#000000;font-style:normal;font-weight:normal;">$</span><span style="font-family:'Fidelity Sans';font-size:12px;color:#000000;font-style:normal;font-weight:normal;"> </span>57<span style="font-family:'Fidelity Sans';font-size:11px;color:#000000;font-style:normal;font-weight:normal;"> </span></div> </td> <td style="width:27%; border-bottom:1px solid #000000;padding:0px 0px 0px 0px;" valign="middle"><div style="text-align:center;text-align-last:auto;">0.64<span style="font-family:'Fidelity Sans';font-size:11px;color:#000000;font-style:normal;font-weight:normal;">%</span></div> </td> <td style="width:1%; " valign="top"><span style="line-height:12px;"> </span><div style="text-align:left;text-align-last:auto;"></div> </td> </tr> </table> </div> <div style="text-align:left;text-align-last:auto;"><span style="font-family:'Fidelity Sans';font-size:6px;color:#000000;font-style:normal;vertical-align:4px;font-weight:normal;">A</span><span style="font-family:'Fidelity Sans Cd';font-size:11px;color:#000000;font-style:normal;font-weight:normal;">Expenses for the full reporting period would be higher.</span></div> <span style="line-height:12px;"> </span><div style="text-align:left;text-align-last:auto;"></div> <div style="text-align:left;text-align-last:auto;"></div> 57 0.0064 Expenses for the full reporting period would be higher. <span style="font-family:'Fidelity Sans';font-size:16px;color:#368627;font-style:normal;font-weight:bold;">What affected the Fund's performance this period?</span> <div style="text-align:left;text-align-last:auto;"><span style="font-family:'Fidelity Sans';font-size:11px;color:#000000;font-style:normal;font-weight:bold;"> </span></div> <div style="text-align:left;text-align-last:auto;text-indent:-24px;margin-bottom:2px;margin-left:24px;margin-top:5px;margin-right:0px;"><span style="font-family:'Fidelity Sans';font-size:12px;color:#000000;font-style:normal;font-weight:normal;">•<span style="padding-right:10px"></span>U.S. stocks achieved a strong gain for the 12 months ending July 31, 2026, reflecting enthusiasm for artificial intelligence, strong corporate fundamentals, a resilient economy and, beginning in September, the Federal Reserve's first interest-rate reductions since December 2024.</span></div> <div style="text-align:left;text-align-last:auto;text-indent:-24px;margin-bottom:2px;margin-left:24px;margin-top:5px;margin-right:0px;"><span style="font-family:'Fidelity Sans';font-size:12px;color:#000000;font-style:normal;font-weight:normal;">•<span style="padding-right:10px"></span>Against this backdrop, market selection was the primary contributor to the fund's performance versus the MSCI US IMI Industrials 25/50 Linked Index for the fiscal year, especially an underweight in human resource &amp; employment services. Picks in construction &amp; engineering also boosted the fund's relative performance. Also helping our relative result was an overweight in heavy electrical equipment.</span></div> <div style="text-align:left;text-align-last:auto;text-indent:-24px;margin-bottom:2px;margin-left:24px;margin-top:5px;margin-right:0px;"><span style="font-family:'Fidelity Sans';font-size:12px;color:#000000;font-style:normal;font-weight:normal;">•<span style="padding-right:10px"></span>The top individual relative contributor was an overweight in Howmet Aerospace (+60%). The company was one of our biggest holdings. A second notable relative contributor was an overweight in Cummins (+74%). This was a position we established this period. The company was one of the fund's biggest holdings this period. An overweight in GE Vernova (+49%) also helped. The stock was one of the fund's biggest holdings.</span></div> <div style="text-align:left;text-align-last:auto;text-indent:-24px;margin-bottom:2px;margin-left:24px;margin-top:5px;margin-right:0px;"><span style="font-family:'Fidelity Sans';font-size:12px;color:#000000;font-style:normal;font-weight:normal;">•<span style="padding-right:10px"></span>In contrast, the biggest detractor from performance versus the sector index was security selection in aerospace &amp; defense. Also hurting our result was stock picking in electrical components &amp; equipment and heavy electrical equipment.</span></div> <div style="text-align:left;text-align-last:auto;text-indent:-24px;margin-bottom:2px;margin-left:24px;margin-top:5px;margin-right:0px;"><span style="font-family:'Fidelity Sans';font-size:12px;color:#000000;font-style:normal;font-weight:normal;">•<span style="padding-right:10px"></span>The biggest individual relative detractor was an underweight in Caterpillar (+88%). This period we increased our stake in Caterpillar. A second notable relative detractor was an overweight in Boeing (-2%). This period we increased our stake in Boeing. The company was among our largest holdings. An overweight in Ingersoll Rand (-2%) also detracted. This period we increased our stake in Ingersoll Rand. The stock was one of the fund's biggest holdings this period.</span></div> <div style="text-align:left;text-align-last:auto;text-indent:-24px;margin-bottom:2px;margin-left:24px;margin-top:5px;margin-right:0px;"><span style="font-family:'Fidelity Sans';font-size:12px;color:#000000;font-style:normal;font-weight:normal;">•<span style="padding-right:10px"></span>Notable changes in positioning include increased exposure to the construction machinery &amp; heavy transportation equipment and construction &amp; engineering industries.</span></div> <div style="text-align:left;text-align-last:auto;"></div> How did the Fund perform over the life of Fund?    CUMULATIVE PERFORMANCE October 9, 2025 through July 31, 2026. Initial investment of $10,000. Industrials Portfolio $10,000 $12,165 MSCI U.S. IMI Industrials 25-50 Index $10,000 $11,740 S&P 500® Index $10,000 $11,225   2025 2026   <span style="font-family:'Fidelity Sans';font-size:9px;color:#000000;font-style:normal;font-weight:normal;">Industrials Portfolio</span> 10000 12165 <span style="font-family:'Fidelity Sans';font-size:9px;color:#000000;font-style:normal;font-weight:normal;">MSCI U.S. IMI Industrials 25-50 Index</span> 10000 11740 <span style="font-family:'Fidelity Sans';font-size:9px;color:#000000;font-style:normal;font-weight:normal;">S&amp;P 500® Index</span> 10000 11225 Visit www.fidelity.com for more recent performance information.    The Fund's past performance is not a good predictor of the Fund's future performance.  The graph does not reflect the deduction of taxes that a shareholder would pay on fund distributions or redemption of fund shares. <span style="font-family:'Fidelity Sans';font-size:11px;color:#000000;font-style:normal;font-weight:normal;">Visit </span><span style="font-family:'Fidelity Sans';font-size:11px;color:#000000;font-style:normal;font-weight:bold;">www.fidelity.com</span><span style="font-family:'Fidelity Sans';font-size:11px;color:#000000;font-style:normal;font-weight:normal;"> for more recent performance information.</span> <span style="font-family:'Fidelity Sans';font-size:11px;color:#000000;font-style:italic;font-weight:normal;">The Fund's past performance is not a good predictor of the Fund's future performance.</span> <span style="font-family:'Fidelity Sans';font-size:11px;color:#000000;font-style:normal;font-weight:normal;">The graph does not reflect the deduction of taxes that a shareholder would pay on fund distributions or redemption of fund shares.</span> <span style="font-family:'Fidelity Sans';font-size:16px;color:#368627;font-style:normal;font-weight:bold;">Key Fund Statistics</span> <div style="text-align:left;text-align-last:auto;"></div> <div style="text-align:left;text-align-last:auto;"><span style="font-family:'Fidelity Sans';font-size:11px;color:#000000;font-style:normal;font-weight:normal;">(as of July 31, 2026)</span></div> <div><span style="font-size:11px;"> </span></div><div style="text-align:left;text-align-last:auto;"></div> <div style="text-align:right;text-align-last:auto;"><table cellpadding="0" cellspacing="1" style="border-collapse:separate;border-style:none;margin:auto;" width="100%"><tr><td style="width:63%; " valign="top"><div style="text-align:left;text-align-last:auto;"><span style="font-family:'Fidelity Sans';font-size:12px;color:#000000;font-style:normal;font-weight:bold;">KEY FACTS</span></div> <div style="text-align:left;text-align-last:auto;"></div> <div style="text-align:left;text-align-last:auto;"><span style="font-family:'Fidelity Sans';font-size:11px;color:#000000;font-style:normal;font-weight:bold;"> <span> </span></span></div> <div style="text-align:left;text-align-last:auto;"></div> </td> <td style="width:32%; " valign="top"><span style="line-height:12px;"> </span><div style="text-align:left;text-align-last:auto;"></div> </td> <td style="width:5%; " valign="top"><span style="line-height:12px;"> </span><div style="text-align:left;text-align-last:auto;"></div> </td> </tr> <tr><td style="width:63%; border-bottom:1px dashed #000000;padding:0px 0px 0px 0px;" valign="middle"><div style="text-align:left;text-align-last:auto;"><span style="font-family:'Fidelity Sans';font-size:11px;color:#000000;font-style:normal;font-weight:normal;">Fund Size</span></div> </td> <td style="width:32%; border-bottom:1px dashed #000000;padding:0px 0px 0px 0px;" valign="middle"><div style="text-align:right;text-align-last:auto;"><span style="font-family:'Fidelity Sans';font-size:11px;color:#000000;font-style:normal;font-weight:normal;">$</span>2,161,544,746</div> <div style="text-align:right;text-align-last:auto;"></div> </td> <td style="width:5%; " valign="top"><span style="line-height:11px;"> </span><div style="text-align:left;text-align-last:auto;"></div> </td> </tr> <tr><td style="width:63%; border-bottom:1px dashed #000000;padding:0px 0px 0px 0px;" valign="middle"><div style="text-align:left;text-align-last:auto;"><span style="font-family:'Fidelity Sans';font-size:11px;color:#000000;font-style:normal;font-weight:normal;">Number of Holdings</span></div> </td> <td style="width:32%; border-bottom:1px dashed #000000;padding:0px 0px 0px 0px;" valign="middle"><div style="text-align:right;text-align-last:auto;">50</div> <div style="text-align:right;text-align-last:auto;"></div> </td> <td style="width:5%; " valign="top"><span style="line-height:11px;"> </span><div style="text-align:left;text-align-last:auto;"></div> </td> </tr> <tr><td style="width:63%; border-bottom:1px dashed #000000;padding:0px 0px 0px 0px;" valign="middle"><div style="text-align:left;text-align-last:auto;"><span style="font-family:'Fidelity Sans';font-size:11px;color:#000000;font-style:normal;font-weight:normal;">Total Advisory Fee</span></div> </td> <td style="width:32%; border-bottom:1px dashed #000000;padding:0px 0px 0px 0px;" valign="middle"><div style="text-align:right;text-align-last:auto;"><span style="font-family:'Fidelity Sans';font-size:11px;color:#000000;font-style:normal;font-weight:normal;">$</span>10,611,345</div> <div style="text-align:right;text-align-last:auto;"></div> </td> <td style="width:5%; " valign="middle"><span style="line-height:11px;"> </span><div style="text-align:left;text-align-last:auto;"></div> </td> </tr> <tr><td style="width:63%; border-bottom:1px dashed #000000;padding:0px 0px 0px 0px;" valign="middle"><div style="text-align:left;text-align-last:auto;"><span style="font-family:'Fidelity Sans';font-size:11px;color:#000000;font-style:normal;font-weight:normal;">Portfolio Turnover</span></div> </td> <td style="width:32%; border-bottom:1px dashed #000000;padding:0px 0px 0px 0px;" valign="middle"><div style="text-align:right;text-align-last:auto;">34<span style="font-family:'Fidelity Sans';font-size:11px;color:#000000;font-style:normal;font-weight:normal;">%</span></div> <div style="text-align:left;text-align-last:auto;"></div> </td> <td style="width:5%; " valign="top"><span style="line-height:11px;"> </span><div style="text-align:left;text-align-last:auto;"></div> </td> </tr> </table> </div> <div style="text-align:left;text-align-last:auto;"></div> 2161544746 50 10611345 0.34       TOP INDUSTRIES (% of Fund's net assets) Aerospace & Defense 30.9   Machinery 24.3   Electrical Equipment 13.6   Building Products 8.8   Ground Transportation 5.6   Construction & Engineering 5.0   Commercial Services & Supplies 3.2   Trading Companies & Distributors 3.0   Industrial Conglomerates 1.8   Others 2.5       Common Stocks 98.7 Short-Term Investments and Net Other Assets (Liabilities) 1.3 ASSET ALLOCATION (% of Fund's net assets)     Common Stocks - 98.7                       Short-Term Investments and Net Other Assets (Liabilities) - 1.3   United States 100.0 GEOGRAPHIC DIVERSIFICATION (% of Fund's net assets)     United States - 100.0                          0.309 0.243 0.136 0.088 0.056 0.050 0.032 0.030 0.018 0.025 0.987 0.013 1.000 TOP HOLDINGS(% of Fund's net assets)     GE Aerospace 8.1   GE Vernova Inc 6.3   Boeing Co 6.2   Trane Technologies PLC 4.6   Howmet Aerospace Inc 4.5   Parker-Hannifin Corp 4.4   Eaton Corp PLC 3.5   RTX Corp 3.5   PACCAR Inc 2.9   Quanta Services Inc 2.9     46.9   0.081 0.063 0.062 0.046 0.045 0.044 0.035 0.035 0.029 0.029 <div style="text-align:left;text-align-last:auto;"><span style="font-family:'Fidelity Sans';font-size:16px;color:#368627;font-style:normal;font-weight:bold;">How has the Fund changed?</span></div> <div style="text-align:left;text-align-last:auto;"><span style="font-family:'Fidelity Sans';font-size:11px;color:#000000;font-style:normal;font-weight:normal;"> </span></div> <div style="text-align:left;text-align-last:auto;"><span style="font-family:'Fidelity Sans';font-size:11px;color:#000000;font-style:normal;font-weight:normal;">This is a summary of certain changes to the Fund since October 9, 2025. For more complete information, you may review the Fund's next prospectus, which we expect to be available by September 29, 2026 at </span><span style="font-family:'Fidelity Sans';font-size:11px;color:#000000;font-style:normal;font-weight:bold;">fundresearch.fidelity.com/prospectus/sec</span><span style="font-family:'Fidelity Sans';font-size:11px;color:#000000;font-style:normal;font-weight:normal;"> or upon request at </span><span style="font-family:'Fidelity Sans';font-size:11px;color:#000000;font-style:normal;font-weight:normal;">1-800-544-8544</span><span style="font-family:'Fidelity Sans';font-size:0px;color:#000000;font-style:normal;font-weight:normal;"> </span><span style="font-family:'Fidelity Sans';font-size:11px;color:#000000;font-style:normal;font-weight:normal;"> or by sending an e-mail to </span><span style="font-family:'Fidelity Sans';font-size:11px;color:#000000;font-style:normal;font-weight:normal;">fidfunddocuments@fidelity.com</span><span style="font-family:'Fidelity Sans';font-size:11px;color:#000000;font-style:normal;font-weight:normal;">.</span></div> <div style="text-align:left;text-align-last:auto;"></div> <span style="line-height:11px;"> </span><div style="text-align:left;text-align-last:auto;"></div> <div style="text-align:left;text-align-last:auto;"><table cellpadding="0" cellspacing="0" style="border-collapse:collapse;border-style:none;" width="100%"><tr><td style="width:50%; background-color:#ebf3e9;border-right:2px dashed #368627;padding:19px 19px 19px 19px;" valign="top"><div style="text-align:left;text-align-last:auto;"><span style="font-family:'Fidelity Sans';font-size:11px;color:#000000;font-style:normal;font-weight:normal;">Industrials Portfolio merged into Fidelity Advisor® Industrials Fund on October 17, 2025.</span></div> <div style="text-align:left;text-align-last:auto;"></div> </td> <td style="width:50%; background-color:#ebf3e9;padding:19px 19px 19px 19px;" valign="top"><div style="text-align:left;text-align-last:auto;"></div> </td> </tr> </table> </div> <div style="text-align:left;text-align-last:auto;"></div> <span style="font-family:'Fidelity Sans';font-size:11px;color:#000000;font-style:normal;font-weight:normal;">This is a summary of certain changes to the Fund since October 9, 2025. For more complete information, you may review the Fund's next prospectus, which we expect to be available by September 29, 2026 at </span><span style="font-family:'Fidelity Sans';font-size:11px;color:#000000;font-style:normal;font-weight:bold;">fundresearch.fidelity.com/prospectus/sec</span><span style="font-family:'Fidelity Sans';font-size:11px;color:#000000;font-style:normal;font-weight:normal;"> or upon request at </span><span style="font-family:'Fidelity Sans';font-size:11px;color:#000000;font-style:normal;font-weight:normal;">1-800-544-8544</span><span style="font-family:'Fidelity Sans';font-size:0px;color:#000000;font-style:normal;font-weight:normal;"> </span><span style="font-family:'Fidelity Sans';font-size:11px;color:#000000;font-style:normal;font-weight:normal;"> or by sending an e-mail to </span><span style="font-family:'Fidelity Sans';font-size:11px;color:#000000;font-style:normal;font-weight:normal;">fidfunddocuments@fidelity.com</span><span style="font-family:'Fidelity Sans';font-size:11px;color:#000000;font-style:normal;font-weight:normal;">.</span> <span style="font-family:'Fidelity Sans';font-size:11px;color:#000000;font-style:normal;font-weight:bold;">fundresearch.fidelity.com/prospectus/sec</span> <span style="font-family:'Fidelity Sans';font-size:11px;color:#000000;font-style:normal;font-weight:normal;">1-800-544-8544</span> <span style="font-family:'Fidelity Sans';font-size:11px;color:#000000;font-style:normal;font-weight:normal;">fidfunddocuments@fidelity.com</span> 2026-07-31 This report describes changes to the Fund that occurred during the reporting period. Fidelity Advisor® Health Care Fund Fidelity Advisor® Health Care Fund Class Z FIKCX This annual shareholder report contains information about Fidelity Advisor® Health Care Fund for the period August 1, 2025 to July 31, 2026. annual shareholder report You can find additional information about the Fund at fundresearch.fidelity.com/prospectus/sec. You can also request this information by contacting us at 1-877-208-0098 or by sending an e-mail to fidfunddocuments@fidelity.com. fundresearch.fidelity.com/prospectus/sec 1-877-208-0098 fidfunddocuments@fidelity.com <span style="font-family:'Fidelity Sans';font-size:16px;color:#368627;font-style:normal;font-weight:bold;">What were your Fund costs for the last year?</span> <div style="text-align:left;text-align-last:auto;"><span style="font-family:'Fidelity Sans';font-size:11px;color:#000000;font-style:normal;font-weight:normal;">(based on hypothetical $10,000 investment)</span></div> <div><span style="font-size:11px;"> </span></div><div style="text-align:left;text-align-last:auto;"></div> <div style="text-align:left;text-align-last:auto;"><span style="font-family:'Fidelity Sans';font-size:12px;color:#000000;font-style:normal;font-weight:bold;">FUND COST (PREVIOUS YEAR)</span></div> <div style="text-align:left;text-align-last:auto;"></div> <div style="text-align:left;text-align-last:auto;"><table cellpadding="0" cellspacing="0" style="border-collapse:collapse;border-style:none;" width="100%"><tr><td style="width:51%; background-color:#dfe0e4;border:1px solid #dfe0e4;padding:0px 0px 0px 0px;" valign="bottom"><div style="text-align:left;text-align-last:auto;"><span style="font-family:'Fidelity Sans';font-size:11px;color:#000000;font-style:normal;font-weight:bold;"> </span></div> </td> <td style="width:21%; background-color:#dfe0e4;border:1px solid #dfe0e4;padding:0px 0px 0px 0px;" valign="bottom"><div style="text-align:center;text-align-last:auto;"><span style="font-family:'Fidelity Sans';font-size:11px;color:#000000;font-style:normal;font-weight:bold;">Costs of a $10,000 investment</span></div> </td> <td style="width:27%; background-color:#dfe0e4;border:1px solid #dfe0e4;padding:0px 0px 0px 0px;" valign="bottom"><div style="text-align:center;text-align-last:auto;"><span style="font-family:'Fidelity Sans';font-size:11px;color:#000000;font-style:normal;font-weight:bold;">Costs paid as a percentage of a $10,000 investment </span></div> </td> <td style="width:1%; " valign="top"><span style="line-height:12px;"> </span><div style="text-align:left;text-align-last:auto;"></div> </td> </tr> <tr><td style="width:51%; border-bottom:1px solid #000000;padding:0px 0px 0px 0px;" valign="top"><div style="text-align:left;text-align-last:auto;"><span style="font-family:'Fidelity Sans';font-size:12px;color:#000000;font-style:normal;font-weight:normal;">Class Z</span><span style="font-family:'Fidelity Sans';font-size:11px;color:#000000;font-style:normal;font-weight:normal;"> </span></div> </td> <td style="width:21%; border-bottom:1px solid #000000;padding:0px 0px 0px 0px;" valign="middle"><div style="text-align:center;text-align-last:auto;"><span style="font-family:'Fidelity Sans';font-size:11px;color:#000000;font-style:normal;font-weight:normal;">$</span><span style="font-family:'Fidelity Sans';font-size:12px;color:#000000;font-style:normal;font-weight:normal;"> </span>68<span style="font-family:'Fidelity Sans';font-size:11px;color:#000000;font-style:normal;font-weight:normal;"> </span></div> </td> <td style="width:27%; border-bottom:1px solid #000000;padding:0px 0px 0px 0px;" valign="middle"><div style="text-align:center;text-align-last:auto;">0.59<span style="font-family:'Fidelity Sans';font-size:11px;color:#000000;font-style:normal;font-weight:normal;">%</span></div> </td> <td style="width:1%; " valign="top"><span style="line-height:12px;"> </span><div style="text-align:left;text-align-last:auto;"></div> </td> </tr> </table> </div> <div style="text-align:left;text-align-last:auto;"></div> 68 0.0059 <span style="font-family:'Fidelity Sans';font-size:16px;color:#368627;font-style:normal;font-weight:bold;">What affected the Fund's performance this period?</span> <div style="text-align:left;text-align-last:auto;"><span style="font-family:'Fidelity Sans';font-size:11px;color:#000000;font-style:normal;font-weight:bold;"> </span></div> <div style="text-align:left;text-align-last:auto;text-indent:-24px;margin-bottom:2px;margin-left:24px;margin-top:5px;margin-right:0px;"><span style="font-family:'Fidelity Sans';font-size:12px;color:#000000;font-style:normal;font-weight:normal;">•<span style="padding-right:10px"></span>U.S. stocks achieved a strong gain for the 12 months ending July 31, 2026, reflecting enthusiasm for artificial intelligence, strong corporate fundamentals, a resilient economy and, beginning in September, the Federal Reserve's first interest-rate reductions since December 2024.</span></div> <div style="text-align:left;text-align-last:auto;text-indent:-24px;margin-bottom:2px;margin-left:24px;margin-top:5px;margin-right:0px;"><span style="font-family:'Fidelity Sans';font-size:12px;color:#000000;font-style:normal;font-weight:normal;">•<span style="padding-right:10px"></span>Against this backdrop, security selection was the primary contributor to the fund's performance versus the MSCI U.S. IMI Health Care 25/50 Index for the fiscal year, led by biotechnology. Picks in pharmaceuticals and health care services also boosted the fund's relative performance.</span></div> <div style="text-align:left;text-align-last:auto;text-indent:-24px;margin-bottom:2px;margin-left:24px;margin-top:5px;margin-right:0px;"><span style="font-family:'Fidelity Sans';font-size:12px;color:#000000;font-style:normal;font-weight:normal;">•<span style="padding-right:10px"></span>The top individual relative contributor was our stake in Exact Sciences (+113%). The stock was not held at period end. Not owning Abbott Laboratories, an index component that returned roughly -14%, was a second notable relative contributor. An overweight in BrightSpring Health Services (+193%) also helped. This period we decreased our position in BrightSpring Health Services.</span></div> <div style="text-align:left;text-align-last:auto;text-indent:-24px;margin-bottom:2px;margin-left:24px;margin-top:5px;margin-right:0px;"><span style="font-family:'Fidelity Sans';font-size:12px;color:#000000;font-style:normal;font-weight:normal;">•<span style="padding-right:10px"></span>In contrast, the primary detractor from performance versus the sector index was an underweight in pharmaceuticals. Stock selection in health care equipment also hampered the fund's result. Also detracting from our result was an overweight in health care technology.</span></div> <div style="text-align:left;text-align-last:auto;text-indent:-24px;margin-bottom:2px;margin-left:24px;margin-top:5px;margin-right:0px;"><span style="font-family:'Fidelity Sans';font-size:12px;color:#000000;font-style:normal;font-weight:normal;">•<span style="padding-right:10px"></span>The largest individual relative detractor was an overweight in Boston Scientific (-55%). This period we decreased our stake in Boston Scientific. The company was one of the fund's largest holdings this period. A non-index stake in Legend Biotech returned -53% and was the second-largest relative detractor. This period we decreased our stake in Legend Biotech. Another notable relative detractor was an overweight in Alnylam Pharmaceuticals (-48%). The company was the fund's 11-th biggest holding this period.</span></div> <div style="text-align:left;text-align-last:auto;text-indent:-24px;margin-bottom:2px;margin-left:24px;margin-top:5px;margin-right:0px;"><span style="font-family:'Fidelity Sans';font-size:12px;color:#000000;font-style:normal;font-weight:normal;">•<span style="padding-right:10px"></span>Notable changes in positioning include increased exposure to the life sciences tools &amp; services and pharmaceuticals industries.</span></div> <div style="text-align:left;text-align-last:auto;"></div> How did the Fund perform over the life of Fund?    CUMULATIVE PERFORMANCE October 2, 2018 through July 31, 2026. Initial investment of $10,000. Class Z $10,000 $9,714 $12,141 $14,709 $13,008 $13,543 $14,506 $13,626 $17,728 MSCI U.S. IMI Health Care 25-50 Index $10,000 $9,682 $11,598 $14,864 $14,388 $14,767 $16,651 $14,869 $19,107 S&P 500® Index $10,000 $10,365 $11,604 $15,833 $15,098 $17,064 $20,843 $24,247 $28,991   2018 2019 2020 2021 2022 2023 2024 2025 2026   <span style="font-family:'Fidelity Sans';font-size:9px;color:#000000;font-style:normal;font-weight:normal;">Class Z</span> 10000 9714 12141 14709 13008 13543 14506 13626 17728 <span style="font-family:'Fidelity Sans';font-size:9px;color:#000000;font-style:normal;font-weight:normal;">MSCI U.S. IMI Health Care 25-50 Index</span> 10000 9682 11598 14864 14388 14767 16651 14869 19107 <span style="font-family:'Fidelity Sans';font-size:9px;color:#000000;font-style:normal;font-weight:normal;">S&amp;P 500® Index</span> 10000 10365 11604 15833 15098 17064 20843 24247 28991 AVERAGE ANNUAL TOTAL RETURNS:   1 Year 5 Year Life of Fund A Class Z 30.10% 3.80% 7.58% MSCI U.S. IMI Health Care 25-50 Index 28.51% 5.15% 8.62% S&P 500® Index 19.56% 12.86% 14.56% A   From October 2, 2018   Visit institutional.fidelity.com for more recent performance information.    The Fund's past performance is not a good predictor of the Fund's future performance.  The graph and table do not reflect the deduction of taxes that a shareholder would pay on fund distributions or redemption of fund shares. 0.3010 0.0380 0.0758 0.2851 0.0515 0.0862 0.1956 0.1286 0.1456 2018-10-02 <span style="font-family:'Fidelity Sans';font-size:11px;color:#000000;font-style:normal;font-weight:normal;">Visit </span><span style="font-family:'Fidelity Sans';font-size:11px;color:#000000;font-style:normal;font-weight:bold;">institutional.fidelity.com</span><span style="font-family:'Fidelity Sans';font-size:11px;color:#000000;font-style:normal;font-weight:normal;"> for more recent performance information.</span> <span style="font-family:'Fidelity Sans';font-size:11px;color:#000000;font-style:italic;font-weight:normal;">The Fund's past performance is not a good predictor of the Fund's future performance.</span> <span style="font-family:'Fidelity Sans';font-size:11px;color:#000000;font-style:normal;font-weight:normal;">The graph and table do not reflect the deduction of taxes that a shareholder would pay on fund distributions or redemption of fund shares.</span> <span style="font-family:'Fidelity Sans';font-size:16px;color:#368627;font-style:normal;font-weight:bold;">Key Fund Statistics</span> <div style="text-align:left;text-align-last:auto;"></div> <div style="text-align:left;text-align-last:auto;"><span style="font-family:'Fidelity Sans';font-size:11px;color:#000000;font-style:normal;font-weight:normal;">(as of July 31, 2026)</span></div> <div><span style="font-size:11px;"> </span></div><div style="text-align:left;text-align-last:auto;"></div> <div style="text-align:right;text-align-last:auto;"><table cellpadding="0" cellspacing="1" style="border-collapse:separate;border-style:none;margin:auto;" width="100%"><tr><td style="width:63%; " valign="top"><div style="text-align:left;text-align-last:auto;"><span style="font-family:'Fidelity Sans';font-size:12px;color:#000000;font-style:normal;font-weight:bold;">KEY FACTS</span></div> <div style="text-align:left;text-align-last:auto;"></div> <div style="text-align:left;text-align-last:auto;"><span style="font-family:'Fidelity Sans';font-size:11px;color:#000000;font-style:normal;font-weight:bold;"> <span> </span></span></div> <div style="text-align:left;text-align-last:auto;"></div> </td> <td style="width:32%; " valign="top"><span style="line-height:12px;"> </span><div style="text-align:left;text-align-last:auto;"></div> </td> <td style="width:5%; " valign="top"><span style="line-height:12px;"> </span><div style="text-align:left;text-align-last:auto;"></div> </td> </tr> <tr><td style="width:63%; border-bottom:1px dashed #000000;padding:0px 0px 0px 0px;" valign="middle"><div style="text-align:left;text-align-last:auto;"><span style="font-family:'Fidelity Sans';font-size:11px;color:#000000;font-style:normal;font-weight:normal;">Fund Size</span></div> </td> <td style="width:32%; border-bottom:1px dashed #000000;padding:0px 0px 0px 0px;" valign="middle"><div style="text-align:right;text-align-last:auto;"><span style="font-family:'Fidelity Sans';font-size:11px;color:#000000;font-style:normal;font-weight:normal;">$</span>3,117,289,219</div> <div style="text-align:right;text-align-last:auto;"></div> </td> <td style="width:5%; " valign="top"><span style="line-height:11px;"> </span><div style="text-align:left;text-align-last:auto;"></div> </td> </tr> <tr><td style="width:63%; border-bottom:1px dashed #000000;padding:0px 0px 0px 0px;" valign="middle"><div style="text-align:left;text-align-last:auto;"><span style="font-family:'Fidelity Sans';font-size:11px;color:#000000;font-style:normal;font-weight:normal;">Number of Holdings</span></div> </td> <td style="width:32%; border-bottom:1px dashed #000000;padding:0px 0px 0px 0px;" valign="middle"><div style="text-align:right;text-align-last:auto;">138</div> <div style="text-align:right;text-align-last:auto;"></div> </td> <td style="width:5%; " valign="top"><span style="line-height:11px;"> </span><div style="text-align:left;text-align-last:auto;"></div> </td> </tr> <tr><td style="width:63%; border-bottom:1px dashed #000000;padding:0px 0px 0px 0px;" valign="middle"><div style="text-align:left;text-align-last:auto;"><span style="font-family:'Fidelity Sans';font-size:11px;color:#000000;font-style:normal;font-weight:normal;">Total Advisory Fee</span></div> </td> <td style="width:32%; border-bottom:1px dashed #000000;padding:0px 0px 0px 0px;" valign="middle"><div style="text-align:right;text-align-last:auto;"><span style="font-family:'Fidelity Sans';font-size:11px;color:#000000;font-style:normal;font-weight:normal;">$</span>20,416,822</div> <div style="text-align:right;text-align-last:auto;"></div> </td> <td style="width:5%; " valign="middle"><span style="line-height:11px;"> </span><div style="text-align:left;text-align-last:auto;"></div> </td> </tr> <tr><td style="width:63%; border-bottom:1px dashed #000000;padding:0px 0px 0px 0px;" valign="middle"><div style="text-align:left;text-align-last:auto;"><span style="font-family:'Fidelity Sans';font-size:11px;color:#000000;font-style:normal;font-weight:normal;">Portfolio Turnover</span></div> </td> <td style="width:32%; border-bottom:1px dashed #000000;padding:0px 0px 0px 0px;" valign="middle"><div style="text-align:right;text-align-last:auto;">74<span style="font-family:'Fidelity Sans';font-size:11px;color:#000000;font-style:normal;font-weight:normal;">%</span></div> <div style="text-align:left;text-align-last:auto;"></div> </td> <td style="width:5%; " valign="top"><span style="line-height:11px;"> </span><div style="text-align:left;text-align-last:auto;"></div> </td> </tr> </table> </div> <div style="text-align:left;text-align-last:auto;"></div> 3117289219 138 20416822 0.74       TOP INDUSTRIES (% of Fund's net assets) Biotechnology 37.8   Life Sciences Tools & Services 24.0   Pharmaceuticals 23.4   Health Care Providers & Services 10.0   Health Care Equipment & Supplies 3.4   Health Care Technology 0.6   Chemicals 0.1   Financial Services 0.1       Common Stocks 97.3 Preferred Stocks 2.1 Bonds 0.2 Short-Term Investments and Net Other Assets (Liabilities) 0.4 ASSET ALLOCATION (% of Fund's net assets)     Common Stocks - 97.3                       Preferred Stocks - 2.1                     Bonds - 0.2                                Short-Term Investments and Net Other Assets (Liabilities) - 0.4   United States 91.5 Netherlands 2.9 Denmark 2.0 Belgium 1.3 Canada 0.9 France 0.8 United Kingdom 0.3 Israel 0.2 Australia 0.1 China 0.0 GEOGRAPHIC DIVERSIFICATION (% of Fund's net assets)     United States - 91.5                       Netherlands - 2.9                          Denmark - 2.0                              Belgium - 1.3                              Canada - 0.9                               France - 0.8                               United Kingdom - 0.3                       Israel - 0.2                               Australia - 0.1                            China - 0.0                                    0.378 0.240 0.234 0.100 0.034 0.006 0.001 0.001 0.973 0.021 0.002 0.004 0.915 0.029 0.020 0.013 0.009 0.008 0.003 0.002 0.001 0.000 TOP HOLDINGS(% of Fund's net assets)     Eli Lilly & Co 7.7   Danaher Corp 6.8   Thermo Fisher Scientific Inc 6.4   UnitedHealth Group Inc 4.2   Johnson & Johnson 3.8   AbbVie Inc 3.6   West Pharmaceutical Services Inc 2.1   Argenx SE ADR 2.1   Merck & Co Inc 2.1   Ascendis Pharma A/S 2.0     40.8   0.077 0.068 0.064 0.042 0.038 0.036 0.021 0.021 0.021 0.020 <div style="text-align:left;text-align-last:auto;"><span style="font-family:'Fidelity Sans';font-size:16px;color:#368627;font-style:normal;font-weight:bold;">How has the Fund changed?</span></div> <div style="text-align:left;text-align-last:auto;"><span style="font-family:'Fidelity Sans';font-size:11px;color:#000000;font-style:normal;font-weight:normal;"> </span></div> <div style="text-align:left;text-align-last:auto;"><span style="font-family:'Fidelity Sans';font-size:11px;color:#000000;font-style:normal;font-weight:normal;">This is a summary of certain changes to the Fund since August 1, 2025. For more complete information, you may review the Fund's next prospectus, which we expect to be available by September 29, 2026 at </span><span style="font-family:'Fidelity Sans';font-size:11px;color:#000000;font-style:normal;font-weight:bold;">fundresearch.fidelity.com/prospectus/sec</span><span style="font-family:'Fidelity Sans';font-size:11px;color:#000000;font-style:normal;font-weight:normal;"> or upon request at </span><span style="font-family:'Fidelity Sans';font-size:11px;color:#000000;font-style:normal;font-weight:normal;">1-877-208-0098</span><span style="font-family:'Fidelity Sans';font-size:0px;color:#000000;font-style:normal;font-weight:normal;"> </span><span style="font-family:'Fidelity Sans';font-size:11px;color:#000000;font-style:normal;font-weight:normal;"> or by sending an e-mail to </span><span style="font-family:'Fidelity Sans';font-size:11px;color:#000000;font-style:normal;font-weight:normal;">fidfunddocuments@fidelity.com</span><span style="font-family:'Fidelity Sans';font-size:11px;color:#000000;font-style:normal;font-weight:normal;">.</span></div> <div style="text-align:left;text-align-last:auto;"></div> <span style="line-height:11px;"> </span><div style="text-align:left;text-align-last:auto;"></div> <div style="text-align:left;text-align-last:auto;"><table cellpadding="0" cellspacing="0" style="border-collapse:collapse;border-style:none;" width="100%"><tr><td style="width:50%; background-color:#ebf3e9;border-right:2px dashed #368627;padding:19px 19px 19px 19px;" valign="top"><div style="text-align:left;text-align-last:auto;"> <div style="text-align:left;text-align-last:auto;"><span style="font-family:'Fidelity Sans';font-size:11px;color:#000000;font-style:normal;font-weight:normal;">The fees associated with this class changed during the reporting year. The variations in class fees are primarily the result of the following changes:</span></div> <ul style="color:#000000;list-style-type:disc;margin:0px 0px 0px 25px;padding:0px;"><li style="margin:5px 0px 2px 24px;padding:0px 0px 0px 0px;"><span style="font-family:'Fidelity Sans';font-size:11px;color:#000000;font-style:normal;font-weight:normal;">Operating expenses</span></li></ul> <span style="line-height:12px;"> </span><div style="text-align:left;text-align-last:auto;"></div> <div style="text-align:left;text-align-last:auto;"></div></div> <div style="text-align:left;text-align-last:auto;"></div> </td> <td style="width:50%; background-color:#ebf3e9;padding:19px 19px 19px 19px;" valign="top"><div style="text-align:left;text-align-last:auto;"></div> </td> </tr> </table> </div> <div style="text-align:left;text-align-last:auto;"></div> <span style="font-family:'Fidelity Sans';font-size:11px;color:#000000;font-style:normal;font-weight:normal;">This is a summary of certain changes to the Fund since August 1, 2025. For more complete information, you may review the Fund's next prospectus, which we expect to be available by September 29, 2026 at </span><span style="font-family:'Fidelity Sans';font-size:11px;color:#000000;font-style:normal;font-weight:bold;">fundresearch.fidelity.com/prospectus/sec</span><span style="font-family:'Fidelity Sans';font-size:11px;color:#000000;font-style:normal;font-weight:normal;"> or upon request at </span><span style="font-family:'Fidelity Sans';font-size:11px;color:#000000;font-style:normal;font-weight:normal;">1-877-208-0098</span><span style="font-family:'Fidelity Sans';font-size:0px;color:#000000;font-style:normal;font-weight:normal;"> </span><span style="font-family:'Fidelity Sans';font-size:11px;color:#000000;font-style:normal;font-weight:normal;"> or by sending an e-mail to </span><span style="font-family:'Fidelity Sans';font-size:11px;color:#000000;font-style:normal;font-weight:normal;">fidfunddocuments@fidelity.com</span><span style="font-family:'Fidelity Sans';font-size:11px;color:#000000;font-style:normal;font-weight:normal;">.</span> <span style="font-family:'Fidelity Sans';font-size:11px;color:#000000;font-style:normal;font-weight:bold;">fundresearch.fidelity.com/prospectus/sec</span> <span style="font-family:'Fidelity Sans';font-size:11px;color:#000000;font-style:normal;font-weight:normal;">1-877-208-0098</span> <span style="font-family:'Fidelity Sans';font-size:11px;color:#000000;font-style:normal;font-weight:normal;">fidfunddocuments@fidelity.com</span> <div style="text-align:left;text-align-last:auto;"><span style="font-family:'Fidelity Sans';font-size:11px;color:#000000;font-style:normal;font-weight:normal;">The fees associated with this class changed during the reporting year. The variations in class fees are primarily the result of the following changes:</span></div> <ul style="color:#000000;list-style-type:disc;margin:0px 0px 0px 25px;padding:0px;"><li style="margin:5px 0px 2px 24px;padding:0px 0px 0px 0px;"><span style="font-family:'Fidelity Sans';font-size:11px;color:#000000;font-style:normal;font-weight:normal;">Operating expenses</span></li></ul> <span style="line-height:12px;"> </span><div style="text-align:left;text-align-last:auto;"></div> <div style="text-align:left;text-align-last:auto;"></div> 2026-07-31 Fidelity Advisor® Health Care Fund Fidelity Advisor® Health Care Fund Class M FACTX This annual shareholder report contains information about Fidelity Advisor® Health Care Fund for the period August 1, 2025 to July 31, 2026. annual shareholder report You can find additional information about the Fund at fundresearch.fidelity.com/prospectus/sec. You can also request this information by contacting us at 1-877-208-0098 or by sending an e-mail to fidfunddocuments@fidelity.com. fundresearch.fidelity.com/prospectus/sec 1-877-208-0098 fidfunddocuments@fidelity.com <span style="font-family:'Fidelity Sans';font-size:16px;color:#368627;font-style:normal;font-weight:bold;">What were your Fund costs for the last year?</span> <div style="text-align:left;text-align-last:auto;"><span style="font-family:'Fidelity Sans';font-size:11px;color:#000000;font-style:normal;font-weight:normal;">(based on hypothetical $10,000 investment)</span></div> <div><span style="font-size:11px;"> </span></div><div style="text-align:left;text-align-last:auto;"></div> <div style="text-align:left;text-align-last:auto;"><span style="font-family:'Fidelity Sans';font-size:12px;color:#000000;font-style:normal;font-weight:bold;">FUND COST (PREVIOUS YEAR)</span></div> <div style="text-align:left;text-align-last:auto;"></div> <div style="text-align:left;text-align-last:auto;"><table cellpadding="0" cellspacing="0" style="border-collapse:collapse;border-style:none;" width="100%"><tr><td style="width:51%; background-color:#dfe0e4;border:1px solid #dfe0e4;padding:0px 0px 0px 0px;" valign="bottom"><div style="text-align:left;text-align-last:auto;"><span style="font-family:'Fidelity Sans';font-size:11px;color:#000000;font-style:normal;font-weight:bold;"> </span></div> </td> <td style="width:21%; background-color:#dfe0e4;border:1px solid #dfe0e4;padding:0px 0px 0px 0px;" valign="bottom"><div style="text-align:center;text-align-last:auto;"><span style="font-family:'Fidelity Sans';font-size:11px;color:#000000;font-style:normal;font-weight:bold;">Costs of a $10,000 investment</span></div> </td> <td style="width:27%; background-color:#dfe0e4;border:1px solid #dfe0e4;padding:0px 0px 0px 0px;" valign="bottom"><div style="text-align:center;text-align-last:auto;"><span style="font-family:'Fidelity Sans';font-size:11px;color:#000000;font-style:normal;font-weight:bold;">Costs paid as a percentage of a $10,000 investment </span></div> </td> <td style="width:1%; " valign="top"><span style="line-height:12px;"> </span><div style="text-align:left;text-align-last:auto;"></div> </td> </tr> <tr><td style="width:51%; border-bottom:1px solid #000000;padding:0px 0px 0px 0px;" valign="top"><div style="text-align:left;text-align-last:auto;"><span style="font-family:'Fidelity Sans';font-size:12px;color:#000000;font-style:normal;font-weight:normal;">Class M</span><span style="font-family:'Fidelity Sans';font-size:11px;color:#000000;font-style:normal;font-weight:normal;"> </span></div> </td> <td style="width:21%; border-bottom:1px solid #000000;padding:0px 0px 0px 0px;" valign="middle"><div style="text-align:center;text-align-last:auto;"><span style="font-family:'Fidelity Sans';font-size:11px;color:#000000;font-style:normal;font-weight:normal;">$</span><span style="font-family:'Fidelity Sans';font-size:12px;color:#000000;font-style:normal;font-weight:normal;"> </span>138<span style="font-family:'Fidelity Sans';font-size:11px;color:#000000;font-style:normal;font-weight:normal;"> </span></div> </td> <td style="width:27%; border-bottom:1px solid #000000;padding:0px 0px 0px 0px;" valign="middle"><div style="text-align:center;text-align-last:auto;">1.21<span style="font-family:'Fidelity Sans';font-size:11px;color:#000000;font-style:normal;font-weight:normal;">%</span></div> </td> <td style="width:1%; " valign="top"><span style="line-height:12px;"> </span><div style="text-align:left;text-align-last:auto;"></div> </td> </tr> </table> </div> <div style="text-align:left;text-align-last:auto;"></div> 138 0.0121 <span style="font-family:'Fidelity Sans';font-size:16px;color:#368627;font-style:normal;font-weight:bold;">What affected the Fund's performance this period?</span> <div style="text-align:left;text-align-last:auto;"><span style="font-family:'Fidelity Sans';font-size:11px;color:#000000;font-style:normal;font-weight:bold;"> </span></div> <div style="text-align:left;text-align-last:auto;text-indent:-24px;margin-bottom:2px;margin-left:24px;margin-top:5px;margin-right:0px;"><span style="font-family:'Fidelity Sans';font-size:12px;color:#000000;font-style:normal;font-weight:normal;">•<span style="padding-right:10px"></span>U.S. stocks achieved a strong gain for the 12 months ending July 31, 2026, reflecting enthusiasm for artificial intelligence, strong corporate fundamentals, a resilient economy and, beginning in September, the Federal Reserve's first interest-rate reductions since December 2024.</span></div> <div style="text-align:left;text-align-last:auto;text-indent:-24px;margin-bottom:2px;margin-left:24px;margin-top:5px;margin-right:0px;"><span style="font-family:'Fidelity Sans';font-size:12px;color:#000000;font-style:normal;font-weight:normal;">•<span style="padding-right:10px"></span>Against this backdrop, security selection was the primary contributor to the fund's performance versus the MSCI U.S. IMI Health Care 25/50 Index for the fiscal year, led by biotechnology. Picks in pharmaceuticals and health care services also boosted the fund's relative performance.</span></div> <div style="text-align:left;text-align-last:auto;text-indent:-24px;margin-bottom:2px;margin-left:24px;margin-top:5px;margin-right:0px;"><span style="font-family:'Fidelity Sans';font-size:12px;color:#000000;font-style:normal;font-weight:normal;">•<span style="padding-right:10px"></span>The top individual relative contributor was our stake in Exact Sciences (+113%). The stock was not held at period end. Not owning Abbott Laboratories, an index component that returned roughly -14%, was a second notable relative contributor. An overweight in BrightSpring Health Services (+193%) also helped. This period we decreased our position in BrightSpring Health Services.</span></div> <div style="text-align:left;text-align-last:auto;text-indent:-24px;margin-bottom:2px;margin-left:24px;margin-top:5px;margin-right:0px;"><span style="font-family:'Fidelity Sans';font-size:12px;color:#000000;font-style:normal;font-weight:normal;">•<span style="padding-right:10px"></span>In contrast, the primary detractor from performance versus the sector index was an underweight in pharmaceuticals. Stock selection in health care equipment also hampered the fund's result. Also detracting from our result was an overweight in health care technology.</span></div> <div style="text-align:left;text-align-last:auto;text-indent:-24px;margin-bottom:2px;margin-left:24px;margin-top:5px;margin-right:0px;"><span style="font-family:'Fidelity Sans';font-size:12px;color:#000000;font-style:normal;font-weight:normal;">•<span style="padding-right:10px"></span>The largest individual relative detractor was an overweight in Boston Scientific (-55%). This period we decreased our stake in Boston Scientific. The company was one of the fund's largest holdings this period. A non-index stake in Legend Biotech returned -53% and was the second-largest relative detractor. This period we decreased our stake in Legend Biotech. Another notable relative detractor was an overweight in Alnylam Pharmaceuticals (-48%). The company was the fund's 11-th biggest holding this period.</span></div> <div style="text-align:left;text-align-last:auto;text-indent:-24px;margin-bottom:2px;margin-left:24px;margin-top:5px;margin-right:0px;"><span style="font-family:'Fidelity Sans';font-size:12px;color:#000000;font-style:normal;font-weight:normal;">•<span style="padding-right:10px"></span>Notable changes in positioning include increased exposure to the life sciences tools &amp; services and pharmaceuticals industries.</span></div> <div style="text-align:left;text-align-last:auto;"></div> How did the Fund perform over the past 10 years?    CUMULATIVE PERFORMANCE July 31, 2016 through July 31, 2026. Initial investment of $10,000 and the current sales charge was paid. Class M $9,650 $10,536 $12,587 $12,915 $16,039 $19,309 $16,969 $17,554 $18,683 $17,443 $22,550 MSCI U.S. IMI Health Care 25-50 Index $10,000 $10,935 $12,626 $13,117 $15,713 $20,138 $19,492 $20,006 $22,558 $20,144 $25,886 S&P 500® Index $10,000 $11,604 $13,489 $14,566 $16,308 $22,251 $21,219 $23,980 $29,292 $34,076 $40,742   2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026   <span style="font-family:'Fidelity Sans';font-size:9px;color:#000000;font-style:normal;font-weight:normal;">Class M</span> 9650 10536 12587 12915 16039 19309 16969 17554 18683 17443 22550 <span style="font-family:'Fidelity Sans';font-size:9px;color:#000000;font-style:normal;font-weight:normal;">MSCI U.S. IMI Health Care 25-50 Index</span> 10000 10935 12626 13117 15713 20138 19492 20006 22558 20144 25886 <span style="font-family:'Fidelity Sans';font-size:9px;color:#000000;font-style:normal;font-weight:normal;">S&amp;P 500® Index</span> 10000 11604 13489 14566 16308 22251 21219 23980 29292 34076 40742 AVERAGE ANNUAL TOTAL RETURNS:   1 Year 5 Year 10 Year Class M (incl. 3.50% sales charge)   24.76% 2.42% 8.47% Class M (without 3.50% sales charge) 29.28% 3.15% 8.86% MSCI U.S. IMI Health Care 25-50 Index 28.51% 5.15% 9.98% S&P 500® Index 19.56% 12.86% 15.08%     Visit institutional.fidelity.com for more recent performance information.    The Fund's past performance is not a good predictor of the Fund's future performance.  The graph and table do not reflect the deduction of taxes that a shareholder would pay on fund distributions or redemption of fund shares. 0.2476 0.0242 0.0847 0.2928 0.0315 0.0886 0.2851 0.0515 0.0998 0.1956 0.1286 0.1508 <span style="font-family:'Fidelity Sans';font-size:11px;color:#000000;font-style:normal;font-weight:normal;">Visit </span><span style="font-family:'Fidelity Sans';font-size:11px;color:#000000;font-style:normal;font-weight:bold;">institutional.fidelity.com</span><span style="font-family:'Fidelity Sans';font-size:11px;color:#000000;font-style:normal;font-weight:normal;"> for more recent performance information.</span> <span style="font-family:'Fidelity Sans';font-size:11px;color:#000000;font-style:italic;font-weight:normal;">The Fund's past performance is not a good predictor of the Fund's future performance.</span> <span style="font-family:'Fidelity Sans';font-size:11px;color:#000000;font-style:normal;font-weight:normal;">The graph and table do not reflect the deduction of taxes that a shareholder would pay on fund distributions or redemption of fund shares.</span> <span style="font-family:'Fidelity Sans';font-size:16px;color:#368627;font-style:normal;font-weight:bold;">Key Fund Statistics</span> <div style="text-align:left;text-align-last:auto;"></div> <div style="text-align:left;text-align-last:auto;"><span style="font-family:'Fidelity Sans';font-size:11px;color:#000000;font-style:normal;font-weight:normal;">(as of July 31, 2026)</span></div> <div><span style="font-size:11px;"> </span></div><div style="text-align:left;text-align-last:auto;"></div> <div style="text-align:right;text-align-last:auto;"><table cellpadding="0" cellspacing="1" style="border-collapse:separate;border-style:none;margin:auto;" width="100%"><tr><td style="width:63%; " valign="top"><div style="text-align:left;text-align-last:auto;"><span style="font-family:'Fidelity Sans';font-size:12px;color:#000000;font-style:normal;font-weight:bold;">KEY FACTS</span></div> <div style="text-align:left;text-align-last:auto;"></div> <div style="text-align:left;text-align-last:auto;"><span style="font-family:'Fidelity Sans';font-size:11px;color:#000000;font-style:normal;font-weight:bold;"> <span> </span></span></div> <div style="text-align:left;text-align-last:auto;"></div> </td> <td style="width:32%; " valign="top"><span style="line-height:12px;"> </span><div style="text-align:left;text-align-last:auto;"></div> </td> <td style="width:5%; " valign="top"><span style="line-height:12px;"> </span><div style="text-align:left;text-align-last:auto;"></div> </td> </tr> <tr><td style="width:63%; border-bottom:1px dashed #000000;padding:0px 0px 0px 0px;" valign="middle"><div style="text-align:left;text-align-last:auto;"><span style="font-family:'Fidelity Sans';font-size:11px;color:#000000;font-style:normal;font-weight:normal;">Fund Size</span></div> </td> <td style="width:32%; border-bottom:1px dashed #000000;padding:0px 0px 0px 0px;" valign="middle"><div style="text-align:right;text-align-last:auto;"><span style="font-family:'Fidelity Sans';font-size:11px;color:#000000;font-style:normal;font-weight:normal;">$</span>3,117,289,219</div> <div style="text-align:right;text-align-last:auto;"></div> </td> <td style="width:5%; " valign="top"><span style="line-height:11px;"> </span><div style="text-align:left;text-align-last:auto;"></div> </td> </tr> <tr><td style="width:63%; border-bottom:1px dashed #000000;padding:0px 0px 0px 0px;" valign="middle"><div style="text-align:left;text-align-last:auto;"><span style="font-family:'Fidelity Sans';font-size:11px;color:#000000;font-style:normal;font-weight:normal;">Number of Holdings</span></div> </td> <td style="width:32%; border-bottom:1px dashed #000000;padding:0px 0px 0px 0px;" valign="middle"><div style="text-align:right;text-align-last:auto;">138</div> <div style="text-align:right;text-align-last:auto;"></div> </td> <td style="width:5%; " valign="top"><span style="line-height:11px;"> </span><div style="text-align:left;text-align-last:auto;"></div> </td> </tr> <tr><td style="width:63%; border-bottom:1px dashed #000000;padding:0px 0px 0px 0px;" valign="middle"><div style="text-align:left;text-align-last:auto;"><span style="font-family:'Fidelity Sans';font-size:11px;color:#000000;font-style:normal;font-weight:normal;">Total Advisory Fee</span></div> </td> <td style="width:32%; border-bottom:1px dashed #000000;padding:0px 0px 0px 0px;" valign="middle"><div style="text-align:right;text-align-last:auto;"><span style="font-family:'Fidelity Sans';font-size:11px;color:#000000;font-style:normal;font-weight:normal;">$</span>20,416,822</div> <div style="text-align:right;text-align-last:auto;"></div> </td> <td style="width:5%; " valign="middle"><span style="line-height:11px;"> </span><div style="text-align:left;text-align-last:auto;"></div> </td> </tr> <tr><td style="width:63%; border-bottom:1px dashed #000000;padding:0px 0px 0px 0px;" valign="middle"><div style="text-align:left;text-align-last:auto;"><span style="font-family:'Fidelity Sans';font-size:11px;color:#000000;font-style:normal;font-weight:normal;">Portfolio Turnover</span></div> </td> <td style="width:32%; border-bottom:1px dashed #000000;padding:0px 0px 0px 0px;" valign="middle"><div style="text-align:right;text-align-last:auto;">74<span style="font-family:'Fidelity Sans';font-size:11px;color:#000000;font-style:normal;font-weight:normal;">%</span></div> <div style="text-align:left;text-align-last:auto;"></div> </td> <td style="width:5%; " valign="top"><span style="line-height:11px;"> </span><div style="text-align:left;text-align-last:auto;"></div> </td> </tr> </table> </div> <div style="text-align:left;text-align-last:auto;"></div> 3117289219 138 20416822 0.74       TOP INDUSTRIES (% of Fund's net assets) Biotechnology 37.8   Life Sciences Tools & Services 24.0   Pharmaceuticals 23.4   Health Care Providers & Services 10.0   Health Care Equipment & Supplies 3.4   Health Care Technology 0.6   Chemicals 0.1   Financial Services 0.1       Common Stocks 97.3 Preferred Stocks 2.1 Bonds 0.2 Short-Term Investments and Net Other Assets (Liabilities) 0.4 ASSET ALLOCATION (% of Fund's net assets)     Common Stocks - 97.3                       Preferred Stocks - 2.1                     Bonds - 0.2                                Short-Term Investments and Net Other Assets (Liabilities) - 0.4   United States 91.5 Netherlands 2.9 Denmark 2.0 Belgium 1.3 Canada 0.9 France 0.8 United Kingdom 0.3 Israel 0.2 Australia 0.1 China 0.0 GEOGRAPHIC DIVERSIFICATION (% of Fund's net assets)     United States - 91.5                       Netherlands - 2.9                          Denmark - 2.0                              Belgium - 1.3                              Canada - 0.9                               France - 0.8                               United Kingdom - 0.3                       Israel - 0.2                               Australia - 0.1                            China - 0.0                                    0.378 0.240 0.234 0.100 0.034 0.006 0.001 0.001 0.973 0.021 0.002 0.004 0.915 0.029 0.020 0.013 0.009 0.008 0.003 0.002 0.001 0.000 TOP HOLDINGS(% of Fund's net assets)     Eli Lilly & Co 7.7   Danaher Corp 6.8   Thermo Fisher Scientific Inc 6.4   UnitedHealth Group Inc 4.2   Johnson & Johnson 3.8   AbbVie Inc 3.6   West Pharmaceutical Services Inc 2.1   Argenx SE ADR 2.1   Merck & Co Inc 2.1   Ascendis Pharma A/S 2.0     40.8   0.077 0.068 0.064 0.042 0.038 0.036 0.021 0.021 0.021 0.020 2026-07-31 Fidelity Advisor® Health Care Fund Fidelity Advisor® Health Care Fund Class I FHCIX This annual shareholder report contains information about Fidelity Advisor® Health Care Fund for the period August 1, 2025 to July 31, 2026. annual shareholder report You can find additional information about the Fund at fundresearch.fidelity.com/prospectus/sec. You can also request this information by contacting us at 1-877-208-0098 or by sending an e-mail to fidfunddocuments@fidelity.com. fundresearch.fidelity.com/prospectus/sec 1-877-208-0098 fidfunddocuments@fidelity.com <span style="font-family:'Fidelity Sans';font-size:16px;color:#368627;font-style:normal;font-weight:bold;">What were your Fund costs for the last year?</span> <div style="text-align:left;text-align-last:auto;"><span style="font-family:'Fidelity Sans';font-size:11px;color:#000000;font-style:normal;font-weight:normal;">(based on hypothetical $10,000 investment)</span></div> <div><span style="font-size:11px;"> </span></div><div style="text-align:left;text-align-last:auto;"></div> <div style="text-align:left;text-align-last:auto;"><span style="font-family:'Fidelity Sans';font-size:12px;color:#000000;font-style:normal;font-weight:bold;">FUND COST (PREVIOUS YEAR)</span></div> <div style="text-align:left;text-align-last:auto;"></div> <div style="text-align:left;text-align-last:auto;"><table cellpadding="0" cellspacing="0" style="border-collapse:collapse;border-style:none;" width="100%"><tr><td style="width:51%; background-color:#dfe0e4;border:1px solid #dfe0e4;padding:0px 0px 0px 0px;" valign="bottom"><div style="text-align:left;text-align-last:auto;"><span style="font-family:'Fidelity Sans';font-size:11px;color:#000000;font-style:normal;font-weight:bold;"> </span></div> </td> <td style="width:21%; background-color:#dfe0e4;border:1px solid #dfe0e4;padding:0px 0px 0px 0px;" valign="bottom"><div style="text-align:center;text-align-last:auto;"><span style="font-family:'Fidelity Sans';font-size:11px;color:#000000;font-style:normal;font-weight:bold;">Costs of a $10,000 investment</span></div> </td> <td style="width:27%; background-color:#dfe0e4;border:1px solid #dfe0e4;padding:0px 0px 0px 0px;" valign="bottom"><div style="text-align:center;text-align-last:auto;"><span style="font-family:'Fidelity Sans';font-size:11px;color:#000000;font-style:normal;font-weight:bold;">Costs paid as a percentage of a $10,000 investment </span></div> </td> <td style="width:1%; " valign="top"><span style="line-height:12px;"> </span><div style="text-align:left;text-align-last:auto;"></div> </td> </tr> <tr><td style="width:51%; border-bottom:1px solid #000000;padding:0px 0px 0px 0px;" valign="top"><div style="text-align:left;text-align-last:auto;"><span style="font-family:'Fidelity Sans';font-size:12px;color:#000000;font-style:normal;font-weight:normal;">Class I</span><span style="font-family:'Fidelity Sans';font-size:11px;color:#000000;font-style:normal;font-weight:normal;"> </span></div> </td> <td style="width:21%; border-bottom:1px solid #000000;padding:0px 0px 0px 0px;" valign="middle"><div style="text-align:center;text-align-last:auto;"><span style="font-family:'Fidelity Sans';font-size:11px;color:#000000;font-style:normal;font-weight:normal;">$</span><span style="font-family:'Fidelity Sans';font-size:12px;color:#000000;font-style:normal;font-weight:normal;"> </span>81<span style="font-family:'Fidelity Sans';font-size:11px;color:#000000;font-style:normal;font-weight:normal;"> </span></div> </td> <td style="width:27%; border-bottom:1px solid #000000;padding:0px 0px 0px 0px;" valign="middle"><div style="text-align:center;text-align-last:auto;">0.70<span style="font-family:'Fidelity Sans';font-size:11px;color:#000000;font-style:normal;font-weight:normal;">%</span></div> </td> <td style="width:1%; " valign="top"><span style="line-height:12px;"> </span><div style="text-align:left;text-align-last:auto;"></div> </td> </tr> </table> </div> <div style="text-align:left;text-align-last:auto;"></div> 81 0.0070 <span style="font-family:'Fidelity Sans';font-size:16px;color:#368627;font-style:normal;font-weight:bold;">What affected the Fund's performance this period?</span> <div style="text-align:left;text-align-last:auto;"><span style="font-family:'Fidelity Sans';font-size:11px;color:#000000;font-style:normal;font-weight:bold;"> </span></div> <div style="text-align:left;text-align-last:auto;text-indent:-24px;margin-bottom:2px;margin-left:24px;margin-top:5px;margin-right:0px;"><span style="font-family:'Fidelity Sans';font-size:12px;color:#000000;font-style:normal;font-weight:normal;">•<span style="padding-right:10px"></span>U.S. stocks achieved a strong gain for the 12 months ending July 31, 2026, reflecting enthusiasm for artificial intelligence, strong corporate fundamentals, a resilient economy and, beginning in September, the Federal Reserve's first interest-rate reductions since December 2024.</span></div> <div style="text-align:left;text-align-last:auto;text-indent:-24px;margin-bottom:2px;margin-left:24px;margin-top:5px;margin-right:0px;"><span style="font-family:'Fidelity Sans';font-size:12px;color:#000000;font-style:normal;font-weight:normal;">•<span style="padding-right:10px"></span>Against this backdrop, security selection was the primary contributor to the fund's performance versus the MSCI U.S. IMI Health Care 25/50 Index for the fiscal year, led by biotechnology. Picks in pharmaceuticals and health care services also boosted the fund's relative performance.</span></div> <div style="text-align:left;text-align-last:auto;text-indent:-24px;margin-bottom:2px;margin-left:24px;margin-top:5px;margin-right:0px;"><span style="font-family:'Fidelity Sans';font-size:12px;color:#000000;font-style:normal;font-weight:normal;">•<span style="padding-right:10px"></span>The top individual relative contributor was our stake in Exact Sciences (+113%). The stock was not held at period end. Not owning Abbott Laboratories, an index component that returned roughly -14%, was a second notable relative contributor. An overweight in BrightSpring Health Services (+193%) also helped. This period we decreased our position in BrightSpring Health Services.</span></div> <div style="text-align:left;text-align-last:auto;text-indent:-24px;margin-bottom:2px;margin-left:24px;margin-top:5px;margin-right:0px;"><span style="font-family:'Fidelity Sans';font-size:12px;color:#000000;font-style:normal;font-weight:normal;">•<span style="padding-right:10px"></span>In contrast, the primary detractor from performance versus the sector index was an underweight in pharmaceuticals. Stock selection in health care equipment also hampered the fund's result. Also detracting from our result was an overweight in health care technology.</span></div> <div style="text-align:left;text-align-last:auto;text-indent:-24px;margin-bottom:2px;margin-left:24px;margin-top:5px;margin-right:0px;"><span style="font-family:'Fidelity Sans';font-size:12px;color:#000000;font-style:normal;font-weight:normal;">•<span style="padding-right:10px"></span>The largest individual relative detractor was an overweight in Boston Scientific (-55%). This period we decreased our stake in Boston Scientific. The company was one of the fund's largest holdings this period. A non-index stake in Legend Biotech returned -53% and was the second-largest relative detractor. This period we decreased our stake in Legend Biotech. Another notable relative detractor was an overweight in Alnylam Pharmaceuticals (-48%). The company was the fund's 11-th biggest holding this period.</span></div> <div style="text-align:left;text-align-last:auto;text-indent:-24px;margin-bottom:2px;margin-left:24px;margin-top:5px;margin-right:0px;"><span style="font-family:'Fidelity Sans';font-size:12px;color:#000000;font-style:normal;font-weight:normal;">•<span style="padding-right:10px"></span>Notable changes in positioning include increased exposure to the life sciences tools &amp; services and pharmaceuticals industries.</span></div> <div style="text-align:left;text-align-last:auto;"></div> How did the Fund perform over the past 10 years?    CUMULATIVE PERFORMANCE July 31, 2016 through July 31, 2026. Initial investment of $10,000. Class I $10,000 $10,978 $13,184 $13,599 $16,977 $20,543 $18,144 $18,866 $20,182 $18,937 $24,605 MSCI U.S. IMI Health Care 25-50 Index $10,000 $10,935 $12,626 $13,117 $15,713 $20,138 $19,492 $20,006 $22,558 $20,144 $25,886 S&P 500® Index $10,000 $11,604 $13,489 $14,566 $16,308 $22,251 $21,219 $23,980 $29,292 $34,076 $40,742   2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026   <span style="font-family:'Fidelity Sans';font-size:9px;color:#000000;font-style:normal;font-weight:normal;">Class I</span> 10000 10978 13184 13599 16977 20543 18144 18866 20182 18937 24605 <span style="font-family:'Fidelity Sans';font-size:9px;color:#000000;font-style:normal;font-weight:normal;">MSCI U.S. IMI Health Care 25-50 Index</span> 10000 10935 12626 13117 15713 20138 19492 20006 22558 20144 25886 <span style="font-family:'Fidelity Sans';font-size:9px;color:#000000;font-style:normal;font-weight:normal;">S&amp;P 500® Index</span> 10000 11604 13489 14566 16308 22251 21219 23980 29292 34076 40742 AVERAGE ANNUAL TOTAL RETURNS:   1 Year 5 Year 10 Year Class I 29.93% 3.67% 9.42% MSCI U.S. IMI Health Care 25-50 Index 28.51% 5.15% 9.98% S&P 500® Index 19.56% 12.86% 15.08%     Visit institutional.fidelity.com for more recent performance information.    The Fund's past performance is not a good predictor of the Fund's future performance.  The graph and table do not reflect the deduction of taxes that a shareholder would pay on fund distributions or redemption of fund shares. 0.2993 0.0367 0.0942 0.2851 0.0515 0.0998 0.1956 0.1286 0.1508 <span style="font-family:'Fidelity Sans';font-size:11px;color:#000000;font-style:normal;font-weight:normal;">Visit </span><span style="font-family:'Fidelity Sans';font-size:11px;color:#000000;font-style:normal;font-weight:bold;">institutional.fidelity.com</span><span style="font-family:'Fidelity Sans';font-size:11px;color:#000000;font-style:normal;font-weight:normal;"> for more recent performance information.</span> <span style="font-family:'Fidelity Sans';font-size:11px;color:#000000;font-style:italic;font-weight:normal;">The Fund's past performance is not a good predictor of the Fund's future performance.</span> <span style="font-family:'Fidelity Sans';font-size:11px;color:#000000;font-style:normal;font-weight:normal;">The graph and table do not reflect the deduction of taxes that a shareholder would pay on fund distributions or redemption of fund shares.</span> <span style="font-family:'Fidelity Sans';font-size:16px;color:#368627;font-style:normal;font-weight:bold;">Key Fund Statistics</span> <div style="text-align:left;text-align-last:auto;"></div> <div style="text-align:left;text-align-last:auto;"><span style="font-family:'Fidelity Sans';font-size:11px;color:#000000;font-style:normal;font-weight:normal;">(as of July 31, 2026)</span></div> <div><span style="font-size:11px;"> </span></div><div style="text-align:left;text-align-last:auto;"></div> <div style="text-align:right;text-align-last:auto;"><table cellpadding="0" cellspacing="1" style="border-collapse:separate;border-style:none;margin:auto;" width="100%"><tr><td style="width:63%; " valign="top"><div style="text-align:left;text-align-last:auto;"><span style="font-family:'Fidelity Sans';font-size:12px;color:#000000;font-style:normal;font-weight:bold;">KEY FACTS</span></div> <div style="text-align:left;text-align-last:auto;"></div> <div style="text-align:left;text-align-last:auto;"><span style="font-family:'Fidelity Sans';font-size:11px;color:#000000;font-style:normal;font-weight:bold;"> <span> </span></span></div> <div style="text-align:left;text-align-last:auto;"></div> </td> <td style="width:32%; " valign="top"><span style="line-height:12px;"> </span><div style="text-align:left;text-align-last:auto;"></div> </td> <td style="width:5%; " valign="top"><span style="line-height:12px;"> </span><div style="text-align:left;text-align-last:auto;"></div> </td> </tr> <tr><td style="width:63%; border-bottom:1px dashed #000000;padding:0px 0px 0px 0px;" valign="middle"><div style="text-align:left;text-align-last:auto;"><span style="font-family:'Fidelity Sans';font-size:11px;color:#000000;font-style:normal;font-weight:normal;">Fund Size</span></div> </td> <td style="width:32%; border-bottom:1px dashed #000000;padding:0px 0px 0px 0px;" valign="middle"><div style="text-align:right;text-align-last:auto;"><span style="font-family:'Fidelity Sans';font-size:11px;color:#000000;font-style:normal;font-weight:normal;">$</span>3,117,289,219</div> <div style="text-align:right;text-align-last:auto;"></div> </td> <td style="width:5%; " valign="top"><span style="line-height:11px;"> </span><div style="text-align:left;text-align-last:auto;"></div> </td> </tr> <tr><td style="width:63%; border-bottom:1px dashed #000000;padding:0px 0px 0px 0px;" valign="middle"><div style="text-align:left;text-align-last:auto;"><span style="font-family:'Fidelity Sans';font-size:11px;color:#000000;font-style:normal;font-weight:normal;">Number of Holdings</span></div> </td> <td style="width:32%; border-bottom:1px dashed #000000;padding:0px 0px 0px 0px;" valign="middle"><div style="text-align:right;text-align-last:auto;">138</div> <div style="text-align:right;text-align-last:auto;"></div> </td> <td style="width:5%; " valign="top"><span style="line-height:11px;"> </span><div style="text-align:left;text-align-last:auto;"></div> </td> </tr> <tr><td style="width:63%; border-bottom:1px dashed #000000;padding:0px 0px 0px 0px;" valign="middle"><div style="text-align:left;text-align-last:auto;"><span style="font-family:'Fidelity Sans';font-size:11px;color:#000000;font-style:normal;font-weight:normal;">Total Advisory Fee</span></div> </td> <td style="width:32%; border-bottom:1px dashed #000000;padding:0px 0px 0px 0px;" valign="middle"><div style="text-align:right;text-align-last:auto;"><span style="font-family:'Fidelity Sans';font-size:11px;color:#000000;font-style:normal;font-weight:normal;">$</span>20,416,822</div> <div style="text-align:right;text-align-last:auto;"></div> </td> <td style="width:5%; " valign="middle"><span style="line-height:11px;"> </span><div style="text-align:left;text-align-last:auto;"></div> </td> </tr> <tr><td style="width:63%; border-bottom:1px dashed #000000;padding:0px 0px 0px 0px;" valign="middle"><div style="text-align:left;text-align-last:auto;"><span style="font-family:'Fidelity Sans';font-size:11px;color:#000000;font-style:normal;font-weight:normal;">Portfolio Turnover</span></div> </td> <td style="width:32%; border-bottom:1px dashed #000000;padding:0px 0px 0px 0px;" valign="middle"><div style="text-align:right;text-align-last:auto;">74<span style="font-family:'Fidelity Sans';font-size:11px;color:#000000;font-style:normal;font-weight:normal;">%</span></div> <div style="text-align:left;text-align-last:auto;"></div> </td> <td style="width:5%; " valign="top"><span style="line-height:11px;"> </span><div style="text-align:left;text-align-last:auto;"></div> </td> </tr> </table> </div> <div style="text-align:left;text-align-last:auto;"></div> 3117289219 138 20416822 0.74       TOP INDUSTRIES (% of Fund's net assets) Biotechnology 37.8   Life Sciences Tools & Services 24.0   Pharmaceuticals 23.4   Health Care Providers & Services 10.0   Health Care Equipment & Supplies 3.4   Health Care Technology 0.6   Chemicals 0.1   Financial Services 0.1       Common Stocks 97.3 Preferred Stocks 2.1 Bonds 0.2 Short-Term Investments and Net Other Assets (Liabilities) 0.4 ASSET ALLOCATION (% of Fund's net assets)     Common Stocks - 97.3                       Preferred Stocks - 2.1                     Bonds - 0.2                                Short-Term Investments and Net Other Assets (Liabilities) - 0.4   United States 91.5 Netherlands 2.9 Denmark 2.0 Belgium 1.3 Canada 0.9 France 0.8 United Kingdom 0.3 Israel 0.2 Australia 0.1 China 0.0 GEOGRAPHIC DIVERSIFICATION (% of Fund's net assets)     United States - 91.5                       Netherlands - 2.9                          Denmark - 2.0                              Belgium - 1.3                              Canada - 0.9                               France - 0.8                               United Kingdom - 0.3                       Israel - 0.2                               Australia - 0.1                            China - 0.0                                    0.378 0.240 0.234 0.100 0.034 0.006 0.001 0.001 0.973 0.021 0.002 0.004 0.915 0.029 0.020 0.013 0.009 0.008 0.003 0.002 0.001 0.000 TOP HOLDINGS(% of Fund's net assets)     Eli Lilly & Co 7.7   Danaher Corp 6.8   Thermo Fisher Scientific Inc 6.4   UnitedHealth Group Inc 4.2   Johnson & Johnson 3.8   AbbVie Inc 3.6   West Pharmaceutical Services Inc 2.1   Argenx SE ADR 2.1   Merck & Co Inc 2.1   Ascendis Pharma A/S 2.0     40.8   0.077 0.068 0.064 0.042 0.038 0.036 0.021 0.021 0.021 0.020 2026-07-31 Fidelity Advisor® Health Care Fund Fidelity Advisor® Health Care Fund Class C FHCCX This annual shareholder report contains information about Fidelity Advisor® Health Care Fund for the period August 1, 2025 to July 31, 2026. annual shareholder report You can find additional information about the Fund at fundresearch.fidelity.com/prospectus/sec. You can also request this information by contacting us at 1-877-208-0098 or by sending an e-mail to fidfunddocuments@fidelity.com. fundresearch.fidelity.com/prospectus/sec 1-877-208-0098 fidfunddocuments@fidelity.com <span style="font-family:'Fidelity Sans';font-size:16px;color:#368627;font-style:normal;font-weight:bold;">What were your Fund costs for the last year?</span> <div style="text-align:left;text-align-last:auto;"><span style="font-family:'Fidelity Sans';font-size:11px;color:#000000;font-style:normal;font-weight:normal;">(based on hypothetical $10,000 investment)</span></div> <div><span style="font-size:11px;"> </span></div><div style="text-align:left;text-align-last:auto;"></div> <div style="text-align:left;text-align-last:auto;"><span style="font-family:'Fidelity Sans';font-size:12px;color:#000000;font-style:normal;font-weight:bold;">FUND COST (PREVIOUS YEAR)</span></div> <div style="text-align:left;text-align-last:auto;"></div> <div style="text-align:left;text-align-last:auto;"><table cellpadding="0" cellspacing="0" style="border-collapse:collapse;border-style:none;" width="100%"><tr><td style="width:51%; background-color:#dfe0e4;border:1px solid #dfe0e4;padding:0px 0px 0px 0px;" valign="bottom"><div style="text-align:left;text-align-last:auto;"><span style="font-family:'Fidelity Sans';font-size:11px;color:#000000;font-style:normal;font-weight:bold;"> </span></div> </td> <td style="width:21%; background-color:#dfe0e4;border:1px solid #dfe0e4;padding:0px 0px 0px 0px;" valign="bottom"><div style="text-align:center;text-align-last:auto;"><span style="font-family:'Fidelity Sans';font-size:11px;color:#000000;font-style:normal;font-weight:bold;">Costs of a $10,000 investment</span></div> </td> <td style="width:27%; background-color:#dfe0e4;border:1px solid #dfe0e4;padding:0px 0px 0px 0px;" valign="bottom"><div style="text-align:center;text-align-last:auto;"><span style="font-family:'Fidelity Sans';font-size:11px;color:#000000;font-style:normal;font-weight:bold;">Costs paid as a percentage of a $10,000 investment </span></div> </td> <td style="width:1%; " valign="top"><span style="line-height:12px;"> </span><div style="text-align:left;text-align-last:auto;"></div> </td> </tr> <tr><td style="width:51%; border-bottom:1px solid #000000;padding:0px 0px 0px 0px;" valign="top"><div style="text-align:left;text-align-last:auto;"><span style="font-family:'Fidelity Sans';font-size:12px;color:#000000;font-style:normal;font-weight:normal;">Class C</span><span style="font-family:'Fidelity Sans';font-size:11px;color:#000000;font-style:normal;font-weight:normal;"> </span></div> </td> <td style="width:21%; border-bottom:1px solid #000000;padding:0px 0px 0px 0px;" valign="middle"><div style="text-align:center;text-align-last:auto;"><span style="font-family:'Fidelity Sans';font-size:11px;color:#000000;font-style:normal;font-weight:normal;">$</span><span style="font-family:'Fidelity Sans';font-size:12px;color:#000000;font-style:normal;font-weight:normal;"> </span>195<span style="font-family:'Fidelity Sans';font-size:11px;color:#000000;font-style:normal;font-weight:normal;"> </span></div> </td> <td style="width:27%; border-bottom:1px solid #000000;padding:0px 0px 0px 0px;" valign="middle"><div style="text-align:center;text-align-last:auto;">1.70<span style="font-family:'Fidelity Sans';font-size:11px;color:#000000;font-style:normal;font-weight:normal;">%</span></div> </td> <td style="width:1%; " valign="top"><span style="line-height:12px;"> </span><div style="text-align:left;text-align-last:auto;"></div> </td> </tr> </table> </div> <div style="text-align:left;text-align-last:auto;"></div> 195 0.0170 <span style="font-family:'Fidelity Sans';font-size:16px;color:#368627;font-style:normal;font-weight:bold;">What affected the Fund's performance this period?</span> <div style="text-align:left;text-align-last:auto;"><span style="font-family:'Fidelity Sans';font-size:11px;color:#000000;font-style:normal;font-weight:bold;"> </span></div> <div style="text-align:left;text-align-last:auto;text-indent:-24px;margin-bottom:2px;margin-left:24px;margin-top:5px;margin-right:0px;"><span style="font-family:'Fidelity Sans';font-size:12px;color:#000000;font-style:normal;font-weight:normal;">•<span style="padding-right:10px"></span>U.S. stocks achieved a strong gain for the 12 months ending July 31, 2026, reflecting enthusiasm for artificial intelligence, strong corporate fundamentals, a resilient economy and, beginning in September, the Federal Reserve's first interest-rate reductions since December 2024.</span></div> <div style="text-align:left;text-align-last:auto;text-indent:-24px;margin-bottom:2px;margin-left:24px;margin-top:5px;margin-right:0px;"><span style="font-family:'Fidelity Sans';font-size:12px;color:#000000;font-style:normal;font-weight:normal;">•<span style="padding-right:10px"></span>Against this backdrop, security selection was the primary contributor to the fund's performance versus the MSCI U.S. IMI Health Care 25/50 Index for the fiscal year, led by biotechnology. Picks in pharmaceuticals and health care services also boosted the fund's relative performance.</span></div> <div style="text-align:left;text-align-last:auto;text-indent:-24px;margin-bottom:2px;margin-left:24px;margin-top:5px;margin-right:0px;"><span style="font-family:'Fidelity Sans';font-size:12px;color:#000000;font-style:normal;font-weight:normal;">•<span style="padding-right:10px"></span>The top individual relative contributor was our stake in Exact Sciences (+113%). The stock was not held at period end. Not owning Abbott Laboratories, an index component that returned roughly -14%, was a second notable relative contributor. An overweight in BrightSpring Health Services (+193%) also helped. This period we decreased our position in BrightSpring Health Services.</span></div> <div style="text-align:left;text-align-last:auto;text-indent:-24px;margin-bottom:2px;margin-left:24px;margin-top:5px;margin-right:0px;"><span style="font-family:'Fidelity Sans';font-size:12px;color:#000000;font-style:normal;font-weight:normal;">•<span style="padding-right:10px"></span>In contrast, the primary detractor from performance versus the sector index was an underweight in pharmaceuticals. Stock selection in health care equipment also hampered the fund's result. Also detracting from our result was an overweight in health care technology.</span></div> <div style="text-align:left;text-align-last:auto;text-indent:-24px;margin-bottom:2px;margin-left:24px;margin-top:5px;margin-right:0px;"><span style="font-family:'Fidelity Sans';font-size:12px;color:#000000;font-style:normal;font-weight:normal;">•<span style="padding-right:10px"></span>The largest individual relative detractor was an overweight in Boston Scientific (-55%). This period we decreased our stake in Boston Scientific. The company was one of the fund's largest holdings this period. A non-index stake in Legend Biotech returned -53% and was the second-largest relative detractor. This period we decreased our stake in Legend Biotech. Another notable relative detractor was an overweight in Alnylam Pharmaceuticals (-48%). The company was the fund's 11-th biggest holding this period.</span></div> <div style="text-align:left;text-align-last:auto;text-indent:-24px;margin-bottom:2px;margin-left:24px;margin-top:5px;margin-right:0px;"><span style="font-family:'Fidelity Sans';font-size:12px;color:#000000;font-style:normal;font-weight:normal;">•<span style="padding-right:10px"></span>Notable changes in positioning include increased exposure to the life sciences tools &amp; services and pharmaceuticals industries.</span></div> <div style="text-align:left;text-align-last:auto;"></div> How did the Fund perform over the past 10 years?    CUMULATIVE PERFORMANCE July 31, 2016 through July 31, 2026. Initial investment of $10,000. Class C $10,000 $10,868 $12,921 $13,193 $16,304 $19,529 $17,076 $17,576 $18,613 $17,422 $22,582 MSCI U.S. IMI Health Care 25-50 Index $10,000 $10,935 $12,626 $13,117 $15,713 $20,138 $19,492 $20,006 $22,558 $20,144 $25,886 S&P 500® Index $10,000 $11,604 $13,489 $14,566 $16,308 $22,251 $21,219 $23,980 $29,292 $34,076 $40,742   2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026   <span style="font-family:'Fidelity Sans';font-size:9px;color:#000000;font-style:normal;font-weight:normal;">Class C</span> 10000 10868 12921 13193 16304 19529 17076 17576 18613 17422 22582 <span style="font-family:'Fidelity Sans';font-size:9px;color:#000000;font-style:normal;font-weight:normal;">MSCI U.S. IMI Health Care 25-50 Index</span> 10000 10935 12626 13117 15713 20138 19492 20006 22558 20144 25886 <span style="font-family:'Fidelity Sans';font-size:9px;color:#000000;font-style:normal;font-weight:normal;">S&amp;P 500® Index</span> 10000 11604 13489 14566 16308 22251 21219 23980 29292 34076 40742 AVERAGE ANNUAL TOTAL RETURNS:   1 Year 5 Year 10 Year Class C  (incl. contingent deferred sales charge) 27.64% 2.64% 8.49% Class C 28.64% 2.64% 8.49% MSCI U.S. IMI Health Care 25-50 Index 28.51% 5.15% 9.98% S&P 500® Index 19.56% 12.86% 15.08%     Visit institutional.fidelity.com for more recent performance information.    The Fund's past performance is not a good predictor of the Fund's future performance.  The graph and table do not reflect the deduction of taxes that a shareholder would pay on fund distributions or redemption of fund shares. 0.2764 0.0264 0.0849 0.2864 0.0264 0.0849 0.2851 0.0515 0.0998 0.1956 0.1286 0.1508 <span style="font-family:'Fidelity Sans';font-size:11px;color:#000000;font-style:normal;font-weight:normal;">Visit </span><span style="font-family:'Fidelity Sans';font-size:11px;color:#000000;font-style:normal;font-weight:bold;">institutional.fidelity.com</span><span style="font-family:'Fidelity Sans';font-size:11px;color:#000000;font-style:normal;font-weight:normal;"> for more recent performance information.</span> <span style="font-family:'Fidelity Sans';font-size:11px;color:#000000;font-style:italic;font-weight:normal;">The Fund's past performance is not a good predictor of the Fund's future performance.</span> <span style="font-family:'Fidelity Sans';font-size:11px;color:#000000;font-style:normal;font-weight:normal;">The graph and table do not reflect the deduction of taxes that a shareholder would pay on fund distributions or redemption of fund shares.</span> <span style="font-family:'Fidelity Sans';font-size:16px;color:#368627;font-style:normal;font-weight:bold;">Key Fund Statistics</span> <div style="text-align:left;text-align-last:auto;"></div> <div style="text-align:left;text-align-last:auto;"><span style="font-family:'Fidelity Sans';font-size:11px;color:#000000;font-style:normal;font-weight:normal;">(as of July 31, 2026)</span></div> <div><span style="font-size:11px;"> </span></div><div style="text-align:left;text-align-last:auto;"></div> <div style="text-align:right;text-align-last:auto;"><table cellpadding="0" cellspacing="1" style="border-collapse:separate;border-style:none;margin:auto;" width="100%"><tr><td style="width:63%; " valign="top"><div style="text-align:left;text-align-last:auto;"><span style="font-family:'Fidelity Sans';font-size:12px;color:#000000;font-style:normal;font-weight:bold;">KEY FACTS</span></div> <div style="text-align:left;text-align-last:auto;"></div> <div style="text-align:left;text-align-last:auto;"><span style="font-family:'Fidelity Sans';font-size:11px;color:#000000;font-style:normal;font-weight:bold;"> <span> </span></span></div> <div style="text-align:left;text-align-last:auto;"></div> </td> <td style="width:32%; " valign="top"><span style="line-height:12px;"> </span><div style="text-align:left;text-align-last:auto;"></div> </td> <td style="width:5%; " valign="top"><span style="line-height:12px;"> </span><div style="text-align:left;text-align-last:auto;"></div> </td> </tr> <tr><td style="width:63%; border-bottom:1px dashed #000000;padding:0px 0px 0px 0px;" valign="middle"><div style="text-align:left;text-align-last:auto;"><span style="font-family:'Fidelity Sans';font-size:11px;color:#000000;font-style:normal;font-weight:normal;">Fund Size</span></div> </td> <td style="width:32%; border-bottom:1px dashed #000000;padding:0px 0px 0px 0px;" valign="middle"><div style="text-align:right;text-align-last:auto;"><span style="font-family:'Fidelity Sans';font-size:11px;color:#000000;font-style:normal;font-weight:normal;">$</span>3,117,289,219</div> <div style="text-align:right;text-align-last:auto;"></div> </td> <td style="width:5%; " valign="top"><span style="line-height:11px;"> </span><div style="text-align:left;text-align-last:auto;"></div> </td> </tr> <tr><td style="width:63%; border-bottom:1px dashed #000000;padding:0px 0px 0px 0px;" valign="middle"><div style="text-align:left;text-align-last:auto;"><span style="font-family:'Fidelity Sans';font-size:11px;color:#000000;font-style:normal;font-weight:normal;">Number of Holdings</span></div> </td> <td style="width:32%; border-bottom:1px dashed #000000;padding:0px 0px 0px 0px;" valign="middle"><div style="text-align:right;text-align-last:auto;">138</div> <div style="text-align:right;text-align-last:auto;"></div> </td> <td style="width:5%; " valign="top"><span style="line-height:11px;"> </span><div style="text-align:left;text-align-last:auto;"></div> </td> </tr> <tr><td style="width:63%; border-bottom:1px dashed #000000;padding:0px 0px 0px 0px;" valign="middle"><div style="text-align:left;text-align-last:auto;"><span style="font-family:'Fidelity Sans';font-size:11px;color:#000000;font-style:normal;font-weight:normal;">Total Advisory Fee</span></div> </td> <td style="width:32%; border-bottom:1px dashed #000000;padding:0px 0px 0px 0px;" valign="middle"><div style="text-align:right;text-align-last:auto;"><span style="font-family:'Fidelity Sans';font-size:11px;color:#000000;font-style:normal;font-weight:normal;">$</span>20,416,822</div> <div style="text-align:right;text-align-last:auto;"></div> </td> <td style="width:5%; " valign="middle"><span style="line-height:11px;"> </span><div style="text-align:left;text-align-last:auto;"></div> </td> </tr> <tr><td style="width:63%; border-bottom:1px dashed #000000;padding:0px 0px 0px 0px;" valign="middle"><div style="text-align:left;text-align-last:auto;"><span style="font-family:'Fidelity Sans';font-size:11px;color:#000000;font-style:normal;font-weight:normal;">Portfolio Turnover</span></div> </td> <td style="width:32%; border-bottom:1px dashed #000000;padding:0px 0px 0px 0px;" valign="middle"><div style="text-align:right;text-align-last:auto;">74<span style="font-family:'Fidelity Sans';font-size:11px;color:#000000;font-style:normal;font-weight:normal;">%</span></div> <div style="text-align:left;text-align-last:auto;"></div> </td> <td style="width:5%; " valign="top"><span style="line-height:11px;"> </span><div style="text-align:left;text-align-last:auto;"></div> </td> </tr> </table> </div> <div style="text-align:left;text-align-last:auto;"></div> 3117289219 138 20416822 0.74       TOP INDUSTRIES (% of Fund's net assets) Biotechnology 37.8   Life Sciences Tools & Services 24.0   Pharmaceuticals 23.4   Health Care Providers & Services 10.0   Health Care Equipment & Supplies 3.4   Health Care Technology 0.6   Chemicals 0.1   Financial Services 0.1       Common Stocks 97.3 Preferred Stocks 2.1 Bonds 0.2 Short-Term Investments and Net Other Assets (Liabilities) 0.4 ASSET ALLOCATION (% of Fund's net assets)     Common Stocks - 97.3                       Preferred Stocks - 2.1                     Bonds - 0.2                                Short-Term Investments and Net Other Assets (Liabilities) - 0.4   United States 91.5 Netherlands 2.9 Denmark 2.0 Belgium 1.3 Canada 0.9 France 0.8 United Kingdom 0.3 Israel 0.2 Australia 0.1 China 0.0 GEOGRAPHIC DIVERSIFICATION (% of Fund's net assets)     United States - 91.5                       Netherlands - 2.9                          Denmark - 2.0                              Belgium - 1.3                              Canada - 0.9                               France - 0.8                               United Kingdom - 0.3                       Israel - 0.2                               Australia - 0.1                            China - 0.0                                    0.378 0.240 0.234 0.100 0.034 0.006 0.001 0.001 0.973 0.021 0.002 0.004 0.915 0.029 0.020 0.013 0.009 0.008 0.003 0.002 0.001 0.000 TOP HOLDINGS(% of Fund's net assets)     Eli Lilly & Co 7.7   Danaher Corp 6.8   Thermo Fisher Scientific Inc 6.4   UnitedHealth Group Inc 4.2   Johnson & Johnson 3.8   AbbVie Inc 3.6   West Pharmaceutical Services Inc 2.1   Argenx SE ADR 2.1   Merck & Co Inc 2.1   Ascendis Pharma A/S 2.0     40.8   0.077 0.068 0.064 0.042 0.038 0.036 0.021 0.021 0.021 0.020 2026-07-31 Fidelity Advisor® Health Care Fund Fidelity Advisor® Health Care Fund Class A FACDX This annual shareholder report contains information about Fidelity Advisor® Health Care Fund for the period August 1, 2025 to July 31, 2026. annual shareholder report You can find additional information about the Fund at fundresearch.fidelity.com/prospectus/sec. You can also request this information by contacting us at 1-877-208-0098 or by sending an e-mail to fidfunddocuments@fidelity.com. fundresearch.fidelity.com/prospectus/sec 1-877-208-0098 fidfunddocuments@fidelity.com <span style="font-family:'Fidelity Sans';font-size:16px;color:#368627;font-style:normal;font-weight:bold;">What were your Fund costs for the last year?</span> <div style="text-align:left;text-align-last:auto;"><span style="font-family:'Fidelity Sans';font-size:11px;color:#000000;font-style:normal;font-weight:normal;">(based on hypothetical $10,000 investment)</span></div> <div><span style="font-size:11px;"> </span></div><div style="text-align:left;text-align-last:auto;"></div> <div style="text-align:left;text-align-last:auto;"><span style="font-family:'Fidelity Sans';font-size:12px;color:#000000;font-style:normal;font-weight:bold;">FUND COST (PREVIOUS YEAR)</span></div> <div style="text-align:left;text-align-last:auto;"></div> <div style="text-align:left;text-align-last:auto;"><table cellpadding="0" cellspacing="0" style="border-collapse:collapse;border-style:none;" width="100%"><tr><td style="width:51%; background-color:#dfe0e4;border:1px solid #dfe0e4;padding:0px 0px 0px 0px;" valign="bottom"><div style="text-align:left;text-align-last:auto;"><span style="font-family:'Fidelity Sans';font-size:11px;color:#000000;font-style:normal;font-weight:bold;"> </span></div> </td> <td style="width:21%; background-color:#dfe0e4;border:1px solid #dfe0e4;padding:0px 0px 0px 0px;" valign="bottom"><div style="text-align:center;text-align-last:auto;"><span style="font-family:'Fidelity Sans';font-size:11px;color:#000000;font-style:normal;font-weight:bold;">Costs of a $10,000 investment</span></div> </td> <td style="width:27%; background-color:#dfe0e4;border:1px solid #dfe0e4;padding:0px 0px 0px 0px;" valign="bottom"><div style="text-align:center;text-align-last:auto;"><span style="font-family:'Fidelity Sans';font-size:11px;color:#000000;font-style:normal;font-weight:bold;">Costs paid as a percentage of a $10,000 investment </span></div> </td> <td style="width:1%; " valign="top"><span style="line-height:12px;"> </span><div style="text-align:left;text-align-last:auto;"></div> </td> </tr> <tr><td style="width:51%; border-bottom:1px solid #000000;padding:0px 0px 0px 0px;" valign="top"><div style="text-align:left;text-align-last:auto;"><span style="font-family:'Fidelity Sans';font-size:12px;color:#000000;font-style:normal;font-weight:normal;">Class A</span><span style="font-family:'Fidelity Sans';font-size:11px;color:#000000;font-style:normal;font-weight:normal;"> </span></div> </td> <td style="width:21%; border-bottom:1px solid #000000;padding:0px 0px 0px 0px;" valign="middle"><div style="text-align:center;text-align-last:auto;"><span style="font-family:'Fidelity Sans';font-size:11px;color:#000000;font-style:normal;font-weight:normal;">$</span><span style="font-family:'Fidelity Sans';font-size:12px;color:#000000;font-style:normal;font-weight:normal;"> </span>110<span style="font-family:'Fidelity Sans';font-size:11px;color:#000000;font-style:normal;font-weight:normal;"> </span></div> </td> <td style="width:27%; border-bottom:1px solid #000000;padding:0px 0px 0px 0px;" valign="middle"><div style="text-align:center;text-align-last:auto;">0.96<span style="font-family:'Fidelity Sans';font-size:11px;color:#000000;font-style:normal;font-weight:normal;">%</span></div> </td> <td style="width:1%; " valign="top"><span style="line-height:12px;"> </span><div style="text-align:left;text-align-last:auto;"></div> </td> </tr> </table> </div> <div style="text-align:left;text-align-last:auto;"></div> 110 0.0096 <span style="font-family:'Fidelity Sans';font-size:16px;color:#368627;font-style:normal;font-weight:bold;">What affected the Fund's performance this period?</span> <div style="text-align:left;text-align-last:auto;"><span style="font-family:'Fidelity Sans';font-size:11px;color:#000000;font-style:normal;font-weight:bold;"> </span></div> <div style="text-align:left;text-align-last:auto;text-indent:-24px;margin-bottom:2px;margin-left:24px;margin-top:5px;margin-right:0px;"><span style="font-family:'Fidelity Sans';font-size:12px;color:#000000;font-style:normal;font-weight:normal;">•<span style="padding-right:10px"></span>U.S. stocks achieved a strong gain for the 12 months ending July 31, 2026, reflecting enthusiasm for artificial intelligence, strong corporate fundamentals, a resilient economy and, beginning in September, the Federal Reserve's first interest-rate reductions since December 2024.</span></div> <div style="text-align:left;text-align-last:auto;text-indent:-24px;margin-bottom:2px;margin-left:24px;margin-top:5px;margin-right:0px;"><span style="font-family:'Fidelity Sans';font-size:12px;color:#000000;font-style:normal;font-weight:normal;">•<span style="padding-right:10px"></span>Against this backdrop, security selection was the primary contributor to the fund's performance versus the MSCI U.S. IMI Health Care 25/50 Index for the fiscal year, led by biotechnology. Picks in pharmaceuticals and health care services also boosted the fund's relative performance.</span></div> <div style="text-align:left;text-align-last:auto;text-indent:-24px;margin-bottom:2px;margin-left:24px;margin-top:5px;margin-right:0px;"><span style="font-family:'Fidelity Sans';font-size:12px;color:#000000;font-style:normal;font-weight:normal;">•<span style="padding-right:10px"></span>The top individual relative contributor was our stake in Exact Sciences (+113%). The stock was not held at period end. Not owning Abbott Laboratories, an index component that returned roughly -14%, was a second notable relative contributor. An overweight in BrightSpring Health Services (+193%) also helped. This period we decreased our position in BrightSpring Health Services.</span></div> <div style="text-align:left;text-align-last:auto;text-indent:-24px;margin-bottom:2px;margin-left:24px;margin-top:5px;margin-right:0px;"><span style="font-family:'Fidelity Sans';font-size:12px;color:#000000;font-style:normal;font-weight:normal;">•<span style="padding-right:10px"></span>In contrast, the primary detractor from performance versus the sector index was an underweight in pharmaceuticals. Stock selection in health care equipment also hampered the fund's result. Also detracting from our result was an overweight in health care technology.</span></div> <div style="text-align:left;text-align-last:auto;text-indent:-24px;margin-bottom:2px;margin-left:24px;margin-top:5px;margin-right:0px;"><span style="font-family:'Fidelity Sans';font-size:12px;color:#000000;font-style:normal;font-weight:normal;">•<span style="padding-right:10px"></span>The largest individual relative detractor was an overweight in Boston Scientific (-55%). This period we decreased our stake in Boston Scientific. The company was one of the fund's largest holdings this period. A non-index stake in Legend Biotech returned -53% and was the second-largest relative detractor. This period we decreased our stake in Legend Biotech. Another notable relative detractor was an overweight in Alnylam Pharmaceuticals (-48%). The company was the fund's 11-th biggest holding this period.</span></div> <div style="text-align:left;text-align-last:auto;text-indent:-24px;margin-bottom:2px;margin-left:24px;margin-top:5px;margin-right:0px;"><span style="font-family:'Fidelity Sans';font-size:12px;color:#000000;font-style:normal;font-weight:normal;">•<span style="padding-right:10px"></span>Notable changes in positioning include increased exposure to the life sciences tools &amp; services and pharmaceuticals industries.</span></div> <div style="text-align:left;text-align-last:auto;"></div> How did the Fund perform over the past 10 years?    CUMULATIVE PERFORMANCE July 31, 2016 through July 31, 2026. Initial investment of $10,000 and the current sales charge was paid. Class A $9,425 $10,317 $12,361 $12,716 $15,831 $19,108 $16,833 $17,459 $18,625 $17,433 $22,597 MSCI U.S. IMI Health Care 25-50 Index $10,000 $10,935 $12,626 $13,117 $15,713 $20,138 $19,492 $20,006 $22,558 $20,144 $25,886 S&P 500® Index $10,000 $11,604 $13,489 $14,566 $16,308 $22,251 $21,219 $23,980 $29,292 $34,076 $40,742   2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026   <span style="font-family:'Fidelity Sans';font-size:9px;color:#000000;font-style:normal;font-weight:normal;">Class A</span> 9425 10317 12361 12716 15831 19108 16833 17459 18625 17433 22597 <span style="font-family:'Fidelity Sans';font-size:9px;color:#000000;font-style:normal;font-weight:normal;">MSCI U.S. IMI Health Care 25-50 Index</span> 10000 10935 12626 13117 15713 20138 19492 20006 22558 20144 25886 <span style="font-family:'Fidelity Sans';font-size:9px;color:#000000;font-style:normal;font-weight:normal;">S&amp;P 500® Index</span> 10000 11604 13489 14566 16308 22251 21219 23980 29292 34076 40742 AVERAGE ANNUAL TOTAL RETURNS:   1 Year 5 Year 10 Year Class A (incl. 5.75% sales charge)   22.17% 2.19% 8.49% Class A (without 5.75% sales charge) 29.62% 3.41% 9.14% MSCI U.S. IMI Health Care 25-50 Index 28.51% 5.15% 9.98% S&P 500® Index 19.56% 12.86% 15.08%     Visit institutional.fidelity.com for more recent performance information.    The Fund's past performance is not a good predictor of the Fund's future performance.  The graph and table do not reflect the deduction of taxes that a shareholder would pay on fund distributions or redemption of fund shares. 0.2217 0.0219 0.0849 0.2962 0.0341 0.0914 0.2851 0.0515 0.0998 0.1956 0.1286 0.1508 <span style="font-family:'Fidelity Sans';font-size:11px;color:#000000;font-style:normal;font-weight:normal;">Visit </span><span style="font-family:'Fidelity Sans';font-size:11px;color:#000000;font-style:normal;font-weight:bold;">institutional.fidelity.com</span><span style="font-family:'Fidelity Sans';font-size:11px;color:#000000;font-style:normal;font-weight:normal;"> for more recent performance information.</span> <span style="font-family:'Fidelity Sans';font-size:11px;color:#000000;font-style:italic;font-weight:normal;">The Fund's past performance is not a good predictor of the Fund's future performance.</span> <span style="font-family:'Fidelity Sans';font-size:11px;color:#000000;font-style:normal;font-weight:normal;">The graph and table do not reflect the deduction of taxes that a shareholder would pay on fund distributions or redemption of fund shares.</span> <span style="font-family:'Fidelity Sans';font-size:16px;color:#368627;font-style:normal;font-weight:bold;">Key Fund Statistics</span> <div style="text-align:left;text-align-last:auto;"></div> <div style="text-align:left;text-align-last:auto;"><span style="font-family:'Fidelity Sans';font-size:11px;color:#000000;font-style:normal;font-weight:normal;">(as of July 31, 2026)</span></div> <div><span style="font-size:11px;"> </span></div><div style="text-align:left;text-align-last:auto;"></div> <div style="text-align:right;text-align-last:auto;"><table cellpadding="0" cellspacing="1" style="border-collapse:separate;border-style:none;margin:auto;" width="100%"><tr><td style="width:63%; " valign="top"><div style="text-align:left;text-align-last:auto;"><span style="font-family:'Fidelity Sans';font-size:12px;color:#000000;font-style:normal;font-weight:bold;">KEY FACTS</span></div> <div style="text-align:left;text-align-last:auto;"></div> <div style="text-align:left;text-align-last:auto;"><span style="font-family:'Fidelity Sans';font-size:11px;color:#000000;font-style:normal;font-weight:bold;"> <span> </span></span></div> <div style="text-align:left;text-align-last:auto;"></div> </td> <td style="width:32%; " valign="top"><span style="line-height:12px;"> </span><div style="text-align:left;text-align-last:auto;"></div> </td> <td style="width:5%; " valign="top"><span style="line-height:12px;"> </span><div style="text-align:left;text-align-last:auto;"></div> </td> </tr> <tr><td style="width:63%; border-bottom:1px dashed #000000;padding:0px 0px 0px 0px;" valign="middle"><div style="text-align:left;text-align-last:auto;"><span style="font-family:'Fidelity Sans';font-size:11px;color:#000000;font-style:normal;font-weight:normal;">Fund Size</span></div> </td> <td style="width:32%; border-bottom:1px dashed #000000;padding:0px 0px 0px 0px;" valign="middle"><div style="text-align:right;text-align-last:auto;"><span style="font-family:'Fidelity Sans';font-size:11px;color:#000000;font-style:normal;font-weight:normal;">$</span>3,117,289,219</div> <div style="text-align:right;text-align-last:auto;"></div> </td> <td style="width:5%; " valign="top"><span style="line-height:11px;"> </span><div style="text-align:left;text-align-last:auto;"></div> </td> </tr> <tr><td style="width:63%; border-bottom:1px dashed #000000;padding:0px 0px 0px 0px;" valign="middle"><div style="text-align:left;text-align-last:auto;"><span style="font-family:'Fidelity Sans';font-size:11px;color:#000000;font-style:normal;font-weight:normal;">Number of Holdings</span></div> </td> <td style="width:32%; border-bottom:1px dashed #000000;padding:0px 0px 0px 0px;" valign="middle"><div style="text-align:right;text-align-last:auto;">138</div> <div style="text-align:right;text-align-last:auto;"></div> </td> <td style="width:5%; " valign="top"><span style="line-height:11px;"> </span><div style="text-align:left;text-align-last:auto;"></div> </td> </tr> <tr><td style="width:63%; border-bottom:1px dashed #000000;padding:0px 0px 0px 0px;" valign="middle"><div style="text-align:left;text-align-last:auto;"><span style="font-family:'Fidelity Sans';font-size:11px;color:#000000;font-style:normal;font-weight:normal;">Total Advisory Fee</span></div> </td> <td style="width:32%; border-bottom:1px dashed #000000;padding:0px 0px 0px 0px;" valign="middle"><div style="text-align:right;text-align-last:auto;"><span style="font-family:'Fidelity Sans';font-size:11px;color:#000000;font-style:normal;font-weight:normal;">$</span>20,416,822</div> <div style="text-align:right;text-align-last:auto;"></div> </td> <td style="width:5%; " valign="middle"><span style="line-height:11px;"> </span><div style="text-align:left;text-align-last:auto;"></div> </td> </tr> <tr><td style="width:63%; border-bottom:1px dashed #000000;padding:0px 0px 0px 0px;" valign="middle"><div style="text-align:left;text-align-last:auto;"><span style="font-family:'Fidelity Sans';font-size:11px;color:#000000;font-style:normal;font-weight:normal;">Portfolio Turnover</span></div> </td> <td style="width:32%; border-bottom:1px dashed #000000;padding:0px 0px 0px 0px;" valign="middle"><div style="text-align:right;text-align-last:auto;">74<span style="font-family:'Fidelity Sans';font-size:11px;color:#000000;font-style:normal;font-weight:normal;">%</span></div> <div style="text-align:left;text-align-last:auto;"></div> </td> <td style="width:5%; " valign="top"><span style="line-height:11px;"> </span><div style="text-align:left;text-align-last:auto;"></div> </td> </tr> </table> </div> <div style="text-align:left;text-align-last:auto;"></div> 3117289219 138 20416822 0.74       TOP INDUSTRIES (% of Fund's net assets) Biotechnology 37.8   Life Sciences Tools & Services 24.0   Pharmaceuticals 23.4   Health Care Providers & Services 10.0   Health Care Equipment & Supplies 3.4   Health Care Technology 0.6   Chemicals 0.1   Financial Services 0.1       Common Stocks 97.3 Preferred Stocks 2.1 Bonds 0.2 Short-Term Investments and Net Other Assets (Liabilities) 0.4 ASSET ALLOCATION (% of Fund's net assets)     Common Stocks - 97.3                       Preferred Stocks - 2.1                     Bonds - 0.2                                Short-Term Investments and Net Other Assets (Liabilities) - 0.4   United States 91.5 Netherlands 2.9 Denmark 2.0 Belgium 1.3 Canada 0.9 France 0.8 United Kingdom 0.3 Israel 0.2 Australia 0.1 China 0.0 GEOGRAPHIC DIVERSIFICATION (% of Fund's net assets)     United States - 91.5                       Netherlands - 2.9                          Denmark - 2.0                              Belgium - 1.3                              Canada - 0.9                               France - 0.8                               United Kingdom - 0.3                       Israel - 0.2                               Australia - 0.1                            China - 0.0                                    0.378 0.240 0.234 0.100 0.034 0.006 0.001 0.001 0.973 0.021 0.002 0.004 0.915 0.029 0.020 0.013 0.009 0.008 0.003 0.002 0.001 0.000 TOP HOLDINGS(% of Fund's net assets)     Eli Lilly & Co 7.7   Danaher Corp 6.8   Thermo Fisher Scientific Inc 6.4   UnitedHealth Group Inc 4.2   Johnson & Johnson 3.8   AbbVie Inc 3.6   West Pharmaceutical Services Inc 2.1   Argenx SE ADR 2.1   Merck & Co Inc 2.1   Ascendis Pharma A/S 2.0     40.8   0.077 0.068 0.064 0.042 0.038 0.036 0.021 0.021 0.021 0.020